A few notes about viewing Plunkett Research books in PDF format… • • • • •
When in Adobe Acrobat Reader, press the [F5] key on your keyboard to display a list of "bookmarks," which are a very thorough table of contents with links to pages within the PDF. Click a bookmark to jump to a particular chapter, table or section. For easiest viewing, increase or decrease the zoom percentage (lower left corner of the page window) as necessary. Press the [F5] key again to hide the list of bookmarks as necessary. In order to use this PDF, you must agree to the terms of the End User License Agreement that follows on page 9 of this PDF.
A few notes about the following pages… • • • • •
The pages immediately following tell you more about our book titles and how to purchase them. We suggest you print out the Customer Support form on the next page and fax it to us at 713.932.7080. You will receive a free CD-ROM version of this book's database of companies. To order other books, print the order form on page 7 of this PDF and fax it to 713.932.7080 or visit our website at www.plunkettresearch.com. The book in its entirety begins on or about page 8 of this PDF. Thank you for interest.
Plunkett’s 2003-2004 Books / CD-ROMS / eBooks in PDF / Online Subscriptions Trends, Statistics Market Research and Industry Analysis in:
Your key to Business & Looking for a job? Industry Research Doing market research?
• Advertising & Branding - NEW
• Apparel & Textiles - NEW Looking for business prospects? • Consulting Industry - NEW • Nanotechnology - NEW Writing a business plan? • Real Estate &
Planning a business strategy?
Plunkett Research, Ltd. When You Need Accurate, Timely, Innovative Information
www.plunkettresearch.com 713.932.0000
•
Construction - NEW Transportation & Logistics - NEW
• Airline, Hotel & Travel • Automobile • Computers & Internet • Energy • Consulting Industry • Engineering & Research • Entertainment & Media • Food • Health Care & Biotech • Job Seekers & Careers • Retail • Telecommunications
• Looking for a job? • Doing market research? • Looking for business
prospects? • Writing a business plan? • Planning a business strategy? Get Market Research, Industry Analysis and Corporate Profiles in One Resource! Each exciting industry title contains all of the information you need to fully understand the trends, technologies, finances and leading companies of a specific industry. Whatever field you are researching, from InfoTech to Energy to Retailing, you’ll find all of the answers you need in one value-packed, industry-specific resource.
Get Reference Titles Packed with 400 to 700 Pages of Valuable Information! Here’s what you’ll find inside each industry book: • Glossary • Industry Overview and Trends • Segment by Segment Analysis • Statistics, Charts, Tables • Technology and Research Trends • Industry Contacts and Associations • Finances • Profiles of Hundreds of Leading Companies • Thorough Indexes and Cross-Indexes
More Industry Reference Books Coming Soon! Now accepting pre-publications order for: Plunkett’s Consulting Industry Almanac 1-593920-02-4 $249.99 APPROX. PUBLICATION DATE: NOV. 2003 INCLUDES CD-ROM
Covers the prestigious consulting industry from one end to the other. Statistics, trends, mergers, finances. Includes profiles of the Consulting Industry 300 Firms, the leading companies providing consulting in marketing, information technology, management, manufacturing, health care and more.
Plunkett’s Real Estate & Construction Industry Almanac 1-593920-03-2 $249.99 APPROX. PUBLICATION DATE: JAN. 2004 INCLUDES CD-ROM
Provides detailed analysis and statistics of all facets of this industry, including architecture, engineering, property management, finance, operations, mortgages, REITs, brokerage, construction and development. Profiles of the leading 300 firms.
Plunkett’s Nanotechnology & MEMS Industry Almanac 1-593920-04-0 $249.99 APPROX. PUBLICATION DATE: MAR. 2004 INCLUDES CD-ROM
This exciting new industry will enhance technologies of all types. Nanotech has applications within biotechnology, manufacturing, aerospace and information systems. This book covers micro-electro-mechanical (MEMS), microengineering, microsystems, microsensors, carbon tubes and much more. Trends, finances and profiles of the 300 leading firms.
Plunkett’s Advertising & Branding Industry Almanac 1-593920-05-9 $249.99 APPROX. PUBLICATION DATE: JUN. 2004 INCLUDES CD-ROM
Vital to businesses of all types, advertising and branding are covered in-depth in this important volume, from media to direct mail, from online advertising to branding and image. Analysis of trends, globalization, technologies, finances and more. Profiles of the 300 leading companies.
Plunkett’s Apparel & Textiles Industry Almanac
Get Detailed Profiles and Useable Information on Hundreds of Leading Firms: • Leading Companies Profiled and Ranked by Sales and Profits • Thorough Business Descriptions • Up to 24 Executive Contacts per Company • Address, Phone, Fax, Web Sites • Growth Plans • Competitive Advantage Statements • Salaries, Benefits and Hiring Plans • Divisions and Subsidiaries
1-593920-06-7 $249.99 APPROX. PUBLICATION DATE: JUL. 2004 INCLUDES CD-ROM
An exciting, global industry, apparel and textiles are covered indepth in this book, from clothing, shoes and accessories to designers, retail stores and manufacturers. Statistics, trends and market analysis. Profiles of the 300 leading firms.
Plunkett’s Transportation & Logistics Industry Almanac 1-593920-07-5 $249.99 APPROX. PUBLICATION DATE: SEP. 2004 INCLUDES CD-ROM
This immense, global sector is vital to all businesses. This book covers exciting trends in supply chain and logistics management, transportation, intermodal shipment systems and advanced technologies. Market analysis, statistics and trends. Profiles of the 300 leading firms.
www.plunkettresearch.com
713.932.0000
TRAVEL & AIRLINES
ENGINEERING & RESEARCH
FINANCE & INVESTMENTS
Plunkett’s Airline, Hotel & Travel Industry Almanac
Plunkett’s Engineering & Research Industry Almanac 2003-2004
Plunkett’s Financial Services Industry Almanac 2002-2003
1-891775-74-X $249.99 NOVEMBER 2002 INCLUDES CD-ROM
450 pg. The only complete reference to the global travel industry, including airlines, hotels, tour operators; travel agencies; e-commerce firms, cruise lines and car rentals. Includes a trends analysis, glossary, statistics, industry contacts, thorough indexes and in-depth profiles of the 300 leading companies in the industry.
AUTOMOBILE Plunkett’s Automobile Industry Almanac 1-891775-76-6 $249.99 MARCH 2003 INCLUDES CD-ROM
412 pg. A key reference tool. Provides industry analysis, statistical tables, an automobile industry glossary, industry contacts, thorough indexes and in-depth profiles of the 300 leading automotive industry firms.
1-891775-24-3 $249.99 JULY 2003 INCLUDES CD-ROM
680 pg. Profiles of 500 leading corporations in research, engineering and development in biotech, electronics, aerospace, medicine. "...The convenience for a typical user makes this volume very attractive for the support of job-seekers and investors." – American Reference Books Annual
RETAIL Plunkett’s Retail Industry Almanac 2003 1-891775-55-3 $229.99 ANNUAL EDITION DEC 2002 INCLUDES CD-ROM
540 pg. Thorough analysis of trends, careers, suppliers, finances, shopping centers and Internet-based retailing. Profiles of 400 leading, fast-growing retailers of all types. “Consider this reference essential...covering everything from malls and superstores to mail order business.” – Midwest Book Review
FOOD & BEVERAGE
COMPUTERS & INTERNET
Plunkett’s Food industry Almanac
Plunkett’s E-Commerce & Internet Business Almanac 2003-2004
1-891775-75-8 $249.99 MAY 2003 INCLUDES CD-ROM
450 pg. Covers the entire food and beverage industry, including food producers, retailers, technologies and distributors. Provides a thorough market analysis, dozens of statistical tables, glossary, contacts, and profiles of the 340 leading companies in the global food industry.
HEALTH CARE & BIOTECH Plunkett’s Health Care Industry Almanac 2003 1-891775-54-5 $229.99 ANNUAL EDITION SEPT 2002 INCLUDES CD-ROM
716 pg. The only complete reference to the American health care industry. Profiles of the Health Care 500 firms. Academic Book of the Year Award Winner.
1-891775-58-8 $249.99 JUNE 2003 INCLUDES CD-ROM
500 pg. Complete access to the exploding Internet business. Profiles of leading corporations in e-commerce, equipment, Internet services and more.
713 pg. Profiles of 500 leading corporations in banking, insurance, mortgages, online finance, credit cards, investments, stocks. “Well researched and presented...excellent value in terms of information versus cost.” – American Reference Book Annual
Plunkett’s Online Trading, Finance & Investment Web Sites Almanac 1-891775-08-1 $149.99 JAN 2000 INCLUDES DISKETTE
547 pg. Save countless hours in your research for data on investments, stocks, bonds, commodities, banking, mortgages, economics, trends and more. Complete profiles of the 211 most vital web sites for investors and financial professionals. "Contains an abundance of useful information." – Journal of Business & Finance Librarianship
ENTERTAINMENT & MEDIA Plunkett’s Entertainment & Media Industry Almanac 2002-2003 1-891775-27-8 $229.99 MAY 2002 INCLUDES CD-ROM
515 pg. Profiles of 350 leading firms in film, radio, TV, cable, multimedia, magazines, books, newspapers and online publishing.
“Unique, well-researched.” – CHOICE Magazine
“A critically important reference.” – Midwest Book Review
Plunkett’s InfoTech Industry Almanac 2003
ENERGY
1-891775-57-X $229.99 ANNUAL EDITION APRIL 2003 INCLUDES CD-ROM
640 pg. In-depth analysis of the InfoTech Revolution. Profiles of the InfoTech 500 firms in computers, software, online, systems integration, networking and more. "Intriguing reference...interesting articles on the industry's trends." – Library Journal
"Highly recommended..." – CHOICE Magazine
TELECOMMUNICATIONS
Plunkett’s Biotech & Genetics Industry Almanac 2003-2004
Plunkett’s Telecommunications Industry Almanac 2003-2004
1-891775-28-6 $249.99 FEB 2003 INCLUDES CD-ROM
1-891775-22-7 $249.99 JULY 2002 INCLUDES CD-ROM
522 pg. Your guide to the technologies revolutionizing health care. Research, growth companies, proteomics, genomics. Vital details on the Biotech 400 firms.
533 pg. Complete guide to the rapidly evolving telecommunications industry. Profiles of leading firms in wireless, long-distance, networks, local service.
“For business researchers and job seekers, this almanac provides an overview of leading biotechnology firms and descriptions of emerging technology.” – CHOICE Magazine
1-891775-23-5 $229.99 MAR 2002 INCLUDES CD-ROM
“Essential for long-term business analysis and industry trends.” – Midwest Book Review
Plunkett’s Energy Industry Almanac 2002-2003 1-891775-20-0 $199.99 JULY 2001 INCLUDES CD-ROM
570 pg. Covers everything from major oil companies to electric and gas utilities, plus pipelines, refiners/retailers, oil field services and alternative energy. Profiles of Plunkett’s Energy 400 firms. “This impressive reference compendium covers all facets of the American energy industry...exhaustively researched...” – Midwest Book Review
Order Today! 713.932.0000 www.plunkettresearch.com
JOB SEEKERS & CAREERS Plunkett’s Employers’ Internet Sites with Careers Information 2002-2003
Each book comes with a complete database on CD-ROM...FREE.
1-891775-19-7 $199.99 JAN 2002 INCLUDES CD-ROM
• The CD-ROM database
696 pg. Profiles 500 Internet sites operated by major employers. Locate web sites with job openings and the ability to apply online. Saves countless hours of research. Indexes include international posts, internships, physically challenged and type of career.
will enable you to search by company, industry, sales, location and keywords • Create and print your own mailing lists addressed to the CEO, Humans Resources V.P. or 24 other executives by title • Build your own spread sheets and databases • Find each company’s website
“(It) will become a core addition to career centers and libraries everywhere...” – Joyce Lain Kennedy, columnist
The Almanac of American Employers 2003 1-891775-56-1 $199.99 ANNUAL EDITION DEC 2002 INCLUDES CD-ROM
718 pg. Fully updated for the job seeker and researcher. Includes salaries, benefits, corporate culture, special hiring/training programs, women and minorities in top posts, contacts. Profiles The American Employers 500. “Recommended for all libraries.” – CHOICE Magazine
Plunkett’s Companion to The Almanac of American Employers: Mid-Size Firms 2002-2003 1-891775-26-X $179.99 DEC 2001 INCLUDES CD-ROM
sample screens
684 pg. Profiles of 500 rapidly growing mid-size firms, from 200 to 2,300 employees. “The best places to work.” – USA Today
Check us out! See sample chapters at www.plunkettresearch.com
Ordering from Plunkett Research is easy. • Use the order form on the back of this brochure • Place your order online at www.plunkettresearch.com • Order by phone at 713.932.0000 • Order by fax at 713.932.7080 • Order by mail at P.O. Drawer 541737 Houston, TX 77254
Plunkett Research Online is your key to Market Research
New Plunkett’s online subscription plans
are available at value-packed prices.
Plunkett’s business, Internet and careers data is available online through subscription plans tailored to fit your organization. Access our online service by IP address, user name or other popular methods. Search and view our industry analysis, statistics and company profiles online.
Accessing our data online has many outstanding advantages. • You access the service via our server, which means that we do all of the maintenance and updating.
• All employees of a corporation, all students of a business school or even an entire university can have access to our online service’s unique data.
• Information on our online service is updated weekly. • Our newest editions and updates will be posted automatically – before they are available in print!
• Thousands of company profiles can easily be searched using a wide array of criteria.
• All profiles are easily printable, and you also have several options for exporting vital data.
• You have instant access to our updated databases of statistics, glossaries of key industry terms and contact lists of industry associations.
• Our online service is fully searchable by keyword so that users can quickly find the subject area and data they are seeking.
Online Pricing and Access Options By User Name and Password Includes online access to all of our publications and every industry covered by Plunkett Research. 1 to 5 seats . . . . . . . . .$1,995 6-20 seats . . . . . . . . . .$2,995
By IP Address Recognition, Organization-wide access Includes online access to all of our publications and every industry covered by Plunkett Research. University or School . . .$2,995 (one campus) Government or . . . . . .$2,995 Non-Profit (one agency) Public Library . . . . . . .$2,995 (one location) Corporation . . . . . . . . .$3,495 Access to Only One Industry Sector $950 You should purchase this subscription if you want access to only one of our main industry sectors, for example health care only or retail only. This subscription will provide you with organization-wide access, by your choice of user name or IP address recognition.
Order Today!
Plunkett Research, Ltd. • P. O. Drawer 541737 • Houston, Texas 77254 USA Phone: 713.932.0000 • FAX: 713.932.7080 • Online: www.plunkettresearch.com Quantity
Airline, Hotel & Travel Plunkett’s Airline, Hotel & Travel Industry Almanac ISBN 1-891775-74-X with CD-ROM
____ @ 249.99
Automobile Plunkett’s Automobile Industry Almanac ISBN 1-891775-76-6 with CD-ROM
____ @ 249.99
Computers & Internet Plunkett’s E-Commerce & Internet Business Almanac 2003-2004 ISBN 1-891775-58-8 with CD-ROM Plunkett’s InfoTech Industry Almanac 2003 ISBN 1-891775-57-X with CD-ROM Energy Plunkett’s Energy Industry Almanac 2002-2003 ISBN 1-891775-20-0 with CD-ROM Engineering & Research Plunkett’s Engineering & Research Industry Almanac 2003-2004 ISBN 1-891775-24-3 with CD-ROM Entertainment & Media Plunkett’s Entertainment & Media Industry Almanac 2002-2003 ISBN 1-891775-27-8 with CD-ROM Finance & Investments Plunkett’s Financial Services Industry Almanac 2002-2003 ISBN 1-891775-23-5 with CD-ROM Plunkett’s Online Trading, Finance & Investment Web Sites Almanac ISBN 1-891775-08-1 with Diskette Food Plunkett’s Food Industry Almanac ISBN 1-891775-75-8 with CD-ROM Health Care & Biotech Plunkett’s Health Care Industry Almanac 2003 ISBN 1-891775-54-5 with CD-ROM Plunkett’s Biotech & Genetics Industry Almanac 2003-2004 ISBN 1-891775-28-6 with CD-ROM Job Seekers & Careers The Almanac of American Employers 2003 ISBN 1-891775-56-1 with CD-ROM Plunkett’s Companion to The Almanac of American Employers: Mid-Size Firms 2002-2003 ISBN 1-891775-26-X with CD-ROM Plunkett’s Employers’ Internet Sites with Careers Information 2002-2003 ISBN 1-891775-19-7 with CD-ROM Retail Plunkett’s Retail Industry Almanac 2003 ISBN 1-891775-55-3 with CD-ROM Telecommunications Plunkett’s Telecommunications Industry Almanac 2003-2004 ISBN 1-891775-22-7 with CD-ROM
Also, we’re accepting pre-publication orders for these upcoming titles: Plunkett’s Consulting Industry Almanac 1-593920-02-4 with CD-ROM Approx. Publication Date: Nov. 2003
____ @ 249.99
____ @ 249.99 Plunkett’s Real Estate & Construction Industry Almanac ____ @ 229.99
____ @ 199.99
____ @ 249.99
____ @ 229.99
1-593920-03-2 with CD-ROM Approx. Publication Date: Jan. 2004
____ @ 249.99
Plunkett’s Nanotechnology & MEMS Industry Almanac 1-593920-04-0 with CD-ROM Approx. Publication Date: Mar. 2004
____ @ 249.99
Plunkett’s Advertising & Branding Industry Almanac 1-593920-05-9 with CD-ROM Approx. Publication Date: Jun. 2004
____ @ 249.99
____ @ 229.99 Plunkett’s Apparel & Textiles Industry Almanac ____ @ 149.99
____ @ 249.99
____ @ 229.99
1-593920-06-7 with CD-ROM Approx. Publication Date: Jul. 2004
____ @ 249.99
Plunkett’s Transportation & Logistics Industry Almanac 1-593920-07-5 with CD-ROM Approx. Publication Date: Sep. 2004
____ @ 249.99
____ @ 249.99
____ @ 199.99
Subtotal
$
Shipping/ Handling add $9.50 per book or
$
____ @ 179.99
Next day air in the US, add $23.50 per book or
$
____ @ 199.99
Airmail outside USA, add $50.00 per book.
$
FedEx outside USA, add $90.00 per book.
$
In Texas add 8.25% sales tax if you are not tax exempt.
$
TOTAL
$
____ @ 229.99
____ @ 249.99
STANDING ORDER l Check here for a standing order and receive a 10% discount on future editions of the book(s) you have ordered, which will be shipped to you automatically. You may cancel your standing order at any time.
METHOD OF PAYMENT (Our Federal ID number is 74-2440918) Purchase order number (if any): l Check enclosed l Bill me l Credit card (check one) l VISA l MasterCard l American Express Credit Card No.
Expiration Date:
SHIP TO: Name Title/Department Organization Address City Telephone E-mail
State Fax
Zip
Plunkett Research, Ltd. P. O. Drawer 541737 Houston, Texas 77254 USA 713.932.0000
PRSRT STD AUTO US POSTAGE PAID DALLAS TX PERMIT NO 6803
Customer Support Information Plunkett’s Engineering & Research Industry Almanac 2003-2004 Please register your book immediately… if you did not purchase it directly from Plunkett Research, Ltd. This will enable us to fulfill your replacement request if you have a damaged product, or your requests for assistance. Also it will enable us to notify you of future editions, so that you may purchase them from the source of your choice.
If you are an actual, original purchaser but did not receive a FREE CD-ROM version with your book…* you may request it by returning this form. ____ YES, please register me as a purchaser of the book. I did not buy it directly from Plunkett Research, Ltd. ____ YES, please send me a free CD-ROM version of the book. I am an actual purchaser, but I did not receive one with my book. (Proof of purchase may be required.) Customer Name ____________________________________________________ Title ______________________________________________________________ Organization _______________________________________________________ Address ___________________________________________________________ City_______________________________State________Zip_________________ Country (if other than USA) ___________________________________________ Phone_________________________Fax ________________________________ E-mail ____________________________________________________________
Mail or Fax to:
Plunkett Research, Ltd.
Attn: FREE CD-ROM and/or Registration P.O. Drawer 541737, Houston, TX 77254-1737 USA 713.932.0000 Fax 713.932.7080 http://www.plunkettresearch.com/ * Purchasers of used books are not eligible to register. Use of CD-ROMs is subject to the terms of their end user license agreements.
PLUNKETT’S ENGINEERING AND RESEARCH INDUSTRY ALMANAC 2003-2004 The Only Comprehensive Guide to the Engineering and Research Industry
Jack W. Plunkett Published by: Plunkett Research, Ltd., Houston, Texas http://www.plunkettresearch.com/
PLUNKETT’S ENGINEERING AND RESEARCH INDUSTRY ALMANAC 2003-2004 Editor and Publisher: Jack W. Plunkett Executive Editor and Database Manager: Martha Burgher Plunkett
E-Commerce Manager: Kevin Hinrichs
Senior Editors and Researchers: Elisa Gabbert Ghazal Siddiqi
Cover Design: Kim Paxson, Just Graphics Junction, TX
Editors, Researchers and Assistants: Elizabeth Lockett Christie Manck Ray Marumahoko Mariya Paterwic Daniel Shirley Jonathan Timms Suzanne Zarosky
Special Thanks to: National Science Foundation, Division of Science Resources Studies, Arlington, VA U.S. Patent and Trademark Office, Division of Technology, Assessment and Forecast, Alexandria, VA
Information Technology Director: Alex Preskovsky Plunkett Research, Ltd. P. O. Drawer 541737, Houston, Texas 77254 Phone: 713.932.0000 Fax: 713.932.7080 http://www.plunkettresearch.com/
Copyright 2003 by Plunkett Research, Ltd.
Published by: Plunkett Research, Ltd. P. O. Drawer 541737 Houston, Texas 77254-1737 USA Phone: 713.932.0000 Fax: 713.932.7080 Internet: www.plunkettresearch.com ISBN # 1-891775-33-2 End-User License Agreement, Limited Warranty & Limitation of Liability--Effective January 2003, Plunkett Research, Ltd. Important, read carefully: This agreement is a legal agreement between you (whether as an individual or an organization) and Plunkett Research, Ltd. By installing, copying, downloading, accessing or otherwise using the Plunkett Data, you agree to be bound by the terms of this Agreement. If you do not agree to the terms of this Agreement, do not install or use the Plunkett Data. The information (the "Data" or the "Plunkett Data") contained in this printed version or electronic file is the property of Plunkett Research, Ltd. Copyright laws and international copyright treaties, as well as other intellectual property laws and treaties, protect the Plunkett Data. LIMITED RIGHTS TO INSTALL DATA ON ELECTRONIC DEVICES: Plunkett Research, Ltd. grants you, as an individual or an organization, a non-exclusive license to use and and/or install this Data, including installation of electronic files on one individual desktop computer AND on one laptop computer AND one personal digital assistant or dedicated portable eBook reader (such as a Palm or iPaq). This is a limited license, which applies to a single user. Organizations desiring multi-user licenses may purchase additional rights at reasonable cost by contacting Plunkett Research, Ltd., 713.932.0000, http://www.plunkettresearch.com/, email:
[email protected]. LIMITED RIGHTS TO EXPORT OR COPY DATA, SUBJECT TO CONTINUED COPYRIGHT NOTICE: Limited exporting or copying of certain limited amounts of Data for creation of mailing lists, summaries and contact lists is allowed, PROVIDED THAT: 1) The exported Data is for use by one organization, company or individual only. 2) The exported Data will not be re-sold, posted to an Internet-based file, commercially published, or broadly distributed outside of the organization/corporation that has purchased the Plunkett Data. 3) Broad use, multi-premises use, or sharing outside of the organization that purchased the Plunkett Data is not allowed. 4) Violators will be subject to all penalties allowed by law. Rights under this license may not be sold or transferred. Data which may be exported or copied under the rights conferred through this paragraph may consist of any of the following: i. Up to 400 words of text; ii. Company names, addresses, telephone numbers,and executives with job titles; iii. Up to 2 tables or charts, PROVIDED THAT
said Data is immediately followed by this information in a font size that is clearly legible and of no less than 9 points in size: Copyright © Plunkett Research, Ltd., www.plunkettresearch.com, all rights reserved.
LIMITED WARRANTY: While Plunkett Research, Ltd. has made an effort to obtain the Data from sources deemed reliable, Plunkett Research, Ltd. makes no warranties, expressed or implied, regarding the accuracy, the installation or usability of an electronic file, or any aspect of the Data contained herein whether in print or electronic version. The Data is provided to the End-User “AS IS” without warranty of any kind. No oral or written information or advice given by Plunkett Research, Ltd. or its employees, distributors or representatives will create a warranty or in any way increase the scope of this Limited Warranty, and the Customer or End-User may not rely on any such information or advice. Among other things, this Limited Warranty applies to your ability to install an electronic file or software or such an installation's effects on your computer or other electronic devices. Plunkett Research, Ltd. assumes no liability and does not guarantee that this Data will install or function correctly on your computer or other electronic devices and further does not guarantee or accept any liability for the results of your attempt to install this Data, including any fault or dysfunction (including, but not limited to: computer viruses and/or alterations to computer files, registries or setups) to your computer or electronic devices that may be caused by installation or use. Customer Remedies: Plunkett Research, Ltd. and its suppliers' entire liability and your exclusive remedy shall be, at Plunkett Research Ltd.'s sole discretion, either (a) return of the price paid, if any, or (b) repair or replacement of the product that does not meet Plunkett Research, Ltd.'s Limited Warranty and that is returned to Plunkett Research, Ltd. with sufficient evidence of or receipt for your original purchase. NO OTHER WARRANTIES: TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, PLUNKETT RESEARCH, LTD. AND ITS SUPPLIERS AND DISTRIBUTORS DISCLAIM ALL OTHER WARRANTIES AND CONDITIONS, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT WITH REGARD TO THE PRODUCT, AND THE PROVISION OF OR FAILURE TO PROVIDE SUPPORT SERVICES. THIS LIMITED WARRANTY GIVES YOU SPECIFIC LEGAL RIGHTS. YOU MAY HAVE OTHERS, WHICH VARY FROM STATE/JURISDICTION TO STATE/JURISDICTION.
LIMITATION OF LIABILITY: TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL PLUNKETT RESEARCH, LTD. BE LIABLE FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES WHATSOEVER (INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, LOSS OF BUSINESS INFORMATION, ABILITY TO OBTAIN OR RETAIN EMPLOYMENT OR REMUNERATION, ABILITY TO PROFITABLY MAKE AN INVESTMENT, OR ANY OTHER PECUNIARY LOSS) ARISING OUT OF THE INSTALLATION OF, USE OF, OR RELIANCE UPON THIS DATA, OR THE INABILITY TO USE THIS DATA (WHETHER IN ELECTRONIC OR PRINTED FORM) OR THE FAILURE OF PLUNKETT RESEARCH, LTD. TO PROVIDE SUPPORT SERVICES, EVEN IF PLUNKETT RESEARCH, LTD. HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN ANY CASE, PLUNKETT RESEARCH, LTD.’S ENTIRE LIABILITY UNDER ANY PROVISION OF THIS END-USER LICENSE AGREEMENT SHALL BE LIMITED TO THE AMOUNT ACTUALLY PAID BY YOU FOR THE PRODUCT. BECAUSE SOME STATES/JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.
PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC 2003-2004 CONTENTS A Short Engineering and Research Industry Glossary Introduction How To Use This Book Chapter 1: Major Trends in the Engineering and Research Industry Company R&D Spotlights: IBM Lucent/Bell Labs Intel Microsoft Xerox Genentech Pfizer DuPont General Electric Chapter 2: Engineering and Research Industry Statistics Chapter 3: Engineering and Research Industry Contacts Addresses, Telephone Numbers and World Wide Web Sites Chapter 4: THE ENGINEERING 500: Who They Are and How They Were Chosen Industry List, With Codes Index of Rankings Within Industry Groups (The ENGINEERING 500 grouped by industry and ranked for sales and profits) Alphabetical Index Index of Headquarters Location by State Index of Headquarters Location by Country Index by Regions of the U.S. Where the ENGINEERING 500 Have Locations Index by Firms With International Operations Individual Profiles on each of THE ENGINEERING 500 Additional Indexes Index of Hot Spots for Advancement for Women/Minorities Index of Subsidiaries, Brand Names and Selected Affiliations List of Major Tables and Charts I. U.S. Research and Development Comparative Measures of Growth for Gross Domestic Product and R&D Federally Funded Research and Development Centers' R&D Expenditures: 2001 National Expenditures for Applied Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Applied Research, from Funding Sectors to Performing Sectors: 1993-2002 Continued on the next page
i 1 3 7 17 17 17 18 18 18 19 19 19 21 61 87 88 90 102 107 112 113 128 133 604 606
p. 23 p. 24 p. 25 p. 27 p. 28
Continued from the previous page
National Expenditures for Basic Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Basic Research, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for Development, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Development, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for R&D, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for R&D, from Funding Sectors to Performing Sectors: 1993-2002 Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 Trends in U.S. Research & Development (R&D) and Federal Outlays: 1970, 1980, 1990, 2000 and 2002 U.S. Federal Basic Research Budget Authority, by Budget Function: Fiscal Years 1995–2001 U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001
II. Research and Development by States-U.S. California Research & Development (R&D) Profile, 1999-2000 Illinois Research & Development (R&D) Profile, 1999-2000 Maryland Research & Development (R&D) Profile, 1999-2000 Massachusetts Research & Development (R&D) Profile, 1999-2000 Michigan Research & Development (R&D) Profile, 1999-2000 New Jersey Research & Development (R&D) Profile, 1999-2000 New York Research & Development (R&D) Profile, 1999-2000 Pennsylvania Research & Development (R&D) Profile, 1999-2000 Texas Research & Development (R&D) Profile, 1999-2000 Washington Research & Development (R&D) Profile, 1999-2000 State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 Top 10 U.S. States in Total R&D Performance, Size of R&D by Performer and R&D as a Percentage of Gross State Product: 2000 III. International Research and Patents International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 Top 20 Global Patenting Organizations, Calendar Year 2001 Top 20 Patenting Countries, 2001
p. 29 p. 30 p. 31 p. 32 p. 33 p. 34 p. 35 p. 37 p. 38 p. 39
p. 41 p. 42 p. 43 p. 44 p. 45 p. 46 p. 47 p. 48 p. 49 p. 50 p. 51 p. 52 p. 54
p. 55 p. 56 p. 58 p. 59
Plunkett Research, Ltd.
A Short Engineering & Research Industry Glossary 510 K: The application filed with the FDA for a new medical device to show that the apparatus is “substantially equivalent” to one that is already marketed. 802.11a: A faster wireless network standard than 802.11b, 802.11a operates in the 5-GHz band at speeds of 50 Mbps or more. This standard may be affected by weather and is not as suitable for outdoor use. This standard may be of little importance if 802.11g becomes popular. 802.16: This very fast wireless network standard includes 802.16 and its extension of 802.16a. 802.16a operates in the 2 to 66 GHz band with speeds as high as 166 Mbps. This standard may eventually enable wireless to compete with T1 lines. Access Network: The network that connects a user's telephone equipment to the telephone exchange. Active Server Page (ASP): A specification for a web page with an ASP extension containing Java Script or Visual Basic code. (See "Java" below.) Active X: A set of technologies developed by Microsoft Corporation for sharing information across different applications. ADME: Absorption, Distribution, Metabolism and Excretion. In clinical trials, the bodily processes studied to determine the extent and duration of systemic exposure to a drug. ADN (Advanced Digital Network): See "IDN (Integrated Digital Network)" below. ADSL (Asymmetrical Digital Subscriber Line): High-speed technology that enables the transfer of data over existing copper phone lines, allowing more bandwidth downstream than upstream. AE (Adverse Event): In clinical trials, a condition not observed at baseline or worsened if present at baseline. Sometimes called Treatment Emergent Signs and Symptoms (TESS). Ambient: Any unconfined portion of the air. Also refers to open air.
www.plunkettresearch.com
Analog: A form of transmitting information characterized by continuously variable quantities. Digital transmission, on the other hand, is characterized by discrete bits of information in numerical steps. An analog signal responds to changes in light, sound, heat and pressure. Analog IC (Integrated Circuit): A semiconductor that processes a continuous wave of electrical signals based on real-world analog quantities such as speed, pressure, temperature, light, sound and voltage. ANDA (Abbreviated New Drug Application): An application filed with the FDA for a drug showing that the substance is the same as an existing, previously approved drug (i.e., a generic version). ANSI: American National Standards Institute. Applied Research: The application of compounds, processes, materials or other items discovered during “basic research” to practical uses. The goal is to move discoveries along to the final development phase. ARPANet: Advanced Research Projects Agency Network. The forefather of the Internet, ARPANet was developed during the latter part of the 1960s by the United States Department of Defense. ASCII: American Standard Code for Information Exchange. 128 standard ASCII codes exist that represent all Latin letters, numbers and punctuation. Each ASCII code is represented by a seven-digit binary number, such as 0000000 or 0000111. This code is accepted as a standard throughout the world. ASP (Application Service Provider): A web site that enables utilization of software and databases that reside permanently on the web site rather than having to be downloaded to the user's computer. Advantages include the fact that multiple remote users may access the same tools over the Internet and that the ASP provider is responsible for developing and maintaining the software. (ASP also refers to Active Server Page. See "Active Server Page" above.) Assay: A laboratory test to identify and/or measure the amount of a particular substance in a sample. Types of assays include endpoint assay, in which a single measurement is made at a fixed time; kinetic assay, in which increasing amounts of a product are formed with time and are monitored at multiple
Plunkett Research, Ltd.
points; microbiological assay, a measurement of the concentration of antimicrobials in biological material; and immunological assay, in which analysis or measurement is based on antigen-antibody reactions. Asynchronous Communications: A stream of data routed through a network as generated instead of in organized message blocks. Most personal computers use this format to send data. ATM (Asynchronous Transfer Mode): A digital switching and transmission technology based on high speed. ATM allows voice, video and data signals to be sent over a single telephone line at speeds from 25 million to 1 billion bits per second (bps). This digital ATM speed is much faster than traditional analog phone lines, which allow no more than 2 million bps. (See "Broadband" below.) Backbone: Traditionally, the part of a communications network that carries the heaviest traffic; the high-speed line or series of connections that forms a large pathway within a network or within a region. The combined networks of AT&T, Worldcom and other large telecommunications companies make up the backbone of the Internet. Bandwidth: The data transmission capacity of a network, measured in the amount of data (in bits and bauds) it can transport in one second. A full page of text is about 15,000 to 20,000 bits. Full-motion, fullscreen video requires about 10,000,000 bits per second, depending on compression. Baseline: A set of data used in clinical studies for control or comparison. Basic Research: Attempts to discover compounds, materials, processes or other items that may be largely or entirely new and/or unique. Basic research may start with a theoretical concept that has yet to be proven. The goal is to create discoveries that can be moved along to "applied research." Basic research is sometimes referred to as “blue sky” research. Baud: Refers to how many times the carrier signal in a modem switches value per second or how many bits a modem can send and receive in a second. Beams: The coverage and geographic service area offered by a satellite transponder. A global beam effectively covers one-third of the earth’s surface. A spot beam provides a very specific high-powered
www.plunkettresearch.com
downlink pattern that is limited to a particular geographical area to which it may be steered or pointed. Binhex: A means of changing non-ASCII (or nontext) files into text/ASCII files so that they can be used, for example, as e-mail. Bioavailability: In pharmaceuticals, the rate and extent to which a drug is absorbed or is otherwise available to the treatment site in the body. Bioequivalence: In pharmaceuticals, the demonstration that a drug’s rate and extent of absorption are not significantly different from those of an existing drug that is already approved by the FDA. Bioinformatics: Computer-simulated generation and testing of new chemical compounds for possible drug use. This method is much faster and more costeffective than manual methods. Biologic: Any virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic or analogous product or arsphenamine or one of its derivatives (or any other trivalent organic arsenic compound) applicable to the prevention, treatment or cure of disease or injury. Biotechnology: A set of powerful tools that employ living organisms (or parts of organisms) to make or modify products, improve plants or animals (including humans) or develop microorganisms for specific uses. Early uses of biotechnology included traditional animal and plant breeding techniques and the use of yeast in making bread, beer, wine and cheese. Today, biotechnology is most commonly thought of to include the development of human medical therapies and processes using recombinant DNA, cell fusion, other genetic techniques and bioremediation. Bit: A single digit number, either a one or a zero, which is the smallest unit of computerized data. Bluetooth: An industry standard for a technology that enables wireless, short-distance infrared connections between devices such as PCs, Palm Pilots or PDAs, laptops, cell phones and Internet appliances. It competes with 802.11b.
Plunkett Research, Ltd.
BPS (Bits Per Second): An indicator of the speed of data movement. Branding: A marketing strategy that takes a wellknown brand and utilizes brand capital in order to increase the brand's market share, sales and availability; establish credibility; improve satisfaction; raise the profile of the firm; and increase profits. Bridge: A device that links two local area networks together so they can share files and e-mail. Broadband: The high-speed transmission range for telecommunications and computer data. Broadband refers to any transmission at 2 million bps (bits per second) or higher (much higher than analog speed). A broadband network can carry voice, video and data all at the same time. Internet users enjoying broadband access typically connect to the Internet via DSL line, cable modem or T1 line. Browse: A term referring to the viewing of computerized data. Several Internet browsers support a browse mode that allows users to sort through data quickly. (See "Browser" below.) Browser: A program that allows a user to read Internet text or graphics and to navigate from one page to another. The most popular browsers are Microsoft Internet Explorer and Netscape Navigator. B-to-B, or B2B: See "Business-to-Business" below. B-to-C, or B2C: See "Business-to-Consumer" below.
www.plunkettresearch.com
Business-to-Government: An organization focused on selling products, services or data to government units, rather than commercial businesses or consumers. Byte: There are eight bits in a byte. This set stands for a single character. Cable Modem: An interface between a cable television system and a computer or router. Most cable modems are external devices that connect to the PC through a standard 10Base-T Ethernet card and twisted-pair wiring. External Universal Serial Bus (USB) modems and internal PCI modem cards are also available. The cable modem enables a computer to access the Internet via the TV cable. Cable modem access can be very high-speed and is much faster than traditional "dial-up" access via a standard telephone line. Cable modem speeds vary, depending on the cable modem system and current traffic load. From the Internet to the computer the modem may connect at speeds as high as 1 to 3 Mbps. From the computer to network, speeds typically run between 500 Kbps and 2.5 Mbps. Cable modem access competes with DSL access. Caching: Storing data in a temporary location closer to the user so that it can be retrieved quickly when requested. CAD (Computer-Aided Design): CAD software, which generally runs on workstations, is a tool used to provide three-dimensional, on-screen design for everything from buildings to automobiles to clothing. (See "CAM" and "CAE" below.) CAE: Computer-aided engineering.
B-to-G, or B2G: See "Business-to-Government" below. Buffer: A location for temporarily storing data being sent or received. Usually located between two devices that have different data transmission rates. Business-to-Business: An organization focused on selling products, services or data to commercial customers rather than individual consumers. Business-to-Consumer: An organization focused on selling products, services or data to individual consumers rather than commercial customers.
Call Automation: Part of the telephone equipment revolution, including voice mail, automated sending and receiving of faxes and the ability for customers to place orders and gather information using a touchtone telephone to access sophisticated databases. (See "Voice Mail" below.) CAM: Computer-aided manufacturing. CANDA (Computer-Assisted New Drug Application): An electronic submission of a new drug application (NDA) to the FDA. Capacitor: An electronic circuit device for temporary storage of electrical energy.
Plunkett Research, Ltd.
www.plunkettresearch.com
CAPLA (Computer-Assisted Product License Application): An electronic submission of a biological product license application (PLA) to the FDA.
CDMA (Code Division Multiple Access): A multiple-access scheme where stations use spreadspectrum modulations and orthogonal codes to avoid interfering with one another.
Cardiac Catheterization Laboratory: Facilities offering special diagnostic procedures for cardiac patients, including the introduction of a catheter into the interior of the heart by way of a vein or artery or by direct needle puncture. Procedures must be performed in a laboratory or a special procedure room.
CDRH (Center for Devices and Radiological Health): The branch of the FDA responsible for the regulation of medical devices. www.fda.gov/cdrh
Carrier: In communications, the basic radio, television or telephony center of transmit signal. The carrier in an analog signal is modulated by varying volume or shifting frequency up or down in relation to the incoming signal. Satellite carriers operating in the analog mode are usually frequency modulated. CASE (Computer Assisted Software Engineering): The application of computer technology to systems development activities, techniques and methodologies. Sometimes referred to as Computer Aided Systems Engineering. Catheter: A tubular instrument used to add or withdraw fluids. Heart or cardiac catheterization involves the passage of flexible catheters into the great vessels and chambers of the heart. IV catheters add intravenous fluids to the veins. Foley catheters withdraw fluid from the bladder. Significant recent advances in technology allow administration of powerful drug and diagnostic therapies via catheters. CATV: Cable television. CBER (Center for Biologics Evaluation and Research): The branch of the FDA responsible for the regulation of biological products, including blood, vaccines, therapeutics and related drugs and devices to ensure purity, potency, safety, availability and effectiveness. www.fda.gov/cber CDER (Center for Drug Evaluation and Research): The branch of the FDA responsible for the regulation of drug products. www.fda.gov/cder CDF (Channel Definition Format): Used in Internet-based broadcasting. With this format, a channel serves as a web site that also sends an information file about that specific site. Users subscribe to a channel by downloading the file.
CFR (Code of Federal Regulations): The CFR is a codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the federal government. The code is divided into 50 titles that represent broad areas subject to federal regulation. Title 21 of the CFR covers FDA regulations. CGI (Common Gateway Interface): A set of guidelines that determines the manner in which a web server receives and sends information to and from software on the same machine. CGI-BIN: The frequently used name of a directory on a web server where CGI programs exist. Class I Device: An FDA classification of medical devices. General controls are sufficient to ensure safety and efficacy. Class II Device: An FDA classification of medical devices. Performance standards and special controls are sufficient to ensure safety and efficacy. Class III Device: An FDA classification of medical devices. Pre-market approval is required to ensure safety and efficacy, unless the device is substantially equivalent to a currently marketed device. (See “510 K” above.) CLEC (Competitive Local Exchange Carrier): A newer company providing local telephone service that competes against larger, traditional firms known as ILECs (Incumbent Local Exchange Carriers). Client/Server: In networking, a way of running a large computer setup. The server is the host computer that acts as the central holding ground for files, databases and application software. The clients are all of the PCs connected to the network that share data with the server. This represents a vast change from past networks, which were connected to expensive, complicated “mainframe” computers.
Plunkett Research, Ltd.
Cloning (Reproductive): A method of reproducing an exact copy of an animal or, potentially, an exact copy of a human being. A scientist removes the nucleus from a donor's unfertilized egg, inserts a nucleus from the animal to be copied and then stimulates the nucleus to begin dividing to form an embryo. In the case of a mammal, such as a human, the embryo would then be implanted in the uterus of a host female. Also see "Cloning (Therapeutic)." Cloning (Therapeutic): A method of reproducing exact copies of cells needed for research or for the development of replacement tissue or organs. A scientist removes the nucleus from a donor's unfertilized egg, inserts a nucleus from the animal whose cells are to be copied and then stimulates the nucleus to begin dividing to form an embryo. However, the embryo is never allowed to grow to any significant stage of development. Instead, it is allowed to grow for a few hours or days and stem cells are then removed from it for use in regenerating tissue. Also see "Cloning (Reproductive)." CMOS (Complementary Metal-Oxide Semiconductor): Integrated-circuit technology used for processors and memory. Coaxial Cable: A type of cable widely used to transmit telephone and broadcast traffic. The distinguishing feature is an inner strand of wires surrounded by an insulator that is in turn surrounded by another conductor, which serves as the ground. Cable TV wiring is typically coaxial. Codec: Hardware or software that converts analog to digital and digital to analog (in both audio and video formats). Codecs can be found in digital telephones, set-top boxes, computers and videoconferencing equipment. The term is also used to refer to the compression of digital information into a smaller format. Co-Location: Refers to the hosting of computer servers at locations operated by service organizations. Co-location is offered by firms that operate specially designed co-location centers with high-levels of security, extremely high-speed telecommunication lines for Internet connectivity and reliable backup electrical power systems in case of power failure, as well as a temperature controlled environment for optimum operation of computer systems.
www.plunkettresearch.com
Commerce Chain Management (CCM): In ecommerce, this refers to Internet-based tools to facilitate sales, distribution, inventory management and content personalization. (See also "Supply Chain.") Compression: A technology in which a communications signal is squeezed so that it uses less bandwidth (or capacity) than it normally would. This saves storage space and shortens transfer time. The original data is decompressed when read back into memory. COMSAT: The Communications Satellite Corporation. COMSAT serves as the U.S. Signatory to INTELSAT and INMARSAT. Coordinator: In clinical trials, the person at an investigative site who handles the administrative responsibilities of a clinical trial, acts as a liaison between the investigative site and the sponsor and reviews data and records during a monitoring visit. COSTART: In medical and drug product development, a dictionary of adverse events and body systems used for coding and classifying adverse events. CPMP (Committee on Proprietary Medicinal Products): A committee, composed of two people from each EU Member State (see “EU” below), that is responsible for the scientific evaluation and assessment of marketing applications for medicinal products in the EU. The CPMP is the major body involved in the harmonization of pharmaceutical regulations within the EU and receives administrative support from the European Medicines Evaluation Agency. (See “EMEA” below.) CPU (Central Processing Unit): The part of a computer that interprets and executes instructions. It is composed of an arithmetic logic unit, a control unit and a small amount of memory. CRA (Clinical Research Associate): An individual responsible for monitoring clinical trial data to ensure compliance with study protocol and FDA GCP regulations. CRF (Case Report Form): In clinical trials, a standard document used by clinicians to record and report subject data pertinent to the study protocol.
Plunkett Research, Ltd.
CRO (Contract Research Organization): An independent organization that contracts with a sponsor of a clinical investigation to conduct part of the work on a clinical study. Drug makers and medical device makers frequently outsource work to CROs. CRT (Case Report Tabulation): In clinical trials, a tabular listing of all data collected on study case report forms. CT Scanner: In medicine, a computed tomographic scanner used for head or whole body scans. CVMP (Committee for Veterinary Medicinal Products): A committee that is a veterinary equivalent of the CPMP (see above) in the EU (see below). Cyberspace: Refers to the entire realm of information available through computer networks. Datanets: Private networks of land-based telephone lines, satellites or wireless networks that allow corporate users to send data at high speeds to remote locations while bypassing the speed and cost constraints of traditional telephone lines. Defibrillator: In medicine, an instrument used externally (as electrodes on the chest) or implanted (as a small device similar in size to a pacemaker) that delivers an electric shock to return the heart to its normal rhythm. Development: The phase of research and development in which researchers attempt to create new products from the results of discoveries and applications created during basic and applied research. Device: In medical product development, according to the FDA, an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent or other similar or related article, including any component, part or accessory, that 1) is recognized in the official National Formulary or United States Pharmacopoeia or any supplement to them, 2) is intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment or prevention of disease, in man or animals or 3) is intended to affect the structure of the body of man or animals and does not achieve any of its principal intended purposes through chemical action within or
www.plunkettresearch.com
on the body of man or animals and is not dependent upon being metabolized for the achievement of any of its principal intended purposes. Diagnostic Radioisotope Facility: In medicine, the use of radioactive isotopes (radiopharmaceuticals) as tracers or indicators to detect an abnormal condition or disease in the body. Dial-Up Access: The connection of a computer or other device to a network through a modem and a public telephone network. The only difference between dial-up access and a telephone connection is that computers are at each end of the connection rather than people. Dial-up access is slower than DSL, ISDN and other advanced connections. Digital: Transmission of a signal reducing all of its information to ones and zeros and then regrouping them at the reception end. Digital transmission vastly improves the carrying capacity of the spectrum while reducing noise and distortion of the transmission. Digital Local Telephone Switch: A computer that interprets signals (dialed numbers) from a telephone caller and routes calls to their proper destinations. A digital switch also provides a variety of calling features not available in older analog switches, such as call waiting. Digital Signal Processor: A chip that converts analog signals such as sound and light into digital signals. Disaster Recovery: A set of rules and procedures that allow a computer site to be put back in operation after a disaster has occurred. Moving backups off-site constitutes the minimum basic precaution for disaster recovery. The remote copy is used to recover data if the local storage is inaccessible after a disaster. Discrete Semiconductor: A chip with one diode or transistor. Disk Mirroring: A data redundancy technique in which data is recorded identically on multiple separate disk drives at the same time. When the primary disk is off-line, the alternate takes over, providing continuous access to data. Disk mirroring is sometimes referred to as RAID. Distributor: Distributors do not manufacture but may be involved in sales, marketing, warehousing or
Plunkett Research, Ltd.
www.plunkettresearch.com
shipping of drugs and/or medical devices. In medicine, distributors are subject to medical device incident reporting, record keeping, tracking and registration and certification requirements under the Safe Medical Devices Act (see “SMDA” below).
EDI (Electronic Data Interchange): An accepted standard format for the exchange of data between various companies’ networks. EDI allows for the transfer of e-mail as well as orders, invoices and other files from one company to another.
DMB (Data Monitoring Board): A committee that monitors the progress of a clinical trial and carefully observes the safety data.
EFGCP (European Forum for Good Clinical Practices): The organization dedicated to finding common ground in Europe on the implementation of Good Clinical Practices. (See “GCP” below.) www.efgcp.org
DOCSIS (Data over Cable Service Interface Specification): Standards for transferring data over cable television. Domain: A domain name that has server records associated with it. (See "Domain Name" below.) Domain (Top-Level): Either an ISO country code or a common domain name such as .com, .org or .net. DRM (Digital Rights Management): Enables control and maintenance of publishers’ rights by delivering encrypted information and, instead of providing the key (or using the recipient’s public key for encryption), in effect permitting the recipient to borrow the decryption key in a highly controlled fashion. Drug Utilization Review: A quantitative assessment of patient drug use and physicians’ patterns of prescribing drugs in an effort to determine the usefulness of drug therapy. DS-1: A digital transmission format that transmits and receives information at a rate of 1,544,000 bits per second. DSL (Digital Subscriber Line): See "Digital Subscriber Line" above. DSMB (Data and Safety Monitoring Board): See “DMB” above. Duplicate Host: A single host name that maps to duplicate IP addresses. Dynamic HTML: Web content that changes with each individual viewing. For example, the same site could appear differently depending on geographic location of the reader, time of day, previous pages viewed or the user’s profile. EC (European Community): See “EU” below.
EFT (Electronic Funds Transfer): A method of moving money from one account to another via computer. Withdrawing funds from an account using an ATM is a good example, as is paying bills using Quicken software on a PC. ELA (Establishment License Application): An ELA is required for the approval of a biologic (see "Biologic" above). It permits a specific facility to manufacture a biological product for commercial purposes. (Compare to “PLA” below.) E-Mail: The use of software that allows the posting of messages (text, audio or video) over a network. Email can be used on a LAN, a WAN or the Internet, as well as via online services such as America Online. It can be used to send a message to a single recipient or may be broadcast to a large group of people at once. EMEA (European Medicines Evaluation Agency): The European agency responsible for supervising and coordinating applications for marketing medicinal products in the European Union (see “EU” below and “CPMP” above). The EMEA is headquartered in the U.K. www.eudraportal.eudra.org Emission: The release or discharge of a substance into the environment; generally refers to the release of gases or particulates into the air. Endpoint: A clinical or laboratory measurement used to assess safety, efficacy or other trial objectives of a test article in a clinical trial. Environmental Audit: An independent assessment of a facility's compliance procedures, policies and controls. Many pollution prevention initiatives require an audit to determine where wastes may be reduced or eliminated or energy conserved.
Plunkett Research, Ltd.
ESWL (Extracorporeal Shock Wave Lithotripter): A medical device used for treating stones in the kidney or urethra. The device disintegrates kidney stones non-invasively through the transmission of acoustic shock waves directed at the stones. Ethernet: The standard format on which local area network equipment works. Abiding by Ethernet standards allows equipment from various manufacturers to work together. EU (European Union): Previously known as the European Community (EC), the EU is a consolidation of different European countries (Member States) functioning as one body to facilitate trade. There are currently 15 member states: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, The Netherlands, Portugal, Spain, Sweden and the United Kingdom. http://erupa.eu.int EU Competence: The jurisdiction in which the EU can taken legal action. Expert Systems: A practical development of AI (see "AI") that requires creation of a knowledge base of facts and rules furnished by human experts and uses a defined set of rules to access this information in order to suggest solutions to problems. Extensible Markup Language: See "XML" below. Extranet: A computer network that is accessible in part to authorized outside persons, as opposed to an intranet, which uses a firewall to limit accessibility.
www.plunkettresearch.com
commerce. The FDA’s mission is to protect the public from harm and encourage technological advances that hold the promise of benefiting society. www.fda.gov FDDI (Fiber Distributed Data Interface): A token ring passing scheme that operates at 100 Mbps over fiber-optic lines with a built in geographic limitation of 100 kilometers. This type of connection is faster than both Ethernet and T-3 connections. (See "Token Ring" below.) Fiber Optics: A type of telephone cable, made from glass, that can handle vast amounts of voice, data and video at once by carrying them along on beams of light. File Server: A computer that is modified to store and transfer large amounts of data to other computers. File servers often receive data from mainframes and store it for transfer to other micros, or from other micros to mainframes. Firewall: Hardware or software that keeps unauthorized users from accessing a server or network. Firewalls are designed to prevent data theft and unauthorized web site manipulation by "hackers." Frame Relay: An accepted standard for sending large amounts of data over phone lines and private datanets. Frame Relay refers to the fact that data is broken down into standard size "frames" prior to transmission.
FAQ: An acronym for "frequently asked questions," this kind of document answers inquiries about a given topic. Generally, FAQs come in the form of a help file or a hypertext document.
Frequency: The number of times that an alternating current goes through its complete cycle in one second. One cycle per second is referred to as one hertz; 1,000 cycles per second, one kilohertz; 1 million cycles per second, one megahertz; and 1 billion cycles per second, one gigahertz.
FCC (Federal Communications Commission): See "Federal Communications Commission" below.
Frequency Band: A term for designating a range of frequencies in the electromagnetic spectrum.
FD&C Act (Food, Drug and Cosmetic Act): The federal body of law that governs the manufacture, sale and distribution of food, drugs and cosmetics.
FTP (File Transfer Protocol): A widely used method of transferring data and files between two Internet sites.
FDA (Food and Drug Administration): The U.S. government agency responsible for the enforcement of the FD&C Act (see above), ensuring industry compliance with laws regulating products in
Fuel Cell: The fuel cell, in basic terms, consists of quantities of hydrogen and oxygen which are separated by a catalyst. Inside the cell, a chemical reaction within the catalyst generates electricity.
Plunkett Research, Ltd.
Byproducts of this reaction may include heat, carbon dioxide and water. Most fuel cells are based on hydrogen extracted from such sources as gasoline or methanol. Each source has its advantages and disadvantages. Eventually, stationary fuel cells may consume hydrogen extracted from biomass, natural gas or even water. Fuzzy Logic: Used in artificial intelligence, fuzzy logic recognizes that statements are not just "true" or "false," but also "more or less certain" or "very unlikely." Gateway: A device connecting two or more networks that may use different protocols and media. Gateways translate between the different networks and can connect locally or over wide area networks. GCP (Good Clinical Practices): FDA regulations and guidelines that define the responsibilities of the key figures involved in a clinical trial, including the sponsor, the investigator, the monitor and the Institutional Review Board. (See “IRB” below.) Gene Chips: See “DNA Chip” above. Genetically Modified (GM): Bioengineered food that is designed to resist herbicides and pests, has higher nutritional value than non-engineered food and/or lasts longer on the shelf. An example of GM food is a soybean that has been specially modified to be impervious to the application of a specific pesticide. Genomics: The study of genes, their role in diseases and our ability to manipulate them. Geostationary: A geosynchronous satellite angle with zero inclination, making a satellite appear to hover over one spot on the earth's equator. GIF (Graphic Interchange Format): A widely used format for image files. Gigabyte: A group of bytes generally defined as either 1,000 or 1,024 megabytes. Gigahertz (GHz): One billion cycles per second. See "Frequency" above. Global System for Mobile Communications (GSM): The standard cellular format used throughout Europe, making one type of cellular
www.plunkettresearch.com
phone usable in every nation on the continent and in the U.K. Globalization: The increased mobility of goods, services, labor, technology and capital throughout the world. Although globalization is not a new development, its pace has increased with the advent of new technologies, especially in the areas of telecommunications, finance and shipping. GLP (Good Laboratory Practices): A collection of regulations and guidelines to be used in laboratories where research is conducted on drugs, biologics or devices that are intended for submission to the FDA. GMP (Good Manufacturing Practices): A collection of regulations and guidelines to be used in manufacturing drugs, biologics and medical devices. Gopher: A way of making menus of material available over the Internet. This is a client/server form of program, meaning that the user must have a gopher client program in order to utilize it. HDML (Handheld Devices Markup Language): A text-based markup language designed for display on a smaller screen (e.g., cellular phone, PDA, pager). Enables the mobile user to send, receive and redirect e-mail as well as access the Internet (HDML-enabled web sites only). HDSL: High data rate digital subscriber line, delivering up to T1 or E1 speeds. Hertz: A measure of frequency equal to one cycle per second. Most radio signals operate in ranges of megahertz or gigahertz. Hit: A single request from a web browser for something from a web server, e.g., a request for text or graphics. Home Page: The main page of a web site. Usually, the home page features links to other pages within the site. Host: A host computer is any machine on a network that is responsible for services received by other machines on that network. Host Name: The first portion of a host's domain name. Also known as a firstname.
Plunkett Research, Ltd.
HotJava: This set of products, developed by Sun Microsystems, utilizes Java technology. A set of libraries intended for building applications and a Java-enabled web browser are among existing HotJava products. HTML (Hypertext Markup Language): A language for coding text for viewing on the World Wide Web. HTML is unique because it enables the use of hyperlinks from one site to another, creating a web. HTTP (Hypertext Transfer Protocol): The protocol used most frequently on the World Wide Web to move hypertext files between clients and servers on the Internet. Hub: In networking, a centralized switch box, or a common connection point, for devices in a network. Hubs contain multiple ports that can intertransmit information in order to maximize the viewing of data. Several types of hubs exist, including passive hubs (data conduits), intelligent or manageable hubs (with additional traffic-monitoring features) and switching hubs. Switching hubs read the destination address of each packet of information and then forward the packet to the correct location.
www.plunkettresearch.com
companies (CLECs, or Competitive Local Exchange Carriers) were enabled to compete against the ILECS and were granted access to their system wiring. Imaging: In medicine, the viewing of the body’s organs through external, high-tech means. This reduces the need for broad exploratory surgery. These advances, along with new types of surgical instruments, have made minimally invasive surgery possible. Imaging includes MRI (Magnetic Resonance Imaging), CT (Computed Tomography or “CAT scan”) and MEG (magnetoencephalography), improved x-ray technology, mammography, ultrasound and angiography. Immunoassay: An immunological assay. Types include agglutination, complement-fixation, precipitation, immunodiffusion and electrophoretic assays. Each type of assay utilizes either a particular type of antibody or a specific support medium (such as a gel) to determine the amount of antigen present. In Vitro: Laboratory experiments conducted in the test tube or otherwise, without using live animals and/or humans. In Vivo: Laboratory experiments conducted with live animals and/or humans.
Hyperlink: An element in an electronic document that links to another document or to another place in the same document. Generally, the user clicks on the hyperlink in order to follow it.
IND (Investigational New Drug Exemption): An IND must be filed with the FDA prior to initiating clinical trials of drugs or biologics.
ICANN: The Internet Corporation for Assigned Names and Numbers. It acts as the central coordinator for the Internet’s technical operations.
Inert Ingredients: Substances that are not active, such as water, petroleum distillates, talc, corn meal or soaps.
ICD9: International Classification of Diseases Version 9. A government coding system used for classifying diseases and diagnoses.
Informed Consent: Must be obtained in writing from people who agree to be clinical trial subjects prior to their enrollment in the study. The document must explain the risks associated with the study and treatment and describe alternative therapy available to the patient. A copy of the document must also be provided to the patient.
IDE (Investigational New Device Exemption): An IDE must be filed with the FDA prior to initiating clinical trials of medical devices considered to pose a significant risk to human subjects. IEEE (Institute of Electrical and Electronic Engineers): A standards body. ILEC (Incumbent Local Exchange Carrier): A traditional telephone company that was providing local service prior to the establishment of the Telecommunications Act of 1996, when upstart
Infrastructure: The telecommunications infrastructure is comprised of all of the cable and equipment installed in the worldwide telecommunications market. Most of today’s telecommunications infrastructure is connected by copper and fiber-optic cable, which represents a huge capital investment that telephone companies would
Plunkett Research, Ltd.
www.plunkettresearch.com
like to continue to utilize in as many ways as possible.
many types of Internet appliances will be of common use in homes in the near future.
INMARSAT: The International Maritime Satellite Organization operates a network of satellites used in international transmissions for all types of international mobile services, including maritime, aeronautical and land mobile.
Internet Telephony: This category of hardware and software enables users to utilize the Internet to make telephone calls, both local and long-distance. Also known as "voice over IP" or VoIP. Internet telephony is growing very rapidly, especially in such Asia Pacific nations as Japan and China.
Integrated Circuit (IC): Another name for a semiconductor, an IC is a piece of silicon on which thousands (or millions) of transistors have been combined. INTELSAT: The International Telecommunications Satellite Organization operates a network of 20 satellites, primarily for international transmissions, and provides domestic services to some 40 countries. Interactive TV: Allows two-way data flow between a viewer and the cable TV system. A user can exchange information with the cable system—for example, by ordering a product related to a show he/she is watching, or by voting in an interactive survey. Interexchange Carrier (IXC or IEC): Any company providing long-distance phone service between LECs and LATAs. (See "LEC" and "LATAs" below.) Interface: Refers to (1) a common boundary between two or more items of equipment or between a terminal and a communication channel, (2) the electronic device that interconnects two or more devices or items of equipment having similar or dissimilar characteristics or (3) the electronic device placed between a terminal and a communication channel to protect the network from the hazard of excess voltage levels. Internet: A global computer network that provides an easily accessible way for hundreds of millions of users to send and receive data electronically when appropriately connected via computers or wireless devices. Access is generally through HTML-enabled sites on the World Wide Web. Also known as "the Net." Internet Appliance: A non-PC device that connects users to the Internet for specific or general purposes. A good example is an electronic game machine with a screen and Internet capabilities. It is anticipated that
Intranet: A network protected by a firewall for sharing data and e-mail within an organization or company. Usually, intranets are used by organizations for internal communication. Investigator: In clinical trials, clinicians who agree to supervise the use of an investigational drug, device or biologic in humans. Responsibilities of the investigator include administering the drug, observing and testing the patient, collecting data and monitoring the care and welfare of the patient. Responsibilities of the investigator are defined in FDA regulations. IP Number/IP Address: A number or address with four parts that are separated by dots. Each machine on the Internet has its own IP (Internet protocol) number, which serves as an identifier. IRB (Institutional Review Board): This group of individuals is found in most medical institutions. The main function of the IRB is to review protocols for ethical consideration (to ensure the rights of the patients). Secondly, the IRB evaluates the benefit-torisk ratio of a new drug to see that the risk is acceptable for patient exposure. Responsibilities of the IRB are defined in FDA regulations. ISDN (Integrated Services Digital Networks): Internet connection services offered at higher speeds than standard "dial-up" service. While ISDN was considered to be an advanced service at one time, it has been eclipsed by much faster DSL, cable modem and T1 line service. ISO 9000, 9001, 9002: Standards set by the International Organization for Standardization for quality procedures. ISO 9000, 9001 and 9002 are the quality certifications for manufacturing. ISP (Internet Service Provider): A company that sells access to the Internet to individual subscribers. Leading examples are MSN and AOL.
Plunkett Research, Ltd.
IT (Information Technology): The systems, including hardware and software, that move and store voice, video and data via computers and telecommunications. ITU (International Telecommunications Union): The international body responsible for telephone and computer communications standards describing interface techniques and practices. These standards include those that define how a nation’s telephone and data systems connect to the worldwide communications network. Java: A programming language developed by Sun Microsystems that allows web pages to display interactive graphics. Java can be read by people using any type of computer or operating system. JPEG (Joint Photographic Experts Group): A widely used format for image files. Just-in-Time Delivery: Refers to a supply chain practice where manufacturers receive components on or just before the time that they are needed on the assembly line, rather than bearing the cost of maintaining several days' or weeks' supply in a warehouse. This adds greatly to the cost-effectiveness of a manufacturing plant and puts the burden of warehousing and timely delivery on the supplier of the components. Ka-Band: The frequency range from 18 to 31 GHz. The spectrum allocated for satellite communication is 30 GHz for the up-link and 20 GHz for the downlink. Kbps: One thousand bits per second. Kilobyte: A measure for 1,000 (to be exact, 1,024) bytes. Kilohertz (kHz): A measure of frequency equal to 1,000 Hertz. LAN (Local Area Network): A computer network that is generally within one office or one building. The LAN can be very inexpensive and efficient to set up when small numbers of computers are involved. It may require a network administrator and a serious investment if hundreds of computers are hooked up to the LAN. A LAN enables all computers within the office to share files and printers, to access common databases and to send e-mail to others on the network.
www.plunkettresearch.com
LATA (Local Access and Transport Area): Operational service areas established after the breakup of AT&T to distinguish local telephone service from long-distance service. The U.S. is divided into over 160 LATAs. Leased Line: A phone line that is rented for use in continuous, long-term data connections. LEC (Local Exchange Carrier): Any local telephone company, i.e., a carrier, that provides ordinary phone service under regulation within a service area. Also see "ILEC" and "CLEC." LINUX: An open, free operating system that is shared readily with millions of users worldwide. These users continuously improve and add to the software's code. It can be used to operate computer networks and Internet appliances as well as servers and PCs. LSI (Large-Scale Integration): The placement of thousands of electronic gates on a single chip. This makes the manufacture of powerful computers possible. MAN (Metropolitan Area Network): A data and communications network that operates over metropolitan areas and recently has been expanded to nationwide and even worldwide connectivity of highspeed data networks. A MAN can carry video and data. Managed Health Care: A system of prepaid plans providing comprehensive coverage to voluntarily enrolled members. Managed health care typically covers professional fees, hospital services, diagnostic services, emergency services, limited mental services, medical treatment for drug or alcohol abuse, home health services and preventive health care. Marketing: Includes all activities and expenses associated with the promotion of an item, such as selling and advertising costs, market research, public relations, royalties or commissions and souvenirs. Mbps (Megabits per second): One million bits transmitted per second. M-Commerce: Mobile e-commerce over wireless devices. Medical Device: See “Device” above.
Plunkett Research, Ltd.
Megabytes: A measure of 1 million bytes, or 1,024 kilobytes. Megahertz (MHz): A measure of frequency equal to 1 million Hertz. Metropolitan Area Network (MAN): See "MAN." Microprocessor: A computer on a digital semiconductor chip. It performs math and logic operations and executes instructions from memory. (Also known as a Central Processing Unit or CPU.) Microwave: Line-of sight, point-to-point transmission of signals at high frequency. Microwaves are used in data, voice and all other types of information transmission. The growth of fiber-optic networks has tended to curtail the growth and use of microwave relays. MIME (Multipurpose Internet Mail Extensions): A widely used method for attaching non-text files to e-mails. Modem: A device that allows a computer to be connected to a phone line, which in turn enables the computer to receive and exchange data with other machines via the Internet. Modulator: A device that modulates a carrier. Modulators are found in broadcasting transmitters and satellite transponders. The devices are also used by cable TV companies to place a baseband video television signal onto a desired VHF or UHF channel. Home video tape recorders also have built-in modulators that enable the recorded video information to be played back using a television receiver tuned to VHF channel 3 or 4. MPEG, MPEG-1, MPEG-2, MPEG-3: The Moving Picture Experts Group digital standards for the compression of motion or still video for transmission or storage. MRI (Magnetic Resonance Imaging): The use of a uniform magnetic field and radio frequencies to study the tissue and structure of the body. This procedure enables the visualization of biochemical activity of the cell in vivo without the use of ionizing radiation, radioisotopic substances or high-frequency sound.
www.plunkettresearch.com
MSP (Managed Service Provider): An outsourcer that deploys, manages and maintains the back-end infrastructure for Internet businesses. Multipoint Distribution System (MDS): A common carrier licensed by the FCC to operate a broadcastlike omni-directional microwave transmission facility within a given city. MDS carriers often pick up satellite pay-TV programming and distribute it, via their local MDS transmitter, to specially installed antennas and receivers. Nanotechnology: The science of designing, building or utilizing unique structures that are smaller than 100 nanometers. (A nanometer is one billionth of a meter.) Nanotechnology involves microscopic structures that might be no larger than the width of some cell membranes. NDA (New Drug Application): An application requesting FDA approval, after completion of Phase III studies, to market a new drug for human use in interstate commerce. Clinical trial results generally account for approximately 80% of the NDA. Network: In computing, a network is created when two or more computers are connected. Computers may be connected by wireless methods, using such technologies as 802.11b, or by a system of cables, switches and routers. Network Numbers: The first portion of an IP address, which identifies the network to which hosts in the rest of the address are connected. NIH (National Institutes of Health): A branch of the U.S. Public Health Service that conducts experimental research. www.nih.gov Node: Any single computer connected to a network or a junction of communications paths in a network. Nonclinical Studies: In vitro (laboratory) or in vivo (animal) pharmacology, toxicology and pharmacokinetic studies that support the testing of a product in humans. Usually at least two species are evaluated prior to Phase I clinical trials. Nonclinical studies continue throughout all phases of research to evaluate long-term safety issues.
Plunkett Research, Ltd.
www.plunkettresearch.com
NS (Nanosecond): A billionth of a second, a common unit of measure of computer operating speed.
Companies that market orphan drugs are granted a period of market exclusivity in return for the limited commercial potential of the drug.
NTIA (National Telecommunications and Information Administration): A unit of the Department of Commerce that addresses U.S. government telecommunications policy, standards setting and radio spectrum allocation. www.ntia.doc.gov
OS (Operating System): The software that allows applications like word processors or web browsers to run on a computer. For example, Windows 2000 is an operating system.
Nutraceutical: Nutrient + pharmaceutical – a food or part of a food that has been isolated and sold in a medicinal form and claims to offer benefits such as the treatment or prevention of disease. Object Technology: By merging data and software into "objects," a programming system becomes object-oriented. For example, an object called "weekly inventory sold" would have the data and programming needed to construct a flow chart. Some new programming systems–including Java–contain this feature. Object technology is also featured in many Microsoft products. (See "Java" above.) OC3, up to OC192: Very high-speed data lines that run at speeds from 155 to 9,600 Mbps. Online: When a device is online, it is turned on and connected to the Internet or to another device. Someone who is browsing a network or the Internet could be said to be online. Open Source: A software program for which the source code is openly available for modification and enhancement as various users and developers see fit. Open software is typically developed as a public collaboration and grows in usefulness over time. See "LINUX" above. Optical Character Recognition (OCR): An industry-wide classification system for coding information onto merchandise. Enables retailers to record information on each SKU when it is sold and to transmit that information to a computer. This is accomplished through computerized cash registers that include bar-code scanners (called point-of-sale terminals). Orphan Drug: A drug, biologic or antibiotic designated by the FDA as providing therapeutic benefit for an indication (disease or condition) affecting less than 200,000 people in the U.S.
OTC (Over-the-Counter): OTC drug products are FDA-regulated products that do not require a physician’s prescription. Some examples are aspirin, sunscreen, nasal spray and sunglasses. Packet Switching: A higher-speed way to move data through a network, in which files are broken down into smaller "packets" that are reassembled electronically after transmission. PC (Personal Computer): An affordable, efficient computer meant to be used by one person and frequently connected to a network as a client. PCMCIA: Personal Computer Memory Card International Association. Peer Review: The process used by the scientific community, whereby review of a paper, project or report is obtained through comments of independent colleagues in the same field. Perl (Practical Extraction and Report Language): A programming language geared towards text processing. Perl was developed by Larry Wall. Pharmacodynamics: The study of reactions between drugs and living systems. It can be thought of as the study of what a drug does to the body. Pharmacoeconomics: The study of the costs and benefits associated with various treatments. Pharmacokinetics (PK): The study of the processes of bodily absorption, distribution, metabolism and excretion of compounds and medicines. It can be thought of as the study of what the body does to a drug. (See “ADME” above.) Phase I Clinical Trials: Studies in this phase include initial introduction of an investigational drug into humans. These studies are closely monitored and are usually conducted in healthy volunteers. Phase I trials are conducted after the completion of extensive non-
Plunkett Research, Ltd.
clinical or pre-clinical trials not involving humans. Phase I studies include the determination of clinical pharmacology, bioavailability, drug interactions and side effects associated with increasing doses of the drug. Phase II Clinical Trials: Phase II studies include randomized, masked, controlled clinical studies conducted to evaluate the effectiveness of a drug for a particular indication(s). During Phase II trials, the minimum effective dose and dosing intervals should be determined. Phase III Clinical Trials: These studies consist of controlled and uncontrolled trials that are performed after preliminary evidence of effectiveness of a drug has been established. They are conducted to document the safety and efficacy of the drug, as well as to determine adequate directions (labeling) for use by the physician. A specific patient population needs to be clearly identified from the results of these studies. Trials during Phase III are conducted in a large number of patients to determine the frequency of adverse events and to obtain data regarding intolerance. Phase IV Clinical Trials: These studies are conducted after approval of a drug has been obtained to gather data supporting new or revised labeling, marketing or advertising claims. Pivotal Studies: In clinical trials, a Phase III trial that is designed specifically to support approval of a product. These studies are well-controlled (usually by placebo) and are generally designed with input from the FDA so that they will provide data that is adequate to support approval of the product. Two pivotal studies are required for drug product approval, but usually only one study is required for biologics. PLA (Product License Agreement): Required for the approval of a biologic, a PLA permits a manufacturer to produce a biological product for commercial purposes. (Compare to “ELA” above). Plug-In: Any small piece of software that adds extra functions to a larger piece of software. PMA (Pre-Market Approval): PMA is required for the approval of a new medical device or a device that is to be used for life-sustaining or life-supporting
www.plunkettresearch.com
purposes, is implanted in the human body or presents potential risk of illness or injury. POP: An acronym for both "Point of Presence" and "Post Office Protocol." Point of presence refers to a location that a network can be connected to (generally used to count the potential subscriber base of a cellular phone system). Post office protocol refers to the way in which e-mail software obtains mail from a mail server. Port: An interface (or connector) between the computer and the outside world. The number of ports on a communications controller or front-end processor determines the number of communications channels that can be connected to it. The number of ports on a computer determines the number of peripheral devices that can be attached to it. Portal: A comprehensive web site that is designed to be the first site seen when a computer logs on to the web. Portal sites are aimed at broad audiences with common interests and often have links to e-mail usage, a search engine and other features. Yahoo! and MSN.com are portals. Positron Emission Tomography (PET) Scanner : Nuclear medicine imaging technology that uses computers and radioactive (positron emitting) isotopes, which are created in a cyclotron or generator, to produce composite pictures of the brain and heart at work. PET scanning produces sectional images depicting metabolic activity or blood flow rather than anatomy. Post-Marketing Surveillance: The FDA’s ongoing safety monitoring of marketed drugs. Powerline: A method of networking computers, peripherals and appliances together via the electrical wiring that is built in to a home or office. Powerline competes with 802.11b and other wireless networking methods. Preclinical Studies: See “Nonclinical Studies” above. Protocol: A set of rules for communicating between computers. The use of standard protocols allows products from different vendors to communicate on a common network.
Plunkett Research, Ltd.
PSTN (Public Switched Telephone Network): A term that refers to the traditional telephone system. QOL (Quality of Life): In medicine, an endpoint of therapeutic assessment used to adjust measures of effectiveness for clinical decision-making. Typically, QOL endpoints measure the improvement of a patient’s day-to-day living as a result of specific therapy. R&D: Research and Development. Radiation Therapy: Frequently used to destroy cancerous cells, this branch of medicine is concerned with radioactive substances and the usage of various techniques of imaging, with the diagnosis and treatment of disease using any of the various sources of radiant energy. Services can include megavoltage radiation therapy, radioactive implants, stereotactic radiosurgery, therapeutic radioisotope facility or xray radiation therapy. Radioisotope: Radioisotopes have varying properties that allow them to penetrate objects at different rates. For example, a sheet of paper can stop an alpha particle, a beta particle can penetrate tissues in the body and a gamma ray can penetrate concrete. The varying penetration capabilities allow radioisotopes to be used in different ways. (Also called radioactive isotope or radionuclide.) RAM (Random Access Memory): Computer memory used to hold programs and data temporarily. RBOC (Regional Bell Operating Company): Former Bell system telephone companies (or their successors), created as a result of the breakup of AT&T by a Federal Court decree on December 31, 1983 (e.g., Southwestern Bell, now known as SBC). Real Time: A real-time system or software is one specially designed to acquire, process, store and display large amounts of rapidly changing information almost instantaneously, with microsecond responses as changes occur. Request for Bids (RFB): A firm that requires products or outsourced services sends a proposal outlining all requirements to various bidding companies. Proposing companies are asked to place a bid based on the requested goods or services.
www.plunkettresearch.com
Request for Qualifications (RFQ): Asks companies to submit qualifications to provide goods or perform a described level of service. It is used to screen who is qualified to respond to an RFB or RFP. Return on Investment (ROI): A measure of a company's profitability, expressed in percentage as: Net Profit (After Taxes)/Total Dollar Investment Router: An electronic link that enables two different local area networks to talk to each other, even though each network may be based on a different standard. S&R: Science and Research. SACD (Super Audio Compact Disc): A technology that offers high-resolution digital audio. SAN (Storage Area Network): Links host computers to advanced data storage systems. SBIR (Small Business Innovative Research): A three-phase program developed by the U.S. Department of Defense that allocates early-stage research and development funding to small technology companies. Scalable: Refers to a network that can grow and adapt as customer needs increase and change. Scalable networks can easily manage increasing numbers of workstations, servers, user workloads and added functionality. SCSI (Small Computer System Interface): A dominant, international standard interface used by UNIX servers and many desktop computers to connect to storage devices; a physical connection between devices. Semiconductor: A generic term for a device that controls electronic signals. It specifically refers to a material (such as silicon, germanium or gallium arsenide) that can be altered either to conduct electrical current or to block its passage. Server: A computer that performs and manages specific duties for a central network. It may include storage devices. Single Nucleotide Polymorphisms (SNPs): The most common type of genetic variation. SNPs are stable mutations consisting of a change at a single base in a DNA molecule. SNPs can be detected by
Plunkett Research, Ltd.
HTP analyses, for instance with gene chips, and they are then mapped by DNA sequencing. SLIP (Serial Line Internet Protocol): The connection of a traditional telephone line, or serial line, and modem to connect a computer to an Internet site.
www.plunkettresearch.com
Stem Cells: Found in human bone marrow, the blood stream and the umbilical cord, stem cells can be replicated indefinitely and can turn into any type of mature blood cell, including platelets, white blood cells or red blood cells. Also referred to as pluripotent cells. Study Coordinator: See “Coordinator” above.
SMDA (Safe Medical Devices Act): This Act became law in 1990 and amends the Food, Drug and Cosmetic Act to impose additional regulations on medical devices. SMDS (Switched Multimegabit Data Service): A method of extremely high-speed transference of data.
Supply Chain: The complete set of suppliers of goods and services required for a company to operate its business. For example, a manufacturer's supply chain may include providers of raw materials, components, custom-made parts and packaging materials.
SMTP (Simple Mail Transfer Protocol): The primary form of protocol used in the transference of e-mail.
Switch: A network device that directs packets of data between multiple ports, often filtering the data so that it travels more quickly.
SNMP (Simple Network Management Protocol): A set of communication standards for use between computers connected to TCP/IP networks.
T1: A standard for broadband digital transmission over phone lines. Generally, it can transmit at least 24 voice channels at once over copper wires, at a high speed of 1.5 million bps.
SNP: See “Single-Nucleotide Polymorphism” above. SONET (Synchronous Optical Network Technology): A mode of high-speed transmission meant to take full advantage of the wide bandwidth in fiber-optic cables. SPECT (Single Photon Emission Computerized Tomography): A nuclear medicine imaging technology that combines existing technology of gamma camera imaging with computed tomographic imaging technology to provide a more precise and clear image. Sponsor: The individual or company that assumes responsibility for the investigation of a new drug, including compliance with the FD&C Act and regulations. The sponsor may be an individual, partnership, corporation or governmental agency and may be a manufacturer, scientific institution or investigator regularly and lawfully engaged in the investigation of new drugs. The sponsor assumes most of the legal and financial responsibility of the clinical trial. SRDF (Symmetrix Remote Data Facility): A highperformance, host-independent business solution that enables users to maintain a duplicate copy of all or some of their data at a remote site.
T3: This type of transmission over phone lines supports data rates of 45 Mbps. T3 lines consist of 672 channels, and such lines are generally used by Internet service providers. These lines are also referred to as DS3 lines. (Also see “OC3.”) Target: The proteins involved in a specific disease. Drug compounds stick to specific targets in order to have the greatest positive effect and cut down on the incidence of side effects. Taste Masking: The creation of a barrier between a drug molecule and taste receptors so the drug is easier to take. It masks bitter or unpleasant tastes. TBT: Technical Barriers to Trade. TCP/IP (Transmission Control Protocol/Internet Protocol): The combination of a network and transport protocol developed by ARPANET for internetworking IP-based networks. TDMA (Time Division Multiple Access): A digital service for relatively large users of international public-switched telephony, data, facsimile and telex. TDMA also refers to a method of multiplexing digital signals that combines a number of signals passing through a common point by transmitting them
Plunkett Research, Ltd.
sequentially, with each signal sent in bursts at different times. Telecommunications: Systems of hardware and software used to carry voice, video and/or data between locations. This includes telephone wires, satellite signals, cellular links, coaxial cable and related devices. Telnet: A terminal emulation program for TCP/IP networks like the Internet, which runs on a computer and connects to a particular network. Directions entered on a computer that is connected using Telnet will be read and followed just as if they had been entered on the server itself. Through Telnet, users are able to control a server and communicate with other servers on the same network at the same time. Telnet is commonly used to control web servers remotely. TESS: See “AE” above. Token Ring: A local area network architecture in which a token, or continuously repeating frame, is passed sequentially from station to station. Only the station possessing the token can communicate on the network. Transistor: Device used for amplification or switching of electrical current. Trial Coordinator: See “Coordinator” above. UDDI: Universal Description, Discovery and Integration (UDDI), a vital protocol used in Web services. UDDI enables businesses to create a standard description of their activities so that they can be searched for appropriately by automatic software tools. Ultrasound: The use of acoustic waves above the range of 20,000 cycles per second to visualize internal body structures. Frequently used to observe a fetus.
www.plunkettresearch.com
UNIX: A multi-user, multitasking operating system that runs on a wide variety of computer systems, from PCs to mainframes. URL (Uniform Resource Locator): The address that allows an Internet browser to locate a homepage or web site. Utilization Review (or Utilization Management): A system where utilization case managers (frequently registered nurses with several years of hospital experience behind them) are assigned to each patient who receives hospitalization or extended treatment. These case managers constantly review the amount of care being provided to the patient in question, frequently resulting in significant cost savings. UWB: See "Ultrawideband" above. Validation of Data: The procedure carried out to ensure that the data contained in a final clinical trial report match the original observations. VDSL: Very high data rate digital subscriber line, operating at data rates from 12.9 to 52.8 MBPS. Vertical Integration: A business model in which one company owns many (or all) of the means of production of the many goods that comprise its product line. For example, Ford Motor Company's early River Rogue plant was designed by founder Henry Ford so that coal, iron ore and other needed raw materials arrived at one end of the plant and were processed into steel, which was then converted onsite into finished components. At the final stage of the plant, completed automobiles were assembled. Very Small Aperture Terminal (VSAT): A small Earth station terminal, generally 0.6 to 2.4 meters in size, that is often portable and primarily designed to handle data transmission and private-line voice and video communications. VOIP (Voice over IP): See "Internet Telephony."
Ultrawideband: A means of low-power, limitedrange wireless data transmission that takes advantage of bandwidth recently set aside by the FCC. Ultrawideband, or UWB, encodes signals in a dramatically different way, sending digital pulses in a relatively secure manner that will not interfere with other wireless systems that may be operating nearby.
VSAT (Very Small Aperture Terminal): A small Earth station terminal, generally between 0.6 and 2.4 meters in size, which is often portable and primarily designed to handle data transmission and private-line voice and video communications.
Plunkett Research, Ltd.
WAN (Wide Area Network): The other office network (see "LAN"), the WAN stretches over a long distance, usually connecting several buildings or locations. WAP (Wireless Access Protocol): A technology that enables the delivery of World Wide Web pages in a smaller format readable by screens on cellular phones. Web Page: A document on the World Wide Web that is identified by a URL. Web Site: A specific domain name location on the World Wide Web. Each site, which contains a homepage, usually consists of additional documents. Webcasting: The act of using the Internet (the World Wide Web, usually) to broadcast information or entertainment. Webmaster: Any individual who runs a web site. Webmasters generally perform maintenance and upkeep. WHO: World Health Organization. Assists governments in strengthening health services, furnishing technical assistance and aid in emergencies, working on the prevention and control of epidemics and promoting cooperation among different countries to improve nutrition, housing, sanitation, recreation and other aspects of environmental hygiene. Any country that is a member of the United Nations may become a member of the WHO by accepting its constitution. The WHO currently has 191 member states. Wi-Fi: A popular phrase that means 802.11b and other 802.11 specifications. See "802.11b" above. Wi-Fi5: A popular phrase that means 802.11a. See "802.11a" above. WLAN: A wireless local area network. WLANs frequently operate on 802.11-enabled equipment. Workstation: A high-powered desktop computer, usually used by engineers. World Wide Web: A computer system that provides enhanced access to various sites on the Internet through the use of hyperlinks. Clicking on a link displayed in one document takes you to a related
www.plunkettresearch.com
document. The World Wide Web is governed by the World Wide Consortium, located at www.w3.org. Also known as "the web." WSDL: An important protocol to web services, WSDL (web services description language) describes the web service being offered. XML (Extensible Markup Language): A programming language that enables designers to add extra functionality to documents that could not otherwise be utilized with standard HTML coding. XML was developed by the World Wide Web Consortium. It can communicate to various software programs the actual meanings contained in HTML documents. For example, it can enable the gathering and use of information from a large number of databases at once and place that information into one web site window. XML is an important protocol to web services.
Plunkett Research, Ltd.
www.plunkettresearch.com
INTRODUCTION
PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC, the second edition of our guide to the engineering and research field, is designed as a general source for researchers of all types. The data and areas of interest covered are intentionally broad, from the various types of businesses involved in engineering and research, to advances in biotechnology, to an in-depth look at the 500 major firms (which we call “THE ENGINEERING 500”) within the many sectors that make up the engineering and research industry, including energy, infotech, transportation and much more. This reference book is designed to be a general source for researchers. It is especially intended to assist with market research, strategic planning, employment searches, contact or prospect list creation (be sure to see the export capabilities of the accompanying CD-ROM that is available to book and eBook buyers) and financial research, and as a data resource for executives and students of all types. PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC takes a rounded approach for the general reader. This book presents a complete overview of the engineering and research field (see “How To Use This Book”). For example, advances in
design automation are discussed, as well as changes in research and development spending and patents. THE ENGINEERING 500 (the actual count is 468 firms) is our unique grouping of the biggest, most successful corporations in all segments of the engineering and research industry. Tens of thousands of pieces of information, gathered from a wide variety of sources, have been researched and are presented in a unique form that can be easily understood. This section includes thorough indexes to THE ENGINEERING 500, by geography, industry, sales, brand names, subsidiary names and many other topics. (See Chapter 4.) Especially helpful is the way in which PLUNKETT'S ENGINEERING AND RESEARCH INDUSTRY ALMANAC enables readers who have no business background to readily compare the financial records and growth plans of engineering companies and major industry groups. You’ll see the mid-term financial record of each firm, along with the impact of earnings, sales and strategic plans on each company’s potential to fuel growth, create new technologies and provide investment and employment opportunities. No other source provides this book’s easy-tounderstand comparisons of growth, expenditures, technologies, imports/exports, corporations, research and many other items of great importance. The
Plunkett Research, Ltd.
information within is crucial to people of all types who may be studying this, one of the most important industries in the world today.
www.plunkettresearch.com
•
This volume is intended to be a general guide to a quickly growing industry. That means that researchers should look to this book for an overview and, when conducting in-depth research, should contact the specific corporations or industry associations in question for the very latest changes and data. Where possible, we have listed contact names, toll-free telephone numbers and World Wide Web site addresses for the companies, government agencies and industry associations involved so that the reader may get further details without unnecessary delay.
•
Tables of industry data and statistics used in this book include the latest numbers available at the time of printing, generally through the end of 2001 or 2002.
•
We have used exhaustive efforts to locate and fairly present accurate and complete data. However, when using this book or any other source for business and industry information, the reader should use caution and due diligence by conducting further research where it seems appropriate. We wish you success in your endeavors, and we trust that your experience with this book will be both satisfactory and productive.
By scanning the data groups and the unique indexes, you can find the best information to fit your personal research needs. The best major companies are profiled and then ranked using several different groups of specific criteria. Which firms are the biggest employers? Which companies earn the most profits? These things and much more are easy to find. In addition to individual company profiles, an overview of global and domestic research and development and its trends is provided. This book’s job is to help you sort through easy-to-understand summaries of today’s technologies and trends in a quick and effective manner. Whatever your purpose for researching the engineering and research field, you’ll find this book to be a valuable guide. Nonetheless, as is true with all resources, this volume has limitations that the reader should be aware of: •
Financial data and other corporate information can change quickly. A book of this type can be no more current than the data that was available as of the time of editing. Consequently, the financial picture, management and ownership of the firm(s) you are studying may have changed since the date of this book. For example, this almanac includes the most up-to-date sales figures and profits available to the editors as of mid 2003. That means that we have typically used corporate financial data as of mid- to late 2002.
•
Corporate mergers, acquisitions and downsizing are occurring at a very rapid rate. Such events may have created significant change, subsequent to the publishing of this book, within a company you are studying.
•
Some of the companies in THE ENGINEERING 500 are so large in scope and in variety of business endeavors conducted within a parent organization that we have been unable to completely list all subsidiaries, affiliations, divisions and activities within a firm’s corporate structure.
Jack W. Plunkett Houston, Texas July 2003
Plunkett Research, Ltd.
www.plunkettresearch.com
HOW TO USE THIS BOOK
The two primary sections of this book are devoted first to an overview of the engineering and research industry and then to the “Individual Data Listings” for THE ENGINEERING 500. If time permits, you should begin your research in the front chapters of this book. Also, you will find lengthy indexes in Chapter 4 and in the back of the book.
Chapter 3: Engineering and Research Industry Contacts – Addresses, Telephone Numbers and World Wide Web Sites. This chapter covers contacts for important government agencies and industry associations. Included are numerous web sites. THE ENGINEERING 500
THE ENGINEERING AND RESEARCH INDUSTRY Glossary: A short list of engineering and research terms. Chapter 1: Major Trends in the Engineering and Research Industry. This chapter presents an encapsulated view of the major trends that are creating rapid changes in the engineering and research industry today. These trends range from changes in venture capital to fluctuations in research and development spending to the recent emphasis on nanotechnology. Chapter 2: Engineering and Research Industry Statistics. This chapter contains charts and tables tracking the scope of the industry.
Chapter 4: THE ENGINEERING 500: Who They Are and How They Were Chosen. The companies compared in this book (the actual count is 468 firms) were carefully selected from the engineering and research industry, primarily in the United States with 64 major foreign firms also included. For a complete description, see THE ENGINEERING 500 indexes in this chapter. Individual Data Listings: Look at one of the companies in THE ENGINEERING 500’s Individual Data Listings. You’ll find the following information fields: Company Name: The company profiles are in alphabetical order by company name. If you don’t find the company you are seeking, it may be a subsidiary or division of one of the firms covered in this book. Try looking it up in
Plunkett Research, Ltd.
the Index by Subsidiaries, Brand Names and Selected Affiliations in the back of the book. Ranks: Industry Group Code: An NAIC code used to group companies within like segments. (See Chapter 4 for a list of codes.) Ranks Within This Company’s Industry Group: Ranks, within this firm’s segment only, for annual sales and annual profits, with 1 being the highest rank. Business Activities: A grid arranged into five major industry categories and several sub-categories. A “Y” indicates that the firm operates within the sub-category. A complete Index by Industry is included in the beginning of Chapter 4. Types of Business: A listing of the primary types of business specialties conducted by the firm. Brands/Divisions/Affiliations: Major brand names, operating divisions or subsidiaries of the firm, as well as major corporate affiliations – such as another firm that owns a significant portion of the company’s stock. A complete Index by Subsidiaries, Brand Names and Selected Affiliations is in the back of the book. Contacts: The names and titles up to 27 top officers of the company are listed, including human resources contacts. Address: The firm’s full headquarters address, the headquarters telephone, plus toll-free and fax numbers where available. Also provided is the World Wide Web site address. Financials: Annual Sales (2002 or the latest fiscal year available to the editors, plus up to four previous years): These are stated in thousands of dollars (add three zeros if you want the full number). This figure represents consolidated worldwide sales from all operations. 2002 figures may be estimates or may be for only part of the year—partial year figures are appropriately footnoted. Annual Profits (2002 or the latest fiscal year available to the editors, plus up to four previous years): These are stated in thousands of dollars (add three zeros if you want the full number). This figure represents consolidated, after-tax net profit from all operations. 2002 figures may be estimates or may be for only part of the year—partial year figures are appropriately footnoted.
www.plunkettresearch.com
Stock Ticker: When available, the unique stock market symbol used to identify this firm’s common stock for trading and tracking purposes is indicated. Where appropriate, this field may contain “private” or “subsidiary” rather than a ticker symbol. Total Number of Employees: The approximate total number of employees, worldwide, as of the end of 2002 (or the latest data available to the editors). Apparent Salaries/Benefits: A “Y” in appropriate fields indicates “Yes.” Due to wide variations in the manner in which corporations report benefits to the U.S. Government’s regulatory bodies, not all plans will have been uncovered during our effort to research this data. Also, the availability to employees of such plans will vary according to the qualifications that employees must meet to become eligible. For example, some benefit plans may be available only to salaried workers—others only to employees who work more than 1,000 hours yearly. Benefits that are available to employees of the main or parent company may not be available to employees of the subsidiaries. NOTE: Generally, employees covered by wealthbuilding benefit plans do not fully own (“vest in”) funds contributed on their behalf by the employer until as many as five years of service with that employer have passed. Pension Plan: The firm offers a pension plan to qualified employees. The type and generosity of these plans vary widely from firm to firm. Caution: Some employers refer to plans as “pension” or “retirement” plans when they are actually 401(k) savings plans that require a contribution by the employee. True pension plans are rarely offered. ESOP Stock Plan (Employees’ Stock Ownership Plan): This type of plan is in wide use. Typically, the plan borrows money from a bank and uses those funds to purchase a large block of the corporation’s stock. The corporation makes contributions to the plan over a period of time, and the stock purchase loan is eventually paid off. The value of the plan grows significantly as long as the market price of the stock holds up. Qualified employees are allocated a share of the plan based on their length of service and their level of salary. Savings Plan, 401(k): Under this type of plan, employees make a tax-deferred deposit into an account. In the best plans, the company makes annual matching donations to the employees’ accounts, typically in some proportion to deposits made by the employees themselves. A good plan will match onehalf of employee deposits of up to 6% of wages. For example, an employee earning $30,000 yearly might
Plunkett Research, Ltd.
deposit $1,800 (6%) into the plan. The company will match one-half of the employee’s deposit, or $900. The plan grows on a tax-deferred basis, similar to an IRA. A very generous plan will match 100% of employee deposits. However, some plans do not call for the employer to make a matching deposit at all. Other plans call for a matching contribution to be made at the discretion of the firm’s board of directors. Actual terms of these plans vary widely from firm to firm. Generally, these savings plans allow employees to deposit as much as 15% of salary into the plan on a tax-deferred basis. However, the portion that the company uses to calculate its matching deposit is generally limited to a maximum of 6%. Stock Purchase Plan: Qualified employees may purchase the company’s common stock at a price below its market value under a specific plan. Typically, the employee is limited to investing a small percentage of wages in this plan. These plans usually offer a 15% discount, but the discount may range from 5 to 15%. Some of these plans allow for deposits to be made through regular monthly payroll deductions. Profit Sharing: Qualified employees are awarded an annual amount equal to some portion of a company’s profits. In a very generous plan, the pool of money awarded to employees would be 15% of profits. Typically, this money is deposited into a long-term retirement account. Caution: Some employers refer to plans as “profit sharing” when they are actually 401(k) savings plans. True profit sharing plans are rarely offered. Highest Executive Salary: The highest executive salary paid, typically a 2002 amount (or the latest year available to the editors) and typically paid to the Chief Executive Officer. Highest Executive Bonus: The apparent bonus, if any, paid to the above person. Second Highest Executive Salary: The nexthighest executive salary paid, typically a 2002 amount (or the latest year available to the editors) and typically paid to the President or Chief Operating Officer. Second Highest Executive Bonus: The apparent bonus, if any, paid to the above person. Competitive Advantage: A brief statement regarding an outstanding feature that gives the firm an edge in the marketplace. Other Thoughts: Apparent Women Officers or Directors: It is difficult to obtain this information on an exact basis, and employers generally do not disclose the data in a
www.plunkettresearch.com
public way. However, we have indicated what our best efforts reveal to be the apparent number of women who either are in the posts of corporate officers or sit on the board of directors. There is a wide variance from company to company. Hot Spot for Advancement for Women/ Minorities: A “Y” in appropriate fields indicates “Yes.” These are firms that appear either to have posted a substantial number of women and/or minorities to high posts or that appear to have a good record of going out of their way to recruit, train, promote and retain women or minorities. (See the Index of Hot Spots For Women and Minorities in the back of the book.) This information may change frequently and can be difficult to obtain and verify. Consequently, the reader should use caution and conduct further investigation where appropriate. Growth Plans/ Special Features: Listed here are observations regarding the firm’s strategy, hiring plans, plans for growth and product development, along with general information regarding a company’s business and prospects. Locations: A “Y” in the appropriate field indicates “Yes.” Primary locations outside of the headquarters, categorized by regions of the United States and by international locations. A complete index by locations is also in the front of this chapter.
Plunkett Research, Ltd.
www.plunkettresearch.com
Chapter 1 Major Trends in the Engineering and Research Industry Major Trends to Watch 1) 2) 3) 4) 5) 6) 7) 8) 9) 10) 11)
Continued Rapid Growth in the Biotech Sector Continued Caution in Investment in New Technology Startup Companies Continued Growth in the Sharing of R&D Initiatives Among Major Corporate Partners Globalization of the Research Efforts of Major Corporations Emphasis on Research and Development in Nanotechnology Continued Growth in Research Partnerships Between Corporations and Universities Continued Growth in Research and Development Spending in the U.S., Despite the Economic Downturn Growth in Defense Research Post 9/11 Number of Patent Applications Soars Growth in the Automation of Research and Design Energy Technology Research Receives Growing Attention, Particularly in Alternative Energy
A Short History of U.S. Industrial Research & Development Corporate research efforts at an organized level began in the chemical dyes industry in Europe in the mid-1800s and soon were launched at a fairly rapid rate in America. In 1876, at the age of 29, Thomas Alva Edison opened a private laboratory in Menlo
Park, New Jersey. Edison’s efforts led to his recordsetting 1,093 U.S. patents, including those for the phonograph and the incandescent light bulb. Edison’s creativity and drive eventually enabled the birth of what would become the General Electric Company, still one of the world’s premier research and manufacturing organizations. By 1900, about 40 various corporate research facilities were operating in the U.S. Rapid acceleration was fostered by a growing middle class that created demand for new products, and later was especially fueled by the intense demands for leading-edge armaments, transport and other products created by World War II. During the war, a man named Vannevar Bush was posted as the director of the Office of Scientific Research and Development within the U.S. Government. Bush’s mandate was to spur intense innovation that would give America a technological edge in warfare. The results, over an astonishingly short period of time, ranged from advanced radar to the atomic bomb. Bush argued persuasively for a long-term federal commitment to supporting industrial research. By 1962, the Federal Government was subsidizing nearly 60% of America’s corporate research budget, for everything from medical breakthroughs to electronics to defense systems. Thereafter, corporations rapidly increased their own investments in research and development efforts, resulting in a nationwide research base of unprecedented scope and cost. By 1992, however, corporate restructuring and cost cutting led to a brief period of retrenching and corporate research budget slashing.
Plunkett Research, Ltd.
In the mid-1990s, companies creating or embracing new technologies were among the most exciting and successful firms in America. As companies were striving to compete, the floodgates of research dollars were once again cranked open. Corporate America’s investments in R&D have climbed at an impressive rate nearly every year since 1996, while Federal Government investments in research have risen at a steady rate. Today, the Federal Government provides about 30% of all research dollars spent in the U.S. As a result, a disproportionate share of America’s economic growth has been created by the technology sector, and the R&D population has blossomed, such that today there are approximately 15,000 corporate research laboratories in America. They employ about 750,000 professionals and invest about $300 billion yearly in research and development. Approximately 20,000 additional U.S. firms conduct R&D at a significant level outside of dedicated labs. Despite the massive scope and highly competitive nature of corporate research, many major companies succeed without significant research efforts. Instead, they rely on components or processes developed by others. A good example is the personal computer manufacturing industry, where leaders Dell and Gateway grew very rapidly by building and marketing computers constructed from components, like hard drives and semiconductors, that were created through the research and development efforts of their suppliers. (Dell has now grown to the point that it has many engineers on its own staff, but it still relies heavily on components developed by suppliers.) A final important thought about the development of industrial R&D: Depending on the nature of their industries, various firms enter into research with widely varying expectations. For example, while aircraft maker Boeing invests nearly $2 billion in R&D yearly, that effort may yield a completely new aircraft model only once every eight or 10 years. In contrast, semiconductor maker Intel, which invests about $4 billion yearly in R&D, introduces breakthrough chip designs on a continual basis and invests only a tiny amount of its total budget in truly long-term research. (See “Intel” below.) Pharmaceutical makers are accustomed to a research-to-market cycle of as long as 10 years in order to discover, develop and commercially launch a new drug. In short, some companies are driven to vast R&D efforts in order to compete in their own rapidly evolving industries, while others patiently invest in long-term R&D hoping it will pay off handsomely through the introduction of entirely new types of
www.plunkettresearch.com
products several years hence. In 2001, publicly held drug firms in the U.S. invested over $15 billion in research and development—double the amount invested in 1994. Nonetheless, the industry launched only 24 new drugs. Here are 11 Major Trends to Watch in Research and Engineering: 1) Continued Rapid Growth in the Biotech Sector Rapid advances in genomics, proteonics and bioinformatics will lead to the introduction of a large number of new genetically engineered drugs over the mid-term. As of mid-2003, there were already approximately 153 approved drugs and 350 drugs in clinical trials that were developed through biotechnology methods. (That is, the use of technology to identify and alter the biological state of a human patient or an organism, such as the use of a drug to change the nature of a human cell. This is a radically different approach to fighting disease from traditional antibiotic methods such as penicillin.) In the most recent economic boom, particularly during late 1999 and much of 2000, venture capitalists and investment bankers bet heavily on biotech, which they saw as a promising technology-based alternative to investing in information technologies such as the Internet. A veritable frenzy of new financing poured into biotech startup companies and initial public offerings (IPOs) in 2000, which funded very aggressive research, development and marketing plans. New investments in U.S. biotech firms totaled about $32 billion in 2000—more than had been invested during the previous six years combined. The level of funding dropped quickly thereafter, largely as a result of the technology industry crash of 2000. New U.S. biotech capital totaled only $12 billion in 2001 (including venture capital, sales of stock and other means), and about $10 to $12 billion in 2002. Future levels of new funding will depend to a large extent on the ability of young biotech firms to get their new drugs successfully through Phase III trials and into the marketplace. Much of the investment burden will be borne by mature, global drug firms that partner with or acquire smaller biotech companies. The U.S. leads the world in biotechnology R&D. While firms in European nations are making serious biotech efforts, Europe as a whole is leagues behind America in the total amount invested in this field.
Plunkett Research, Ltd.
Stem cell and cloning controversies abound in the U.S. while research in these fields flourishes overseas. During the 1980s, a biologist at Stanford University, Irving L. Weissman, was the first to isolate the stem cell that builds human blood (the mammalian hematopoietic cell). Later, Weissman isolated a stem cell in a laboratory mouse and went on to co-found SysTemix, Inc. (now part of drug giant Novartis) and StemCells, Inc. to continue this work in a commercial manner. In November 1998, two different university-based groups of researchers announced that they had accomplished the first isolation and characterization of the human embryonic stem cell (ESC). James A. Thomson at the University of Wisconsin at Madison led one group. John D. Gearhart at the Johns Hopkins University School of Medicine at Baltimore led the second. The ESC is among the most versatile basic building blocks in the human body. Embryos, when first conceived, begin creating small numbers of ESCs, and these cells eventually differentiate and develop into the 200+ cell types that make up the distinct tissues and organs of the human body, from bones to brains. If scientists can reproduce and then guide the development of these basic ESCs, they could theoretically grow replacement organs and tissues in the laboratory—even such complicated tissue as brain cells or heart cells. Ethical and regulatory difficulties have arisen from the fact that the only source for human embryonic stem cells is, logically enough, human embryos. A laboratory can obtain these cells in one of three ways: 1) By inserting a patient’s DNA into an egg and thus producing a blastocyst that is a clone of the patient— which is then destroyed after only a few days of development; 2) by harvesting stem cells from aborted fetuses; or 3) by harvesting stem cells from embryos that are left over and unused after an in vitro fertilization of a hopeful mother. (Artificial in vitro fertilization requires the creation of a large number of test tube embryos per instance, but only one of these embryos is used in the final process.) A rich source of similar but non-embryonic stem cells is bone marrow. Doctors have been performing bone marrow transplants in humans for years. This procedure essentially harnesses the healing power of stem cells, which proliferate to create healthy new blood cells in the recipient. Several other nonembryonic stem cell sources have great promise (see below). In the fall of 2001, a small biotech company called Advanced Cell Technology announced the first cloning of a human embryo. The announcement set
www.plunkettresearch.com
off yet another firestorm of rhetoric and debate on the scientific and ethical questions that cloning and related stem cell technology inspire. While medical researchers laud the seemingly infinite possibilities stem cells promise for fighting disease and the aging process, conservative theologians, policy makers and pro-life groups decry the harvest of cells from aborted fetuses and the possibility of cloning as an ethical and moral abomination. Congress, under the Bush Administration, has banned the use of federal funding for the creation of new embryonic stem cell lines. This action was taken in spite of impassioned testimony regarding the healing potential of stem cells by physicians, researchers and celebrities, such as actor Michael J. Fox on behalf of research for Parkinson's disease, actor Christopher Reeve for spinal injury study and former first lady Nancy Reagan on behalf of Alzheimer's research. Stem cell research has been underway for years at biotech companies including Stem Cells, Inc., Geron and ViaCell. One company, Osiris Therapeutics, has been at work long enough to have several clinical trial programs in progress. The potential benefits are staggering. Through stem cell therapies, neurological disorders could be reversed with the growth of healthy cells in the brain. Injured cells in the spinal column could be regenerated and function fully again. Damaged organs such as hearts, livers and kidneys could be infused with healthy cells. Stem cell (and cloning) research activity is brisk in certain nations outside the U.S. To begin with, certain institutions around the world have stem cell lines in place, and some make them available for purchase. Groups that own existing lines include the National University of Singapore, Monash University in Australia and Hadassah Medical Centre in Israel. More importantly, several Asian nations, including Singapore, South Korea, Japan and China, are investing intensely in biotech research centered on cloning and the development of stem cell therapies. The global lead in the development of stem cell therapies may eventually pass to China, where the Chinese Ministry of Science and Technology readily sees the commercial potential and is enthusiastically funding research. In addition to funding from the Chinese government, investments in labs and research are being backed by Chinese universities, private companies, venture capitalists and Hong Kong investors. Meanwhile, back in the U.S., in December 2002 Stanford University announced plans to develop a privately funded library of human stem cell lines,
Plunkett Research, Ltd.
which means it will be able to operate outside of the restrictions placed on federally funded ESC research and development. It is the first U.S. university to take this path. Potential methods of developing “post-embryonic” stem cells without the use of human embryos: • • • • •
Parthenogenesis—manipulation of unfertilized eggs. Adult Stem Cells—harvesting of stem cells from bone marrow or brain tissue. Other Cells—harvesting of stem cells from human placentas or other cells. De-Differentiation—use of the nucleus of an existing cell, such as a skin cell, that is altered by an egg that has had its own nucleus removed. Transdifferentiation—making a skin cell dedifferentiate back to its primordial state so that it can then morph into a useable organ cell, such as heart tissue.
ESCs (typically harvested from five-day-old human embryos which are destroyed during the process) are used because of their ability to evolve into any cell or tissue in the body. Their versatility is undeniable, yet the implications of the death of the embryo are at the heart of the ethical and moral concerns. Meanwhile, scientists have discovered that there are stem cells in existence in many diverse places in the adult human body, and they are thus succeeding in creating stem cells without embryos, from “postembryonic” cells. Such cells are already showing the ability to differentiate and function in animal and human recipients. Best of all, these types of stem cells are not plagued by problems found in the use of ESCs, such as the tendency to form tumors when ESCs develop into differentiated cells. For scientists, the biggest challenge at present may be to discover the exact process by which stem cells are signaled to differentiate. (Differentiation is the molecular programming that causes stem cells to grow into specific types of tissue such as heart tissue or brain tissue.) Another immense challenge lies in the fact that broad use of therapeutic cloning may require immense numbers of human eggs in which to grow blastocysts.
www.plunkettresearch.com
2) Continued Caution in Investment in New Technology Startup Companies After the crash in tech company stocks in 2000, investors have been downright skittish about putting money into new technology ventures. In 2002, only $850 million was invested by venture capital firms in 110 new and existing companies (of all types), compared to $13.1 billion invested in 750 companies during the peak year of 2000. As for firms able to go public, the start of 2003 has seen a mere four IPOs of American corporations, tech-based or not, as of the end of April. (There were 158 during the same period in 2000.) However, the dark days of tech companies appear to be waning with recent technological advances and a small rebound of the tech stock market. Slowly, investors are beginning to test the waters again. For example, venture capital firm Draper Fisher Jurvetson has invested $47.5 million in 13 firms involved in the exciting new field of nanotechnology since 2000. Over the mid-term, watch for more careful, slow investment in technology firms that are up and running and have respectable numbers with regard to sales and profits. In order to receive scarce venture capital, tech companies must prove that they understand the importance of the bottom line. This depressed climate in venture capital investment is having a seriously detrimental effect on research and development overall. In recent years, many exciting new technologies were developed thanks to basic and applied research conducted by startup companies that were financed by venture capital firms and later by IPOs. While professional venture capital investors know that only about three out of 10 companies they invest in will succeed to any significant degree, they also know that occasionally research conducted at one of those startup firms will create something truly significant and will reap immense profits. Nonetheless, the venture capital market will remain sluggish until (if ever) the stock market regains serious enthusiasm for initial public stock offerings (IPOs) from young firms. This is due to the fact that selling stock in an IPO is the prime method for reaping a cash profit from a venture capital investment. 3) Continued Growth in the Sharing of R&D Initiatives Among Major Corporate Partners In fields as diverse as telecommunications, semiconductors, alternative energy, aerospace, transportation and pharmaceuticals, major corporations are sharing the increasingly immense costs of research and development. These efforts may
Plunkett Research, Ltd.
www.plunkettresearch.com
InnoCentive, a unique, online collaborative research effort: At www.innocentive.com, drug maker Eli Lilly has created a collaborative research portal. Companies needing answers to research problems can post details regarding their projects, along with a stated fee they are willing to pay for completion of research needs. Scientists and engineers from anywhere in the world can log in to select projects to work on. Fees offered run from a few thousand dollars to $50,000. Participants who log in may choose to view the site in English, Chinese, German, Russian or Spanish. The site was launched in June 2001. By May 2003, 23,000 scientists, graduate students and researchers of various types had participated. InnoCentive’s management expects to have more than 30 corporate clients posting their research requests by the end of 2003. Many of these clients prefer to remain anonymous.
as overnight international courier services and wellestablished jet airliner service to nearly anywhere in the world, helps to spur globalization on. Meanwhile, there are legions of extremely well educated scientists and engineers in areas such as India, China and Eastern Europe who can be hired for salaries that are significantly below those of their U.S.-based peers. These factors all combine to make globalized research efforts attractive for many reasons. For example, a major automotive, pharmaceutical, software or hardware company in the U.S. can create a cost-effective, 24/7 research department by handing off research or design work from America to Russia to India to Japan—it will always be daylight in some part of the world, and collaboration software makes it possible for employees to work together on the same project from anyplace on the planet. The hottest spot for U.S. firms to open foreign research centers is the city of Bangalore in India. Initially a center for writing software code, Bangalore’s supply of highly educated, Englishspeaking residents has enabled the city to evolve into a truly world-class research and development center. The labor pool is not only high-quality but also lowcost. Well-paid software engineers earn in the $10,000 to $15,000 range yearly, with PhDs earning up to $30,000—salaries much lower than those in the U.S. Intel will have 3,000 R&D people working in Bangalore by 2005. Software maker Oracle already has about 2,500, and Microsoft is investing heavily in research within India. India isn’t the only nation enjoying growth in research and engineering jobs fostered by U.S., Japanese or Western European firms. In Eastern Europe, such nations as Hungary, Poland, the Czech Republic and Romania offer well-trained people who speak English and/or German. Russia has a growing assortment of research offices funded by foreigners, and China may become a significant development center for foreign multinationals.
4) Globalization of the Research Efforts of Major Corporations Globalization is deeply affecting the corporate world at all levels. This can be seen in everything from the flood of inexpensive consumer goods flowing into the U.S. from manufacturers in China, to the growing business that American software makers are finding overseas. The advent of extremely fast communication systems, such as the Internet, global fiber-optic lines, e-mail and instant messaging, as well
5) Emphasis on Research and Development in Nanotechnology Nanotechnology is the science of designing, building or utilizing unique structures that are smaller than 100 nanometers. (A nanometer is one-billionth of a meter.) The science involves microscopic structures that might be no larger than the width of some cell membranes. In practical terms, nanotechnology will ultimately allow scientists and engineers to piece atoms together to build all manner of objects, from miniscule semiconductors to medical treatments that
be as simple as a sharing of knowledge between labs or as complex and far-ranging as major research consortia paid for by dues from corporate members, such as the semiconductor industry’s Sematech or MIT’s famous Media Lab. (However, the tough business climate since 2001 has caused many companies to curtail their support of some of these research consortia.) A highly effective research collaboration model has been established within the aircraft industry, where component suppliers, such as manufacturers of jet engines, collaborate with systems suppliers, such as makers of navigation gear (avionics) and airframes to do the R&D necessary to create an entirely new aircraft. This is precisely how the extremely successful Airbus firm was established, with more than a little encouragement from government agencies in the U.K. and France. The automobile industry is likewise benefiting from similar collaborative research and development partnerships to create new or improved cars.
Plunkett Research, Ltd.
work on the molecular level, to the clothes we wear and the structures in which we live. The National Nanotechnology Initiative, established by the Federal Government in 2000, oversees funding for 10 separate government agencies (including the Department of Energy, the Department of Defense, NASA, the National Institutes of Health, USDA and the Food and Drug Administration). Congress passed $849 million in funding for nanotechnology research in 2003, up from the $604 million approved in 2002. U.S. federal funding is expected to exceed $1 billion in the mid-term, due to increasing competition from foreign powers. As with the space race in the 1950s and 1960s, the contest for supremacy in nanotechnology is a key global issue. All associated U.S. departments and agencies plan to focus on nanotech manufacturing processes, uses of nanotechnology for chemical-biological-radioactiveexplosive detection and protection and also on instrumentation and metrology. In the private sector, companies both large and small are investing in the tiny technology in a big way. For example, Motorola Labs, a research subsidiary of telecom company Motorola, Inc., is making strides in carbon nanotechnology for use in flat-panel displays. Concurrently, tiny Sirna Therapeutics is focused on breakthroughs in RNA interference (RNAi) technology to fight disease. Nanotechnology continues to attract a reasonable flow of new money from the venture capital community. Despite the fact that commercialization of nanotech-based products may be a long way off, professional investors see great potential in firms that may become early leaders and patent-holders in this field. Much of the future of technology in general will be based on miniaturization, and nanotechnolgy, the smallest possible level of product development, will play a key role in this miniaturization trend. 6) Continued Growth in Research Partnerships Between Corporations and Universities Corporations have long seen the benefit of tapping the intellectual powers of labs, graduate students and professors at universities that focus on technologyintense disciplines. At the same time, such universities have been anxious to receive corporate funding for their research projects. This has always been a winwin situation. Lately, however, universities have enhanced their position in such partnerships by negotiating research collaboration contracts that are potentially more lucrative than was the norm in years past. Cash-strapped universities are anxious to capitalize on commercial successes that stem from
www.plunkettresearch.com
their research. At the same time, cash-strapped corporations are happy to utilize top grad students who work in university labs at nominal pay. Pharmaceutical giant Pfizer is an excellent example of a major corporation conducting research and development with the assistance of universities. Its Discovery Technology Center, located in Cambridge, Massachusetts, regularly offers fellowships to students from nearby campuses such as Harvard, MIT and the Whitehead Institute. Pfizer is currently involved in a three-year program in computational biology with students from the latter. In addition to academic institutions, Pfizer also has close ties with other companies. BioTrove, a biotech company focusing on nanotechnology within the drug discovery arena, is involved in a two-year collaborative effort with Pfizer. It is hoped that the collaboration will produce nanoscale liquid handling tools that Pfizer will use to develop new drugs. Intel is another example of a company with major in-house R&D efforts as well as external alliances. The technology giant has delivered approximately 500 active research grants to universities, which create small labs or "lablets" that combine the efforts of students and Intel staff. Associated institutions include the University of California at Berkeley, Carnegie Mellon and the University of Washington. 7) Continued Growth in Research and Development Spending in the U.S., Despite the Economic Downturn The general economic downturn in 2001-2002, combined with the terrorist attacks of September 11th and a shift in government priorities with regard to research, had a seriously detrimental effect on total R&D dollars budgeted in the U.S. through 2002, according to widely watched annual studies conducted by the Battelle Memorial Institute and R&D Magazine. These same budgets experienced healthy annual growth previously, with increases of 10.8% in 2000 and approximately 5.4% in 2001. R&D budget growth for 2002 dropped to 3.5%. For 2003, U.S. research and development budgets were forecast by the study to grow about 3.4% to a total of $302 billion, as follows: Federal spending on R&D of $89 billion (up 10.5%); industrial spending at $194 billion (up less than 1%); and university and nonprofit spending combined at $18 billion (up about 7%). In recent months, companies scrambled to cut costs, and in many cases, R&D budgets suffered. In the short-term, many firms were successful in boosting their bottom lines. In the long-term,
Plunkett Research, Ltd.
however, most are rethinking their R&D strategies. In order to stay competitive in the domestic and most certainly in the global marketplace, significant funding for R&D is a vital expense. Tech firms appear to have been the exception to this trend through 2002, spending $100.8 billion from mid-2001 through mid-2002 (up from $86.5 billion for the same period the previous year). The concept behind this continued high investment despite falling revenues is that developing the next great idea will enable a company to grab market share and pull itself into the black. Another change is the way R&D funding is allocated. Strategies are shifting to include more alliances and joint ventures with other companies, more subsidiary spin-offs based on established technologies, more contracts and cooperative efforts with federal labs and projects and higher grants and projects of greater scope on the university level. Investment levels are slowly rising, but companies are also looking for ways to leverage their investment to get more bangs for their bucks. 8) Growth in Defense Research Post 9/11 In the aftermath of the terrorist attacks of September 11, 2001, Congress approved a defense budget of $343 billion for fiscal 2002, a 10% increase from the previous fiscal year. Of that amount, $51 billion was earmarked for research and development, a 13% increase from the previous year. More than $10 billion of those dollars were to be devoted to new technology. Most government funding traditionally goes to defense contractors such as Lockheed Martin, General Dynamics and Raytheon. Post 9/11, a larger and more diverse number of firms in the private sector are receiving more government funding and bearing more of the responsibility for developing new defense technologies. In addition to conventional defense equipment such as aircraft, weapons and enemy detection systems, R&D must now focus on biological warfare and protection from attacks via data systems and the Internet. The establishment of the new Department of Homeland Security has served to focus federal dollars on anti-terrorism defense, including the gathering of intelligence. At the same time, the successes and failures of various defense systems engaged in the wars in Afghanistan and Iraq are creating demand for new defense research initiatives. The U.S. Defense Advanced Research Projects Agency (DARPA), which began as a response to the Soviet launch of the satellite Sputnik in 1957, has a long reputation of over-the-top R&D that has been responsible for a significant number of breakthroughs
www.plunkettresearch.com
since its formation more than 40 years ago. Its projects in large part brought about the Internet, the mouse, telecommunications semiconductors used in cell phones and PCs and radar-absorbent materials that are now found in stealth aircraft. After the September 11th attacks, DARPA created the Information Awareness Office (IAO) with the specific mission of detecting terrorist activities. IAO is currently developing an experimental system that focuses on technologies for language translation; data search and pattern recognition; and collaboration and decision support. As a whole, the project is called Terrorism Information Awareness (TIA) and has a projected 2004 budget of $20 million. The project is a five-year effort, progressing along with the agency's Wargaming the Asymmetric Environment (WAE) program, which focuses on predictive technology relating to observed behaviors of known terrorists. 9) Number of Patent Applications Soars In 2001, the U.S. Patent & Trademark Office (PTO) received 345,732 patent applications, up from 315,015 in 2000 and only 177,830 in 1991. The PTO forecasts that that number will reach 500,000 by 2006. To some extent, patents tend to reflect the health of R&D budgets. The greater the funding, the more patents are filed. At the same time, however, the rapid growth in the number of patent applications reflects today’s increased focus on protection of intellectual property by corporations and universities along with the extremely high traffic from biotech firms attempting to patent gene expressions and other biological discoveries. A patent application leads either to a patent grant or to a denial. The PTO granted 183,975 patents during 2001, up by about 8,000 over the previous year. Of those patents granted, 46% were to foreign applicants. A patent typically takes 18 to 24 months after application to receive a grant. In an effort to keep up with all of this patent activity, the PTO is upgrading its information systems to the extent that it hopes to launch a fully paperless patent system by fiscal 2004. Meanwhile, the overwhelmed PTO hired 768 patent examiners in fiscal 2002, bringing the total to 3,538. The term of patent protection is currently defined as beginning on the date the patent is granted and ending 20 years from the earliest filing date of the application.
Plunkett Research, Ltd.
Internet Research Tip: For the latest official statistics from the U.S. Patent & Trademark Office, visit the website of TAF, the patent office’s Technology Assessment and Forecast branch. www.uspto.gov/web/offices/ac/ido/oeip/taf/ Globally, there are 120 different national patent systems, and recent proposals to create a unified global patent system are creating buzz. "Harmonization" is the word used to describe the effort, and it will be difficult to bring about. According to the World Intellectual Property Organization, 90% of the 7 million applications filed annually worldwide are filed in more than one country, which multiplies application fees, legal fees and hours spent exponentially (fees for multinational applications can surpass $75,000, and legal fess often reach $200,000 or more). IBM, the company that holds more patents than any other company in the world, spends more than $200 million annually on the protection of its intellectual property both at home and abroad. An aborted 1989 attempt to establish an international system bogged down when the U.S. could not agree with most other participating countries on a simple first-to-file regulation when awarding patents to filers with similar claims. In the U.S., the practice has traditionally been to award a patent to the filer who can prove to be the first to conceive an idea and develop it. Although fair, the system can prove costly as applicants spend time and money in the court systems to prove who was first with an idea. Another critical difference between the U.S. patent system and those elsewhere around the globe is the one-year waiting period, during which American filers may publish or speak at public forums about their ideas without jeopardizing their patent rights. Abroad, filers are required to keep their ideas top secret until a patent is awarded. Yet another point of argument centers on patent subject matter. In the U.S., just about anything or any idea can be patented. Business practices, for example, are commonly patented, such as Amazon.com's "oneclick" technology, as well as genetic discoveries and treatments. The latter is a particularly sticky point for developing nations such as those in Latin America and Africa. Their participation in a global patent effort may well hinge on the protection of their natural resources from exploitation by foreign companies. The debate continues, but proponents of a global patent body hope to have a treaty written by late 2004. In June 2002, the Director of the U.S. Patent & Trademark Office published a comprehensive plan,
www.plunkettresearch.com
titled “21st Century Strategic Plan,” outlining his official efforts to enhance the effectiveness of the office while making it more efficient for U.S. companies to obtain patent protection abroad. Among competing tech companies, patents are something like badges of honor. Patents protect ideas and technologies as well as exclude competitors from making strides in particular areas of research. IBM leads the pack in the total number of patents awarded each year, with 3,431 new patents granted during 2001. Patents are an immense asset to IBM, and it garners more than $1.5 billion in yearly licensing revenue from the patents it holds. IBM is followed by a short list of Japanese firms including Canon (1,937 patents in 2002), NEC (1,920 patents in 2002) and Hitachi (1,882 patents in 2002). Other top patent winners in 2002 were Micron Technology (1,851), GE (1,681) and Sony (1,601). Not only do these extraordinary numbers of patents give these companies substantial bragging rights, the revenues generated can often make the difference between red and black ink in a difficult economy. As a result, watch for continued growth in the number of patent applications. 10) Growth in the Automation of Research and Design The news in automated research tools is excellent, and many firms that manufacture such tools are enjoying booming times. Advances in CAD (computer aided design) and CAE (computer aided engineering) hybrids are revolutionizing the way in which new designs are tested and enhanced. The combination of disciplines creates virtual prototypes on computers that make R&D faster and more efficient than ever before. Finite element analysis (FEA) checks a computergenerated model for flaws. It analyzes how the model would react to extremes in heat, vibration and pressure by breaking a model down into small pieces or cells in a three-dimensional grid. The computer applies simulated stimuli to one cell in the model and then tracks the response of that cell and those that surround it. The results often keep a flawed design from progressing to production and distribution. The next big thing in automated R&D is design of experiments (DOE). This statistical technology helps researchers program FEA to concentrate on particularly vulnerable areas, rather than running thousands of scans on all parts of a model, which may not be necessary. Another stride in automation is behavioral modeling. It is a software application that takes the
Plunkett Research, Ltd.
results found by the combination of FEA and DOE into family trees of cause and effect scenarios. Major variables such as model size and power are represented by large limbs, which branch out into scenarios showing how those variables react to different situations. The process allows researchers to isolate deal-breaking problems early on and pinpoint exact circumstances in which problems will likely occur. Industries adopting this new technology include automotive manufacturing, aerospace and shipyards. Meanwhile, combinatorial chemistry, DNA chips and myriad other technology-intense tools have largely automated research in biotechnology to the extent that the field has been accelerated dramatically. 11) Energy Technology Research Receives Growing Attention, Particularly in Alternative Energy Overall, the energy sector has been running far behind other industries in terms of research and development. For example, a recent study showed that of the total number of patents granted in the U.S. during the 20-year period from 1976 through 1996, only about 100 per year were energy-specific patents. Energy-specific R&D expenditures plummeted from about $12 billion during 1980 to about $4 billion during 1996, despite the fact that 1) energy is a vital and strategic sector, and 2) energy conservation, utilization, generation and production can all benefit greatly from new technologies, and those technologies will be developed only through significant R&D efforts. Here’s the bottom line: The energy sector has barely begun to tap the potential of new technologies. It is critical that R&D efforts are accelerated and that the money to back them begins to flow in larger total amounts. Post 9/11, a focus on national security, combined with concerns about clean air, global warming, trade deficits and unstable governments in the Middle East and Africa, have put a renewed emphasis on R&D focused on energy development and conservation of all types. Suddenly, both corporate and government dollars are flooding into research on fuel cells, solaror wind-generated power and energy management. In addition, research is intensifying on methods to drill extremely deep offshore wells along with technology for enhancing the flow of oil and gas from existing fields. An interesting new nuclear technology, called pebble bed reactors, is being developed, while superconductor technology has also seen renewed interest.
www.plunkettresearch.com
As a niche, energy management has tremendous potential to create profit-generating new technologies by developing synergies between advanced electronics/communications and traditional heating, cooling and refrigeration systems. For example, Alameda, California-based Silicon Energy, www.siliconenergy.com, manufactures software solutions that interact between energy sources and major commercial/industrial energy users to reduce energy usage, lower costs and optimize the energy procurement process. Energy management professionals at Oracle’s headquarters in California wear pagers that alert them if electricity demand is nearing an overload condition. U.S.-based Echelon is working on a project with a utility company in Italy to enable residential electricity consumers to regulate their home energy usage remotely via the wireless web. Meanwhile, both gas and electric utilities are using computers and wireless technology to cut operating costs. For example, millions of wireless transmitters are now installed on electric meters around the nation, automatically sending usage data to computers for billing and tracking purposes, without the use of human meter readers. By 1999, soaring oil and gas prices created a renewed interest in all things energy-efficient. Smaller cars, high-efficiency homes and even solar power are once again part of popular culture. After all, if you’ve been enduring a rolling electricity blackout in California or New York, alternative energy sources must seem extremely interesting. At the same time, renewable energy sources and cleaner-burning fuels are of great appeal to the large number of American consumers who have developed a true interest in protecting the environment. Some surveys have shown that consumers would even be willing to pay somewhat more for electricity if they knew it was coming from non-polluting, renewable sources. Alternative energy is of growing interest to some investors. Analysts at the research firm of Clean Edge, based in Oakland, California, estimate that alternative energy firms raised $2 billion during 2000 from public stock offerings and venture capital funds. Government is once again keenly interested in promoting renewable, alternative energy sources. Many states have created rebates and other incentives to encourage investment in renewable energy systems, and 33 states have new net metering policies that require electric utility companies to pay customers for generating electricity at the same price that they charge those customers for consuming it. In other words, consumers who use solar, microturbines or
Plunkett Research, Ltd.
other methods to generate more electricity than they need from time to time could see their electric meters running backwards. This is a big step forward when you consider the fact that utilities previously purchased such power from consumers at wholesale rates, which may only be 30% or 40% of the retail price. Fuel Cells: One of the hottest alternative energy technologies is the fuel cell. The fuel cell, in basic terms, consists of quantities of hydrogen and oxygen which are separated by a catalyst. Inside the cell, a chemical reaction within the catalyst generates electricity. Byproducts of this reaction may include heat, carbon dioxide and water. In other words, fuel cells do no create the toxic emissions that we currently live with from gasoline engines. Most fuel cells are based on hydrogen as a fuel, extracted from such sources as natural gas, gasoline or methanol. Each source has its advantages and disadvantages. Unfortunately, creating a hydrogen supply from fossil fuel sources such as gasoline can create emission problems. Ideally, fuel cells would burn hydrogen that is derived by using renewable energy sources, such as solar or wind, to break down water molecules into their basic components: hydrogen and oxygen. The potential market for fuel cells encompasses diverse uses in fixed applications (such as providing an electric generating plant for a home or a neighborhood), portable systems (such as portable generators for construction sites) or completely mobile uses (including the obvious use of powering an automobile). One of the greatest potential advantages of fuel cells is the fact that they are generally clean, efficient energy sources. Fuel cells are already in wide use, even powering a U.S. Post Office in Alaska. General Motors, Ford, Honda, DaimlerChrysler and Toyota all have significant fuel-cell research initiatives. In fact, GM recently exhibited a full-size pickup truck sporting a prototype fuel-cell engine that runs on hydrogen extracted from gasoline. Automakers may have a fuel-cell-powered car, perhaps a fuel-cell/electric hybrid, on the market as early as 2010, especially if the Federal Government provides substantial sponsorship for research. Not only is the automotive industry keenly interested in fuel-cell power for automobiles and trucks, it is also betting on the use of fuel cells for many other purposes. In mid-2001, General Motors made the remarkable announcement that it is developing an affordable fuel-cell-powered electric generator for ownership by individual consumers and businesses.
www.plunkettresearch.com
Meanwhile, fuel cells remain grossly expensive due to their limited production and industry’s currently low-technology base, with the estimated price for a fuel-cell-powered car hovering around $700,000. Moreover, hydrogen is not readily available to drivers. California's South Coast Air Quality Management District plans a minimum of six hydrogen-fueling stations by early 2004. Despite these difficulties, Honda and Toyota are both testing fuel-cell-powered cars in California. Five Honda cars are leased to the city of Los Angeles, each at $500 per month, while Toyota is leasing a fuel cell version of its Highlander SUV to UC Irvine and UC Davis, for which private donations have made a lease of $10,000 per month per vehicle feasible. Fuel cells may not be in wide use in automobiles until seven to 20 years have passed. However, they are currently used with great success in many special situations. For example, fuel-cell-powered electric generators currently power many remote sites. The Japanese automakers are outpacing U.S. rivals in fuel cell advances. GM hopes to market a line of fuel-cell-powered cars by 2010. The company is planning a wide variety of car and truck bodies that will mount onto a single, radical “skateboard” chassis design. The skateboard stores fuel-cell stacks and hydrogen supplies as well as circuitry that manages the flow of electric power through the various systems necessary to stop, start and maneuver the vehicle. The chassis will include a docking port that links the body above to the electronic systems. The working name for the groundbreaking design is Autonomy. Each vehicle will be equipped with software that corresponds to the type of driving associated with the selected body style. Sporty cars and light trucks will have software that provides rapid acceleration, responsive steering and rigid suspension. The software for family cars and touring sedans will provide less pickup, easier steering and a more comfortable ride even though the underlying chassis would be the same. The electric utility industry may become a large user of fuel-cell technology over the long-term. For example, the nation of Japan plans to generate a significant portion of its electricity needs by fuel cell by the year 2010. Also, fuel-cell-powered generating plants of immense size may become practical as upgrades for aging oil-, gas- or nuclear-powered generating facilities. If the concept of distributed power catches on, fuel cells could easily be the neighborhood- or home-based generator of choice in the U.S. by 2015, especially if the electric utilities
Plunkett Research, Ltd.
become involved in the manufacture or distribution of such units.
Spotlight: IBM While IBM has had its detractors in recent years (because of its difficulties in fighting off disruptive competition in many facets of the computer business), no one could ever doubt this premier firm’s leadership in the arenas of research and development. In terms of sheer numbers, IBM rules in research. During the early 1990s, the firm refocused its research efforts and boosted R&D budgets while slashing jobs and budgets throughout the rest of the company structure. By 2001, for example, the company marked the ninth year in a row of receiving more U.S. patents than any other organization—3,411, up from 2,886 patents during 2000. (At the time, IBM was the first company ever to obtain 3,000 patents in one year.) IBM's 2002 corporate R&D budget of approximately $5 billion represents about 6% of the company's annual sales. Big Blue traces its roots to an innovative entrepreneur who used machines running on punch cards to tabulate the U.S. Census of 1890. IBM’s research division traces its beginnings to 1944, when a “Pure Science Department” was launched with a handful of people. By the early 1950s, the effort had grown to about 120 people. Today, IBM has eight major research facilities scattered around the globe, employing about 3,000 researchers, including two Nobel Prize recipients. The firm is not resting on past success. Its IBM Life Sciences division created a highly sophisticated database called Design Link, which effectively manages experimental data for drug companies that is stored on up to 13 incompatible systems. The database is part of the division's larger mission to fashion IT systems that assist biotech and pharmaceutical companies in new drug development and testing. More recently, IBM is putting cuttingedge computer technology to work scanning Internet data and making intelligent analysis of market patterns and trends. The new division, called Web Fountain, has the potential to revolutionize traditional marketing efforts. Another new concept in R&D at IBM is the depth of customer involvement. Researchers are now spending up to 25% of their time working with customers, seeking opinions and ideas.
www.plunkettresearch.com
Spotlight: Lucent/Bell Labs Lucent is the telecommunications equipment manufacturer that once was a division of AT&T. During the 1990s, the breakup of “Ma Bell” created the “Baby Bells” and led to the eventual 1996 spin-off of what is now Lucent Technologies, Inc. to operate the telecom equipment business. Lucent also received a prize asset: Bell Labs—once the world’s premier telecom research organization. Bell Labs began in the early 1900s, as a descendant of the small laboratory operated by telephone inventor Alexander Graham Bell, with a $3,500 annual budget and a handful of workers. It eventually grew to become one of the most innovative and productive research organizations the world has ever known. Today, Lucent, like IBM, is a mature organization that faces daunting, and sometimes painful, competition from upstarts. Unlike IBM, the company cut its R&D budget as part of a corporate cost-cutting program. Lucent’s annual R&D budget fell from $3.5 billion in 2001 to $2.3 billion in 2002. Despite the cut, the company's budget is still ranked 21st in a list of the largest R&D budgets among U.S. companies compiled by Schonfeld & Associates. Lucent recently received its 30,000th patent. Through the years, Bell Labs/Lucent Labs has helped to develop breakthroughs such as the transistor, the laser, the orbiting communications satellite and the molecular transistor, and 11 employees have won the Nobel Prize in Physics.
Spotlight: Intel By far the world’s leader in the semiconductor industry, Intel didn’t establish its separate, central research laboratory, named Microprocessor Research Labs (MRL), until late in the game in 1995. Instead, research and development have been continuous efforts within the many units operated by the firm. In fact, the effort to produce faster, more powerful generations of semiconductors is a major daily focus of the entire semiconductor industry. Research director David Tennenhouse, a veteran of DARPA, brought to Intel a new, broader outlook with regard to research when he joined the firm in 1999. As has traditionally been the practice at DARPA, Tennenhouse expanded the scope of Intel's research beyond a focus on semiconductors. Today, Intel employs 7,000 researchers in more than 75 labs in universities and cities around the globe. In addition to the study of semiconductors, the company's $4-billion budget covers research in networking and communications, software technology
Plunkett Research, Ltd.
and computing platforms. Intel maintains U.S. labs in California, Oregon, Arizona, Washington and Massachusetts, with international facilities in Israel, Malaysia, India, China and Russia. These labs are concerned primarily with component development and design. Additional facilities in Arizona and Malaysia study potential improvements in assembly and test processes. Intel’s unique MRL research effort is divided between facilities in Santa Clara, California and Hillsboro, Oregon. It also has efforts in Israel and China. MRL is focused on long-term, blue-sky projects that may be very speculative in nature. Intel has introduced entirely new chips every one to four years. Beginning with the “4004” chip in 1971 that ran at a snail-like pace and had a small number of transistors, the company leapt to the 386 in 1985 (275,000 transistors) to the Pentium II (7.5 million transistors) in 1997 and has introduced rapidly evolving families of chips in the early 2000s that approach 1 billion transistors per chip. As of April 2003, Intel had shipped over a billion x86 processors to customers around the world.
Spotlight: Microsoft Logically enough, the world’s leading software firm is one of the world’s leading practitioners of research and development. While Microsoft has a scientific staff of only a few hundred people, it also has thousands of highly skilled engineers. Together, these R&D employees do everything from searching for innovative ideas that may lead to future services or products to writing code in development of the next edition of MS Office. In terms of pure research, few organizations can top Microsoft’s computer science labs, which rank near those of IBM, Lucent, Carnegie Mellon and MIT. Microsoft’s internal research organization (sometimes referred to as “Bill Labs” as a play on the name of famous Bell Labs) was launched early in the company’s history in 1991. The research organization grew by 50% from 1999 to 2000, to reach a total of 600 professionals on staff. The company currently has 55 separate research projects in operation, studying everything from .NET to natural language processing to wireless technology. Microsoft has increased its R&D budget significantly in recent years (to $5.3 billion in 2002) and boasts a formidable roster of talent. At its Redmond, Washington facility, for example, the firm currently has 150 interns with Ph.D.s. Current projects include Gestures, special stylus movements when using a tablet PC that approximate using keyboard
www.plunkettresearch.com
shortcuts on a desktop PC; a spam filter for e-mail; and MyLifeBits, a technology in which a computer captures episodes in human life and stores them for later access.
Spotlight: Xerox Xerox, founder of the Palo Alto Research Center (PARC), is, at the same time, one of the most admired and least admired research organizations in the world. It is among the most admired because of PARC’s development of such ground-breaking technologies for the computer industry as the graphical user interface (GUI), the process now known as local area networking (also known as LAN or Ethernet) and the laser printer. Xerox sometimes ranks among the least admired due to management’s failure to fully capitalize on some of these groundbreaking innovations. For example, while Xerox did introduce an unpopular computer (Star) using a graphical user interface, it took the upstart Apple computer company to successfully introduce GUI to the world, creating an entire culture around the Macintosh computer. PARC is so focused on innovation in business machines and business processes that it has developed a full-time staff of anthropologists whose job is to study the way that people in offices and factories interact with the machines that are supposed to serve them. The result is logical interfaces between man and machine that are sometimes the envy of other firms. While Xerox has been assaulted by fierce competition on all sides, that competition was brought on by the attention caused by its many successes. Xerox literally enabled the masses to benefit from plain paper copying at reasonable cost. As a result, it became the first U.S. firm in business history to achieve $1 billion in yearly revenues in less than 10 years—and it reached that achievement back in 1968 when $1 billion was a lofty goal for any company. Recent successes include Xerox’s incredibly profitable Docutech system. Docutech is an entire printing plant with bindery in one easy-to-operate unit that is based on highly advanced laser copying. For most of its history, PARC was an internal business unit at Xerox, but in 2002 its status was changed to that of a wholly owned subsidiary.
Spotlight: Genentech Research at the booming drug company Genentech is a very different world than that at most major drug companies. Instead of developing new drugs that treat large numbers of people, such as Pfizer's Lipitor (which helps lower cholesterol levels)
Plunkett Research, Ltd.
and Schering-Plough's Clarinex (for allergy sufferers), Genentech targets small sets of patients with specific problems. For example, take its recent successful trials of colorectal cancer drug Avastin, which treats malignant tumors through the highly novel method of cutting off their blood supply. Another Genentech drug, Herceptin, treats specific types of breast cancer, which occur in only about 25% of breast cancer patients—patients who have a distinct genetic makeup that can be identified prior to treatment to see whether they are likely to benefit from the drug. The results of this targeted R&D are higher success rates in cancer treatment and impressive sales that topped $2.7 billion in 2002. Its Founders Research Center is an $85-million research facility that was recently expanded to a total of 500,000 square feet in South San Francisco. An additional 420,000-square-foot facility is located in Vacaville, California. A relatively small company, Genentech's R&D budget for 2002 was $623.5 million, up from $526.2 million the previous year.
Spotlight: Pfizer Drug giant Pfizer's R&D illustrates the opposite end of the spectrum from Genentech. With 10 blockbuster drugs in its extensive product line that each generate more than $1 billion in annual sales, Pfizer is focused on developing drugs that will enjoy widespread use and reap huge revenues. Pfizer's $5.3 billion R&D budget for 2003 is the largest within the pharmaceutical sector. The company pioneered robotic high-throughput chemical compound screening, and uses it along with a variety of other cutting-edge technologies to study and develop new drugs. Pfizer employs approximately 12,500 researchers and scientists around the world with locations in La Jolla, California; Ann Arbor, Michigan; New London and Groton, Connecticut; and Cambridge, Massachusetts. There are also international facilities in Canada, the U.K., France and Japan. The company has lofty goals for sales growth. In order to meet those goals, it must continue to develop blockbuster drugs at a steady pace.
Spotlight: DuPont Once highly regarded as a laboratory that regularly developed products with global impact (e.g., nylon, lycra), DuPont R&D has dropped the ball in recent years with regard to new products. The company is the victim of narrow thinking, focusing primarily on improving productivity as opposed to
www.plunkettresearch.com
developing new products. The company sold DuPont Pharmaceuticals to Bristol-Meyers Squibb in 2001, thereby divesting itself of significant R&D efforts and facilities. In 2003, the company announced its plans to restructure its R&D labs, allocating half the $1.2billion annual research budget to new products (twothirds of the budget previously went to improving productivity for existing products). Researchers are to seek customer input at all stages of product development on the 75 selected projects deemed the most promising. DuPont maintains 40 research and development labs in the U.S. and an additional 35 labs in 11 other countries. Its main facilities are in Wilmington, Delaware, split between its Experimental Station, Chestnut Run and Stine-Haskell Research Center laboratories. Together, they employ more than 1,500 researchers and scientists.
Spotlight: General Electric Innovation and a renewed emphasis on R&D have been the story at GE since Jeffrey Immelt became CEO in 2001. GE's R&D efforts historically have been groundbreaking, including work in magnetic resonance imaging (MRI), fiber optics, synthetic diamonds and the 1909 tungsten filament still in use in light bulbs today. After a brief period in the ‘90s when the conglomerate appeared to devote more funding and attention to its lucrative entertainment and financial services subsidiaries, R&D is once again a major concern for GE's plethora of manufacturing arms (which include aerospace, appliances, lighting, generators, nuclear reactors and plastics, to name a few). Its Niskayuna, New York facility received a $100million facelift in 2002. The 500-plus-acre campus now boasts new laboratories and meeting facilities. GE owns and operates other facilities as part of its Global Research arm in Bangalore, India and Shanghai, China. Moreover, GE recently broke ground on a new research center in Munich, Germany. In total, the company employs more than 2,000 researchers working in a wide variety of disciplines. Long-term research areas receiving the lion's share of funding are nanotechnology, light sources, advanced propulsion and molecular imaging. Approximately 20% of the $2.6-billion annual research budget is devoted to long-range projects.
Plunkett Research, Ltd.
www.plunkettresearch.com
Chapter 2 ENGINEERING AND RESEARCH INDUSTRY STATISTICS CONTENTS: IV. U.S. Research and Development Comparative Measures of Growth for Gross Domestic Product and R&D Federally Funded Research and Development Centers' R&D Expenditures: 2001 National Expenditures for Applied Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Applied Research, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for Basic Research, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Basic Research, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for Development, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for Development, from Funding Sectors to Performing Sectors: 1993-2002 National Expenditures for R&D, by Performing Sector and Source of Funding: 1993-2002 National Expenditures for R&D, from Funding Sectors to Performing Sectors: 1993-2002 Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 Trends in U.S. Research & Development (R&D) and Federal Outlays: 1970, 1980, 1990, 2000 and 2002 U.S. Federal Basic Research Budget Authority, by Budget Function: Fiscal Years 1995–2001 U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001 V. Research and Development by States-U.S. California Research & Development (R&D) Profile, 1999-2000 Illinois Research & Development (R&D) Profile, 1999-2000 Maryland Research & Development (R&D) Profile, 1999-2000 Massachusetts Research & Development (R&D) Profile, 1999-2000 Michigan Research & Development (R&D) Profile, 1999-2000 New Jersey Research & Development (R&D) Profile, 1999-2000 New York Research & Development (R&D) Profile, 1999-2000 Pennsylvania Research & Development (R&D) Profile, 1999-2000 Texas Research & Development (R&D) Profile, 1999-2000 Washington Research & Development (R&D) Profile, 1999-2000 State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 Top 10 U.S. States in Total R&D Performance, Size of R&D by Performer and R&D as a Percentage of Gross State Product: 2000
p. 23
VI. International Research and Patents
p. 55
International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 Top 20 Global Patenting Organizations, Calendar Year 2001 Top 20 Patenting Countries, 2001
p. 24 p. 25 p. 27 p. 28 p. 29 p. 30 p. 31 p. 32 p. 33 p. 34 p. 35 p. 37 p. 38 p. 39
p. 41 p. 42 p. 43 p. 44 p. 45 p. 46 p. 47 p. 48 p. 49 p. 50 p. 51 p. 52 p. 54 p. 56 p. 58 p. 59
Plunkett Research, Ltd.
www.plunkettresearch.com
I.
U.S. Research and Development
Plunkett Research, Ltd.
www.plunkettresearch.com
Comparative Measures of Growth for Gross Domestic Product and R&D (Federally-funded, Nonfederal and Total): 1993-2002 Gross domestic product (GDP)
GDP in billions of current dollars Calendar year
R&D
R&D as a percent of GDP Federal support Nonfederal Federal GDP in R&D in R&D in GDP for R&D support support Nonfederal billions millions for R&D in millions implicit for support in of of of price millions millions of R&D as a percent of GDP R&D as for R&D as constant constant current deflator of a percent constant a 1996 1996 (1996=1.00) constant 1996 percent of GDP dollars dollars dollars of GDP dollars 1996 dollars
1993
6,642
0.9405
7,063 165,716 176,200
64,344
111,856
2.49
0.91
1.58
1994
7,054
0.9601
7,348 169,217 176,249
63,318
112,931
2.40
0.86
1.54
1995
7,401
0.9810
7,544 183,614 187,170
64,182
122,988
2.48
0.85
1.63
1996
7,813
1.0000
7,813 197,344 197,344
63,397
133,947
2.53
0.81
1.71
1997
8,318
1.0195
8,160 212,156 208,098
63,348
144,750
2.55
0.78
1.77
1998
8,782
1.0320
8,509 226,367 219,340
64,322
155,017
2.58
0.76
1.82
1999
9,274
1.0469
8,859 243,562 232,654
64,013
168,641
2.63
0.72
1.90
2000
9,825
1.0689
9,191 264,616 247,561
61,940
185,620
2.69
0.67
2.02
2001
10,082
1.0942
9,215 281,767 257,520
66,645
190,875
2.79
0.72
2.07
2002
10,441
1.1064
9,437 291,663 263,617
73,215
190,402
2.79
0.78
2.02
Note: Data are preliminary for 2001 and 2002. See the historical database provided in Table D for the full series of historical data, arranged by the same data columns as defined in this and other tables. Source: Department of Commerce, Bureau of Economic Analysis; Office of Management and Budget, and National Science Foundation/Division of Science Resources Statistics tabulations.
Plunkett Research, Ltd.
www.plunkettresearch.com
Federally Funded Research and Development Centers' R&D Expenditures: Fiscal Year 2001 (Latest Data Available) FFRDC
Total R&D
Federal R&D
Administrator
Sponsoring agency
Thousands of dollars All FFRDCs, total
9,997,231
9,615,716
University-administered FFRDCs, total Ames Laboratory
5,944,110 22,916
5,771,399 22,916
Argonne National Laboratory
478,391
452,860
Iowa State University of Sci. and Tech. University of Chicago
Ernest Orlando Lawrence Berkeley National Laboratory
408,487
337,757
University of California
Department of Energy
Fermi National Accelerator Laboratory
310,928
310,928
Department of Energy
Jet Propulsion Laboratory
1,355,461
1,355,461
Universities Research Association, Inc. California Institute of Technology
Lawrence Livermore National Laboratory
1,090,875
1,049,675
Lincoln Laboratory Los Alamos National Laboratory
380,200 1,333,194
University of California
370,616 Massachusetts Inst. of Technology 1,312,974 University of California
Department of Energy Department of Energy
National Aeronautics and Space Administration Department of Energy DoD, Department of the Air Force Department of Energy
National Astronomy and Ionosphere Center
10,986
10,979
Cornell University
National Center for Atmospheric Research
119,846
116,553
University Corporation for National Science Foundation Atmospheric Research
National Optical Astronomy Observatory
37,364
37,364
National Radio Astronomy Observatory
34,208
34,043
Princeton Plasma Physics Laboratory
76,021
75,387
Associatiation of National Science Foundation Universities for Research in Astronomy, Inc. Associated Universities, National Science Foundation Inc. Princeton University Department of Energy
Software Engineering Institute
37,052
37,052
Stanford Linear Accel Center
145,979
145,979
Thomas Jefferson National Accelerator Facility
102,202
100,855
1,887,833
1,805,952
Idaho National Engineering and Enviornmental Laboratory
14,547
13,610
Bechtel BWXT Idaho, LLC Department of Energy
National Cancer Institute at Frederick
187,222
183,478
1,598,900
1,521,700
87,164
87,164
SAIC; Charles River Department of Health and Human Laboratories, Inc.; Data Services, National Institutes of Management Services, Inc. Health Sandia Corporation, a Department of Energy subsidiary of Lockheed Martin Corporation Westinghouse Savannah Department of Energy River Co.
Industry-administered FFRDCs, total
Sandia National Laboratory Savannah River Technology Nonprofit-administered FFRDCs, total
2,165,288
2,038,365
Aerospace FFRDC
17,600
5,600
Arroyo Center
24,317
Brookhaven National Laboratory C3I FFRDC
National Science Foundation
Carnegie Mellon University DoD, Office of the Secretary of Defense Leland Stanford, Jr. Department of Energy University Southeastern Universities Department of Energy Research Association, Inc.
Aerospace Corporation
DoD, Department of the Air Force
24,317
RAND Corporation
DoD, Department of the Army
454,500
435,400
Department of Energy
29,458
29,458
Brookhaven Science Associates, Inc. MITRE Corporation
DoD, Office of the Secretary of Defense
Plunkett Research, Ltd.
www.plunkettresearch.com
Federally Funded Research and Development Centers' R&D Expenditures: Fiscal Year 2001 (Latest Data Available) (cont.) Center for Advanced Aviation System Development
5,683
5,683
Center for Naval Analyses
69,102
66,616
The CNA Corporation
DoD, Department of the Navy
Center for Nuclear Waste Regulatory Analyses
14,977
14,135
Southwest Research Institute
Nuclear Regulatory Commission
Institute for Defense Analyses Communications and Computing
43,100
43,100
Institute for Defense Analysis
National Security Agency
Institute for Defense Analysis Studies
92,930
92,930
1,161
1,161
Institute for Defense Analysis MITRE Corporation
DoD, Office of the Secretary of Defense Department of Treasury, Internal Revenue Service
National Defense Research Institute
25,512
25,512
RAND Corporation
National Renewable Energy Laboratory
207,230
205,665
DoD, Office of the Secretary of Defense Midwest Research Institute Department of Energy
Oak Ridge National Laboratory
581,046
540,116
UT-Battelle, LLC
Pacific Northwest National Laboratory
562,000
512,000
Battelle Memorial Institute Department of Energy
Project Air Force
29,361
29,361
RAND Corporation
DoD, Department of the Air Force
7,311
7,311
RAND Corporation
National Science Foundation
Internal Revenue Service (IRS) FFRDC
The Science and Technology Policy Institute
MITRE Corporation
Department of Transportation, Federal Aviation Administration
Department of Energy
Key: FFRDC = Federally funded research and development center; DoD = Department of Defense. Note: More information about the 36 FFRDCs can be found on the National Science Foundation website (www.nsf.gov/sbe/srs/ffrdc/start.htm). Source: National Science Foundation/Division of Science Resources Stastistics, Survey of Academic Research and Development Expenditures: Fiscal Year 2001.
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Applied Research, by Performing Sector and Source of Funding: 1993-2002 Performing Total Federal sector: U.S. Govt. Industry Funding sector: Calendar year5
Industry Universities FFRDCs & colleges1
Federal Total Federal Federal U.S. Govt. Total Govt.2 Industry3 Govt.2
Total
U&C FFRDCs Federal Nonfed. Non- Federal Govt. govt. Industry U&C profits Govt.4
Millions of current dollars
1993
37,286
4,838 24,251
4,295
19,956
435
5,146
2,539
496
443 1,181
487
969
1994
36,614
4,985 22,988
3,616
19,372
503
5,387
2,640
517
464 1,256
508
981
1995
40,999
4,952 26,919
3,164
23,755
535
5,653
2,775
559
494 1,311
516
1,119
1996
43,178
4,872 29,010
3,640
25,370
231
5,878
2,859
583
524 1,390
522
1,283
1997
46,689
4,997 32,430
2,648
29,782
213
5,630
2,635
557
523 1,399
516
1,364
1998
S
5,146
S
S
S
230
5,350
2,376
533
527 1,396
519
1,326
1999
S
5,530
S
S
S
274
5,945
2,776
558
556 1,494
562
1,267
2000
S
5,938
S
S
S
198
6,855
3,425
596
581 1,639
615
1,329
2001 Prelim
S
6,483
S
S
S
223
7,555
3,852
632
601 1,807
664
1,465
2002 Prelim Calendar year5
S
7,175
S
S
S
268
8,330
4,372
654
620 1,974
711
1,586
Millions of constant 1996 dollars
1993
39,645
5,144 25,785
4,567
21,219
463
5,471
2,699
527
471 1,256
518
1,030
1994
38,136
5,192 23,943
3,766
20,177
524
5,610
2,750
539
484 1,308
530
1,022
1995
41,793
5,048 27,440
3,225
24,215
545
5,763
2,828
569
503 1,336
526
1,140
1996
43,178
4,872 29,010
3,640
25,370
231
5,878
2,859
583
524 1,390
522
1,283
1997
45,796
4,901 31,810
2,597
29,212
209
5,522
2,585
546
513 1,372
506
1,338
1998
S
4,986
S
S
S
223
5,184
2,302
516
510 1,353
503
1,285
1999
S
5,282
S
S
S
262
5,679
2,651
533
531 1,427
537
1,210
2000
S
5,556
S
S
S
185
6,413
3,204
557
543 1,533
576
1,243
2001Prelim
S
5,925
S
S
S
204
6,905
3,521
577
549 1,652
606
1,339
2002 Prelim
S
6,485
S
S
S
242
7,529
3,951
591
560 1,784
642
1,433
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 2 Historically, expenditures of industry FFRDCs for 1953-63 were not separated from total Federal support to the industrial sector. Thus, the figure for Federal support to industry includes support to FFRDCs or those years. The same is true for expenditures of nonprofit FFRDCs, which are included in Federal support for nonprofit institutions in 1953-87. 3 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 4 Includes all R&D expenditures of FFRDCs administered by academic institutions. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Source: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Applied Research, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing Total sector U.S. Calendar year5
Federal Government
Total
Industry
U&C
Industry U&C Non- Nonprofit NonFederal Govt. Industry FFRDCs U&C2 FFRDCs3 profits FFRDCs Total Industry4 U&C2 profits U&C2 Millions of current dollars
1993
37,286 14,078
4,838
4,295
435 2,539
969
900
103 20,547
19,956
443
148 1,181
1994
36,614 13,797
4,985
3,616
503 2,640
981
960
111 19,995
19,372
464
158 1,256
1995
40,999 13,608
4,952
3,164
535 2,775
1,119
934
129 24,418
23,755
494
170 1,311
1996
43,178 13,967
4,872
3,640
231 2,859
1,283
960
122 26,076
25,370
524
182 1,390
1997
46,689 12,996
4,997
2,648
213 2,635
1,364
1,011
128 30,510
29,782
523
205 1,399
1998
S 12,794
5,146
S
230 2,376
1,326
1,060
123
S
S
527
223 1,396
1999
S 14,717
5,530
S
274 2,776
1,267
1,301
130
S
S
556
247 1,494
2000
S 15,776
5,938
S
198 3,425
1,329
1,810
209
S
S
581
279 1,639
2001 prelim
S 17,485
6,483
S
223 3,852
1,465
2,098
302
S
S
601
294 1,807
2002 prelim Calendar year5
S 19,442
7,175
S
268 4,372
1,586
2,326
275
S
S
620
295 1,974
Millions of constant 1996 dollars
1993
39,645 14,968
5,144
4,567
463 2,699
1,030
957
109 21,847
21,219
471
157 1,256
1994
38,136 14,370
5,192
3,766
524 2,750
1,022
999
116 20,826
20,177
484
165 1,308
1995
41,793 13,871
5,048
3,225
545 2,828
1,140
952
131 24,891
24,215
503
173 1,336
1996
43,178 13,967
4,872
3,640
231 2,859
1,283
960
122 26,076
25,370
524
182 1,390
1997
45,796 12,748
4,901
2,597
209 2,585
1,338
992
126 29,926
29,212
513
201 1,372
1998
S 12,396
4,986
S
223 2,302
1,285
1,027
119
S
S
510
216 1,353
1999
S 14,058
5,282
S
262 2,651
1,210
1,243
124
S
S
531
236 1,427
2000
S 14,759
5,556
S
185 3,204
1,243
1,694
195
S
S
543
261 1,533
2001prelim
S 15,980
5,925
S
204 3,521
1,339
1,918
276
S
S
549
269 1,652
2002 prelim
S 17,573
6,485
S
242 3,951
1,433
2,102
248
S
S
560
266 1,784
Because of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits included in nonprofits' is support for their own R&D. 2 Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscalyear data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Basic Research, by Performing Sector and Source of Funding: 1993-2002 Industry Universities FFRDCs & colleges1
Performing Total Federal sector: U.S. Govt. Industry Funding sector: Calendar year5
Federal Total Federal Federal U.S. Govt. Total Govt. Industry2 Govt.
Total
U&C FFRDCs Non- Federal Federal Nonfed. Govt. govt.3 Industry U&C profits Govt.4
Millions of current dollars
1993
28,754
2,621
6,427
466
5,961
492
13,643
8,637
952
851 2,268
936
2,968
1994
29,580
2,547
6,514
436
6,078
503
14,393
9,135
991
889 2,405
973
2,870
1995
29,562
2,689
5,569
190
5,379
530
15,139
9,629
1,069
945 2,509
987
2,661
1996
32,816
2,680
7,498
650
6,848
708
16,033 10,087
1,148
1,032 2,738 1,028
2,632
1997
36,741
2,746
9,795
1,029
8,766
625
17,485 10,788
1,242
1,170 3,129 1,156
2,660
1998
S
3,003
S
S
S
568
19,135 11,746
1,323
1,308 3,468 1,290
2,684
1999
S
3,347
S
S
S
634
20,799 12,723
1,421
1,416 3,806 1,432
2,798
2000
S
3,683
S
S
S
459
22,909 14,093
1,531
1,493 4,211 1,581
2,927
2001prelim
S
3,978
S
S
S
516
25,300 15,821
1,617
1,539 4,626 1,699
2,997
2002 prelim Calendar year5
S
4,437
S
S
S
620
27,797 17,665
1,675
1,586 5,052 1,819
3,057
Millions of constant 1996 dollars
1993
30,573
2,787
6,834
495
6,338
523
14,506
9,183
1,012
905 2,411
995
3,156
1994
30,809
2,653
6,785
454
6,331
524
14,991
9,515
1,032
926 2,505 1,014
2,989
1995
30,134
2,741
5,677
194
5,483
540
15,432
9,815
1,090
963 2,558 1,006
2,713
1996
32,816
2,680
7,498
650
6,848
708
16,033 10,087
1,148
1,032 2,738 1,028
2,632
1997
36,038
2,693
9,608
1,009
8,598
613
17,151 10,582
1,219
1,148 3,069 1,133
2,609
1998
S
2,909
S
S
S
550
18,541 11,382
1,282
1,268 3,360 1,250
2,601
1999
S
3,197
S
S
S
606
19,868 12,154
1,357
1,353 3,636 1,368
2,672
2000
S
3,446
S
S
S
429
21,432 13,184
1,432
1,397 3,940 1,479
2,738
2001prelim
S
3,636
S
S
S
472
23,123 14,459
1,477
1,406 4,228 1,552
2,739
2002 prelim
S
4,010
S
S
S
560
25,124 15,966
1,514
1,434 4,566 1,644
2,763
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 2 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 3 Because of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits is included in nonprofits' support for their own R&D. 4 Includes all R&D expenditures of FFRDCs administered by academic institutions. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data was derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Basic Research, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing Total sector U.S. Calendar year5
Federal Government Total
Industry
U&C
Industry U&C NonFederal Non- Nonprofit Govt. Industry FFRDCs U&C2 FFRDCs3 profits FFRDCs Total Industry4 U&C2 profits U&C2 Millions of current dollars
1993
28,754 16,412
2,621
466
492 8,637
2,968
1,157
72 7,136
5,961
851
324 2,268
1994
29,580 16,702
2,547
436
503 9,135
2,870
1,137
75 7,323
6,078
889
356 2,405
1995
29,562 16,945
2,689
190
530 9,629
2,661
1,170
75 6,714
5,379
945
390 2,509
1996
32,816 18,083
2,680
650
708 10,087
2,632
1,248
79 8,308
6,848 1,032
428 2,738
1997
36,741 19,272
2,746
1,029
625 10,788
2,660
1,317
108 10,385
8,766 1,170
449 3,129
1998
S 21,001
3,003
S
568 11,746
2,684
1,461
213
S
S 1,308
489 3,468
1999
S 23,639
3,347
S
634 12,723
2,798
1,734
397
S
S 1,416
541 3,806
2000
S 26,630
3,683
S
459 14,093
2,927
2,054
616
S
S 1,493
612 4,211
2001prelim
S 29,529
3,978
S
516 15,821
2,997
2,326
903
S
S 1,539
644 4,626
2002 prelim Calendar year5
S 32,670
4,437
S
620 17,665
3,057
2,613
921
S
S 1,586
645 5,052
Millions of constant 1996 dollars
1993
30,573 17,451
2,787
495
523 9,183
3,156
1,230
77 7,587
6,338
905
344 2,411
1994
30,809 17,396
2,653
454
524 9,515
2,989
1,184
78 7,627
6,331
926
370 2,505
1995
30,134 17,273
2,741
194
540 9,815
2,713
1,193
77 6,844
5,483
963
398 2,558
1996
32,816 18,083
2,680
650
708 10,087
2,632
1,248
79 8,308
6,848 1,032
428 2,738
1997
36,038 18,903
2,693
1,009
613 10,582
2,609
1,291
106 10,186
8,598 1,148
440 3,069
1998
S 20,349
2,909
S
550 11,382
2,601
1,415
206
S
S 1,268
473 3,360
1999
S 22,580
3,197
S
606 12,154
2,672
1,656
379
S
S 1,353
517 3,636
2000
S 24,913
3,446
S
429 13,184
2,738
1,922
576
S
S 1,397
573 3,940
2001prelim
S 26,988
3,636
S
472 14,459
2,739
2,126
825
S
S 1,406
588 4,228
2002 prelim
S 29,529
4,010
S
560 15,966
2,763
2,361
832
S
S 1,434
583 4,566
Because of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits is included in nonprofits' support for their own R&D. 2 Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscalyear data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Development, by Performing Sector and Source of Funding: 1993-2002 Performing Total Federal sector: U.S. Govt. Industry
Industry Universities FFRDCs & colleges1
U&C FFRDCs
Federal Funding Total Federal Federal Federal Nonfed. Non- Federal Govt. govt. Industry U&C profits Govt.3 sector: U.S. Govt. Total Govt. Industry2 Govt. Total Calendar Millions of current dollars year4 1993
99,677
9,071
84,757 16,083
68,674
1,038
1,698
1,126
109
97 259
107
1,346
1994
103,023
8,823
87,890 16,209
71,681
1,196
1,814
1,212
114
102 276
112
1,466
1995
113,053
9,262
97,342 17,824
79,518
1,208
1,810
1,178
123
108 288
113
1,592
1996
121,350
9,033 105,863 17,066
88,797
1,358
1,789
1,127
128
115 305
115
1,495
1997
128,726
9,077 113,184 18,121
95,063
1,292
1,750
1,092
122
115 307
113
1,462
1998
S
9,214
S
S
S
1,280
1,677
1,024
117
116 306
114
1,577
1999
S
8,974
S
S
S
1,412
1,412
717
122
122 328
123
1,595
2000
S
7,847
S
S
S
1,021
1,210
457
131
127 360
135
1,546
2001 prelim
S
8,670
S
S
S
1,149
1,319
506
139
132 397
146
1,479
2002 prelim
S
9,954
S
S
S
1,380
1,364
495
144
136 433
156
1,416
Calendar year4
Millions of constant 1996 dollars
1993
105,982
9,645
90,119 17,100
73,019
1,104
1,806
1,197
116
103 276
114
1,431
1994
107,305
9,190
91,543 16,883
74,660
1,246
1,890
1,262
118
106 287
116
1,526
1995
115,242
9,441
99,227 18,169
81,058
1,231
1,845
1,201
125
110 293
115
1,623
1996
121,350
9,033 105,863 17,066
88,797
1,358
1,789
1,127
128
115 305
115
1,495
1997
126,264
8,903 111,019 17,774
93,245
1,267
1,716
1,071
120
113 301
111
1,434
1998
S
8,928
S
S
S
1,240
1,625
992
113
112 297
110
1,528
1999
S
8,572
S
S
S
1,349
1,349
685
117
117 313
118
1,523
2000
S
7,341
S
S
S
956
1,132
428
122
119 337
126
1,446
2001 prelim
S
7,924
S
S
S
1,050
1,206
463
127
121 363
133
1,352
2002 prelim
S
8,997
S
S
S
1,247
1,232
447
130
123 392
141
1,280
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 2 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures.2 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscalyear data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development 'Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for Development, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing sector Calendar year5
Total U.S.
Federal Government Total
Industry
U&C
U&C Non- Nonprofit Federal Industry NonGovt. Industry FFRDCs U&C2 FFRDCs3 profits FFRDCs Total Industry4 U&C2 profits U&C2 Millions of current dollars
1993
99,677 30,026
9,071
16,083
1,038 1,126
1,346
787
574 68,866
68,674
97
95
259
1994
103,023 30,293
8,823
16,209
1,196 1,212
1,466
815
573 71,886
71,681
102
103
276
1995
113,053 32,410
9,262
17,824
1,208 1,178
1,592
744
603 79,738
79,518
108
111
288
1996
121,350 31,347
9,033
17,066
1,358 1,127
1,495
698
571 89,032
88,797
115
120
305
1997
128,726 32,315
9,077
18,121
1,292 1,092
1,462
687
585 95,332
95,063
115
155
307
1998
S 32,589
9,214
S
1,280 1,024
1,577
760
507
S
S
116
168
306
1999
S 28,658
8,974
S
1,412
717
1,595
726
467
S
S
122
187
328
2000
S 23,802
7,847
S
1,021
457
1,546
515
640
S
S
127
211
360
2001 prelim
S 25,907
8,670
S
1,149
506
1,479
580
948
S
S
132
222
397
2002 prelim Calendar year5
S 28,891
9,954
S
1,380
495
1,416
587
926
S
S
136
222
433
Millions of constant 1996 dollars
1993
105,982 31,925
9,645
17,100
1,104 1,197
1,431
836
611 73,223
73,019
103
101
276
1994
107,305 31,552
9,190
16,883
1,246 1,262
1,526
849
596 74,873
74,660
106
107
287
1995
115,242 33,038
9,441
18,169
1,231 1,201
1,623
758
615 81,282
81,058
110
113
293
1996
121,350 31,347
9,033
17,066
1,358 1,127
1,495
698
571 89,032
88,797
115
120
305
1997
126,264 31,697
8,903
17,774
1,267 1,071
1,434
673
573 93,509
93,245
113
152
301
1998
S 31,578
8,928
S
1,240
992
1,528
736
491
S
S
112
163
297
1999
S 27,375
8,572
S
1,349
685
1,523
693
446
S
S
117
178
313
2000
S 22,268
7,341
S
956
428
1,446
482
599
S
S
119
197
337
2001 prelim
S 23,678
7,924
S
1,050
463
1,352
530
866
S
S
121
203
363
2002 prelim S 26,113 8,997 S 1,247 447 1,280 530 837 S S 123 201 392 of limitations in the survey information, data on nonfederal government funding to other performers are not available and are consequently included in other sectors' support for their own R&D performance. For example, nonfederal government support to nonprofits is included in nonprofits' support for their own R&D. 2 Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. The character of work estimation procedure for university and college R&D also was revised for 1998 and later years; hence these data are not directly comparable with data for 1997 and earlier years. 1 Because
3 Includes 4 Industry
all R&D expenditures of FFRDCs administered by academic institutions.
sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 5 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges; S = Suppressed pending data quality review Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development 'Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997.
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for R&D, by Performing Sector and Source of Funding: 1993-2002 Performing Total Federal sector: U.S. Govt. Industry Funding sector: Calendar year4
U&C FFRDCs
Industry Universities FFRDCs & colleges1
Total Federal Federal Federal U.S. Govt. Total Govt. Industry2 Govt.
Total
Federal Nonfed. Non- Federal Govt. govt. Industry U&C profits Govt.3
Millions of current dollars
1993
165,716
16,531 115,435
20,844
94,591
1,965
20,487
12,301
1,557
1,391 3,708
1,530
5,283
1994
169,217
16,355 117,392
20,261
97,131
2,202
21,594
12,987
1,622
1,456 3,937
1,594
5,317
1995
183,614
16,904 129,830
21,178
108,652
2,273
22,602
13,582
1,750
1,547 4,108
1,616
5,372
1996
197,344
16,585 142,371
21,356
121,015
2,297
23,701
14,072
1,860
1,671 4,433
1,665
5,410
1997
212,156
16,819 155,409
21,798
133,611
2,130
24,865
14,516
1,921
1,807 4,836
1,785
5,486
1998
226,367
17,362 167,102
22,086
145,016
2,078
26,162
15,146
1,973
1,951 5,170
1,923
5,588
1999
243,562
17,851 180,390
20,214
160,176
2,321
28,157
16,215
2,101
2,094 5,628
2,118
5,660
2000
264,616
17,469 197,861
17,440
180,421
1,678
30,974
17,975
2,257
2,201 6,210
2,331
5,801
2001 prelim 281,767
19,130 208,068
18,625
189,442
1,888
34,175
20,179
2,387
2,272 6,830
2,508
5,940
2002 prelim 291,663
21,566 210,848
20,933
189,915
2,268
37,491
22,531
2,473
2,342 7,459
2,686
6,059
Calendar year4
Millions of constant 1996 dollars
1993
176,200
17,576 122,738
22,163
100,575
2,089
21,783
13,079
1,655
1,479 3,943
1,627
5,617
1994
176,249
17,035 122,271
21,103
101,168
2,294
22,491
13,527
1,689
1,516 4,100
1,660
5,538
1995
187,170
17,231 132,345
21,588
110,756
2,317
23,039
13,845
1,784
1,577 4,187
1,647
5,476
1996
197,344
16,585 142,371
21,356
121,015
2,297
23,701
14,072
1,860
1,671 4,433
1,665
5,410
1997
208,098
16,497 152,436
21,381
131,055
2,089
24,390
14,238
1,885
1,773 4,743
1,751
5,381
1998
219,340
16,823 161,915
21,400
140,514
2,013
25,350
14,676
1,911
1,890 5,010
1,863
5,414
1999
232,654
17,052 172,311
19,309
153,002
2,217
26,896
15,489
2,007
2,001 5,376
2,023
5,406
2000
247,561
16,343 185,108
16,316
168,792
1,570
28,978
16,816
2,112
2,059 5,809
2,181
5,427
2001 prelim 257,520
17,484 190,163
17,023
173,140
1,725
31,234
18,443
2,181
2,076 6,242
2,292
5,429
2002 prelim 263,617
19,493 190,573
18,920
171,653
2,050
33,886
20,365
2,235
2,117 6,741
2,428
5,476
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. Data for 1998 and later years are not directly comparable to data for 1997 and earlier years. For fiscal year 1998, $479 million in passthrough funds were reported. For fiscal year 2002, $881 million in passthrough funds are estimated. 2 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 3 Includes all R&D expenditures of FFRDCs administered by academic institutions. 4 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges. Sources: National Science Foundation/Division of Science Resources Statistics. Data was derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
National Expenditures for R&D, from Funding Sectors to Performing Sectors: 1993-2002 Funding sector:
Total U.S.
Performing sector Calendar year4
Total U.S.
Federal Government Total
Industry
U&C Federal Industry Non- Nonprofit Govt. Industry FFRDCs U&C1 FFRDCs2 profits FFRDCs
U&C
NonTotal Industry3 U&C1 profits U&C1
Millions of current dollars
1993
165,716 60,516 16,531
20,844
1,965 12,301
5,283
2,843
749
96,549
94,591 1,391
567 3,708
1994
169,217 60,792 16,355
20,261
2,202 12,987
5,317
2,911
758
99,203
97,131 1,456
617 3,937
1995
183,614 62,963 16,904
21,178
2,273 13,582
5,372
2,847
808 110,870 108,652 1,547
671 4,108
1996
197,344 63,397 16,585
21,356
2,297 14,072
5,410
2,906
772 123,416 121,015 1,671
730 4,433
1997
212,156 64,583 16,819
21,798
2,130 14,516
5,486
3,014
821 136,227 133,611 1,807
809 4,836
1998
226,367 66,383 17,362
22,086
2,078 15,146
5,588
3,281
843 147,847 145,016 1,951
880 5,170
1999
243,562 67,014 17,851
20,214
2,321 16,215
5,660
3,761
993 163,245 160,176 2,094
975 5,628
2000
264,616 66,208 17,469
17,440
1,678 17,975
5,801
4,380
1,465 183,724 180,421 2,201
1,103 6,210
2001 prelim 281,767 72,920 19,130
18,625
1,888 20,179
5,940
5,005
2,153 192,873 189,442 2,272
1,160 6,830
2002 prelim 291,663 81,004 21,566 Calendar year4
20,933
2,268 22,531
6,059
5,525
2,121 193,420 189,915 2,342
1,163 7,459
Millions of constant 1996 dollars
1993
176,200 64,344 17,576
22,163
2,089 13,079
5,617
3,023
796 102,657 100,575 1,479
603 3,943
1994
176,249 63,318 17,035
21,103
2,294 13,527
5,538
3,032
790 103,326 101,168 1,516
642 4,100
1995
187,170 64,182 17,231
21,588
2,317 13,845
5,476
2,902
823 113,017 110,756 1,577
684 4,187
1996
197,344 63,397 16,585
21,356
2,297 14,072
5,410
2,906
772 123,416 121,015 1,671
730 4,433
1997
208,098 63,348 16,497
21,381
2,089 14,238
5,381
2,956
805 133,622 131,055 1,773
793 4,743
1998
219,340 64,322 16,823
21,400
2,013 14,676
5,414
3,179
817 143,257 140,514 1,890
853 5,010
1999
232,654 64,013 17,052
19,309
2,217 15,489
5,406
3,592
948 155,934 153,002 2,001
931 5,376
2000
247,561 61,940 16,343
16,316
1,570 16,816
5,427
4,098
1,371 171,883 168,792 2,059
1,032 5,809
2001 prelim 257,520 66,645 17,484
17,023
1,725 18,443
5,429
4,574
1,968 176,276 173,140 2,076
1,060 6,242
2002 prelim 263,617 73,215 19,493
18,920
2,050 20,365
5,476
4,994
1,917 174,821 171,653 2,117
1,051 6,741
Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another. Data for 1998 and later years are not directly comparable to data for 1997 and earlier years. For fiscal year 1998, $479 million in passthrough funds were reported. For fiscal year 2002, $881 million in passthrough funds are estimated. 2 Includes all R&D expenditures of FFRDCs administered by academic institutions. 3 Industry sources of industry R&D expenditures include all non-Federal sources of industry R&D expenditures. 4 Expenditure levels for academic and Federal government performers are also in reference to calendar years. These levels are approximations based on fiscal-year data. For Federal government expenditures starting in 1977, the calendar-year approximation is equal to 75 percent of the amount reported in the same fiscal year plus 25 percent of the amount reported in the subsequent fiscal year. For academic expenditures in all years and for Federal government expenditures prior to 1977 the respective percentages are 50 and 50, because those fiscal years (for most academic institutions and the Federal government before 1977) begin on July 1 instead of October 1. Key: FFRDCs=federally funded research and development centers; U&C=universities and colleges Sources: National Science Foundation/Division of Science Resources Statistics. Data were derived from NSF/SRS, Research and Development in Industry 2000; NSF/SRS, Academic Research and Development Expenditures: Fiscal Year 2000; NSF/SRS, Federal Funds for Research and Development: Fiscal Years 2000, 2001, and 2002; and NSF/SRS Survey of R&D Funding & Performance by Nonprofit Organizations: Fiscal Years 1996 and 1997. 1
Plunkett Research, Ltd.
www.plunkettresearch.com
Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 Federal Calendar year
Total Federal
Defense related
Space related Percent
Civilian related
Nonfederal
1953
53.9
48.0
1.0
4.9
46.1
1954
55.2
49.0
1.0
5.2
44.8
1955
57.4
48.7
1.0
7.7
42.6
1955
58.6
49.7
1.0
7.9
41.4
1957
62.9
53.2
0.9
8.8
37.1
1958
63.9
53.1
1.1
9.7
36.1
1959
65.4
54.3
2.6
8.6
34.6
1960
65.0
52.6
3.2
9.3
35.0
1961
65.1
50.4
5.6
9.2
34.9
1962
64.8
49.1
6.6
9.1
35.2
1963
66.5
41.9
13.6
11.0
33.5
1964
66.8
37.0
19.0
10.9
33.2
1965
65.1
33.2
20.9
11.1
34.9
1966
64.2
32.4
19.6
12.2
35.8
1967
62.4
35.3
14.4
12.7
37.6
1968
60.7
34.7
13.6
12.4
39.3
1969
58.6
34.7
11.5
12.4
41.4
1970
57.0
33.4
10.3
13.3
43.0
1971
56.4
32.7
9.6
14.1
43.6
1972
55.8
33.0
7.9
14.9
44.2
1973
53.6
32.0
6.7
14.8
46.4
1974
51.8
29.3
6.9
15.6
48.2
1975
52.0
27.6
7.5
16.8
48.0
1976
51.5
26.9
7.7
16.9
48.5
1977
51.0
27.2
6.6
17.2
49.0
1978
50.2
25.9
6.2
18.0
49.8
1979
49.2
24.8
5.6
18.8
50.8
1980
47.5
24.3
5.3
17.9
52.5
1981
46.7
24.4
5.2
17.0
53.3
1982
46.1
26.1
4.9
15.0
53.9
1983
46.2
27.7
4.2
14.2
53.8
1984
45.5
28.7
3.0
13.8
54.5
1985
46.0
29.9
3.2
12.9
54.0
1986
45.5
31.5
3.0
10.9
54.5
1987
46.4
31.8
3.2
11.4
53.6
1988
44.9
30.5
3.4
11.0
55.1
1989
42.6
27.9
3.7
11.0
57.4
1990
40.6
25.4
4.2
11.0
59.4
1991
37.8
22.6
4.5
10.8
62.2
1992
36.8
21.6
4.3
11.0
63.2
1993
36.5
21.6
4.4
10.6
63.5
1994
35.9
19.9
4.4
11.6
64.1
1995
34.3
18.5
4.5
11.2
65.7
1996
32.1
17.6
4.1
10.5
67.9
1997
30.4
16.8
4.1
9.6
69.6
Plunkett Research, Ltd.
www.plunkettresearch.com
Trends in Federal and Non-Federal R&D Expenditures as a Percentage of Total R&D: 1953-2002 (cont.) Federal Calendar year
Total Federal
Defense related
Space related Percent
Civilian related
Nonfederal
1998
29.3
15.9
3.9
9.6
70.7
1999
27.5
14.6
3.5
9.4
72.5
2000
25.0
13.5
2.4
9.1
75.0
2001 prelim
25.9
13.6
2.3
9.9
74.1
2002 prelim 27.8 15.0 2.5 10.3 72.2 Note: Data are preliminary for 2001 and 2002. Details may not sum totals because of rounding. Source: National Science Foundation/Division of Science Resources Statistics
Plunkett Research, Ltd.
www.plunkettresearch.com
Trends in U.S. Research & Development (R&D) and Federal Outlays: 1970, 1980, 1990, 2000 and 2002 (Estimate) Composition of Federal Outlays
1970
1980
1990
2002 (estimate)
2000
Billions of Current US$ Total Federal outlays
195.6
590.9
1,253.2
1,788.8
1,960.6
1
Mandatory programs
61.0
262.1
568.2
950.8
1,080.7
Net interest
14.4
52.5
184.4
223.2
188.1
120.3
276.3
500.6
614.8
691.7
81.9
134.6
300.1
295.0
319.2
8.0
14.6
41.1
41.1
46.8
4.0
12.8
19.1
21.3
24.5
N/A
N/A
N/A
N/A
N/A
34.4
128.9
181.4
298.6
348.0
7.1
15.6
22.7
32.9
40.4
15.1
30.2
63.8
74.0
87.2
Total discretionary Defense discretionary R&D outlays International discretionary R&D outlays Domestic discretionary R&D outlays Total Federal R&D outlays
Total U.S. Federal Outlays (Percent) Total Federal outlays
100.0
100.0
100.0
100.0
100.0
1
31.2
44.4
45.3
53.2
55.1
7.4
8.9
14.7
12.5
9.6
61.5
46.8
39.9
34.4
35.3
41.9
22.8
23.9
16.5
16.3
4.1
2.5
3.3
2.3
2.4
2.0
2.2
1.5
1.2
1.2
N/A
N/A
N/A
N/A
N/A
17.6
21.8
14.5
16.7
17.7
3.6
2.6
1.8
1.8
2.1
7.7
5.1
5.1
4.1
4.4
Mandatory programs Net interest Total discretionary
Defense discretionary R&D outlays International discretionary R&D outlays Domestic discretionary R&D outlays Total Federal R&D outlays
U.S. Federal R&D Outlays as Proportion of Corresponding Discretionary Outlays (Percent) Total Federal R&D as a percent of total discretionary outlays
12.6%
10.9%
12.7%
12.0%
12.6%
Defense as a percent of defense outlays
9.8%
10.8%
13.7%
13.9%
14.7%
Domestic as a percent of domestic outlays
20.7%
12.1%
12.5%
11.0%
11.6%
N/A = not available 1
Includes Social Security, Medicare, Medicaid, and other programs.
Sources: U.S. Office of Management and Budget, Historical Tables, Budget of the United States Government: Fiscal Year 2002 (Washington, DC, U.S. Government Printing Office). Science & Engineering Indicators – 2002.
Plunkett Research, Ltd.
www.plunkettresearch.com
U.S. Federal Basic Research Budget Authority, by Budget Function: Fiscal Years 1995–2001 (latest data available) US$ Mil. Budget function
1995
1996
1997
1998
1999
2000
2001
Millions of Current US$ Total
Health General science Space research and tech. National defense Energy Agriculture Natural resources and env. Transportation Education, training, employment and social services Commerce & housing credit Vet. benefits and services Administration of justice Community and regional dev. General government International affairs Income security
13,772 6,068 2,622 1,614 1,181 930 565 187 389
14,442 6,395 2,662 1,685 1,165 1,182 547 147 456
14,961 6,852 2,753 1,653 1,090 1,288 548 153 420
15,523 7,356 4,121 1,610 1,067 34 571 145 411
17,433 8,634 4,464 1,667 1,110 36 602 142 358
18,965 9,834 4,648 1,737 1,205 37 659 155 255
20,259 10,399 5,272 1,761 1,262 46 702 162 202
153 35 16 9 3 0 0 0
140 37 13 12 0 0 2 0
142 34 14 13 0 0 2 0
133 35 23 16 0 0 1 0
99 41 263 18 0 0 0 0
106 41 268 21 0 0 0 0
112 53 268 19 0 0 0 0
Millions of Constant FY 1996 US$ Total
Health General science Space research and tech. National defense Energy Agriculture Natural resources and env. Transportation Education, training, employment and social services Commerce & housing credit Vet. benefits and services Administration of justice Community and regional dev. General government International affairs Income security
14,037 6,185 2,673 1,646 1,204 948 576 190 397
14,442 6,395 2,662 1,685 1,165 1,182 547 147 456
14,711 6,738 2,707 1,625 1,072 1,266 539 150 413
15,071 7,142 4,000 1,563 1,036 33 554 141 399
16,708 8,275 4,278 1,597 1,063 34 577 136 343
17,908 9,286 4,389 1,641 1,138 35 622 146 241
18,755 9,627 4,880 1,631 1,168 43 650 150 187
156 36 16 9 3 0 0 0
140 37 13 12 0 0 2 0
140 33 14 13 0 0 2 0
129 34 23 16 0 0 1 0
95 39 252 17 0 0 0 0
100 38 253 20 0 0 0 0
104 49 248 18 0 0 0 0
Notes: Data for 1995–99 are actual budget authority. Data for 2000 are preliminary estimates, and data for 2001 are proposed based on FY 2001 budget. See Appendix table 4-1 for fiscal year gross domestic product implicit price deflators used to convert current dollars to constant 1996 dollars. Beginning in FY 1998, a number of Department of Energy programs were reclassified from energy to general science. Beginning FY 1999, the increase in the Veterans Administration basic research totals was a result of data reclassifications. Source: National Science Foundation, Division of Science Resources Studies (NSF/SRS), Federal R&D Funding by Budget Function: Fiscal Years 1999–2001, NSF 01-316 (Arlington, VA, 2001).
Plunkett Research, Ltd.
www.plunkettresearch.com
U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001
4,890 5,065 3,932 3,110 3,233 3,708 3,845 4,394 4,612 5,493 6,700 7,283 7,351 7,440 7,726 8,074 7,844 7,694 7,928 7,864
Millions of Constant 1996 US$ 6,435 2,202 1,784 1,584 1,045 5,700 2,182 1,727 1,415 1,073 4,583 2,068 1,468 1,204 1,054 3,757 2,189 1,388 1,277 1,086 3,628 2,356 1,354 1,462 1,071 3,251 2,534 1,441 1,402 1,138 3,037 2,489 1,411 1,218 1,083 2,655 2,641 1,465 1,174 1,063 2,662 2,705 1,453 1,122 1,104 2,917 2,861 1,513 1,283 1,094 3,168 2,801 1,611 1,214 1,104 3,303 2,947 1,770 1,377 1,177 3,437 2,898 1,840 1,660 1,259 2,850 2,865 1,918 1,813 1,226 2,994 2,826 1,944 1,967 1,243 2,901 2,850 2,028 1,870 1,218 2,521 2,846 1,802 1,795 1,176 2,327 2,888 1,850 1,751 1,180 917 4,217 1,794 1,773 1,208 1,079 4,473 1,757 1,645 1,228
General Gov't
6,598 6,303 5,887 6,264 6,718 7,372 7,394 8,478 8,861 9,373 9,655 10,320 10,960 10,944 11,456 11,635 11,867 12,428 13,130 14,834
Income security
26,421 24,946 21,371 20,160 20,983 22,029 21,689 23,170 23,800 25,865 27,723 29,720 30,864 30,485 31,854 32,218 31,248 31,449 32,636 34,650
Admin. of justice
26,694 29,979 33,582 36,345 41,168 45,854 49,065 50,630 50,212 49,035 46,397 43,991 43,692 43,915 39,354 37,948 37,801 38,834 38,514 39,395
Millions of Current US$ 1,233 999 887 585 1,340 1,061 869 659 1,359 965 791 693 1,502 952 876 745 1,676 963 1,040 762 1,862 1,059 1,030 836 1,873 1,062 917 815 2,042 1,133 908 822 2,160 1,160 896 882 2,373 1,255 1,064 907 2,410 1,386 1,045 950 2,635 1,582 1,231 1,052 2,659 1,688 1,523 1,155 2,691 1,802 1,703 1,152 2,712 1,865 1,888 1,193 2,794 1,988 1,833 1,194 2,846 1,802 1,795 1,176 2,944 1,886 1,785 1,203 4,360 1,855 1,833 1,249 4,690 1,842 1,725 1,288 4,885 1,906 1,570 1,405 5,529 1,932 1,665 1,450
Commerce & housing credit Community & reg. Development
1980 53,115 1981 54,925 1982 54,953 1983 56,505 1984 62,151 1985 67,883 1986 70,753 1987 73,799 1988 74,012 1989 74,901 1990 74,121 1991 73,711 1992 74,556 1993 74,400 1994 71,208 1995 70,166 1996 69,049 1997 70,282 1998 71,150 1999 74,046
Agriculture Educ., training, employ. & social serv.
3,603 3,501 3,012 2,578 2,581 2,389 2,286 2,053 2,126 2,419 2,726 2,953 3,153 2,677 2,873 2,844 2,521 2,372 948 1,131 1,112 1,184
Transportation
2,738 3,111 2,584 2,134 2,300 2,725 2,894 3,398 3,683 4,555 5,765 6,511 6,744 6,988 7,414 7,916 7,844 7,844 8,198 8,245 8,447 8,732
International affairs Vets benefits & services
Natural resources & environment
Energy
3,694 3,871 3,869 4,298 4,779 5,418 5,565 6,556 7,076 7,773 8,308 9,226 10,055 10,280 10,993 11,407 11,867 12,670 13,576 15,553 17,762 18,858
General science
Space research & technology
14,793 15,322 14,045 13,832 14,927 16,189 16,323 17,917 19,007 21,450 23,856 26,570 28,315 28,635 30,567 31,587 31,248 32,062 33,746 36,331 38,887 41,316
Total defense 14,946 18,413 22,070 24,936 29,287 33,698 36,926 39,152 40,099 40,665 39,925 39,328 40,083 41,249 37,764 37,204 37,801 39,591 39,823 41,306 41,846 41,414
Total
1980 29,739 1981 33,735 1982 36,115 1983 38,768 1984 44,214 1985 49,887 1986 53,249 1987 57,069 1988 59,106 1989 62,115 1990 63,781 1991 65,898 1992 68,398 1993 69,884 1994 68,331 1995 68,791 1996 69,049 1997 71,653 1998 73,569 1999 77,637 2000 80,733 2001 82,730
Year
Health
Total non-defense
(latest data available)
468 298 228 189 200 220 248 267 285 347 374 433 365 348 373 369 331 373 444 403 476 497
125 160 165 177 192 210 211 223 224 279 375 378 371 382 254 287 252 190 163 190 142 114
126 143 139 157 218 193 183 215 195 212 216 219 245 250 265 257 259 267 587 644 655 655
101 106 104 107 110 114 111 110 122 128 140 178 192 220 380 525 432 409 398 432 373 516
119 104 63 44 46 50 88 99 108 74 67 88 95 57 68 70 50 48 42 59 46 63
45 34 31 37 24 47 41 49 51 45 44 51 51 49 46 59 56 59 72 88 77 74
47 43 32 32 26 21 14 25 23 27 33 30 37 36 45 43 16 9 18 38 25 42
22 22 10 6 8 17 14 17 17 15 17 4 4 1 0 1 2 2 2 3 6 6
836 485 347 275 281 299 330 345 357 418 435 484 398 370 389 376 331 366 429 384
223 261 251 258 270 286 280 288 280 336 436 423 404 407 265 293 252 186 158 181
225 233 212 229 306 263 243 278 244 256 251 245 267 266 276 262 259 262 568 614
180 173 158 156 155 155 147 142 153 154 163 199 209 234 396 535 432 401 385 412
213 169 96 64 65 68 117 128 135 89 78 98 104 61 71 71 50 47 41 56
80 55 47 54 34 64 54 63 64 54 51 57 56 52 48 60 56 58 70 84
84 70 49 47 37 29 19 32 29 33 38 34 40 38 47 44 16 9 17 36
39 36 15 9 11 23 19 22 21 18 20 4 4 1 0 1 2 2 2 3
Plunkett Research, Ltd.
www.plunkettresearch.com
U.S. Federal R&D Budget Authority, by Budget Function: FY 1980–2001 (cont.)
2000 75,543 39,156 2001 75,823 37,956
Millions of Current US$ 36,387 16,620 7,904 1,041 4,571 1,783 1,469 1,315 37,866 17,283 8,003 1,085 5,067 1,771 1,526 1,329
445 456
133 104
613 600
349 473
43 58
72 68
23 38
General Gov't
Income security
Admin. of justice
Commerce & housing credit Community & reg. Development
International affairs Vets benefits & services
Agriculture Educ., training, employ. & social serv.
Transportation
Natural resources & environment
General science
Energy
Space research & technology
Health
Total non-defense
Total defense
Total
Year
(latest data available)
6 5
Notes: Data for 1980–99 are actual budget authority, data for 2000 are preliminary estimates, and data for 2001 are proposed based on fiscal year 2001 budget. See Appendix table 4-1 for fiscal year GDP implicit price deflators used to convert current dollars to constant 1996 dollars. Beginning in fiscal year 1998, a number of Department of Energy programs were reclassified from energy to general science. Sources: National Science Foundation, Division of Science Resources Studies (NSF/SRS), Federal R&D Funding by Budget Function: Fiscal Years 1999–2001, NSF 01–316 (Arlington, VA, 2001). Science & Engineering Indicators – 2002.
Plunkett Research, Ltd.
www.plunkettresearch.com
II. Research and Development by States-U.S.
Plunkett Research, Ltd.
www.plunkettresearch.com
California Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
66,800
518,670
1
19,980
107,100
1
3,321
25,979
1
of which, in life sciences
22%
26%
in engineering
22%
21%
17%
14%
6,009
41,548
1
43,907
435,612
1
Population, 2000 (thousands)
33,872
285,231
1
Civilian labor force, 2000 (thousands)
17,091
142,172
1
Personal income per capita, 2000
$32,225
$29,451
9
Total expenditures, 2000 (millions)
$175,751
$1,615,468
1
R&D obligations, 1999 (millions)
$15,600
$73,718
1
Total R&D performance, 1999 (millions)
$47,965
$231,832
1
Industry R&D, 1999 (millions)
$39,047
$177,171
1
Academic R&D, 1999 (millions)
$3,573
$27,038
1
of which, in life sciences
56%
57%
in engineering
15%
15%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Federal spending
in physical sciences
12%
9%
$15,707
$125,236
1
Number of SBIR awards, 1995-2000
5,510
26,424
1
Patents issued to state residents, 2000
17,492
85,068
1
Gross state product, 1999 (billions)
$1,229
$9,369
1
of which, agriculture
2%
1%
manufacturing, mining, construction
19%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
16%
16%
finance, insurance, real estate
22%
19%
services
23%
21%
government
11%
12%
Public higher education current-fund expenditures, 1997 (millions)
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Illinois Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
20,540
518,670
7
4,020
107,100
9 5
1,345
25,979
of which, in life sciences
22%
26%
in engineering
22%
21%
18%
16%
1,225
41,548
8
23,370
435,612
4
Population, 2000 (thousands)
12,419
285,231
5
Civilian labor force, 2000 (thousands)
6,419
142,172
5
$31,842
$29,451
11
Total expenditures, 2000 (millions)
$60,008
$1,615,468
7
R&D obligations, 1999 (millions)
$1,316
$73,718
16
Total R&D performance, 1999 (millions)
$9,719
$231,832
8
Industry R&D, 1999 (millions)
$7,715
$177,171
8
Academic R&D, 1999 (millions)
$1,087
$27,038
7
54%
57%
in engineering
15%
15%
in physical sciences
11%
9%
$4,713
$125,236
7
393
26,424
19
Patents issued to state residents, 2000
3,833
85,068
5
Gross state product, 1999 (billions)
$446
$9,369
4
of which, agriculture
1%
1%
manufacturing, mining, construction
21%
22%
transportation, communication, utilities
9%
8%
wholesale and retail trade
16%
16%
finance, insurance, real estate
20%
19%
services
23%
21%
government
10%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
of which, in life sciences
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Maryland Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
21,510
518,670
6
3,440
107,100
10 13
635
25,979
of which, in life sciences
29%
26%
in engineering
22%
21%
17%
16%
1,572
41,548
6
9,563
435,612
13
Population, 2000 (thousands)
5,296
285,231
19
Civilian labor force, 2000 (thousands)
2,805
142,172
18
$33,621
$29,451
6
Total expenditures, 2000 (millions)
$45,089
$1,615,468
10
R&D obligations, 1999 (millions)
$8,094
$73,718
2
Total R&D performance, 1999 (millions)
$8,087
$231,832
10
Industry R&D, 1999 (millions)
$1,700
$177,171
22
Academic R&D, 1999 (millions)
$1,380
$27,038
6
42%
57%
in engineering
23%
15%
in physical sciences
13%
9%
Public higher education current-fund expenditures, 1997 (millions)
$2,353
$125,236
18
Number of SBIR awards, 1995-2000
1,255
26,424
4
Patents issued to state residents, 2000
1,355
85,068
20
Gross state product, 1999 (billions)
$175
$9,369
16
of which, agriculture
1%
1%
manufacturing, mining, construction
14%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
15%
16%
finance, insurance, real estate
21%
19%
services
24%
21%
government
17%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
of which, in life sciences
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Massachusetts Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
24,880
518,670
4
4,850
107,100
4 4
1,452
25,979
of which, in life sciences
25%
26%
in engineering
22%
21%
21%
16%
5,468
41,548
2
22,530
435,612
5
Population, 2000 (thousands)
6,349
285,231
13
Civilian labor force, 2000 (thousands)
3,237
142,172
13
$37,710
$29,451
3
Total expenditures, 2000 (millions)
$40,824
$1,615,468
14
R&D obligations, 1999 (millions)
$3,129
$73,718
6
Total R&D performance, 1999 (millions)
$12,190
$231,832
5
Industry R&D, 1999 (millions)
$9,314
$177,171
6
Academic R&D, 1999 (millions)
$1,381
$27,038
5
44%
57%
in engineering
18%
15%
in physical sciences
13%
9%
Public higher education current-fund expenditures, 1997 (millions)
$1,740
$125,236
28
Number of SBIR awards, 1995-2000
3,958
26,424
2
Patents issued to state residents, 2000
3,463
85,068
8
Gross state product, 1999 (billions)
$263
$9,369
11
of which, agriculture
1%
1%
manufacturing, mining, construction
18%
22%
transportation, communication, utilities
6%
8%
wholesale and retail trade
15%
16%
finance, insurance, real estate
24%
19%
services
27%
21%
government
9%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
of which, in life sciences
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Michigan Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
13,770
518,670
13
4,530
107,100
7 8
993
25,979
of which, in life sciences
27%
21%
in engineering
22%
26%
17%
16%
1,108
41,548
11
17,407
435,612
9
Population, 2000 (thousands)
9,938
285,231
8
Civilian labor force, 2000 (thousands)
5,201
142,172
8
$29,071
$29,451
19
$46,823
$1,615,468
9
$840
$73,718
22
Total R&D performance, 1999 (millions)
$18,799
$231,832
2
Industry R&D, 1999 (millions)
$17,714
$177,171
2
$914
$27,038
9
of which, in life sciences
58%
57%
in engineering
20%
15%
in physical sciences
9%
5%
$5,987
$125,236
4
525
26,424
15
Patents issued to state residents, 2000
3,724
85,068
6
Gross state product, 1999 (billions)
$308
$9,369
9
of which, agriculture
1%
1%
manufacturing, mining, construction
31%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
17%
16%
finance, insurance, real estate
14%
19%
services
20%
21%
government
10%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending Total expenditures, 2000 (millions) R&D obligations, 1999 (millions)
Academic R&D, 1999 (millions)
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
New Jersey Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
State
U.S.
Rank
19,740
518,670
8
4,750
107,100
6 14
597
25,979
of which, in life sciences
25%
26%
in engineering
22%
21%
18%
16%
672
41,548
18
11,110
435,612
12
Population, 2000 (thousands)
8,414
285,231
9
Civilian labor force, 2000 (thousands)
4,188
142,172
9
$37,112
$29,451
4
Total expenditures, 2000 (millions)
$43,469
$1,615,468
11
R&D obligations, 1999 (millions)
$2,661
$73,718
8
Total R&D performance, 1999 (millions)
$10,536
$231,832
7
Industry R&D, 1999 (millions)
$9,453
$177,171
5
$521
$27,038
17
47%
57%
in engineering
18%
15%
in physical sciences
11%
9%
$3,148
$125,236
11
803
26,424
10
Patents issued to state residents, 2000
3,889
85,068
4
Gross state product, 1999 (billions)
$332
$9,369
8
of which, agriculture
1%
1%
manufacturing, mining, construction
16%
22%
transportation, communication, utilities
10%
8%
wholesale and retail trade
17%
16%
finance, insurance, real estate
24%
19%
services
23%
21%
government
10%
12%
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending
Academic R&D, 1999 (millions) of which, in life sciences
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
New York Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
41,230
518,670
2
6,230
107,100
3
2,217
25,979
2
of which, in life sciences
25%
26%
in engineering
20%
16%
16%
14%
3,925
41,548
3
36,420
435,612
2
Population, 2000 (thousands)
18,976
285,231
3
Civilian labor force, 2000 (thousands)
8,941
142,172
3
$34,502
$29,451
5
$110,333
$1,615,468
2
$2,689
$73,718
7
Total R&D performance, 1999 (millions)
$14,110
$231,832
3
Industry R&D, 1999 (millions)
$11,388
$177,171
3
Academic R&D, 1999 (millions)
$2,029
$27,038
2
of which, in life sciences
66%
57%
in engineering
11%
15%
in physical sciences
10%
9%
Public higher education current-fund expenditures, 1997 (millions)
$6,872
$125,236
3
Number of SBIR awards, 1995-2000
1,112
26,424
6
Patents issued to state residents, 2000
6,083
85,068
3
Gross state product, 1999 (billions)
$755
$9,369
2
of which, agriculture
0%
1%
manufacturing, mining, construction
13%
22%
transportation, communication, utilities
7%
8%
wholesale and retail trade
13%
16%
finance, insurance, real estate
33%
19%
services
23%
21%
government
10%
12%
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Personal income per capita, 2000 Federal spending Total expenditures, 2000 (millions) R&D obligations, 1999 (millions)
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Pennsylvania Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
23,820
518,670
5
4,290
107,100
8
1,240
25,979
6
of which, in life sciences
25%
21%
in engineering
23%
26%
16%
14%
2,582
41,548
5
19,609
435,612
6
12,281
285,231
6
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Population, 2000 (thousands) Civilian labor force, 2000 (thousands)
5,972
142,172
6
$29,533
$29,451
17
Total expenditures, 2000 (millions)
$73,715
$1,615,468
5
R&D obligations, 1999 (millions)
$1,907
$73,718
13
Total R&D performance, 1999 (millions)
$10,695
$231,832
6
Industry R&D, 1999 (millions)
$8,932
$177,171
7
Academic R&D, 1999 (millions)
$1,389
$27,038
4
of which, in life sciences
57%
57%
in engineering
17%
15%
in physical sciences
7%
5%
$4,941
$125,236
5
889
26,424
9
Patents issued to state residents, 2000
3,636
85,068
7
Gross state product, 1999 (billions)
$383
$9,369
6
of which, agriculture
1%
1%
Personal income per capita, 2000 Federal spending
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
manufacturing, mining, construction
24%
22%
transportation, communication, utilities
9%
8%
wholesale and retail trade
15%
16%
finance, insurance, real estate
18%
19%
services
22%
21%
government
10%
12%
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Texas Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
27,170
518,670
3
8,340
107,100
2
1,572
25,979
3
of which, in life sciences
28%
26%
in engineering
25%
21%
12%
14%
2,583
41,548
4
29,314
435,612
3
20,852
285,231
2
Civilian labor force, 2000 (thousands)
10,325
142,172
2
Personal income per capita, 2000
$27,722
$29,451
25
$106,493
$1,615,468
3
$3,853
$73,718
4
Total R&D performance, 1999 (millions)
$12,429
$231,832
4
Industry R&D, 1999 (millions)
$9,935
$177,171
4
Academic R&D, 1999 (millions)
$1,801
$27,038
28
of which, in life sciences
63%
57%
in engineering
15%
15%
in physical sciences
8%
9%
Public higher education current-fund expenditures, 1997 (millions)
$8,758
$125,236
2
Number of SBIR awards, 1995-2000
1,004
26,424
7
Patents issued to state residents, 2000
6,323
85,068
2
Gross state product, 1999 (billions)
$687
$9,369
3
1%
1%
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Population, 2000 (thousands)
Federal spending Total expenditures, 2000 (millions) R&D obligations, 1999 (millions)
of which, agriculture manufacturing, mining, construction
24%
22%
transportation, communication, utilities
11%
8%
wholesale and retail trade
18%
16%
finance, insurance, real estate
15%
19%
services
20%
21%
government
11%
12%
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
Washington Research & Development (R&D) Profile, 1999-2000 Latest data available Characteristic
State
U.S.
Rank
13,250
518,670
15
2,370
107,100
13
406
25,979
21
of which, in life sciences
32%
26%
in engineering
20%
21%
16%
16%
1,168
41,548
9
6,210
435,612
24
5,894
285,231
15
Doctoral scientists, 19991 1
Doctoral engineers, 1999
1
S&E doctorates awarded, 2000
in psychology S&E postdoctorates in doctorate-granting institutions, 2000
1
S&E graduate students in doctorate-granting institutions, 2000
1
Population, 2000 (thousands) Civilian labor force, 2000 (thousands)
3,045
142,172
15
$31,129
$29,451
12
Total expenditures, 2000 (millions)
$33,897
$1,615,468
16
R&D obligations, 1999 (millions)
$1,307
$73,718
17
Total R&D performance, 1999 (millions)
$8,336
$231,832
9
Industry R&D, 1999 (millions)
$7,231
$177,171
9
$580
$27,038
48
of which, in life sciences
68%
57%
in engineering
11%
6%
in physical sciences
8%
15%
$3,127
$125,236
12
661
26,424
11
Patents issued to state residents, 2000
1,821
85,068
15
Gross state product, 1999 (billions)
$209
$9,369
14
of which, agriculture
2%
1%
Personal income per capita, 2000 Federal spending
Academic R&D, 1999 (millions)
Public higher education current-fund expenditures, 1997 (millions) Number of SBIR awards, 1995-2000
manufacturing, mining, construction
18%
22%
transportation, communication, utilities
8%
8%
wholesale and retail trade
17%
16%
finance, insurance, real estate
17%
19%
services
25%
21%
government
13%
12%
S&E= Science & Engineering; SBIR=Small Business Innovation Research NOTE: Rankings and totals are based on data for the 50 States, District of Columbia, and Puerto Rico. Reliability of the estimates of industry R&D and of doctoral scientists and engineers varies by State, because the sample allocation was not based on geography. The rankings do not take into account the margin of error of estimates from sample surveys. 1 Data on graduate students, doctoral scientists and engineers, and postdoctorates include all graduate degree (except M.D.) candidates and recipients in S&E fields, including health fields. Data on S&E doctorates awarded do not include health fields. Source: National Science Foundation/Division of Science Resources Statistics.
Plunkett Research, Ltd.
www.plunkettresearch.com
State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 (Latest Available Data) Performing sector: Funding sector: State
Total R&D Total R&D
Federal Govt. Federal Govt.
Rank
U&C Universities & colleges1 FFRDCs
Industry Federal Total2 Govt.2 Industry3 Thousands of current dollars
264,616,008 17,468,589 199,539,000 19,118,000 180,421,000
United States, total
Gross state R&D product intensity6 Rank % Rank 30,973,891 5,801,2299,941,551,000 2.66 Total
Alabama
27
Alaska
47
196,448
75,446
9,000
D
D
107,417
Arizona
19
3,107,291
145,601
2,445,000
153,000
2,292,000
465,777
Arkansas
42
454,401
45,489
273,000
D
D
45,769,000 4,229,000
41,540,000
California
1,730,117
664,981
1 55,092,936 1,655,628
607,000
184,000
423,000
428,122
Federal Govt.4
0 119,921,000
31
27,747,000
460.71
45
36,409 156,303,000
231.99
19
67,724,000
340.67
47
4,053,042 2,812,1341,344,623,000
14.10
8
130,894
0
251.44
0
Colorado
17
4,229,501
241,771
3,140,000
D
D
544,204
115,510 167,918,000
212.52
15
Connecticut
14
4,888,469
19,373
4,371,000
127,000
4,244,000
468,435
0 159,288,000
223.07
12
Delaware
28
1,532,130
7,598
1,444,000
7,000
1,437,000
78,126
0
36,336,000
444.22
6
D.C.
24
2,296,233 1,722,640
112,000
46,000
67,000
245,828
0
59,397,000
363.87
10
Florida
15
4,662,727
573,140
3,212,000
498,000
2,714,000
851,932
0 472,105,000
40.99
36
Georgia
21
2,796,192
273,713
1,579,000
83,000
1,496,000
926,749
0 296,142,000
100.94
37
Hawaii
46
291,409
58,658
44,000
17,000
27,000
161,300
0
42,364,000
400.69
46
Idaho
30
1,433,567
21,722
1,338,000
D
D
73,726
0
37,031,000
423.87
9
6 12,767,496
85,344
10,661,000
37,000
10,624,000
1,170,625
759,002 467,284,000
52.73
13
Illinois Indiana
18
3,252,494
71,630
2,668,000
75,000
2,593,000
509,141
Iowa
34
1,017,300
34,586
538,000
D
D
418,263
Kansas
31
1,420,089
20,162
1,140,000
D
D
Kentucky
35
866,052
7,500
582,000
1,000
581,000
Louisiana
38
626,793
99,196
126,000
1,000
125,000
399,411
Maine
45
318,726
4,755
201,000
53,000
148,000
57,753
Maryland
10
8,633,558 4,869,668
2,032,000
428,000
1,604,000
0 192,195,000
151.69
25
301.14
33
23,281
89,600,000
258,336
0
85,063,000
311.67
26
274,238
0 118,508,000
270.73
43
0 137,700,000
240.46
49
0
35,981,000
450.89
38
1,507,549
0 186,108,000
164.64
4
Massachusetts
5 13,004,427
259,172
8,032,000
1,485,792
348,339 284,934,000
114.56
5
Michigan
2 18,892,070
239,543
17,640,000
80,000
17,559,000
995,756
0 325,384,000
95.81
1
9,863,000 1,831,000
Minnesota
16
4,298,967
32,014
3,722,000
173,000
3,550,000
416,411
0 184,766,000
172.33
17
Mississippi
39
512,789
186,799
101,000
19,000
83,000
217,064
0
350.76
42
Missouri
23
2,583,036
43,851
1,893,000
18,000
1,876,000
614,101
0 178,845,000
181.44
30
Montana
48
169,856
35,344
28,000
D
D
99,069
0
21,777,000
480.78
41
Nebraska
43
438,996
25,082
199,000
D
D
208,480
0
56,072,000
370.78
40
Nevada
44
377,412
20,696
248,000
D
D
106,340
0
74,745,000
320.50
48
New Hampshire
36
775,004
35,717
586,000
D
D
150,982
0
47,708,000
391.62
27
4 13,133,222
567,666
New Jersey
417,685
12,062,000
253,000
11,809,000
New Mexico
20
3,085,199
320,838
1,158,000
D
D
New York North Carolina North Dakota
3 13,555,586 13 5,045,250 49 145,671
176,034 262,003 25,842
10,539,000 1,773,000 3,672,000 30,000 51,000 D
8,766,000 3,641,000 D
Ohio
11
7,661,540
615,458
5,962,000
539,000
Oklahoma
37
659,684
58,619
333,000
3,000
67,315,000
65,305 363,089,000
83.62
11
54,364,000
385.68
2
2,290,812 1,040,017 67,406
0 799,202,000 0 281,741,000 0 18,283,000
21.70 121.79 510.80
24 22 39
5,423,000
918,500
0 372,640,000
72.06
18
331,000
252,419
0
290.72
44
246,258 1,333,194
91,773,000
Plunkett Research, Ltd.
www.plunkettresearch.com
State Distribution of Expenditures for R&D, by Performing Sector and Source of Funding: 2000 (Latest Available Data) (cont.) Performing sector: Funding sector: State Oregon
Total R&D
Federal Govt.
Total R&D
Federal Govt.
Rank
U&C Universities & colleges1 FFRDCs
Industry Federal Total2 Govt.2 Industry3 Thousands of current dollars
Total
Gross state R&D product intensity6 Rank % Rank
Federal Govt.4
25
2,116,232
88,618
1,651,000
7,000
1,644,000
346,149
0 118,637,000
261.78
23
Pennsylvania
9
9,841,912
151,955
7,873,000
460,000
7,412,000
1,549,050
55,955 403,985,000
62.44
16
Rhode Island
29
1,500,828
240,862
1,090,000
D
D
129,697
0
36,453,000
434.12
7
South Carolina
33
1,126,164
45,754
781,000
D
D
294,184
0 113,377,000
280.99
35
South Dakota
50
84,801
13,232
44,000
16,000
28,000
27,269
0
23,192,000
470.37
50
Tennessee
26
2,057,293
88,947
1,215,000
D
D
405,013
0 178,362,000
191.15
32
7 11,552,437
464,699
8,961,000
230,000
8,731,000
2,039,642
0 742,274,000
31.56
28
Texas Utah
32
1,360,644
69,871
979,000
D
D
308,059
0
68,549,000
331.98
20
Vermont
40
465,349
3,599
396,000
D
D
64,762
0
18,411,000
502.53
14
Virginia
12
5,069,481 1,449,209
Washington
8 10,516,331
2,718,000
800,000
1,918,000
587,718
79,342 261,355,000
131.94
21
258,718
9,265,000
D
D
642,934
0 219,937,000
144.78
3
411.08
34
West Virginia
41
457,128
102,958
235,000
D
D
73,420
Wisconsin
22
2,692,876
37,816
1,981,000
18,000
1,963,000
661,470
Wyoming Other unknown
51
60,969
7,298
7,000
0
7,000
43,094
35,536
42,271,000
0 173,478,000
201.55
29
0
490.32
51
19,294,000
NA 12,130,343 42,207 11,994,000 1,094,000 10,900,000 81,969 11,268 NA NA NA NA Adjustment NA 7,630,582 949,548 1,000 NA NA 911,520 125,954 NA NA NA NA 1Adjustments have been made to university R&D for 1998 and later years to eliminate double counting of funds passed through from one academic institution to another at the national level. State-level university R&D data have not been adjusted to correct for this double counting. 2Includes performance at industry FFRDCs. 3Industry sources of R&D expenditures include all non-Federal sources of industry R&D expenditures. 4Includes all R&D expenditures of the FFRDCs, over 95% of these expenditures are Federally funded nationally. 5R&D intensity is the ratio of total R&D performed in a state to the GSP of the state. KEY: FFDRCs = federally funded research and development centers U&C = universities and colleges NA = not available D = data withheld to avoid disclosing operations of individual companies NOTES: Industry R&D data are in reference to calendar years; other R&D data are in reference to fiscal years but may serve as approximations to calendar year data. The "other unknown" category reflects reported data that could not be assigned to a geographic location. The "adjustment" category reflects the difference in state totals (and other unknown) when reported on a fiscal year basis and the U.S. Totals that have been adjusted to calendar year estimates. SOURCE: National Science Foundation/Division of Science Resources Statistics. These data were derived from four NSF surveys: Survey of Industrial R&D; Survey of R&D Expenditures at Universities and Colleges, Survey of Federal Funds for R&D, and Survey of R&D Funding and Performance by Nonprofit Organizations. Gross State Product data are from the U.S. Bureau of Economic Analysis.
Plunkett Research, Ltd.
www.plunkettresearch.com
Top 10 U.S. States in Total R&D Performance, Size of R&D by Performer and R&D as a Percentage of Gross State Product: 2000 Rank
State
Top 10 States in Total R&D Performance1 Total R&D (Mil. of Current US$)
1
California
55,092.94
2
Michigan
18,892.07
3
New York
13,555.59
4
New Jersey
13,133.22
5
Massachusetts
13,004.43
6
Illinois
12,767.50
7
Texas
11,552.44
8
Washington
10,516.33
9
Pennsylvania
9,841.91
10
Maryland
8,633.56
Rank 1 2 3 4 5 6 7 8 9 10
Top 10 States in Size of R&D, by Type of Performing Sector Universities & Colleges3 Federal Government4 Sector Industry Sector Sector California California Maryland Michigan New York District of Columbia New Jersey Texas California Illinois Pennsylvania Virginia New York Maryland Alabama Massachusetts Massachusetts Ohio Washington Illinois Florida Texas North Carolina Texas Pennsylvania Michigan New Jersey Ohio Georgia New Mexico 2
Top 10 States in R&D Intensity (States with the Highest R&D/GSP Ratio)
Rank 1 2 3 4
Michigan New Mexico Washington Maryland
5.81 5.68 4.78 4.64
GSP (Bil. of Current US$) 325.4 54.4 219.9 186.1
5 6
Massachusetts Delaware
4.56 4.22
284.9 36.3
7 8
Rhode Island California
4.12 4.10
36.5 1,344.6
9 10
Idaho District of Columbia
3.87 3.87
37.0 59.4
State
R&D/GSP (percent)
Note: GSP = gross state product; FFRDC = federally funded research and development center. Reliability of the estimates of industry R&D varies by state because the sample allocation was not based on geography. Rankings do not take into account the margin of error of estimates from sample surveys. 1 Includes in-state total R&D performance of industry, universities, Federal agencies, FFRDCs, and federally financed nonprofit R&D. 2 Includes R&D activities of industry-administered FFRDCs located within these states. 3 Excludes R&D activities of university-administered FFRDCs located within these states. 4 Includes costs associated with the administration of intramural and extramural programs by Federal personnel as well as actual intramural performance. Sources: National Science Foundation/Division of Science Resources Statistics, National Patterns of R&D Resources, annual series; GSP data are from the U.S. Bureau of Economic Analysis.
Plunkett Research, Ltd.
www.plunkettresearch.com
III. International Research and Patents
Plunkett Research, Ltd.
www.plunkettresearch.com
International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 (Selected Nations) Total R&D expenditures U.S.
Japan2
Year
Germany3
France
Billions of constant 1996
U.K.
Italy
Canada
dollars4
1981
115.9
40.4
28.6
17.4
19.1
7.9
6.1
1985
155.8
55.6
33.6
21.5
20.1
10.9
7.9
1986
159.8
56.6
34.7
21.8
21.1
11.2
8.3
1987
162.8
60.6
36.4
22.7
21.4
12.2
8.3
1988
167.0
65.3
37.7
23.8
22.0
12.9
8.6
1989
170.4
71.4
39.1
25.3
22.6
13.5
9.2
1990
175.8
77.2
39.6
26.9
22.7
14.4
9.6
1991
179.5
79.0
42.2
27.2
21.6
13.9
9.8
1992
180.1
78.1
41.0
27.7
21.2
13.5
10.3
1993
176.2
76.1
39.6
27.7
22.0
12.7
10.8
1994
176.2
75.3
38.9
27.6
22.5
12.1
11.7
1995
187.2
80.1
39.6
27.6
22.5
11.9
11.9
1996
197.3
85.5
39.9
27.8
22.3
12.1
11.7
1997
208.1
89.0
41.1
27.4
22.1
12.9
12.4
1998
219.3
91.3
42.3
27.6
22.7
13.3
13.5
1999
232.7
91.8
45.5
28.7
24.2
13.2
14.3
2000
247.6
95.4
47.7
29.0
24.6
NA
15.3
2001
257.5
NA
48.7 NA Percent of national GDP
NA
NA
16.2
1981
2.31
2.11
2.47
1.93
2.38
0.88
1.24
1985
2.72
2.54
2.75
2.22
2.24
1.12
1.44
1986
2.70
2.51
2.77
2.21
2.26
1.13
1.47
1987
2.66
2.57
2.87
2.24
2.20
1.19
1.42
1988
2.62
2.60
2.86
2.24
2.14
1.22
1.40
1989
2.59
2.70
2.86
2.29
2.15
1.24
1.47
1990
2.62
2.78
2.75
2.37
2.15
1.29
1.53
1991
2.69
2.75
2.53
2.37
2.07
1.23
1.59
1992
2.62
2.70
2.41
2.38
2.02
1.18
1.65
1993
2.49
2.62
2.35
2.40
2.05
1.13
1.70
1994
2.40
2.57
2.26
2.34
2.01
1.05
1.76
1995
2.48
2.69
2.26
2.31
1.95
1.00
1.73
1996
2.53
2.77
2.26
2.30
1.88
1.01
1.69
1997
2.55
2.83
2.29
2.22
1.81
1.05
1.70
1998
2.58
2.94
2.31
2.17
1.80
1.07
1.79
1999
2.63
2.94
2.44
2.19
1.88
1.04
1.80
2000
2.69
2.98
2.48
2.15
1.86
NA
1.84
2001 2.79 NA 2.52 NA NA NA 1.93 1Nondefense R&D data are estimates. Foreign nondefense R&D/GDP ratios are obtained directly from OECD reports or are estimated by NSF from OECD data for: Japan for 1995 and later years; Germany for 1990 and earlier years; United Kingdom for 1988 and earlier years (except 1985); Italy for 1986 and earlier years; and Canada for 1990 and later years. NOTE: See continued table on the next page for further footnotes.
Plunkett Research, Ltd.
www.plunkettresearch.com
International R&D Expenditures in Constant Dollars and as a Percentage of GDP: 1981–2001 (Selected Nations) (Cont.) Total non-defense R&D expenditures1 U.S.
Japan2
Germany3 France U.K. Billions of constant 1996 dollars4
Year
Italy
Canada
1981
88
40
28
14
15
8
6
1985
109
55
32
17
16
10
8
1986
109
56
33
18
17
11
8
1987
111
60
35
18
18
12
8
1988
116
65
36
19
19
13
8
1989
123
71
37
21
17
13
9
1990
131
76
38
22
18
14
9
1991
139
78
41
22
18
14
10
1992
141
77
40
23
18
13
10
1993
138
75
38
24
19
13
11
1994
141
74
38
23
19
12
12
1995
152
79
38
24
19
12
12
1996
163
85
38
24
19
12
12
1997
173
88
40
25
19
13
12
1998
185
90
41
25
19
13
13
1999
199
91
45
26
21
13
14
2000
214
95
47
NA
21
NA
NA
2001
222
NA
48 NA Percent of National GDP
NA
NA
NA
1981
1.7
2.1
2.4
1.6
1.9
0.9
1.2
1985
1.9
2.5
2.6
1.8
1.8
1.1
1.4
1986
1.9
2.5
2.6
1.8
1.8
1.1
1.4
1987
1.8
2.6
2.7
1.8
1.8
1.2
1.4
1988
1.8
2.6
2.7
1.8
1.8
1.2
1.3
1989
1.9
2.7
2.7
1.9
1.7
1.2
1.4
1990
2.0
2.8
2.6
1.9
1.7
1.3
1.5
1991
2.1
2.7
2.4
1.9
1.7
1.2
1.6
1992
2.1
2.7
2.3
2.0
1.7
1.2
1.6
1993
2.0
2.6
2.3
2.0
1.7
1.1
1.7
1994
1.9
2.5
2.2
2.0
1.7
1.0
1.7
1995
2.0
2.7
2.2
2.0
1.7
1.0
1.7
1996
2.1
2.7
2.2
2.0
1.6
1.0
1.7
1997
2.1
2.8
2.2
2.0
1.5
1.1
1.7
1998
2.2
2.9
2.3
2.0
1.5
1.1
1.8
1999
2.2
2.9
2.4
2.0
1.6
1.0
1.8
2000
2.3
3.0
2.4
NA
1.6
NA
NA
2001 2.4 NA 2.5 NA NA NA NA 2 Due to changes in methodology, data on Japanese R&D in 1996 and later years may not be consistent with data in earlier years. 3 Germany's data for 1981-90 are for West Germany. Conversions of foreign currencies to U.S. dollars are calculated with OECD purchasing power parity exchange rates. Constant 1996 dollars are based on OECD implicit GDP price indices. Key: GDP = gross domestic product; NA = not available Sources: Organisation for Economic Co-operation and Development, Main Science and Technology Indicators data base (Paris, May 2002) and National Science Foundation/ Division of Science Resources Statistics.
4
Plunkett Research, Ltd.
www.plunkettresearch.com
Top 20 Global Patenting Organizations, Calendar Year 2001 Based on Number of U.S. Utility Patents Received
Rank
Organization
Number of Patents, 2001
1
International Business Machines Corp.
3,411
2
NEC Corp.
1,953
3
Canon Kabushiki Kaisha
1,877
4
Micron Technology, Inc.
1,643
5
Samsung Electronics Co., Ltd.
1,450
6
Matsushita Electric Industrial Co., Ltd.
1,440
7
Sony Corp.
1,363
8
Hitachi, Ltd.
1,271
9
Mitsubishi Denki Kabushiki Kaisha
1,184
10
Fujitsu Limited
1,166
11
Toshiba Corp.
1,149
12
Lucent Technologies, Inc.
1,109
13
General Electric Co.
1,107
14
Advanced Micro Devices, Inc.
1,086
15
Hewlett-Packard Co.
978
16
Intel Corp.
809
17
Texas Instruments, Inc.
799
18
Siemens
793
19
Motorola, Inc.
778
20
Eastman Kodak Co.
719
Note: Patent information presented reflects patent ownership at patent grant and does not include ownership changes that occur after the patent grant. Where more than one assignee (owner) exists, patents are attributed to the first-named assignee. No attempt has been made to combine data based on subsidiary relationships. However, where possible, spelling variations and variations based on name changes have been merged into a single name. While every effort is made to accurately identify all organizational entities and to report data by a single organization name, achievement of a totally clean record is not expected, particularly in view of the many variations that occur in corporate identifications. Source: U.S. Patent and Trademark Office, Technology Assessment and Forecast.
Plunkett Research, Ltd.
www.plunkettresearch.com
Top 20 Patenting Countries, 2001 (latest data available) Based on Number of U.S. Patents Received from Country of Headquarters Location Rank
Country
Number of Patents Received, 2001
1
United States of America
87,607
2
Japan
33,223
3
Germany
11,260
4
Taiwan
5,371
5
France
4,041
6
United Kingdom
3,965
7
Canada
3,606
8
South Korea
3,538
9
Sweden
1,743
10
Italy
1,709
11
Switzerland
1,420
12
Netherlands
1,332
13
Israel
970
14
Australia
875
15
Finland
732
16
Belgium
718
17
Austria
589
18
Denmark
479
19
Singapore
296
20
Spain Total Number of Patents
269 166,039
Source: U.S. Patent and Trademark Office, Technology Assessment and Forecast.
Plunkett Research, Ltd.
www.plunkettresearch.com
Chapter 3 ENGINEERING AND RESEARCH INDUSTRY CONTACTS World Wide Web Sites, Publications and Industry Associations I. II. III. IV. V. VI. VII. VIII. IX. X. XI. XII. XIII. XIV. XV. XVI. XVII.
Automotive Associations-Consumer and Safety Automotive-Parts and Supplies Biotech Associations Biotech Careers Biotech Resources Computer/Technology Careers Corporate Information E-Commerce and Internet Industry Associations E-Commerce Education and Training Economic Data and Research Electrical Engineering Industry Associations Energy Associations Energy Education Links Engineering Associations Engineering Indices Engineering Software Film and Television Associations
XVIII. XIX. XX. XXI. XXII. XXIII. XXIV. XXV. XXVI. XXVII. XXVIII. XXIX. XXX.
First Time Jobs/New Grads Food Industry Associations Health Care Careers Industry Associations-Automotive Industry Associations-Construction Industry Research/Market Research Internet Business/Technology Internet Organizations-International Job Listings, General Job Reference Tools Laboratories/Research Microelectronics Industry Associations Satellite-Related Professional Organizations XXXI. Telecommunications Industry Associations XXXII. Telecommunications Information, General XXXIII. Testing Resources XXXIV. U.S. Government Agencies
Plunkett Research, Ltd.
I.
Automotive Associations-Consumer and Safety
American Traffic Safety Services Institute (ATSSA) 15 Riverside Pkwy., Ste. 100 Fredericksburg, VA 22406-1022 Phone: 540-368-1701 Fax: 540-368-1717 Toll Free: 800-272-8772 Web Address: http://www.atssa.com/ ATSSA members provide the majority of safety features, services and materials used on our nation's roadways.
www.plunkettresearch.com
V.
BioTech Web Address: http://biotech.icmb.utexas.edu This site offers a comprehensive dictionary of biotech terms, plus extensive research data regarding biotechnology. Biotech Rumor Mill E-Mail:
[email protected] Web Address: http://www.biofind.com/rumor An open discussion forum that attracts participants from the many biotech disciplines. VI.
II.
Biotech Associations
Biotechnology Industry Organization 1625 K St. NW, Ste. 1100 Washington, DC 20006 Phone: 202-962-9200 Web Address: http://www.bio.org/ The BIO is involved in the research and development of health care, agricultural, industrial and environmental biotechnology products. IV.
Computer/Technology Careers
Automotive-Parts and Supplies
Automotive Learning Center (Plastics Council) 1300 Wilson Blvd. Arlington, VA 22209 Phone: 800-243-5790 Web Address: http://www.plastics-car.com/ The American Plastics Council's Automotive Learning Center strives to provide the automobile designer, stylist or engineer with up-to-the-minute research and information on plastics applications in cars. III.
Biotech Resources
Biotech Careers
Chase Group (The) 7300 W. 110th St., Ste. 560 Overland Park, KS 66210 Phone: 913-663-3100 Fax: 913-663-3131 E-Mail:
[email protected] Web Address: http://www.chasegroup.com/ Executive search firm specializing in biomedical and pharmaceutical placement.
Aquent 711 Boylston St. Boston, MA 02116 Phone: 617-535-5000 Fax: 617-535-5005 Toll Free: 877-727-8637 Web Address: http://www.aquent.com/ Specializes in providing businesses with computer experts (in Macintosh and Windows), filling temporary and permanent positions around the world. Brassring.com 170 High St. Waltham, MA 02454 Phone: 781-736-1000 Fax: 781-893-2433 Toll Free: 888-999-6505 E-Mail:
[email protected] Web Address: http://www.brassring.com/ Career management and development, technology trends and future outlooks. Permits the posting of resumes. ComputerJobs.com 280 Interstate North Pkwy. SE Atlanta, GA 30339-2411 Toll Free: 800-850-0045 Web Address: http://www.computerjobs.com/ Employment web site which offers users a link to computer-related job opportunities. It is organized by skill and market. Dice.com 4101 NW Urbandale Dr. Urbandale, IA 50322 Phone: 515-280-1144
Plunkett Research, Ltd.
Fax: 515-280-1452 Toll Free: 877-386-3323 Web Address: http://www.dice.com/ Provides free employment services for IT jobs. Includes advanced job searches by geographic location and category, availability announcements and resume postings, as well as employer profiles and a recruiter’s page. Also provides career links. Information Week Online Careers 600 Community Dr. Manhasset, NY 11030 Phone: 516-562-5000 Fax: 516-562-5036 Web Address: http://www.informationweek.com/career3/ Provides career services, links and job listings, as well as salary surveys and other information. Institute for Electrical and Electronics Engineers Employment Service 3 Park Ave., 17th Fl. New York, NY 10016 Phone: 212-419-7900 Fax: 212-752-4929 Web Address: http://jobs.ieeeusa.org/jobs/services IEEE-USA provides a line of employment services for technical professionals, employers and recruiters. It offers job listings by geographic area, a resume bank and links to employment services. Pencom Systems, Inc. 40 Fulton St. New York, NY 10038-1850 Phone: 212-513-7777 Fax: 212-227-1854 Web Address: http://www.pencom.com/ Geared for software professionals, this open systems recruiting company offers an interactive salary survey, career advisor, job listings and technology resources. SearchTech Solutions 307 Orchard City Dr., Ste. 206 Campbell, CA 95008 Phone: 408-540-1800 Fax: 408-540-1815 E-Mail:
[email protected] Web Address: http://www.stecs.com/ A specialty firm that establishes direct hiring and contract hiring relationships between software engineers and software engineering companies.
www.plunkettresearch.com
Provides personal assistance to people seeking jobs in computer science and information technology. Techies.com 7580 Quattro Dr. Chanhassen, MN 55317 Phone: 952-392-2040 Fax: 952-392-2020 Toll Free: 800-829-3424 Web Address: http://www.techies.com/ Allows technical job seekers to view highly technical jobs and apply for jobs online. The site also offers online training and job advice. Technology Locator 5055 Avienda Encinas, Ste. 240 Carlsbad, CA 92008 Phone: 760-579-0302 Fax: 760-579-0312 Toll Free: 877-579-0302 Web Address: http://www.tlcsd.com/ Provides engineering and information technology consultants on a contract basis to companies throughout California. Telecom Insight, Ltd. 9457 S. University Blvd., Ste. 352 Highlands Ranch, CO 80126 Phone: 303-740-6104 Fax: 303-470-6104 Web Address: http://www.telecominsight.com/ Provides IT and management resources and jobs for start-up and established companies in the wireless, IP and fixed line telecommunications industries. TeleCom Resources 1824 NE Division, Ste. 1 Bend, OR 97708 Phone: 541-388-6911 Fax: 541-388-1663 Toll Free: 800-800-6577 Web Address: http://www.telecomresources.com/ Offers search and placement services for the telecommunications industry. Webmonkey Terra Lycos Calle Nicaragua, 54 Barcelona, Spain Phone: 34-91452-3000 Web Address: http://www.hotwired.lycos.com/webmonkey/frontdoo r
Plunkett Research, Ltd.
This publication serves as a how-to guide for web developers, in addition to offering tips on what kind of web jobs are out there. VII.
Corporate Information
bizjournals.com 120 W. Morehead St., Ste. 200 Charlotte, NC 28202 Phone: 704-973-1000 Fax: 704-973-1001 E-Mail:
[email protected] Operated by the American Business Journals firm, the publisher of dozens of leading city business journals nationwide, this site provides access to research into the latest news regarding companies small and large. Business Wire Web Address: http://www.businesswire.com/ Business Wire strives to deliver news in an innovative manner. Smart News releases, industryspecific and company-specific news, today's headlines, conference calls, IPOs on the Internet, media services, Tradeshownews.com and BW Connect On-line are all accessible through this informative and continuously updated site. CNNfn Home Page Web Address: http://money.cnn.com Provides the same in-depth financial information online that CNN's cable television financial news unit provides to television viewers. Edgar Online Web Address: http://www.edgar-online.com/ A gateway and search tool for viewing corporate documents, such as annual reports on form 10K, filed with the U.S. Securities Exchange Commission. Hoover’s Online 5800 Airport Blvd. Austin, TX 78752 Phone: 512-374-4500 Fax: 512-374-4505 Toll Free: 800-486-8666 Web Address: http://www.hoovers.com/ Hoover's provides thousands of corporate profiles online. This comprehensive site also features links to news, lists, stock quotes and other corporate and business data.
www.plunkettresearch.com
PRNewswire 810 7th Ave., 35th Fl. New York, NY 10019 Phone: 212-596-1500 Toll Free: 800-832-5522 E-Mail:
[email protected] Web Address: http://www.prnewswire.com/ PR Newswire provides comprehensive communications services for public relations and investor relations professionals ranging from information distribution and market intelligence to the creation of online multimedia content and investor relations web sites. Users can also view recent corporate press releases. Silicon Investor InfoSpace, Inc. 601 108th Ave. NE, Ste. 1200 Bellevue, WA 98004 Phone: 425-201-6100 Fax: 425-201-6150 Web Address: http://www.siliconinvestor.com/ Silicon Investor is focused on technology companies. The site serves as a financial discussion forum and offers quotes, profiles and charts. VIII. E-Commerce and Internet Industry Associations Advanced Network and Services Web Address: http://www.advanced.org/ This organization strives to advance education through the increased use of computer network applications and technology. American Registry for Internet Numbers Web Address: http://www.arin.net/ ARIN is a nonprofit organization that administers and registers Internet protocol (IP) numbers. Berkman Center for Internet and Society Web Address: http://cyber.law.harvard.edu/ This research center focuses on the exploration of the development and inner-workings of and laws pertaining to the Internet. The center offers Internet courses, conferences and more. CommerceNet Web Address: http://www.commerce.net/ An industry consortium for companies using, promoting and building electronic commerce solutions on the Internet.
Plunkett Research, Ltd.
Congressional Internet Caucus Web Address: http://www.netcaucus.org/ The Congressional Internet Caucus is a bi-partisan group of over 100 members of the House and Senate working to educate their colleagues about the promise and potential of the Internet. Cooperative Association for Internet Data Analysis Web Address: http://www.caida.org/ CAIDA works to promote an atmosphere of greater cohesion on the Internet. CyberSkills Association Web Address: http://www.cyberskills.org/ This association’s program serves to provide the skills, knowledge and training needed to compete and thrive in today’s changing Internet industry.
www.plunkettresearch.com
This site offers information concerning the Internet and its surrounding laws. Internet Assigned Numbers Authority Web Address: http://www.iana.org/ This association serves as the central coordinator for the assignment of parameter values for Internet protocols. Internet Service Providers’ Consortium 1301 Shiloh Rd., Ste. 720 Kennesaw, GA 30144-8086 Fax: 678-819-1028 Toll Free: 866-533-6990 Web Address: http://www.ispc.org/ Provides services to startups, small and mediumsized ISPs and represents the needs of small and growing businesses.
Data Interchange Standards Association 333 John Carlyle St., Ste. 600 Alexandria, VA 22314 Phone: 703-548-7005 Fax: 703-548-5738 Web Address: http://www.disa.org/ The DISA is a leading association for electronic commerce. This nonprofit organization supports the development and use of electronic business interchange standards in electronic commerce.
Internet Software Consortium Web Address: http://www.isc.org/ This nonprofit organization has extensive expertise in the development, management, maintenance and implementation of Internet technologies.
Global Business Dialogue on Electronic Commerce Web Address: http://www.gbd.org/ GBDe is a company-led response to the need for strengthened international coordination with regard to worldwide electronic commerce. Steering committee includes CEOs from 24 international companies, including IBM, AOL, Bertelsmann, Fujitsu, HP and Time Warner.
National Industrial Information Infrastructure Protocols (NIIIP) Consortium Web Address: http://www.niiip.org/ A team of organizations that has entered into a cooperative development agreement with the U.S. Government to develop open industry software protocols that will make it possible for manufacturers and their suppliers to effectively interoperate.
Information Systems Security Association Web Address: http://www.issa-intl.org/ ISSA is geared towards those in the information security industry.
NASA's Learning Technologies Project Web Address: http://learn.iw.nasa.gov/ Promotes growth of a national information infrastructure using information NASA has acquired.
NetCoalition Web Address: http://www.netcoalition.com/ Some of the most innovative Internet companies in the world belong to this organization, which serves as a discussion forum for exchanging ideas about the Internet.
Internet Alliance Web Address: http://www.internetalliance.org/ Strives to assist the Internet industry in becoming the most important mass-market medium of the 21st century.
OpenNET Coalition Web Address: http://www.opennetcoalition.org/ Strives to promote the rights of all consumers to obtain affordable, high-speed Internet access.
Internet and Computer Law Association Web Address: http://www.cla.org/
People For Internet Responsibility Web Address: http://www.pfir.org/
Plunkett Research, Ltd.
PFIR is a global, grassroots, ad hoc network of individuals who are concerned about the current and future operations, development, management and regulation of the Internet in responsible manners. RosettaNet Web Address: http://www.rosettanet.org/ A consortium of computer makers, resellers and users creating e-commerce standards for transactioncentered data exchanges using a standardized set of terms for product, partner and transaction properties. Smart Card Industry Association Web Address: http://www.scia.org/ SCIA is a global trade association that strives to stimulate the use and understanding of smart card technology in the marketplace. Voice On the Net Coalition Web Address: http://www.von.org/ The VON Coalition's mission is twofold: to actively advocate the viewpoint that the IP telephony industry should remain as free of governmental regulations as possible and to educate consumers and the media on Internet communications technologies. World Wide Web Consortium (W3C) MIT Laboratory for Computer Science 200 Technology Sq. Cambridge, MA 02139 Phone: 617-253-2613 Fax: 617-258-5999 Web Address: http://www.w3.org/ This organization, housed at the Laboratory for Computer Science on the MIT campus, develops technologies and standards to enhance the performance and utility of the World Wide Web. IX.
E-Commerce Education and Training
International Center for Electronic Commerce Web Address: http://www.icec.net/ Based in Korea, the center's objectives include development of next-generation electronic commerce technologies and management schemes and establishing an international research consortium of e-commerce-related companies. X.
Economic Data and Research
STAT-USA HCHB Room 4885
www.plunkettresearch.com
U.S. Department of Commece Washington, DC 20230 Phone: 202-482-1986 Fax: 202-482-2164 Toll Free: 800-782-8872 E-Mail:
[email protected] Web Address: http://www.stat-usa.gov/ STAT-USA is an agency in the Economics and Statistics Administration of the U.S. Department of Commerce. The site offers daily economic news, statistical releases, export and trade databases and information and domestic economic databases. XI.
Electrical Engineering Industry Associations
American Institute of Physics One Physics Ellipse College Park, MD 20740 Phone: 301-209-3100 Fax: 301-209-0843 E-Mail:
[email protected] Web Address: http://www.aip.org/ A nonprofit organization aimed at the advancement and diffusion of knowledge of the science of physics and its application to human welfare. ASEE Clearinghouse for Engineering Education 1818 North St. NW Washington, DC 20036 Phone: 202-331-3500 Fax: 202-265-8504 Web Address: http://www.asee.org/ The ASEE is dedicated to promoting and improving engineering and technology education. Institute of Electrical and Electronics Societies 3 Park Ave., 17th Fl. New York, NY 10016-5997 Phone: 212-419-7900 Fax: 212-752-4929 Web Address: http://www.ieee.org/society.html This section of the IEEE site offers a directory of technical societies. International Electrotechnical Commission 3 Rue de Varembe Geneva 20, CH-1211 Switzerland Phone: 41-22-919-02-11 Fax: 41-22-919-03-00 Web Address: http://www.iec.ch/ This is the site of the Switzerland-based IEC, which promotes international cooperation on all questions
Plunkett Research, Ltd.
of standardization and related matters in electrical and electronic engineering. International Society for Optical Engineering P.O. Box 10 Bellingham, WA 98227-0010 Phone: 360-676-3290 Fax: 360-647-1445 E-Mail:
[email protected] Web Address: http://www.spie.org/ A nonprofit technical society aimed at the advancement and dissemination of knowledge in optical and optoelectronic applied science and engineering. National Institute of Standards and Technology 100 Bureau Dr., Stop 3460 Gaithersburg, MD 20899 Phone: 301-975-6478 Fax: 301-975-8295 Web Address: http://www.nist.gov/ An agency of the U.S. Department of Commerce's Technology Administration, the NIST works with industry to develop and apply technology, measurements and standards. Professional Organizations and Government Labs for Electrical Engineers Web Address: http://www.ece.umr.edu/links/professional/orgs.html This site provides a list of professional societies and government laboratories of interest to electrical engineers. XII.
Energy Associations
Electric Power Research Institute 3412 Hillview Ave. Palo Alto, CA 94304 E-Mail:
[email protected] Web Address: http://www.epri.com/ EPRI provides solutions about science and technology of importance to its global energy customers. Uranium Institute 114 Knightsbridge Bowater House W, 12th Fl. London, England SW1X 7LJ Phone: 44-20-7225-0303 Fax: 44-20-7225-0308 E-Mail:
[email protected] Web Address: http://www.uilondon.org/
www.plunkettresearch.com
International nonprofit organization involved in all stages of the production of nuclear-generated electricity. XIII.
Energy Education Links
Uranium and Nuclear Information Centre P.O. Box 1649N Melbourne, Australia 3001 Phone: 03-9629-7744 Fax: 03-9629-7207 E-Mail:
[email protected] Web Address: http://www.uic.com.au/ Provides information about the development of the Australium uranium industry, uranium mining and nuclear electricity. XIV.
Engineering Associations
Alfred P. Sloan Foundation 630 5th Ave., Ste. 2550 New York, NY 10111 Phone: 212-649-1649 Fax: 212-757-5117 Web Address: http://www.sloan.org/ Funds science and technology, economic performance, education, national issues and civics programs. American Chemical Society 1155 16th St. NW Washington, DC 20036 Phone: 202-872-4600 Fax: 202-872-4615 Toll Free: 800-227-5558 Web Address: http://www.acs.org/ A nonprofit organization aimed at promoting the understanding of chemistry and chemical sciences, representing a wide range of disciplines including chemistry, chemical engineering and other technical fields. American Concrete Institute P.O. Box 9094 Farmington Hills, MI 48333 Phone: 248-848-3700 Web Address: http://www.aci-int.org/ A professional organization that provides information on the use of concrete for structures and facilities.
Plunkett Research, Ltd.
American Institute of Aeronautics and Astronautics 1801 Alexander Bell Dr., Ste. 500 Reston, VA 20191 Phone: 703-264-7500 Fax: 703-264-7551 Toll Free: 800-699-2422 Web Address: http://www.aiaa.org/ Nonprofit society aimed at advancing the arts, sciences and technology of aeronautics and astronautics. Represents the U.S. in the International Astronautical Federation and the International Council on the Aeronautical Sciences. American Nuclear Society 555 N. Kensington Ave. LaGrange Park, IL 60526 Phone: 708-352-6611 Fax: 708-352-0499 E-Mail:
[email protected] Web Address: http://www.ans.org/ A nonprofit organization unifying the professional activities within the nuclear science and technology fields. American Physical Society One Physics Ellipse College Park, MD 20740 Phone: 301-209-3200 Fax: 301-209-0865 Web Address: http://www.aps.org/ Develops and implements effective programs in physics education and outreach. American Society for Nondestructive Testing P.O. Box 28518 1711 Arlingate Ln. Columbus, OH 43228-0518 Phone: 614-274-6003 Fax: 614-274-6899 Toll Free: 800-222-2768 Web Address: http://www.asnt.org/ The world's largest technical society for nondestructive testing professionals. ASNT promotes the discipline of nondestructive testing as a profession and facilitates nondestructive testing research and technology applications. American Society of Agricultural Engineers 2950 Niles Rd. St. Joseph, MI 49085 Phone: 269-429-0300 Fax: 269-429-3852
www.plunkettresearch.com
E-Mail:
[email protected] Web Address: http://www.asae.org/ Nonprofit professional and technical organization of members interested in engineering knowledge and technology for food and agriculture, associated industries and related resources. American Society of Civil Engineers 1801 Alexander Bell Dr. Reston, VA 20191 Phone: 703-295-6300 Toll Free: 800-548-2723 Web Address: http://www.asce.org/ The leading professional organization serving civil engineers. Ensures safer buildings, water systems and other civil engineering works by developing technical codes and standards. American Society of Mechanical Engineers 3 Park Ave. New York, NY 10016 Phone: 212-591-7722 Fax: 212-591-7674 Toll Free: 800-849-2763 E-Mail:
[email protected] Web Address: http://www.asme.org/ Offers quality programs and activities in mechanical engineering. Also facilitates the development and application of technology in areas of interest to the mechanical engineering profession. American Society of Naval Engineers 1452 Duke St. Alexandria, VA 22314 Phone: 703-836-6727 Fax: 703-836-7491 Web Address: http://www.navalengineers.org/ Nonprofit professional organization which advances the knowledge and practice of naval engineering in public and private operations. American Society of Safety Engineers 1800 E. Oakton St. Des Plaines, IL 60018 Phone: 847-699-2929 Fax: 847-768-3434 E-Mail:
[email protected] Web Address: http://www.asse.org/ World's oldest and largest professional safety organization. Manages, supervises and consults on safety, health and environmental issues in industry, insurance, government and education.
Plunkett Research, Ltd.
American Vacuum Society 120 Wall St., 32nd Fl. New York, NY 10005 Phone: 212-248-0200 Fax: 212-248-0245 Web Address: http://www.vacuum.org/ Nonprofit organization which promotes communication, dissemination of knowledge, recommended practices, research and education in the use of vacuum and other controlled environments to develop new materials, process technology and devices. ASM International 9639 Kinsman Rd. Materials Park, OH 44073 Phone: 440-338-5151 Fax: 440-338-4634 Web Address: http://www.asm-intl.org/ Society for materials engineers, a worldwide network aimed at advancing industry, technology and applications of metals and materials. Association for Computing Machinery 1515 Broadway New York, NY 10036 Phone: 212-626-0500 Fax: 212-944-1318 Toll Free: 800-342-6626 Web Address: http://www.acm.org/ World's first education and scientific computing society. Dedicated to advancing the arts, sciences and applications of information technology. Association of Iron and Steel Engineers 3 Gateway Ctr., Ste. 1900 Pittsburgh, PA 15222 Phone: 412-281-6323 Fax: 412-281-4657 Web Address: http://www.aise.org/ Largest member-based organization for the steel industry worldwide. Aimed at advancing the technical and engineering phases of the production of iron and steel. Association of Professional Engineers of Nova Scotia P.O. Box 129 Halifax, NS B3J 2M4 Canada Phone: 902-429-2250 Fax: 902-423-9769 Toll Free: 888-802-7367 E-Mail:
[email protected]
www.plunkettresearch.com
Web Address: http://www.apens.ns.ca/ British Cement Association Century House Telford Ave. Crowthorne, Berkshire RG45 6YS England Phone: 01344-762676 Fax: 01344-761214 E-Mail:
[email protected] Web Address: http://www.bca.org.uk/ A professional organization, based in the U.K., to promote the better use of concrete. Cryogenic Society of America 1033 South Blvd., Ste. 13 Oak Park, IL 60302 Phone: 708-383-6220 Fax: 708-383-9337 E-Mail:
[email protected] Web Address: http://www.csa.fnal.gov/ Nonprofit organization that brings together those in all disciplines concerned with the applications of low-temperature technology. Also increases public awareness of the usefulness of cryogenic technology. Earthquake Engineering Research Institute 199 14th St., Ste. 320 Oakland, CA 94612 Phone: 510-451-0905 Fax: 510-451-5411 E-Mail:
[email protected] Web Address: http://www.eeri.org/ National nonprofit technical organization of engineers, geoscientists, architects, planners, public officials and social scientists. Aimed at reducing earthquake risk by advancing the science and practice of earthquake engineering. Engineer's Club (The) 1737 Silverwood Dr. San Jose, CA 95124 Phone: 408-445-2902 Fax: 408-265-2410 Web Address: http://www.engineers.com/ Resources and web sites for engineers and technical professionals. IEEE Communications Society 305 E. 47th St. New York, NY 10017 Phone: 212-705-8900 Fax: 212-705-8999 Web Address: http://www.comsoc.org/
Plunkett Research, Ltd.
The IEEE Communications Society is composed of industry professionals with a common interest in advancing communications technologies. Illuminating Engineering Society of North America 120 Wall St., 17th Fl. New York, NY 10005 Phone: 212-248-5000 Fax: 212-248-5017 E-Mail:
[email protected] Web Address: http://www.iesna.org/ A recognized authority on lighting in North America, te IESNA establishes scientific lighting recommendations.. Industrial Research Institute 1550 M St. NW, Ste. 1100 Washington, DC 20005-1712 Phone: 202-296-8811 Fax: 202-776-0756 Web Address: http://www.iriinc.org/ A nonprofit organization of over 260 leading industrial companies representing fields such as aerospace, automotive, chemical, computer and electronics, which carry out over 80% of industrial research effort in the United States' manufacturing sector, employ some 500,000 scientists and engineers and account for at least 30% of the gross national product. Institute for Research in Construction National Research Council of Canada Ottawa, Ontario K1A 0R6 Canada Phone: 613-993-2607 Fax: 613-952-7673 E-Mail:
[email protected] Web Address: http://www.nrc.ca/irc Provides research, building code development and materials evaluation services. The IRC is Canada's construction technology center and a division of the National Research Council. Institute of Biological Engineering 3938 West Rd., Ste. 277 Cortland, NY 13045 Phone: 607-753-9227 Fax: 607-753-9227 Toll Free: 877-423-2255 E-Mail:
[email protected] Web Address: http://www.ibeweb.org/ Professional organization encouraging inquiry and interest in biological engineering.
www.plunkettresearch.com
Institute of Industrial Engineers 25 Technology Park Norcross, GA 30092 Phone: 770-449-0460 Fax: 770-441-3295 Toll Free: 800-494-0460 E-Mail:
[email protected] Web Address: http://www.iienet.org/ This society is dedicated to the professional needs of industrial engineers. Institute of Structural Engineers 11 Upper Belgrave St. London, England SW1X 8BH Phone: 020-7235-4535 Fax: 020-7235-4294 E-Mail:
[email protected] Web Address: http://www.istructe.org.uk/ A professional organization, headquartered in the U.K., which sets and maintains standards for professional structural engineers International Society for Measurement and Control 67 Alexander Dr. Research Triangle Park, NC 27709 Phone: 919-549-8411 Fax: 919-549-8288 E-Mail:
[email protected] Web Address: http://www.isa.org/ Serves the professional development and credential needs of control system engineers, instrument technicians and others within the field of measurement and control. International Society of Pharmaceutical Engineers 3816 W. Linebaugh Ave., Ste. 412 Tampa, FL 33624 Phone: 813-960-2105 Fax: 813-264-2816 Web Address: http://www.ispe.org/ Worldwide nonprofit society of technical professionals who apply their practical knowledge in the regulated health care manufacturing industries. Materials Research Society 506 Keystone Dr. Warrendale, PA 15086 Phone: 724-779-3003 Fax: 724-779-8313 E-Mail:
[email protected] Web Address: http://www.mrs.org/
Plunkett Research, Ltd.
Dedicated to basic and applied research on materials of technological importance. Emphasizes an interdisciplinary approach to materials science and engineering. National Academy of Engineering 2101 Constitution Ave. NW Washington, DC 20418 Web Address: http://www.nae.edu/ Nonprofit institution which conducts independent studies to examine important topics in engineering and technology. National Society of Professional Engineers 1420 King St. Alexandria, VA 22314 Phone: 703-684-2800 Fax: 703-836-4875 Web Address: http://www.nspe.org/ Represents individual engineering professionals and licensed engineers across all disciplines. Netherlands Organization for Applied Scientific Research P.O. Box 6050 JA Delft, The Netherlands NL-2600 Phone: 31-15-269-69-00 Fax: 31-15-261-24-03 E-Mail:
[email protected] Web Address: http://www.tno.nl/ Large contract research organization based in The Netherlands, provides a link between fundamental research and practical application. Optical Society of America 2010 Massachusetts Ave. NW Washington, DC 20036 Phone: 202-223-8130 Fax: 202-223-1096 Web Address: http://www.osa.org/ An interdisciplinary society offering a synergy between all components of optics, from basic research to commercial applications. Society of Automotive Engineers 400 Commonwealth Dr. Warrendale, PA 15096 Phone: 724-776-4841 Toll Free: 877-606-7323 Web Address: http://www.sae.org/ Resource for technical information and expertise used in designing, building, maintaining and
www.plunkettresearch.com
operating self-propelled vehicles for use on land or sea, in air or space. Society of Cable Telecommunications Engineers 140 Philips Rd. Exton, PA 19341 Phone: 610-363-6888 Fax: 610-363-5898 Toll Free: 800-542-5040 E-Mail:
[email protected] Web Address: http://www.scte.org/ The SCTE is a nonprofit professional association dedicated to advancing the careers and serving the industry of telecommunications professionals by providing technical training, certification and standards. Society of Hispanic Professional Engineers 5400 E. Olympic Blvd., Ste. 210 Los Angeles, CA 90022 Phone: 323-725-3970 Fax: 323-725-0316 E-Mail:
[email protected] Web Address: http://www.shpe.org/ National nonprofit organization that promotes Hispanics in science, engineering and math. Society of Manufacturing Engineers One SME Dr. Dearborn, MI 48121 Phone: 313-271-1500 Fax: 313-271-2861 Toll Free: 800-733-4763 Web Address: http://www.sme.org/ The world's leading professional organization serving the manufacturing industries. Society of Nuclear Medicine 1850 Samuel Morse Dr. Reston, VA 20190 Phone: 703-708-9000 Fax: 703-708-9015 Web Address: http://www.snm.org/ International scientific and professional organization founded to promote the science, technology and practical application of nuclear medicine. Society of Petroleum Engineers 222 Palisades Creek Dr. P.O. Box 833836 Richardson, TX 75083-3836 Phone: 972-952-9393 Fax: 972-952-9435
Plunkett Research, Ltd.
E-Mail:
[email protected] Web Address: http://www.spe.org/ The SPE helps connect the oil and gas industry with ideas, answers, resources and technological information. Society of Women Engineers 120 Wall St., 11th Fl. New York, NY 10005 Phone: 212-509-9577 E-Mail:
[email protected] Web Address: http://www.swe.org/ A nonprofit educational and service organization of graduate engineers. Serves as a center of information on women in engineering. Civil Engineering Research Foundation 1015 15th St. NW, Ste. 600 Washington, DC 20005 Phone: 202-842-0555 Fax: 202-789-2943 Web Address: http://www.cerf.org/ Independent nonprofit research organization established by the American Society of Civil Engineers. Minerals Metals & Materials Society 184 Thorn Hill Rd. Warrendale, PA 15086 Phone: 724-776-9000 Fax: 724-776-3770 E-Mail:
[email protected] Web Address: http://www.tms.org/ Professional organization that encompasses the entire range of materials and engineering, from minerals processing and primary metals production to basic research and the advanced applications of materials. United Engineering Foundation 3 Park Ave., 27th Fl. New York, NY 10016 Phone: 212-591-7836 Fax: 212-591-7441 E-Mail:
[email protected] Web Address: http://www.uefoundation.org/ A nonprofit organization chartered for the advancement of engineering arts and sciences in all branches. XV.
Engineering Indices
Internet Connections for Engineering Index Web Address: http://www.englib.cornell.edu/ice
www.plunkettresearch.com
A comprehensive catalog of engineering resources. XVI.
Engineering Software
ADAPT Corporation 1773 Woodside Rd., Ste. 220 Redwood City, CA 94061 Phone: 650-306-2400 Fax: 650-364-4678 E-Mail:
[email protected] Web Address: http://www.adaptsoft.com/ Offers structural engineering software and consulting. ALGOR, Inc. 150 Beta Dr. Pittsburgh, PA 15238 Phone: 412-967-2700 Fax: 412-967-2781 E-Mail:
[email protected] Web Address: http://www.algor.com/ Offers computer-aided engineering software, including finite element analysis software and FEAbased mechanical event simulation software. ATIR Engineering Software Development, Ltd. 3314 W. Rance Terrace Chicago, IL 60645 Phone: 847-677-1945 Fax: 847-677-3456 Toll Free: 800-644-6441 E-Mail:
[email protected] Web Address: http://www.atir.com/ Provides structural analysis and design software for use on personal computers. CAiCE Software Corporation 410 Ware Blvd., Ste. 1200 Tampa, FL 33619 Phone: 813-620-1444 Fax: 813-620-9019 E-Mail:
[email protected] Web Address: http://www.caice.com/ Designs software for applications ranging from survey data processing to final plans production. Also provides consulting, custom development, training and technical services. Computers & Structures, Inc. 1995 University Ave., Ste. 540 Berkeley, CA 94704 Phone: 510-845-2177 Fax: 510-845-4096
Plunkett Research, Ltd.
E-Mail:
[email protected] Web Address: http://www.csiberkeley.com/ Offers structural and earthquake engineering software products. Data Surge 70 Autran Ave. North Andover, MA 01845 Phone: 978-664-0258 Fax: 978-664-0269 E-Mail:
[email protected] Web Address: http://www.data-surge.com/ Develops geotechnical and hydrogeologic software products for universities, companies and government institutions worldwide. Daystar Software, Inc. 8120 NW Hillside Kansas City, MO 64152 Phone: 816-741-4310 Fax: 816-741-4607 E-Mail:
[email protected] Web Address: http://www.daystarsoftware.com/ Offers structural engineering software products, developed and tested by registered professional engineers. Daystar software products are designed specifically for Windows. GEOPAK Corporation 1190 NE 163rd St. North Miami Beach, FL 33162 Phone: 305-944-5151 Toll Free: 888-436-7251 Web Address: http://www.geopak.com/ Designs civil engineering software, developed and supported by practicing civil engineers and professional land surveyors. Widely used for transportation design and engineering in the U.S. GEO-SLOPE International 1400, 633 6th Ave. SW Calgary, Alberta T2P 2Y5 Canada Phone: 403-269-2002 Fax: 403-266-4851 E-Mail:
[email protected] Web Address: http://www.geo-slope.com/ Develops and markets CAD software for geotechnical and geo-environmental modeling. LEAP Software P.O. Box 16827 Tampa, FL 33687 Phone: 813-985-9170
www.plunkettresearch.com
Fax: 813-980-3642 Toll Free: 800-451-5327 E-Mail:
[email protected] Web Address: http://www.leapsoft.com/ Designs software for structural engineering professionals. MARC Analysis Research Corporation 500 Arguello St., Ste. 200 Redwood City, CA 94063-1526 Phone: 650-381-3300 Fax: 650-381-3400 E-Mail:
[email protected] Web Address: http://www.marc.com/ Leading supplier of finite element analysis (FEA) software and nonlinear FEA technology, used to analyze and optimize designs in the aerospace, automotive, biomedical, chemical, consumer, construction, electronics, energy and manufacturing industries. Research Engineers International 22700 Savi Ranch Pkwy. Yorba Linda, CA 92887 Phone: 714-974-2500 Fax: 714-974-4771 E-Mail:
[email protected] Web Address: http://www.reiusa.com/ Develops and distributes PC-based civil and structural engineering software products for the architectural, survey, construction, transportation and utility industries. Space Radiation Associates 1430 Willamette, Ste. 1 Eugene, OR 97401 Phone: 541-746-7504 Fax: 541-746-7504 E-Mail:
[email protected] Web Address: http://www.spacerad.com/ Develops and markets software for scientific and engineering modeling tasks. Specializes in nuclear and space radiation effects in aircraft and spacecraft electronic systems and modeling the natural radiation environment. Spectra Precision Software 5901 Peachwood-Dunwoody Rd., Ste. A-300 Atlanta, GA 30328 Phone: 770-396-0700 Fax: 770-396-4290 Toll Free: 800-235-4972 E-Mail:
[email protected]
Plunkett Research, Ltd.
Web Address: http://www.plus3.com/ Provides earthwork quantity takeoff, 3-D land design and visualization solutions. Products include laser alignment instruments, machine control systems, survey instruments and software. Zentech, Inc. 8582 Katy Fwy., Ste. 205 Houston, TX 77024 Phone: 713-984-9171 Fax: 713-984-9175 E-Mail:
[email protected] Web Address: http://www.zentech-usa.com/ Provides a wide range of services, including project management, specialized consulting, custom software development and joint engineering ventures. Develops and customizes software for structural analysis and design. XVII. Film and Television Associations National Cable and Telecommunications Association 1724 Massachusetts Ave. NW Washington, DC 20036 Phone: 202-775-3550 Web Address: http://www.ncta.com/ The NCTA is the principal trade association of the cable television industry in the United States. XVIII. First Time Jobs/New Grads Black Collegian Home Page Web Address: http://www.black-collegian.com/ Listings for job and internship opportunities. Includes a list of the top 100 minority corporate employers and an assessment of job opportunities. California School-to-Career Information System Phone: 916-654-6138 Web Address: http://www.stc.cahwnet.gov/ A joint project of California’s public school systems and local business partners. Aimed at helping students move easily from school into employment. CollegeGrad.com 1629 Summit Dr., Ste. 200 Cedarburg, WI 53012-9399 Phone: 262-376-1000 Fax: 262-376-1030 Web Address: http://www.collegegrad.com/
www.plunkettresearch.com
Offers in-depth resources for new grads seeking entry-level jobs. JobWeb 62 Highland Ave. Bethlehem, PA 18017-9085 Phone: 610-868-1421 Fax: 610-868-0208 Toll Free: 800-544-5272 Web Address: http://www.jobweb.com/ Provided by the National Association of Colleges and Employers, this site includes job openings and employer descriptions. Also offers a database of career fairs, searchable by state or keyword, with contact information. MonsterTrak 5 Clock Tower Pl., Ste. 500 Maynard, MA 01754 Fax: 310-474-2537 Toll Free: 800-999-8725 Web Address: http://www.monstertrak.com/ Links to hundreds of university and college career centers across the U.S. with entry-level job listings categorized by industry. Major companies also utilize MonsterTrak. National Association of Colleges and Employers 62 Highland Ave. Bethlehem, PA 18017-9085 Phone: 610-868-1421 Fax: 610-868-0208 Toll Free: 800-544-5272 Web Address: http://www.naceweb.org/ The premier U.S. organization representing college placement offices and corporate recruiters who focus on hiring new grads. This site offers in-depth resources. XIX.
Food Industry Associations
Institute of Food Technologies Department of Career Education 221 N. LaSalle St., Ste. 300 Chicago, IL 60601 Web Address: http://www.ift.org/jobs The IFT is devoted to the advancement of the science and technology of food through the exchange of knowledge. The site provides information and resources for job seekers in the food industry.
Plunkett Research, Ltd.
XX.
Health Care Careers
HMonster Toll Free: 800-666-7837 Web Address: http://myh.monster.com Managed by Monster.com, HMonster provides listings, job searches and search agents for the medical field. XXI.
Industry Associations-Automotive
Alliance of Automobile Manufacturers 1401 H St. NW, Ste. 900 Washington, DC 20005 Phone: 202-326-5500 Fax: 202-326-5567 Web Address: http://www.autoalliance.org/ The Alliance of Automobile Manufacturers is a trade association composed of 10 car and light truck manufacturers with about 600,000 employees at more than 250 facilities in 35 states. Alliance members account for more than 90% of vehicles sold in the U.S. Association for Manufacturing Technology 7901 Westpark Dr. McLean, VA 22102-4206 Phone: 703-893-2900 Fax: 703-893-1151 Toll Free: 800-524-0475 Web Address: http://www.mfgtech.org/ Actively supports and promotes American manufacturers of machine tools and manufacturing technology. Association of International Automobile Manufacturers, Inc. 1001 19th St. N, Ste. 1200 Arlington, VA 22209 Phone: 703-525-7788 Fax: 703-525-8817 Web Address: http://www.aiam.org/ The Association of International Automobile Manufacturers is the voice of non-U.S. automobile manufacturers in Washington, D.C. Automotive Multimedia Interface Collaboration 280 Enterprise Ct. Bloomfield Hills, MI 48302-0312 Phone: 248-322-5900 Fax: 248-322-5976 Web Address: http://www.ami-c.org/
www.plunkettresearch.com
AMIC is a worldwide organization of motor vehicle manufacturers created to facilitate the development and standardization of automotive information and entertainment interfaces to motor vehicle communication networks. Canadian Vehicle Manufacturers' Association 170 Attwell Dr., Ste. 400 Toronto, ON M9W 5Z5 Canada Phone: 416-364-9333 Fax: 416-367-3221 Toll Free: 800-758-7122 Web Address: http://www.cvma.ca/ The CVMA creates a framework within which member companies work together to achieve shared industry objectives on issues such as consumer protection, the environment and vehicle safety. Coordinating Research Council 3650 Mansell Rd., Ste. 140 Alpharetta, GA 30022 Phone: 678-795-0506 Fax: 678-795-0509 Web Address: http://www.crcao.com/ A nonprofit organization that directs, through committee action, engineering and environmental studies on the interaction between automotive equipment and petroleum products. Engine Manufacturers Association 2 N. LaSalle St., Ste. 2200 Chicago, IL 60602 Phone: 312-827-8700 Fax: 312-827-8737 Web Address: http://www.engine-manufacturers.org/ The voice of the engine manufacturing industry on domestic and international public policy, as well as regulatory and technical issues that impact manufacturers of engines used in a broad array of mobile and stationary applications. International Motor Vehicle Program MIT E40-207, One Amherst St. MIT Center for Technology, Policy and Industrial Development Cambridge, MA 02139-4307 Phone: 617-253-8973 Fax: 617-253-7140 E-Mail:
[email protected] Web Address: http://web.mit.edu/afs/athena/org/c/ctpid/www/imvp/ index.html
Plunkett Research, Ltd.
Launched in 1979, IMVP is a research project, funded by leading global car makers as well as government agencies, focused on research that can enhance automotive design and manufacturing methods. Through the program, more than 50 senior scientists, management experts, social scientists and engineers have conducted interdisciplinary automotive research at more than 25 universities on six continents. One of IMVP's researchers coined the phrase "lean production." Motor and Equipment Manufacturers Association 10 Laboratory Dr. P.O. Box 13966 Research Triangle Park, NC 27709-3966 Phone: 919-549-4800 Fax: 919-549-4824 E-Mail:
[email protected] Web Address: http://www.mema.org/ MEMA exclusively represents and serves manufacturers of motor vehicle components, tools and equipment, automotive chemicals and related products used in the production, repair and maintenance of all classes of motor vehicles. National Tooling and Machining Association 9300 Livingston Rd. Ft. Washington, MD 20744 Phone: 800-248-6862 Fax: 301-248-7104 Web Address: http://www.ntma.org/ Helping members of the U.S. precision custom manufacturing industries achieve business success in a global economy through advocacy, advice, networking, information, programs and services. XXII. Industry Associations-Construction Portland Cement Association 5420 Old Orchard Rd. Skokie, IL 60077 Phone: 847-966-6200 Fax: 847-966-8389 E-Mail:
[email protected] Web Address: http://www.portcement.org/ Collaborating with several allied organizations, aims to improve and expand the uses of portland cement and concrete. Precast/Prestressed Concrete Institute 209 W. Jackson Blvd. Chicago, IL 60606 Phone: 312-786-0300
www.plunkettresearch.com
Fax: 312-786-0353 E-Mail:
[email protected] Web Address: www.pci.org XXIII. Industry Research/Market Research Debbie Flanagan’s Industry Information E-Mail:
[email protected] Web Address: http://home.sprintmail.com/~debflanagan/industry.ht ml This site provides a wealth of information about where and how to get industry-specific information. The links are useful for job seekers and researchers of all types. Forrester Research 400 Technology Square Cambridge, MA 02139 Phone: 617-613-6000 Fax: 617-613-5000 Web Address: http://www.forrester.com/ Iidentifies and analyzes emerging trends in technology and their impact on business. Among the firm's specialties are the financial services, retail, healthcare, entertainment, automotive and infotech industries. Marketresearch.com 11810 Parklawn Dr. Rockville, MD 20852 Phone: 301-468-3650 Fax: 301-468-3651 Web Address: http://www.marketresearch.com/ This firm is a leading broker for market research and industry analysis written by professionals. Users can search the company's database of market research publications. Mindbranch 160 Water St. Williamstown, MA 01267 Phone: 413-458-7600 Fax: 413-458-1706 Toll Free: 800-774-4410 Web Address: http://www.mindbranch.com/ Mindbranch is a broker for industry research prepared by market research professionals. Users can browse the research organized by different industries. The site is user-friendly and covers a broad range of industries and business topics. Customers can also receive superb telephone support and suggestions about research reports.
Plunkett Research, Ltd.
www.plunkettresearch.com
Multex Investor Web Address: http://www.multexinvestor.com/ This site is an excellent source for industry and company reports written by professional stock analysts and business analysts. It also offers news and advice on stocks, funds and personal finance, and it has a superb tool that will let you screen a database of major corporations and view pertinent financial and business data on the firms that you select.
XXVI. Job Listings, General
Plunkett Research, Ltd. P.O. Drawer 541737 Houston, TX 77254-1737 Phone: 713-932-0000 Fax: 713-932-7080 E-Mail:
[email protected] Web Address: http://www.plunkettresearch.com/ Plunkett Research, Ltd. is a leading provider of market research, industry trends analysis and business statistics. Since 1985, it has served clients worldwide, including corporations, universities, libraries, consultants and government agencies. At the firm's web site, visitors can view product information and pricing, and visitors can access a great deal of basic market information on industries such as financial services, infotech, e-commerce, health care and biotech.
Career Exposure, Inc. 805 SW Broadway, Ste. 2250 Portland, OR 97205 Phone: 503-221-7779 Fax: 503-221-7780 E-Mail:
[email protected] Web Address: http://www.careerexposure.com/ An online career center and job placement service, with features for employers, recruiters and job seekers.
XXIV. Internet Business/Technology OASIS UDDI P.O. Box 455 Billerica, MA 01821 Phone: 978-667-5115 Fax: 978-667-5114 Web Address: http://www.uddi.org/ OASIS is an international technology consortium. This web site enables readers to learn about UDDI, the Universal Description, Discovery and Integration protocol, a critical component of web services. XXV. Internet Organizations-International CORDIS (Community Research and Development Information Service) Web Address: http://www.cordis.lu/ Provides information about research and development sponsored and supported by the European Union.
America's Job Bank Toll Free: 877-872-5627 Web Address: http://www.jobsearch.org/ Developed by the U.S. Department of Labor as part of an array of web-based job tools, America's Job Bank offers an extensive list of searchable employment vacancies as well other job resources.
CareerBuilder 333 Research Ct., Ste. 200 Norcross, GA 30092 Phone: 866-438-1485 Toll Free: 800-891-8880 Web Address: http://www.careerbuilder.com/ Focuses on the needs of companies but also provides a database of job openings. Resumes are sent directly to the company, and CareerBuilder allows applicants to set up a special e-mail account for job-seeking purposes. Careers.wsj.com from the Publishers of the Wall Street Journal Fax: 609-520-4731 Toll Free: 800-369-2834 Web Address: http://www.careers.wsj.com/ The Wall Street Journal's interactive job search and career-management site posts job opportunities with employers worldwide. Provides a weekly career column and a range of articles about topics including promotion, career crisis and negotiation for higher wages. DirectEmployers E-Recruiting Association, Inc. 4040 Vincennes Cir., 4th Fl. Indianapolis, IN 46268 Phone: 317-874-9000 Fax: 317-874-9100 Toll Free: 866-268-6206 E-Mail:
[email protected]
Plunkett Research, Ltd.
Web Address: http://www.directemployers.com/ Operated by the nonprofit E-Recruiting Association, this site links you directly to job opportunities posted on the sites of participating employers, thus bypassing the usual job search sites. Since employers must pay Monster.com and other listing sites for each job opportunity they want to list, it can become too expensive for a growing employer to list all available jobs on third-party sites. Consequently, using DirectEmployers.com saves the employer money and gives job seekers an opportunity to see many more jobs than they might see through other jobs sites. FlipDog.com 3210 N. Canyon Rd., Ste. 300 Provo, UT 84604 Fax: 801-818-0879 E-Mail:
[email protected] Web Address: http://www.flipdog.com/ A job search engine, free to both job seekers and employers. This unique site scours the Internet to find jobs available at over 45,000 corporate sites. HotJobs 406 W. 31st St. New York, NY 10001 Web Address: http://hotjobs.yahoo.com/ Designed for experienced professionals, this Yahoobased site provides company profiles, a resume posting service and a resume workshop. The site allows posters to block resumes from being viewed by certain companies and provides a notification service of new jobs. HRS Federal Job Search Web Address: http://www.hrsjobs.com/ Database of federal jobs available across the U.S. A profile with desired job type, salary and location will initiate numerous e-mailed applicable postings to the job seeker. Monster Board (The) Toll Free: 800-666-7837 Web Address: http://www.monster.com/ An electronic career center that hosts more than 8,000 employers and serves more than 1 million job seekers each month. Job seekers can build and store a resume online, and find job listings that match their profiles. Monster e-mails the results once a week. Recruiters OnLine Network 947 Essex Ln. Medina, OH 44256
www.plunkettresearch.com
Fax: 888-237-8686 Toll Free: 888-364-4667 E-Mail:
[email protected] Web Address: http://www.recruitersonline.com/ Provides Job postings from more than 7,000 recruiters, Careers Online Magazine and a resume database, as well as other resources. TrueCareers, Inc. 11600 Sallie Mae Dr. Reston, VA 20193 Toll Free: 800-441-4062 Web Address: http://www.truecareers.com/ In addition to offering job listings, TrueCareers provides an array of career resources. XXVII. Job Reference Tools NewspaperLinks.com E-Mail:
[email protected] Web Address: http://www.newspaperlinks.com/ A useful web site that links individuals to local, national and international newspapers. Job seekers can search through the classified sections of thousands of newspapers. The site is a service of the Newspaper Association of America. Society of Human Resource Management 1800 Duke St. Alexandria, VA 22314 Phone: 703-548-3440 Fax: 703-535-6490 Toll Free: 800-283-7476 Web Address: http://www.shrm.org/ Frequently updated information for hiring managers. Also has an online library of articles by key words and provides the latest news in employment and labor law. Vault.com 150 W. 22nd St. New York, NY 10011 Phone: 212-366-4212 Web Address: http://www.vault.com/ A comprehensive career web site for employers and employees, with job postings and valuable information on the employment industry. The site focuses on helping the user understand what it's really like to work at a particular firm. Many of the features are focused on MBAs, and the site offers a wide variety of industry guides for sale.
Plunkett Research, Ltd.
XXVIII. Laboratories/Research Alberta Research Council 250 Karl Clark Rd. Edmonton, Alberta T6N 1E4 Canada Phone: 780-450-5111 Fax: 780-450-5333 E-Mail:
[email protected] Web Address: http://www.arc.ab.ca/ Provides research and development services on a contract basis. Access to resources at facilities in western Canada and to 600 experienced scientists, researchers and business experts. Applied Research Laboratories P.O. Box 8029 Austin, TX 78713 Phone: 512-835-3200 Fax: 512-835-3259 Web Address: http://www.arlut.utexas.edu/ Applied Research Laboratories at the University of Texas provides organizational directories and electronic resources. Argonne National Laboratory, Technology Development Division 9700 S. Cass Ave. Argonne, IL 60439-4814 Web Address: http://www.td.anl.gov/ Engaged in research and development in the applied nuclear technology fields. Battelle Memorial Institute 505 King Ave. Columbus, OH 43201 Phone: 614-424-6424 Toll Free: 800-201-2011 Web Address: http://www.battelle.org/ Serves industry and government in developing new technologies and products. Inserts technology into systems and processes for manufacturers; pharmaceutical and agrochemical industries; trade associations; and government agencies supporting energy, the environment, health, national security and transportation. The company has annual revenues of approximately $1 billion. Brookhaven National Laboratory P.O. Box 5000 Upton, NY 11973-5000 Phone: 631-344-8000 E-Mail:
[email protected] Web Address: http://www.bnl.gov/
www.plunkettresearch.com
Managed by the U.S. Department of Energy. Responsible for safely cleaning up and managing the site's legacy wastes. Currently engaged in the world's largest environmental cleanup project. Canada's National Research Council 1200 Montreal Rd., Bldg. M-58 Ottawa, Ontario K1A 0R6 Canada Phone: 613-993-9084 Fax: 613-952-7656 Toll Free: 877-672-2672 E-Mail:
[email protected] Web Address: http://www.nrc.ca/ Through the NRC, 16 research institutes carry out multi-disciplinary research with partners in industries and sectors key to Canada's economic development. Commonwealth Scientific and Industrial Research Organization Bag 10 Clayton South, Australia VIC 3169 Phone: 61-3-9545-2176 Fax: 61-3-9545-2175 E-Mail:
[email protected] Web Address: http://www.csiro.au/ Performs research and development over a broad range of areas including agriculture, minerals and energy, manufacturing, communications, construction, health and the environment. Daresbury Laboratory Daresbury, Warrington Cheshire, UK WA4 4AD Phone: 44-1925-603000 Fax: 44-1925-603100 E-Mail:
[email protected] Web Address: http://www.dl.ac.uk/ Operated by the Council of the Central Laboratory of Research Councils, a strong resource in computational science and engineering. Hanford Nuclear Site Web Address: http://www.hanford.gov/ Solves critical problems related to the environment, energy production and use, U.S. economic competitiveness and national security. Idaho National Engineering and Environmental Laboratory P.O. Box 1625 Idaho Falls, IL 83415 Phone: 208-526-0111 Toll Free: 800-708-2680
Plunkett Research, Ltd.
E-Mail:
[email protected] Web Address: http://www.inel.gov/ Multidisciplinary, multiprogram laboratory which designs, develops and tests nuclear weapons. MITRE Corporation 202 Burlington Rd. Bedford, MA 01730-1420 Phone: 781-271-2000 E-Mail:
[email protected] Web Address: http://www.mitre.org/ A nonprofit engineering institution offering expertise in communications, information, space, environmental and aviation systems. Operates two federally funded research and development centers for the U.S. government. National Renewable Energy Laboratory Golden, CO 80401 Phone: 303-275-3000 Web Address: http://www.nrel.gov/ Reduces nuclear danger, transfers applied environmental technology to government and nongovernment entities and forms economic and industrial alliances. Sandia National Laboratories P.O. Box 5800 Albuquerque, NM 87185 Web Address: http://www.sandia.gov/ A national security laboratory operated for the U.S. Department of Energy by the Sandia Corporation. Designs all non-nuclear components for the nation's nuclear weapons and performs a wide variety of energy research and development projects. Savannah River Site 1617 Cole Blvd. Web Address: http://www.srs.gov/ A project meant to determine if Yucca Mountain, Nevada, is a suitable site for a spent nuclear fuel and high-level radioactive waste depository. SRI International 333 Ravenswood Ave. Menlo Park, CA 94025-3493 Phone: 650-859-2000 Fax: 650-326-5512 Toll Free: 866-451-5998 E-Mail:
[email protected] Web Address: http://www.sri.com/ A nonprofit organization offering a wide range of services, including engineering services, information
www.plunkettresearch.com
technology, pure and applied physical sciences, product development, pharmaceutical discovery, biopharmaceutical discovery and policy issues. Yucca Mountain Project Web Address: http://www.ocrwm.doe.gov/ymp/index.shtml Creates and operates major facilities available to university, industrial and government personnel for basic and applied research in physical, biomedical and environmental sciences and in selected energy technologies. Partly managed by the U.S. Department of Energy. XXIX. Microelectronics Industry Associations American Electronics Association 5201 Great America Pkwy. Santa Clara, CA 54990 Phone: 408-987-4200 Fax: 408-970-8565 Web Address: http://www.aeanet.org/ AEA represents thousands of U.S. electronics firms, including electronic systems and component manufacturers, suppliers and end users. It also publishes the annual AEA Directory with geographic and product indexes. Electronic Industries Alliance 2500 Wilson Blvd. Arlington, VA 22201-3834 Phone: 703-907-7500 Web Address: http://www.eia.org/ EIA, formerly known as the Electronics Industries Association, represents thousands of electronics firms, including electronic components and consumer electronics manufacturers. Institute for Interconnecting and Packaging Electronic Circuits (IPC) 2215 Sanders Rd. Northbrook, IL 60062 Phone: 847-509-9700 Fax: 847-509-9798 Web Address: http://www.ipc.org/ The IPC is a trade association dedicated to furthering the competitive excellence and financial success of its worldwide members, participants in the electronic interconnect industry. International Microelectronics and Packaging Society 611 2nd St. NE
Plunkett Research, Ltd.
Washington, DC 20002 Phone: 202-548-4001 Fax: 202-548-6115 Web Address: http://www.imaps.org/ IMAPS is a society dedicated to the advancement and growth of the use of microelectronics and electronic packaging through professional and public education, the dissemination of information and the promotion of its portfolio of technologies. International Semiconductor Manufacturing Technology (SEMATECH) 2706 Montopolis Dr. Austin, TX 78741 Phone: 512-356-3500 Web Address: http://www.sematech.org/public/home.htm International SEMATECH is is a consortium of 12 semiconductor manufacturing companies from seven countries. National Consortia of Manufacturing Sciences 3025 Boardwalk Ann Arbor, MI 48108-3266 Phone: 734-995-0300 Fax: 734-995-4004 Web Address: http://www.ncms.org/ A nonprofit membership organization dedicated to advancing the global competitiveness of North American industry through collaboration. National Electrical Manufacturers Association 1300 N. 17th St., Ste. 1847 Rosslyn, VA 22209 Phone: 703-841-3200 Fax: 703-841-5900 Web Address: http://www.nema.org/ NEMA develops standards for the electrical manufacturing industry and promotes safety in the manufacture and use of electrical products. Semiconductor Business Association 66 Hill Grove Huddersfield, West Yorkshire HD3 2TL UK Phone: 01484-656865 Fax: 01204-370916 E-Mail:
[email protected] Web Address: http://www.semiconductor.org/ The SBA is a national trade association with members in the semiconductor and electronics industry throughout the United Kingdom.
www.plunkettresearch.com
Semiconductor Equipment and Materials International (SEMI) 3081 Zanker Rd. San Jose, CA 95134 Phone: 408-943-6900 Fax: 408-428-9600 E-Mail:
[email protected] Web Address: http://www.semi.org/ SEMI is a trade association serving the global semiconductor equipment, materials and flat panel display industries. Semiconductor Industry Association 181 Metro Dr., Ste. 450 San Jose, CA 95110 Phone: 408-436-6600 Fax: 408-436-6646 E-Mail:
[email protected] Web Address: http://www.semichips.org/ SIA represents U.S. semiconductor manufacturers and publishes the annual Status Report and Industry Directory and World Semiconductor Trade Statistics, which tracks semiconductor shipments by regional market and by product. Surface Mount Technology Association 5200 Willson Rd., Ste. 215 Edina, MN 55424 Phone: 952-920-7682 Fax: 952-926-1819 Web Address: http://www.smta.org/ SMTA represents manufacturers of products utilizing SMT applications. It is involved in technical conferences and seminar organization. Virginia Center for Innovative Technology 2214 Rock Hill Rd., Ste. 600 Herndon, VA 20170 Phone: 703-689-3000 Fax: 703-689-3041 Web Address: http://www.cit.org/ A nonprofit organization designed to enhance the research and development capability of the state's major research universities. XXX. Satellite-Related Professional Organizations Geospatial Information and Technology Association 14456 E. Evans Ave. Aurora, CO 80014-1409 Phone: 303-337-0513 Fax: 303-337-1001
Plunkett Research, Ltd.
Web Address: http://www.gita.org/ GITA is an educational association for geospatial information and technology professionals. Society of Satellite Professionals International The New York Technology Information Center 55 Broad St., 14th Fl. New York, NY 10004 Phone: 212-809-5199 Fax: 212-825-0075 Web Address: http://www.sspi.org/ The SSPI is a nonprofit member-benefit society that serves satellite professionals throughout their careers. Washington Space Business Roundtable 2200 Wilson Blvd., Ste. 102-248 Arlington, VA 22201 Phone: 703-522-7745 Fax: 703-522-4226 E-Mail:
[email protected] Web Address: http://www.wsbr.org/ WSBR is a leadership forum for the promotion of commercial space business and education in the national capital region. XXXI. Telecommunications Industry Associations CDMA Development Group (CDG) 575 Anton Blvd., Ste. 560 Costa Mesa, CA 92626 Phone: 714-545-5211 Fax: 714-545-4601 Toll Free: 888-800-2362 E-Mail:
[email protected] Web Address: http://www.cdg.org/ The CDG is comprised of the world's leading CDMA service providers and manufacturers that have joined together to lead the adoption and evolution of CDMA wireless systems around the world. Cellular Telecommunications Industry Association 1250 Connecticut Ave. NW, Ste. 800 Washington, DC 20036 Phone: 202-785-0081 Web Address: http://www.wow-com.com/ CTIA is an international organization that represents all elements of wireless communication (cellular, personal communication services, enhanced specialized mobile radio and mobile satellite services) serving the interests of service providers, manufacturers and others.
www.plunkettresearch.com
CompTel 1900 M St. NW, Ste. 800 Washington, DC 20036 Phone: 202-296-6650 Fax: 202-296-7585 Web Address: http://www.comptel.org/ CompTel is a leading association representing competitive telecommunications companies in virtually every sector of the marketplace: incumbent local exchange carriers, competitive local exchange carriers, long-distance carriers of every size, wireless service providers, Internet service providers, equipment manufacturers and software suppliers. European Telecommunications Standards Institute 650 Rte. des Lucioles Sophia Antipolis, France 06921 Phone: 33-492-944-200 Fax: 33-493-654-716 E-Mail:
[email protected] Web Address: http://www.etsi.org/ ETSI is a nonprofit organization whose mission is to produce the telecommunications standards that will be used for decades to come throughout Europe and beyond. Global System for Mobile Communications 6-8 Old Bond St. London, UK W1S 6PH Phone: 44 20-7518-0530 Fax: 44 20-7518-0531 Web Address: http://www.gsmworld.com/ A leading wireless industry representative body. Institute for Telecommunication Sciences 325 Broadway Boulder, CO 80305-3328 Phone: 303-497-5216 E-Mail:
[email protected] Web Address: http://www.its.bldrdoc.gov/ ITS is the research and engineering branch of the National Telecommunications and Information Administration, a division of the U.S. Department of Commerce. International Telecommunication Union Place des Nations 1211 Geneva 20 Switzerland Phone: 41-22-730-5111 Fax: 41-22-733-7256 E-Mail:
[email protected]
Plunkett Research, Ltd.
Web Address: http://www.itu.int/ The ITU is an international organization within the United Nations in which governments and the private sector coordinate global telecom networks and services. Personal Communications Industry Association 500 Montogmery St., Ste. 700 Alexandria, VA 22314-1561 Phone: 703-739-0300 Fax: 703-836-1608 Toll Free: 800-759-0300 Web Address: http://www.pcia.com/ PCIA is an association of companies working together to increase the reach, frequency and impact of wireless technology integration into the enterprise, business and consumer markets. Telecom Research Foundation E-Mail:
[email protected] Web Address: http://www.telecomresearch.com/ A nonprofit organization that provides a free platform for sharing information worldwide on telecom regulation changes, industry and market research, product and service offerings and technology development trends. Telecommunications Industry Association 2500 Wilson Blvd., Ste. 300 Arlington, VA 22201 Phone: 703-907-7700 Fax: 703-907-7727 Web Address: http://www.tiaonline.org/ The TIA is is the leading trade association in the communications and information technology industry, focusing on market development, trade promotion, trade shows, domestic and international advocacy, standards development and enabling ebusiness. United States Telecom Association 1401 H St. NW, Ste. 600 Washington, DC 20005-2164 Phone: 202-326-7300 Fax: 202-326-7333 Web Address: http://www.usta.org/ The leading broad-based association for the local exchange carrier industry worldwide. Wireless Application Protocol Forum 2570 W El Camino Real, Ste. 304 Mountain View, CA 94040-1313 Phone: 650-949-6760
www.plunkettresearch.com
Fax: 650-949-6765 E-Mail:
[email protected] Web Address: http://www.wapforum.org/ The WAP Forum provides Internet communications and advanced telephony services on digital mobile phones, pagers, personal digital assistants and other wireless terminals. Wireless Communications Association International 1140 Connecticut Ave. NW, Ste. 810 Washington, DC 20036 Phone: 202-452-7823 Fax: 202-452-0041 Web Address: http://www.wcai.com/ The principal nonprofit trade association representing the wireless broadband industry. XXXII. Telecommunications Information, General IMT-2000 Place des Nations 1211 Geneva 20 Switzerland Phone: 41-22-730-5111 Fax: 41-22-733-7256 E-Mail:
[email protected] Web Address: http://www.imt-2000.org/ This site offers information on IMT-2000, the term used by the International Telecommunications Union for a set of globally harmonized standards for thirdgeneration mobile telecom services and equipment. XXXIII. Testing Resources Kenexa 11 Penn Ctr. 1835 Market St., 20th Fl. Philadelphia, PA 19103 Phone: 215-546-7330 Fax: 215-546-7331 Toll Free: 800-935-6694 Web Address: http://www.proveit.com/ Provides PC- and Internet-based exams to test people’s skills in everything from Windows 95 and Microsoft Access to programming languages like C++ and COBOL. Provides a downloadable demo. TeckCheck Bookman Testing Services, Inc. 2 Park Ave., Ste. 1102
Plunkett Research, Ltd.
www.plunkettresearch.com
New York, NY 10016 Phone: 212-251-6341 Fax: 509-693-6076 Web Address: http://www.teckcheck.com/ PC-based tests in 90 competencies including C, C++, CICS, DB2, Lotus Notes, Oracle, PowerBuilder, RPG and Visual Basic. Sample questions are provided.
FCC-Wireless Bureau 445 12th St. SW Washington, DC 20554 Fax: 202-418-0232 Toll Free: 888-225-5322 Web Address: http://wireless.fcc.gov Handles nearly all FCC domestic wireless telecommunications programs and policies.
XXXIV. U.S. Government Agencies
Federal Communications Commission (FCC) 445 12th St. SW Washington, DC 20554 Fax: 202-418-0232 Toll Free: 888-225-5322 E-Mail:
[email protected] Web Address: http://www.fcc.gov/ The FCC is an independent U.S. Government agency established by the Communications Act of 1934 and charged with regulating interstate and international communications by radio, television, wire, satellite and cable.
Bureau of Economic Analysis 1441 L St. Washington, DC 20230 Phone: 202-606-9900 Web Address: http://www.bea.doc.gov/ The BEA, an agency of the U.S. Department of Commerce, is the nation's economic accountant, preparing estimates that illuminate key national, international and regional aspects of the United States economy. Bureau of Labor Statistics Division of Information Services 2 Massachussets Ave. NE Washington, DC 20212 Phone: 202-691-5200 Fax: 202-691-6325 E-Mail:
[email protected] Web Address: http://stats.bls.gov/ The BLS is the principal fact-finding agency for the Federal Government in the field of labor economics and statistics. It is an independent national statistical agency that collects, processes, analyzes and disseminates statistical data to the American public, the U.S. Congress, other Federal agencies, state and local governments, business and labor. The BLS also serves as a statistical resource to the Department of Labor. Equal Employment Opportunity Commission U.S. Equal Employment Opportunity 1801 L St. NW Washington, DC 20507 Phone: 202-663-4900 Toll Free: 800-669-4000 Web Address: http://www.eeoc.gov/ Features details about various protective laws regarding employment that help gauge how much testing job candidates can be required to go through. Also provides information on how to file a discrimination claim.
FedWorld.gov U.S. Department of Commerce Springfield, VA 22161 Phone: 703-605-6000 Web Address: http://www.fedworld.gov/jobs/jobsearch.html Annotated index of links to job-, labor- and management-related U.S. Government servers. Employment opportunities, labor statistics and pointers to other government information servers are also offered. Government Printing Office 732 N. Capitol St. NW Washington, DC 20401 Phone: 202-512-0000 E-Mail:
[email protected] Web Address: http://www.gpo.gov/ The GPO is the online source for many government books and documents. International Trade Association E-Mail:
[email protected] Web Address: http://www.trade.gov/ This U.S. Government agency provides a wealth of information regarding imports and exports. In addition, it publishes in-depth analysis and statistics on various industry sectors and provides assistance to U.S. firms that wish to increase their exports.
Plunkett Research, Ltd.
Los Alamos National Laboratory University of California Phone: 510-987-0570 Web Address: http://www.lanl.gov/external Home page of the famous national energy laboratory at Los Alamos, New Mexico. This lab was originally built as a work site for the team that designed the first atomic bomb during World War Two. Currently, it provides a continual stream of research in physics and energy matters. Much of that research is put to use in the commercial sector. National Science Foundation 4201 Wilson Blvd. Arlington, VA 22230 Phone: 703-292-5111 Toll Free: 800-877-8339 E-Mail:
[email protected] Web Address: www.nsf.gov Independent government agency responsible for promoting science and engineering. National Telecommunications and Information Administration 1401 Constitution Ave. NW Washington, DC 20230 Phone: 202-482-7002 Web Address: http://www.ntia.doc.gov/ The NTIA, an agency of the U.S. Department of Commerce, is the Executive Branch's principal voice on domestic and international telecommunications and information technology issues. Oak Ridge National Laboratory P.O. Box 2008 Oak Ridge, TN 37831 Web Address: http://www.ornl.gov/ Multiprogram science and technology laboratory managed for the U.S. Department of Energy by U.T.Battelle, LLC. Conducts basic and applied research and development to create scientific knowledge and technological solutions. Office of Telecommunications Technologies Herbert C. Hoover Bldg., Rm. 4324 14th St. and Constitution Ave. NW Washington, DC 20230 Phone: 202-482-4466 Fax: 202-482-5834 Web Address: http://infoserv2.ita.doc.gov/ot/home.nsf
www.plunkettresearch.com
The OTT in the U.S. Department of Commerce supports the growth and competitiveness of the U.S. telecommunications industry. U.S. Business Advisor Web Address: http://www.business.gov/ Offers a searchable directory of business-specific government information. Topics include taxes, regulations, international trade, financial assistance and business development. The U.S. Business Advisor was created by the Small Business Administration (SBA) and an interagency task force U.S. Census Bureau Washington, DC 20233 Web Address: http://www.census.gov/ The U.S. Census Bureau is the official collector of data about the people and economy of the U.S. It provides official social, demographic and economic information. U.S. Department of Labor Francis Perkins Bldg. 200 Constitution Ave. NW Washington, DC 20210 Toll Free: 866-487-2365 Web Address: http://www.dol.gov/ The Federal Government agency responsible for labor regulations. This site provides tools to help citizens find out whether companies are complying with family and medical-leave requirements. U.S. Nuclear Regulatory Commission One White Flint N. 11555 Rockville Pike Rockville, MD 20852 Phone: 301-415-7000 Web Address: http://www.nrc.gov/ Independent agency established by the U.S. Congress to ensure adequate protection of public health and safety, common defense and security and the environment in use of nuclear materials in the United States. U.S. Patent and Trademark Office Crystal Plaza 3, Room 2C02 P.O. Box 1450 Alexandria, VA 22313-1450 Phone: 703-308-4357 Toll Free: 800-786-9199 Web Address: http://www.uspto.gov/ This agency grants trademarks and patents for protection within the United States. For statistics
Plunkett Research, Ltd.
regarding patent applications and grants, visit http://www.uspto.gov/web/patents/stats.htm. U.S. Securities and Exchange Commission (SEC) Phone: 202-942-8088 Web Address: http://www.sec.gov/ The SEC is a nonpartisan, quasi-judicial regulatory agency responsible for administering federal securities laws. These laws are to protect investors in securities markets and ensure they have access to disclosure of all material information concerning publicly traded securities. Users can access the EDGAR database of corporate financial and business information. White House (The) 1600 Pennsylvania Ave. Washington, DC 20500 Phone: 202-456-1414 Web Address: http://www.whitehouse.gov/ This site was designed for communication between the Federal Government and the American people. It provides access to all government information and services that are available on the Internet.
www.plunkettresearch.com
Plunkett Research, Ltd.
www.plunkettresearch.com
Chapter 4 THE ENGINEERING & RESEARCH 500: WHO THEY ARE AND HOW THEY WERE CHOSEN Includes Indexes by Company Name, Industry & Location And a Complete Table of Sales, Profits and Ranks The companies chosen to be listed in PLUNKETT’S ENGINEERING & RESEARCH INDUSTRY ALMANAC are not the same as the “Fortune 500” or any other list of corporations. THE ENGINEERING & RESEARCH 500 (the actual count is 468 companies) were chosen specifically for their dominance in the many facets of engineering and research in which they operate. Complete information about each firm can be found in the “Individual Profiles,” beginning at the end of this chapter. These profiles are in alphabetical order by company name. THE ENGINEERING & RESEARCH 500 includes companies from all parts of the United States, Canada, Europe and beyond. The companies operate in all engineering and research related industry segments: design and development, technology-based research and development and manufacturing. We have included companies that are making significant investments in research and development via as many disciplines as possible, whether that research is being funded by internal investment, by fees received from clients and
customers or by fees or grants collected from government agencies. Simply stated, the list contains nearly 500 of the largest, most successful, fastest growing firms in engineering, research and related industries in the United States and abroad. To be included in our list, the firms had to meet the following criteria: 1) Generally, these are U.S.-based, private sector corporations. (We have also added 64 foreignbased companies in order to better list leading firms in certain industry sectors.) 2) Publicly-held companies where stocks or bonds issued by the firm have been sold to the public (except for a number of firms that are privatelyheld that we have added in order to round-out certain niche sets of companies). 3) Prominence, or a significant presence, in research and development, engineering and supporting fields. (See the following Industry Codes section for a complete list of types of businesses that are covered). 4) The companies in THE ENGINEERING & RESEARCH 500 do not have to be exclusively in engineering or research fields.
Plunkett Research, Ltd.
5) Financial data and vital statistics must have been available to the editors of this book, either directly from the company being written about or from outside sources deemed reliable and accurate by the editors. A small number of companies that we would like to have included are not listed because of a lack of sufficient, objective data. The companies were chosen in this manner for the following reasons: • 468 Companies so there is a broad base with which to make comparisons and from which you can study the major players in this industry. • Non-Government because information about government agencies can be obtained elsewhere, and so that researchers using PLUNKETT'S ENGINEERING & RESEARCH INDUSTRY ALMANAC can best study firms in the profitseeking private sector, where innovation and financially-motivated investors are creating dynamic changes in exciting engineering and research fields. • Companies with publicly-traded stock because publicly-held firms can be compared fairly, since they are required by law to meet federal government standards in their methods of reporting and accounting for their vital statistics. INDEXES TO THE ENGINEERING & RESEARCH 500, AS FOUND IN THIS CHAPTER AND IN THE BACK OF THE BOOK: Industry List, With Codes p. 88 Index of Rankings Within Industry Groups p. 90 Alphabetical Index p. 102 Geographic Indexes Index of Headquarters Location, by State p. 107 Index of Headquarters Location, by Country p. 112 Index by Regions of the U.S. where THE ENGINEERING & RESEARCH 500 have Locations p. 113 Index by Firms with International Operations p. 128 Index of Firms Noted as “Hot Spots for Advancement” for Women/Minorities p. 604 Index of Subsidiaries, Brand Names and Selected Affiliations p. 606
www.plunkettresearch.com
INDUSTRY LIST, WITH CODES This book refers to the following list of unique industry codes, based on the NAIC code system (NAIC is used by many analysts as a replacement for older SIC codes because NAIC is more specific to today’s industry sectors): Energy 211111 213111 325110 335929
Fuel Mining & Extraction Oil and Natural Gas Exploration and Development Petroleum--Drilling Oil and Gas Wells Support Petroleum-Refining & Manufacturing Petrochemicals Manufacturing Manufacturing, Electrical Superconducting Materials and Other Wire
Entertainment & Hospitality 513210
Broadcasting Cable TV Networks
Health Care 325412 325414 339113 421450 621511 621991
Health Products, Manufacturing Drugs, Manufacturing Biological Products Medical/Dental/Surgical Equipment and Supplies, Manufacturing Health Products, Wholesale Distribution Medical/Dental/Surgical Equipment and Supplies, Distribution Health Care-Clinics, Labs and Organizations Laboratories and Diagnostics--Medical Blood and Organ Banks
InfoTech 334110 334111 334112 334119 334310 334413 334419 334515 335921 335999
Computers & Electronics Manufacturing Computer Networking and Related Equipment, Manufacturing Computer Hardware, Manufacturing Computer Storage Equipment and Misc Parts, Manufacturing Computer Accessories, Manufacturing Audio and Video Equipment, Manufacturing Chips (Semiconductors)/Integrated Circuits/Components, Manufacturing Contract Electronics Manufacturing Test Equipment/Instruments, Manufacturing Electrical Equipment & Wire, Manufacturing Fibre Optic Cable and Electrical Wire Electrical and Electronic Equipment, Manufacturing
Plunkett Research, Ltd. 511200 514191A
541512
Software Computer Software Information & Data Processing Services Online Business-to-Business or to-Consumer Intermediary Information Services-Professional Consulting--Computer and Internet
Manufacturing 236100 325000 325411 325413 326000 331000 332210 333000 333298 333313 333314 334200 334210 335000 336111 336390 336120 336410 513340
Construction Construction, Residential Chemicals Chemicals, Manufacturing Medicinals and Botanicals, Manufacturing In Vitro Diagnostic Substances, Manufacturing Plastics & Rubber Plastics and Rubber, Manufacturing Primary Minerals Steel and Metals, Manufacturing Fabricated Metals Cutlery and Hand Tools, Manufacturing Machinery Machinery, Manufacturing Fuel Cells, Solar Cells, Other Industrial Machinery, Manufacturing Business Machines, Manufacturing Optical Instrument and Lens, Manufacturing Telecommunications Equipment Communications Equipment, Manufacturing Telecommunications Equipment, Manufacturing and Related Services Electrical Equipment, Appliances, Tools Electrical Equipment/Appliances/Tools, Manufacturing Transportation-Manufacturing of Equipment Automobiles, Manufacturing Automobile Parts Manufacturing Trucks, RVs and Misc. Automotive, Manufacturing Aerospace Aerospace Related Manufacturing Satellites, Manufacturing Satellite Equipment, Manufacturing
Services 115112 230000 541310 541320 541611 541620
Agriculture Agriculture, Crop Production Support Activities Construction Construction Services Consulting & Professional Services Engineering Services Architectural Services Consulting & Professional Services Consulting--Management and Business Consulting--Environmental
www.plunkettresearch.com 541690 541710
Consulting--Scientific and Technical Research and Development--Physical, Engineering and Life Sciences 541810A Advertising/Marketing--Online Management 551110 Management of Companies and Enterprises
Plunkett Research, Ltd.
www.plunkettresearch.com
INDEX OF RANKINGS WITHIN INDUSTRY GROUPS 2002 2002 Industry Sales Sales Profits Profits Code Rank Rank (thousands) (thousands) Advertising/Marketing--Online GOOGLE INC 541810A 100,000 2 YAHOO! INC 541810A 953,100 1 42,800 1 Aerospace Related Manufacturing AIRBUS SAS 336410 20,333,000 4 BAE SYSTEMS 336410 12,953,000 8 -1,100 7 BOEING CO 336410 54,069,000 1 492,000 3 BOMBARDIER INC 336410 14,865,500 6 268,600 5 GENERAL DYNAMICS 336410 13,829,000 7 917,000 1 GOODRICH CORPORATION 336410 3,910,200 10 117,900 6 HONEYWELL INTERNATIONAL 336410 22,274,000 3 -220,000 8 ITT INDUSTRIES INC 336410 4,985,300 9 379,900 4 LOCKHEED MARTIN CORP 336410 26,578,000 2 500,000 2 RAYTHEON CO 336410 16,760,000 5 -587,000 9 Agriculture, Crop Production Support Activities EXELIXIS PLANT SCIENCES INC 115112 Architectural Services SKIDMORE OWINGS & MERRILL 541320 STV GROUP INC 541320 Audio and Video Equipment, Manufacturing SONY CORPORATION 334310 57,117,000 1 115,000 1 Automobile Parts Manufacturing DENSO CORPORATION 336390 18,102,000 3 545,000 2 JOHNSON CONTROLS INC 336390 20,103,000 1 600,000 1 VISTEON CORPORATION 336390 18,395,000 2 -352,000 3 Automobiles, Manufacturing ADAM OPEL AG 336111 14,459,000 15 AUDI AG 336111 23,690,000 13 812,000 10 BAYERISCHE MOTOREN WERKE AG 336111 44,316,000 10 2,117,000 6 DAIMLERCHRYSLER AG 336111 156,838,000 3 4,947,000 1 FIAT SPA 336111 61,014,000 6 -4,147,000 17 FORD MOTOR CO 336111 162,586,000 2 -980,000 16 FUJI HEAVY INDUSTRIES LTD 336111 10,272,000 18 228,000 11 GENERAL MOTORS CORP 336111 186,763,000 1 1,736,000 8 HONDA MOTOR CO LTD 336111 55,253,000 8 2,722,000 4 HYUNDAI MOTOR COMPANY 336111 40,187,000 11 1,198,000 9 ISUZU MOTORS LTD 336111 12,045,000 17 -324,000 15 MAZDA MOTOR CORPORATION 336111 15,794,000 14 67,000 14 MITSUBISHI MOTORS CORP 336111 24,024,255 12 84,473 13 NISSAN MOTOR CO LTD 336111 46,588,000 9 2,799,000 3 PSA PEUGEOT CITROEN SA 336111 57,054,000 7 1,771,000 7 SUZUKI MOTOR CORP 336111 12,577,000 16 169,000 12 TOYOTA MOTOR CORP 336111 107,443,000 4 4,177,000 2
Company
Plunkett Research, Ltd.
www.plunkettresearch.com
Company
2002 Sales
2002 Profits
Industry Sales Profits Code Rank Rank (thousands) (thousands) VOLKSWAGEN AG 336111 91,130,000 5 2,708,000 5 Biological Products ANIKA THERAPEUTICS INC 325414 13,200 2 -3,000 2 GTC BIOTHERAPEUTICS INC 325414 10,400 3 -24,300 3 LIFECELL CORPORATION 325414 34,400 1 1,400 1 Blood and Organ Banks SEROLOGICALS CORP 621991 145,500 1 13,900 1 Business Machines, Manufacturing PITNEY BOWES INC 333313 4,409,800 2 475,700 1 XEROX CORP 333313 15,849,000 1 91,000 2 Cable TV Networks AOL TIME WARNER INC 513210 41,065,000 1 -98,686,000 1 Chemicals, Manufacturing AIR PRODUCTS & CHEMICALS 325000 5,401,000 6 525,000 3 ALBEMARLE CORPORATION 325000 980,200 14 74,700 8 BASF AG 325000 35,031,700 1 1,635,400 1 BAYER AG 325000 32,213,100 2 1,152,600 2 CABOT CORPORATION 325000 1,557,000 11 106,000 6 DOW CHEMICAL COMPANY 325000 27,609,000 3 -338,000 12 E I DU PONT DE NEMOURS & CO 325000 24,006,000 4 -1,103,000 13 (DUPONT) IMC GLOBAL INC 325000 2,057,400 9 -110,200 10 MONSANTO CO 325000 4,673,000 8 -1,693,000 14 PRAXAIR INC 325000 5,128,000 7 409,000 4 SCOTTS CO 325000 1,760,600 10 82,500 7 SIGMA ALDRICH CORP 325000 1,207,000 12 130,700 5 SYNGENTA AG 325000 6,197,000 5 -27,000 9 TERRA INDUSTRIES INC 325000 1,042,400 13 -258,400 11 Chips (Semiconductors)/Integrated Circuits/Components, Manufacturing ADVANCED MICRO DEVICES 334413 2,697,000 3 -1,303,000 21 AFFYMETRIX INC 334413 289,947 20 -1,630 8 ALTERA CORP 334413 711,700 15 91,300 5 AMKOR TECHNOLOGY INC 334413 1,639,707 7 -826,759 19 ANALOG DEVICES INC 334413 1,707,500 6 105,300 3 ATMEL CORP 334413 1,193,800 9 -641,800 18 BROADCOM CORP 334413 1,082,900 10 -2,236,600 22 CIRRUS LOGIC INC 334413 417,500 18 -206,100 16 CYPRESS SEMICONDUCTOR 334413 774,700 13 -37,000 10 HADCO CORP 334413 INTEL CORP 334413 26,764,000 1 3,117,000 1 INTERNATIONAL RECTIFIER 334413 720,200 14 48,700 6 LSI LOGIC CORP 334413 1,816,900 5 -42,200 11 MAXIM INTEGRATED PRODUCTS INC 334413 1,025,100 11 259,200 2 MEMC ELECTRONIC MATERIALS 334413 687,200 16 -5,100 9 MICROCHIP TECHNOLOGY INC 334413 571,300 17 94,800 4 MICRON TECHNOLOGY INC 334413 2,589,000 4 -907,000 20
Plunkett Research, Ltd.
www.plunkettresearch.com
NATIONAL SEMICONDUCTOR
Company
334413
1,494,800 2002 Sales
8
-121,900 15 2002 Profits Profits Rank (thousands) -65,000 13 5,900 7 -43,500 12 -344,000 17 -113,600 14
Industry Sales Code Rank (thousands) PMC-SIERRA INC 334413 218,100 21 STANDARD MICROSYSTEMS 334413 159,300 22 TECHNITROL INC 334413 406,400 19 TEXAS INSTRUMENTS INC 334413 8,383,000 2 XILINX INC 334413 1,015,600 12 Communications Equipment, Manufacturing GLENAYRE TECHNOLOGIES 334200 67,400 2 -7,700 L3 COMMUNICATIONS HOLDINGS INC 334200 4,011,200 1 178,000 Computer Accessories, Manufacturing INFOCUS CORP 334119 653,098 3 -63,971 LEXMARK INT'L GROUP INC 334119 4,356,400 1 366,700 SYMBOL TECHNOLOGIES INC 334119 1,320,100 2 10,500 Computer Hardware, Manufacturing APPLE COMPUTER INC 334111 5,742,000 5 65,000 COGNEX CORP 334111 114,100 12 -6,000 DELL COMPUTER CORP 334111 31,168,000 3 1,246,000 DIEBOLD INC 334111 1,940,200 7 99,200 GERBER SCIENTIFIC INC 334111 502,700 10 -119,700 HEWLETT-PACKARD CO 334111 56,588,000 2 -903,000 INTERNATIONAL BUSINESS MACHINES (IBM) 334111 81,186,000 1 3,579,000 MILTOPE GROUP INC 334111 48,470 13 4,663 NCR CORPORATION 334111 5,585,000 6 -220,000 PALM INC 334111 1,030,800 9 -82,200 RADISYS CORP 334111 200,100 11 -3,300 SILICON GRAPHICS INC 334111 1,341,400 8 -46,300 SUN MICROSYSTEMS INC 334111 12,496,000 4 -587,000 Computer Networking and Related Equipment, Manufacturing 3COM CORP 334110 1,477,900 2 -596,000 ADAPTEC INC 334110 418,700 5 -196,200 CISCO SYSTEMS INC 334110 18,915,000 1 1,893,000 ELECTRONICS FOR IMAGING 334110 350,200 6 16,000 ENTERASYS NETWORKS INC 334110 484,797 4 -153,514 JUNIPER NETWORKS INC 334110 546,500 3 -119,700 NETWORK EQUIPMENT TECHNOLOGIES INC 334110 101,500 8 -37,400 TERAYON COMMUNICATION SYSTEMS 334110 129,400 7 -44,200 INC Computer Software ADOBE SYSTEMS INC 511200 1,164,800 18 191,400 AMDOCS LTD 511200 1,613,600 11 249,000 ASCENTIAL SOFTWARE 511200 113,000 37 -63,600 ASPECT COMMUNICATIONS 511200 396,100 34 -108,300 AUTODESK INC 511200 947,500 22 90,300 AVAYA INC 511200 4,956,000 4 -666,000 BEA SYSTEMS INC 511200 975,900 21 -35,700
2 1 3 1 2 4 7 2 3 10 13 1 5 11 9 6 8 12 8 7 1 2 6 5 3 4 7 6 26 30 12 35 24
Plunkett Research, Ltd.
www.plunkettresearch.com
BMC SOFTWARE INC
Company
511200 Industry Code 511200 511200 511200
1,288,900 2002 Sales (thousands)
14
-184,100 31 2002 Sales Profits Profits Rank Rank (thousands) 13 71,900 14 27 48,000 16 30 93,900 11
CADENCE DESIGN SYSTEMS 1,293,100 CERNER CORP 751,900 CITRIX SYSTEMS INC 527,400 COMPUTER ASSOCIATES INTERNATIONAL INC 511200 2,964,000 5 -1,102,000 COMPUWARE CORP 511200 1,728,500 8 -245,300 COMVERSE TECHNOLOGY INC 511200 1,270,200 15 54,600 ELECTRONIC ARTS INC 511200 1,724,700 9 101,500 ERESEARCH TECHNOLOGY 511200 41,500 39 6,200 FILENET CORP 511200 347,000 35 8,300 I2 TECHNOLOGIES INC 511200 522,500 31 -1,003,700 IDX SYSTEMS CORP 511200 460,100 33 10,000 INTERGRAPH CORP 511200 501,200 32 377,800 INTUIT INC 511200 1,358,300 12 140,200 MENTOR GRAPHICS CORP 511200 596,200 29 -14,300 MICROSOFT CORP 511200 28,365,000 1 7,829,000 MSC.SOFTWARE CORP 511200 344,200 36 -51,300 NETWORK ASSOCIATES INC 511200 941,900 23 90,200 NOVELL INC 511200 1,134,300 19 -246,800 ORACLE CORP 511200 9,673,000 2 2,224,000 PARAMETRIC TECHNOLOGY 511200 753,900 26 -75,000 PEOPLESOFT INC 511200 1,948,900 7 182,600 RATIONAL SOFTWARE CORP 511200 689,800 28 -75,900 SAP AKTIENGESELLSCHAFT 511200 7,786,000 3 534,000 SAS INSTITUTE 511200 1,180,000 17 SIEBEL SYSTEMS INC 511200 1,635,300 10 -35,700 SUNGARD DATA SYSTEMS INC 511200 2,530,300 6 325,600 SYBASE INC 511200 829,900 25 -94,700 SYMANTEC CORP 511200 1,071,400 20 -28,200 SYNOPSYS INC 511200 906,500 24 -200,000 TRIPOS INC 511200 51,100 38 900 VERISIGN INC 511200 1,221,700 16 -4,961,300 Computer Storage Equipment and Misc Parts, Manufacturing EMC CORP 334112 5,438,000 2 -119,000 HUTCHINSON TECHNOLOGY 334112 390,700 9 15,000 IOMEGA CORP 334112 614,400 8 34,700 KOMAG INC 334112 174,700 11 -41,900 MAXTOR CORP 334112 3,779,514 3 -334,067 NETWORK APPLIANCE INC 334112 798,400 7 3,000 QUANTUM CORP 334112 1,087,800 6 42,500 READ-RITE CORP 334112 262,800 10 -234,700 SEAGATE TECHNOLOGY INC 334112 6,087,000 1 153,000 STORAGE TECHNOLOGY 334112 2,039,600 5 110,000 WESTERN DIGITAL CORP 334112 2,151,200 4 65,400 Construction Services
37 33 15 10 19 18 36 17 4 9 21 1 25 13 34 2 27 8 28 3 23 5 29 22 32 20 38 9 6 5 8 11 7 4 10 1 2 3
Plunkett Research, Ltd.
www.plunkettresearch.com
DUALSTAR TECHNOLOGIES FOSTER WHEELER LTD
Company
230000 230000
81,200 3,519,200 2002 Sales
-9,600 3 -525,200 4 2002 Sales Profits Profits Rank Rank (thousands) 2 9,600 2 3 15,500 1
Industry Code (thousands) MICHAEL BAKER CORPORATION 230000 405,300 TRC COMPANIES INC 230000 180,100 Construction, Residential FLUOR CORP 236100 9,959,000 Consulting--Computer and Internet AMERICAN MANAGEMENT SYSTEMS INC 541512 986,700 CACI INTERNATIONAL INC 541512 681,900 COMPUTER SCIENCES CORP 541512 11,426,000 ELECTRONIC DATA SYSTEMS 541512 21,502,000 GETRONICS NV 541512 3,796,300 PERFICIENT INC 541512 20,500 PEROT SYSTEMS CORP 541512 1,332,100 TITAN CORP (THE) 541512 1,392,200 UNISYS CORP 541512 5,607,000 Consulting--Environmental OYO CORPORATION 541620 417,537 Consulting--Management and Business ACCENTURE 541611 13,105,000 Consulting--Scientific and Technical ONSITE ENERGY CORP 541690 12,100 US LABORATORIES 541690 Contract Electronics Manufacturing JABIL CIRCUIT INC 334419 3,545,500 Cutlery and Hand Tools, Manufacturing MEDTRONIC AVE INC 332210 Drugs, Manufacturing ABBOTT LABORATORIES 325412 17,685,000 ABGENIX INC 325412 39,438 ABLE LABORATORIES 325412 52,930 AKORN INC 325412 51,419 ALCON LABORATORIES INC 325412 3,009,100 ALLERGAN INC 325412 1,425,300 ALLIANCE PHARMACEUTICAL 325412 10,300 ALPHARMA INC 325412 1,238,000 ALZA CORP 325412 AMGEN INC 325412 5,523,000 AMYLIN PHARMACEUTICALS 325412 13,400 ANDRX CORP 325412 771,000 ASCENT PEDIATRICS INC 325412 ASTRAZENECA PLC 325412 17,841,000 AVENTIS SA 325412 21,659,000 BARR LABORATORIES INC 325412 1,189,000 BENTLEY PHARMACEUTICALS 325412 39,100 BIO TECHNOLOGY GENERAL 325412 103,000
4 1
1
164,000
1
7 8 2 1 4 9 6 5 3
28,200 30,400 344,000 1,116,000 -431,900 -2,400 78,300 -271,400 223,000
6 5 2 1 9 7 4 8 3
1
3,500
1
1
244,900
1
1
300
1
1
34,700
1
9 73 62 64 14 18 103 20
2,794,000 -208,898 23,446 -12,952 466,900 75,200 -34,200 -98,800
8 97 36 58 13 26 73 86
13 -1,392,000 99 -109,800 29 -91,800
102 89 83
8 6 23 74 53
2,836,000 2,285,000 212,200 1,600 9,700
7 10 17 49 41
Plunkett Research, Ltd.
www.plunkettresearch.com
BIOGEN INC BIOMARIN PHARMACEUTICAL
Company
325412 325412
Industry Code BRADLEY PHARMACEUTICALS 325412 BRISTOL MYERS SQUIBB CO 325412 CAMBREX CORP 325412 CARRINGTON LABORATORIES 325412 CELGENE CORP 325412 CELL GENESYS INC 325412 CELL THERAPEUTICS INC 325412 CENTOCOR INC 325412 CEPHALON INC 325412 CHIRON CORP 325412 CHRONIMED INC 325412 CIMA LABS INC 325412 COLLAGENEX PHARMACEUTICAL 325412 COLLATERAL THERAPEUTICS 325412 CONNETICS CORPORATION 325412 CORIXA CORPORATION 325412 CUBIST PHARMACEUTICALS 325412 CYTOGEN CORPORATION 325412 CYTYC CORP 325412 DEL LABORATORIES INC 325412 ELAN CORP PLC 325412 ELI LILLY & CO 325412 ENDO PHARMACEUTICALS HOLDINGS INC 325412 ENZON INC 325412 FIRST HORIZON PHARMACEUTICALS 325412 FOREST LABORATORIES INC 325412 GELTEX PHARMACEUTICALS 325412 GENENTECH INC 325412 GENZYME CORP 325412 GILEAD SCIENCES INC 325412 GLAXOSMITHKLINE PLC 325412 GUILFORD PHARMACEUTICALS 325412 HESKA CORP 325412 HI TECH PHARMACAL CO INC 325412 HYBRIDON INC 325412 ICN PHARMACEUTICALS INC 325412 ICOS CORPORATION 325412 IDEC PHARMACEUTICALS 325412 ILEX ONCOLOGY INC 325412 IMCLONE SYSTEMS INC 325412 IMMUNEX CORP 325412 IMPAX LABORATORIES INC 325412 ISIS PHARMACEUTICALS INC 325412 IVAX CORPORATION 325412
1,148,400 13,900 2002 Sales
25 98
39,700 18,119,000 526,900 18,041 135,700 39,100 16,900
Sales Rank 71 7 31 90 49 75 93
506,897 972,900 397,400 46,600 44,600
32 27 37 67 69
(thousands)
52,800 48,700 11,500 12,900 236,500 350,700 1,470,100 11,078,000 399,000 75,800 115,200 1,566,600
199,100 18 -77,500 80 2002 Profits Profits Rank (thousands) 7,600 42 2,066,000 11 36,200 33 -3,378 51 -100,000 87 -26,600 70 -49,900 77 171,528 180,800 3,700 18,600 900
21 19 45 38 50
63 -16,600 66 -207,400 101 -82,400 100 -15,700 42 47,900 40 19,500 17 -2,394,800 11 2,708,000 36 30,800 56 45,800 51 6,100 16 338,000
62 96 81 61 30 37 103 9 35 31 44 14
2,252,300 1,329,500 466,800 31,819,000 14,700 51,300 33,300 30,256 737,100 92,900 404,200 30,900 60,005
15 19 33 4 97 65 79 81 30 55 35 80 58
63,800 -13,100 72,100 5,903,000 -59,300 -8,700 3,500 16,472 -134,900 -161,600 148,100 -46,200 -157,949
28 59 27 4 79 53 46 39 91 95 22 75 94
24,500 58,320 1,197,200
86 59 22
-20,000 -56,413 122,800
64 78 24
Plunkett Research, Ltd.
www.plunkettresearch.com
JOHNSON & JOHNSON K V PHARMACEUTICAL CO KING PHARMACEUTICALS INC
Company KOS PHARMACEUTICALS INC LIGAND PHARMACEUTICALS MATRIX PHARMACEUTICAL MEDAREX INC MEDICIS PHARMACEUTICAL MEDIMMUNE INC MERCK & CO INC MGI PHARMA INC MILLENNIUM PHARMACEUTICALS MYLAN LABORATORIES INC NABI BIOPHARMACEUTICALS NAPRO BIOTHERAPEUTICS NEORX CORPORATION NEUROCRINE BIOSCIENCES NEUROGEN CORP NOVARTIS AG NOVEN PHARMACEUTICALS ORPHAN MEDICAL INC OSI PHARMACEUTICALS INC PENWEST PHARMACEUTICALS PFIZER INC PHARMACEUTICAL FORMULATIONS PHARMACEUTICAL RESOURCES PROTEIN DESIGN LABS INC REGENERON PHARMACEUTICALS SANGSTAT MEDICAL CORP SCHERING-PLOUGH CORP SCICLONE PHARMACEUTICALS SCIOS INC SEPRACOR INC SHIRE-BIOCHEM INC SICOR INC SUPERGEN INC SYNCOR INTERNATIONAL TARGETED GENETICS CORP TARO PHARMACEUTICAL INDUSTRIES TRANSKARYOTIC THERAPIES TRIANGLE PHARMACEUTICALS TULARIK INC UNITED THERAPEUTICS CORP VERTEX PHARMACEUTICALS VIRBAC INC WATSON PHARMACEUTICALS WYETH
325412 325412 325412 Industry Code 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412 325412
36,298,000 204,100 1,179,500 2002 Sales (thousands)
172,700 96,600 39,500 212,800 847,700 51,790,000 28,200 353,000 1,104,100 196,000 34,200 11,100 18,000 15,700 23,151,000 55,400 16,100 21,800 42,000 32,373,000 53,600 381,600 46,400 22,000 120,100 10,180,000 17,800 107,300 239,000
2 45 24
6,597,000 3 31,500 34 255,100 16 2002 Sales Profits Profits Rank Rank (thousands) 47 -20,800 65 54 -32,600 71 72 -157,500 43 50,000 28 -1,098,000 1 7,150,000 84 -36,100 39 -590,200 26 260,300 46 2,100 78 -8,700 102 -23,100 91 -94,500 95 -23,700 5 3,546,000 60 13,900 94 -11,400 88 -218,500 70 -17,100 3 9,126,000 61 -6,900 38 79,500 68 -14,600 87 -124,400 50 6,300 12 1,974,000 92 -10,000 52 -88,100 41 -276,500
93 29 101 2 74 100 15 48 54 66 85 68 6 40 56 98 63 1 52 25 60 90 43 12 55 82 99
456,000 15,300
34 96
128,300 -49,500
23 76
19,300 211,600 36,500
89 44 76
-23,800 44,600 -139,800
69 32 92
25,300 30,100 161,100 63,800 1,223,200 14,584,000
85 82 48 57 21 10
-93,800 -23,700 -108,600 3,400 175,800 4,447,200
84 67 88 47 20 5
Plunkett Research, Ltd.
www.plunkettresearch.com
XOMA LTD ZILA INC
325412 325412
Company
29,900 34,900 2002 Sales
83 77
-33,200 -12,000 2002 Profits
72 57
Industry Sales Profits Code Rank Rank (thousands) (thousands) Electrical and Electronic Equipment, Manufacturing APPLIED MATERIALS INC 335999 5,062,000 5 269,000 2 CANON INC 335999 24,501,000 2 1,590,000 1 CUBIC CORP 335999 559,600 9 29,400 5 KEMET CORP 335999 508,600 10 27,300 6 LAM RESEARCH CORP 335999 943,100 7 -90,100 9 NOVELLUS SYSTEMS INC 335999 840,000 8 22,900 7 ROCKWELL AUTOMATION 335999 3,909,000 6 121,000 3 ROYAL PHILIPS ELECTRONICS 335999 33,421,000 1 -3,367,000 10 SANYO ELECTRIC COMPANY 335999 15,881,000 3 12,900 8 SHARP CORPORATION 335999 13,599,000 4 85,000 4 Electrical Equipment/Appliances/Tools, Manufacturing 3M COMPANY 335000 16,332,000 2 1,974,000 2 GENERAL ELECTRIC CO 335000 130,685,000 1 14,118,000 1 TELEFLEX INC 335000 2,076,200 3 125,300 3 Engineering Services ABB LTD 541310 18,295,000 2 -787,000 11 AMEY PLC 541310 ARCADIS NV 541310 880,661 12 41,700 3 BECHTEL GROUP INC 541310 13,300,000 3 CH2M HILL COMPANIES LTD 541310 1,999,000 7 29,700 4 CHIYODA CORPORATION 541310 1,066,800 10 900 8 EG&G INC 541310 900,000 11 ENGLOBAL CORP 541310 91,600 14 1,800 7 GEORG FISCHER LTD 541310 2,491,500 5 -14,400 9 GRUPO DRAGADOS 541310 5,377,960 4 380,494 1 KEITH COMPANIES INC (THE) 541310 91,600 15 7,800 6 PARSONS BRINCKERHOFF INC 541310 1,350,000 8 PHILIPP HOLZMANN GROUP 541310 TECHNIP-COFLEXIP 541310 TREVI-FINANZIARIA INDUSTRIALE SPA 541310 391,557 13 -17,269 10 URS CORPORATION 541310 2,427,800 6 55,200 2 VINCI 541310 18,423,000 1 WS ATKINS PLC 541310 1,149,500 9 16,800 5 Fibre Optic Cable and Electrical Wire CORNING INC 335921 3,164,000 1 -1,302,000 1 Fuel Cells, Solar Cells, Other Industrial Machinery, Manufacturing ASTROPOWER INC 333298 BALLARD POWER SYSTEMS 333298 90,900 2 -147,700 4 ENERGY CONVERSION DEVICES 333298 91,700 1 -20,900 1 FUELCELL ENERGY INC 333298 41,200 3 -48,800 3 PLUG POWER INC 333298 11,800 4 -47,200 2 In Vitro Diagnostic Substance, Manufacturing
Plunkett Research, Ltd.
www.plunkettresearch.com
BIOSITE INC BIOSOURCE INTERNATIONAL BOSTON BIOMEDICA INC
Company
325413 325413 325413
105,200 40,100 22,800 2002 Sales
2 6 8
13,400 2 -1,000 6 -1,500 8 2002 Profits Profits Rank (thousands) 22,200 1 600 5 -1,300 7 -3,700 9 5,000 3 -14,000 10 3,900 4 -14,401 11 -21,800 12
Industry Sales Code Rank (thousands) EPIX MEDICAL INC 325413 12,300 12 E-Z-EM INC 325413 122,100 1 HYCOR BIOMEDICAL INC 325413 18,600 10 IMMUNOMEDICS INC 325413 14,300 11 MERIDIAN BIOSCIENCE INC 325413 59,100 3 MYRIAD GENETICS INC 325413 53,800 4 NEOGEN CORPORATION 325413 41,100 5 SYNBIOTICS CORP 325413 21,671 9 VIROLOGIC INC 325413 25,300 7 VYSIS INC 325413 Laboratories and Diagnostics--Medical BIORELIANCE CORP 621511 82,400 3 10,800 ENZO BIOCHEM INC 621511 54,000 4 6,900 IDEXX LABORATORIES INC 621511 412,700 1 45,400 LIFE SCIENCES RESEARCH 621511 115,742 2 2,697 MEDTOX SCIENTIFIC INC 621511 52,000 5 11,700 Machinery, Manufacturing LINDE AG 333000 10,102,000 1 278,000 VALLEN CORP 333000 Management of Companies and Enterprises HLM DESIGN INC 551110 63,300 1 3 Medical/Dental/Surgical Equipment and Supplies, Distribution FISHER SCIENTIFIC INTERNATIONAL INC 421450 3,238,400 1 50,600 Medical/Dental/Surgical Equipment and Supplies, Manufacturing ABAXIS INC 339113 30,600 37 1,300 ACUSON CORPORATION 339113 ADAC LABORATORIES 339113 ALARIS MEDICAL INC 339113 460,300 25 8,200 ALKERMES INC 339113 54,100 32 -61,400 ANALOGIC CORP 339113 313,600 29 3,300 APOGENT TECHNOLOGIES INC 339113 1,074,600 16 121,100 ARROW INTERNATIONAL INC 339113 340,800 27 39,000 BAUSCH & LOMB INC 339113 1,816,700 8 72,500 BAXTER INTERNATIONAL INC 339113 8,110,000 1 778,000 BECKMAN COULTER INC 339113 2,059,400 7 135,500 BECTON DICKINSON & CO 339113 4,033,100 3 480,000 BIO RAD LABORATORIES INC 339113 892,700 17 67,900 BIOMET INC 339113 1,191,900 13 239,700 BOSTON SCIENTIFIC CORP 339113 2,919,000 6 373,000 CONMED CORP 339113 453,100 26 34,200 CR BARD INC 339113 1,273,800 12 155,000 DADE BEHRING INC 339113 1,281,500 11 DEPUY INC 339113
3 4 1 5 2 1
1 1 33
28 38 30 13 22 16 2 12 4 17 9 5 24 11
Plunkett Research, Ltd.
www.plunkettresearch.com
DIGENE CORPORATION EDWARDS LIFESCIENCES GUIDANT CORP
Company
339113 339113 339113
48,800 704,000 3,239,600 2002 Sales
33 20 4
-9,400 36 55,700 19 611,800 3 2002 Profits Profits Rank (thousands) 30,000 25 163,600 10 64,770 18 47,700 20 106,400 14 -4,700 34 -24,900 37
Industry Sales Code Rank (thousands) HAEMONETICS CORPORATION 339113 320,000 28 INSTRUMENTARIUM 339113 1,183,400 14 INVACARE CORP 339113 1,089,161 15 INVITROGEN CORPORATION 339113 648,600 21 KINETIC CONCEPTS INC 339113 579,000 22 LIFECORE BIOMEDICAL INC 339113 38,800 36 LUMINEX CORPORATION 339113 13,000 39 MALLINCKRODT INC 339113 MEDTRONIC INC 339113 6,411,000 2 984,000 NORTH AMERICAN SCIENTIFIC 339113 20,800 38 -5,200 QUIDEL CORP 339113 74,600 31 1,300 RESPIRONICS INC 339113 494,900 24 38,400 SOLA INTERNATIONAL INC 339113 529,500 23 19,100 ST JUDE MEDICAL INC 339113 1,589,900 9 276,300 STERIS CORP 339113 866,700 19 46,200 STRYKER CORP 339113 3,011,600 5 345,600 SUNRISE MEDICAL INC 339113 SYNOVIS LIFE TECHNOLOGIES 339113 39,962 35 3,041 TECHNE CORP 339113 130,900 30 27,100 THERAGENICS CORP 339113 41,900 34 5,600 VARIAN MEDICAL SYSTEMS 339113 873,100 18 93,600 ZIMMER HOLDINGS INC 339113 1,372,400 10 257,800 Medicinal and Botanicals, Manufacturing ATRIX LABORATORIES INC 325411 26,400 5 -18,200 HAUSER INC 325411 57,600 3 -5,400 IOMED INC 325411 11,800 7 -2,400 MARTEK BIOSCIENCES CORP 325411 45,500 4 -24,200 MEDPOINTE INC 325411 200,000 2 NBTY INC 325411 964,100 1 95,800 PURE WORLD INC 325411 18,100 6 -1,800 Oil and Natural Gas Exploration and Development BP PLC 211111 283,108,000 1 34,428,200 CHEVRONTEXACO CORP 211111 98,691,000 4 1,132,000 CONOCOPHILLIPS 211111 57,224,000 5 -295,000 ENI SPA 211111 EXXONMOBIL CORPORATION 211111 178,909,000 2 11,460,000 MARATHON OIL 211111 30,595,000 6 516,000 ROYAL DUTCH PETROLEUM 211111 107,659,000 3 5,651,000 SHELL OIL CO 211111 Online Business-to-Business or to-Consumer Intermediary WEBMD CORPORATION 514191A 925,900 1 -49,700 Optical Instrument and Lens, Manufacturing EASTMAN KODAK CO 333314 12,853,000 1 770,000
1 35 32 23 27 7 21 6 31 26 29 15 8 5 4 3 6 1 2 1 4 6 2 5 3
1 1
Plunkett Research, Ltd. POLAROID CORP
www.plunkettresearch.com
333314 Petrochemicals Manufacturing LYONDELL CHEMICAL 325110 3,262,000 1 -148,000 1 2002 2002 Company Industry Sales Sales Profits Profits Code Rank Rank (thousands) (thousands) Petroleum--Drilling Oil and Gas Wells Support GLOBAL INDUSTRIES LTD 213111 494,000 2 -29,400 1 HALLIBURTON COMPANY 213111 12,498,000 1 -998,000 2 Plastics and Rubber, Manufacturing COMPAGNIE MICHELIN 326000 16,398,000 1 GOODYEAR TIRE & RUBBER 326000 13,850,000 2 -1,106,000 1 Research and Development--Physical, Engineering and Life Sciences ALBANY MOLECULAR RESEARCH 541710 122,800 6 40,600 3 CELERA GENOMICS GROUP 541710 120,900 7 -211,800 20 CHESAPEAKE BIOLOGICAL LAB 541710 COVALENT GROUP INC 541710 24,700 16 2,500 5 COVANCE INC 541710 924,700 2 63,800 2 CURAGEN CORPORATION 541710 18,200 18 -90,400 17 DIVERSA CORPORATION 541710 31,700 14 -28,000 10 EXELIXIS INC 541710 44,300 11 -86,200 16 GENE LOGIC INC 541710 54,800 9 -24,100 9 GENOME THERAPEUTICS 541710 23,000 17 -34,000 12 INCYTE GENOMICS INC 541710 101,612 8 -136,885 18 KENDLE INTERNATIONAL INC 541710 214,000 4 -54,800 13 LEXICON GENETICS INC 541710 35,200 13 -59,700 14 LYNX THERAPEUTICS INC 541710 17,400 19 -15,500 7 MAXYGEN INC 541710 41,800 12 -33,900 11 ORCHID BIOSCIENCES INC 541710 50,400 10 -80,100 15 PANVERA LLC 541710 PARADIGM GENETICS INC 541710 17,200 20 -23,500 8 PAREXEL INTERNATIONAL 541710 564,900 3 13,200 4 PHARMACOPEIA INC 541710 124,400 5 -11,600 6 QUINTILES TRANSNATIONAL 541710 1,992,400 1 127,400 1 SEQUENOM INC 541710 30,900 15 -205,600 19 Satellite Equipment, Manufacturing HUGHES ELECTRONICS CORP 513340 8,934,900 1 -891,100 2 LORAL SPACE & COMMUNICATIONS LTD 513340 1,098,425 2 -1,469,211 3 ORBITAL SCIENCES CORP 513340 551,600 3 800 1 Steel and Metals, Manufacturing NKK CORPORATION 331000 12,466,000 1 -510,000 1 Superconducting Materials and Other Wire AMERICAN SUPERCONDUCTOR 335929 11,700 1 -57,000 1 Telecommunications Equipment, Manufacturing and Related Services ADC TELECOMMUNICATIONS 334210 1,047,700 12 -1,145,000 11 ADTRAN INC 334210 345,700 15 24,800 8 ADVANCED FIBRE COMMUNICATIONS 334210 344,100 16 31,800 7 ALCATEL USA INC 334210 CIENA CORP 334210 361,200 14 -1,597,500 12
Plunkett Research, Ltd. JDS UNIPHASE CORP LUCENT TECHNOLOGIES INC MOTOROLA INC
www.plunkettresearch.com 334210 334210 334210
1,098,200 12,321,000 26,679,000 2002 Sales
11 -8,738,300 16 6 -11,753,000 17 4 -2,485,000 14 2002 Company Industry Sales Profits Profits Code Rank Rank (thousands) (thousands) NOKIA CORPORATION 334210 31,526,000 3 3,351,000 2 NORTEL NETWORKS CORP 334210 10,560,000 7 -3,585,000 15 PROXIM CORPORATION 334210 144,700 17 -239,900 9 QUALCOMM INC 334210 3,039,600 8 359,700 4 SAMSUNG ELECTRONICS CO 334210 50,175,000 2 5,941,000 1 SCIENTIFIC ATLANTA INC 334210 1,671,100 9 104,400 6 SIEMENS AG 334210 82,865,000 1 2,561,000 3 TELEFON AB LM ERICSSON 334210 16,808,000 5 -2,192,000 13 TELLABS INC 334210 1,317,000 10 -313,100 10 UTSTARCOM INC 334210 981,800 13 107,900 5 Test Equipment/Instruments, Manufacturing ACTERNA CORPORATION 334515 1,132,700 6 -374,900 4 AGILENT TECHNOLOGIES INC 334515 6,010,000 1 -1,032,000 6 KLA TENCOR CORP 334515 1,637,300 3 216,200 2 PERKINELMER INC 334515 1,505,000 4 -151,900 3 TERADYNE INC 334515 1,222,200 5 -718,500 5 THERMO ELECTRON CORP 334515 2,086,400 2 309,700 1 Trucks, RVs and Misc. Automotive, Manufacturing AB VOLVO 336120 21,469,000 1 161,000 1
Plunkett Research, Ltd.
ALPHABETICAL INDEX If you are seeking a company by name and you do not find it on this list, please turn to the back of the book to the Index by Subsidiaries, Brand Names and Selected Affiliations. You might find your target firm there. 3COM CORP 3M COMPANY AB VOLVO ABAXIS INC ABB LTD ABBOTT LABORATORIES ABGENIX INC ABLE LABORATORIES ACCENTURE ACTERNA CORPORATION ACUSON CORPORATION ADAC LABORATORIES ADAM OPEL AG ADAPTEC INC ADC TELECOMMUNICATIONS INC ADOBE SYSTEMS INC ADTRAN INC ADVANCED FIBRE COMMUNICATIONS INC ADVANCED MICRO DEVICES INC AFFYMETRIX INC AGILENT TECHNOLOGIES INC AIR PRODUCTS & CHEMICALS INC AIRBUS SAS AKORN INC ALARIS MEDICAL INC ALBANY MOLECULAR RESEARCH ALBEMARLE CORPORATION ALCATEL USA INC ALCON LABORATORIES INC ALKERMES INC ALLERGAN INC ALLIANCE PHARMACEUTICAL CORP ALPHARMA INC ALTERA CORP ALZA CORP AMDOCS LTD AMERICAN MANAGEMENT SYSTEMS INC AMERICAN SUPERCONDUCTOR AMEY PLC AMGEN INC AMKOR TECHNOLOGY INC AMYLIN PHARMACEUTICALS INC ANALOG DEVICES INC
www.plunkettresearch.com
ANALOGIC CORP ANDRX CORP ANIKA THERAPEUTICS INC AOL TIME WARNER INC APOGENT TECHNOLOGIES INC APPLE COMPUTER INC APPLIED MATERIALS INC ARCADIS NV ARROW INTERNATIONAL INC ASCENT PEDIATRICS INC ASCENTIAL SOFTWARE CORPORATION ASPECT COMMUNICATIONS CORP ASTRAZENECA PLC ASTROPOWER INC ATMEL CORP ATRIX LABORATORIES INC AUDI AG AUTODESK INC AVAYA INC AVENTIS SA BAE SYSTEMS BALLARD POWER SYSTEMS BARR LABORATORIES INC BASF AG BAUSCH & LOMB INC BAXTER INTERNATIONAL INC BAYER AG BAYERISCHE MOTOREN WERKE AG BEA SYSTEMS INC BECHTEL GROUP INC BECKMAN COULTER INC BECTON DICKINSON & CO BENTLEY PHARMACEUTICALS INC BIO RAD LABORATORIES INC BIO TECHNOLOGY GENERAL CORP BIOGEN INC BIOMARIN PHARMACEUTICAL BIOMET INC BIORELIANCE CORP BIOSITE INC BIOSOURCE INTERNATIONAL INC BMC SOFTWARE INC BOEING CO BOMBARDIER INC BOSTON BIOMEDICA INC BOSTON SCIENTIFIC CORP BP PLC BRADLEY PHARMACEUTICALS BRISTOL MYERS SQUIBB CO BROADCOM CORP CABOT CORPORATION CACI INTERNATIONAL INC
Plunkett Research, Ltd.
CADENCE DESIGN SYSTEMS INC CAMBREX CORP CANON INC CARRINGTON LABORATORIES INC CELERA GENOMICS GROUP CELGENE CORP CELL GENESYS INC CELL THERAPEUTICS INC CENTOCOR INC CEPHALON INC CERNER CORP CH2M HILL COMPANIES LTD CHESAPEAKE BIOLOGICAL LAB CHEVRONTEXACO CORPORATION CHIRON CORP CHIYODA CORPORATION CHRONIMED INC CIENA CORP CIMA LABS INC CIRRUS LOGIC INC CISCO SYSTEMS INC CITRIX SYSTEMS INC COGNEX CORP COLLAGENEX PHARMACEUTICAL COLLATERAL THERAPEUTICS COMPAGNIE MICHELIN COMPUTER ASSOCIATES INTERNATIONAL INC COMPUTER SCIENCES CORP COMPUWARE CORP COMVERSE TECHNOLOGY INC CONMED CORP CONNETICS CORPORATION CONOCOPHILLIPS CORIXA CORPORATION CORNING INC COVALENT GROUP INC COVANCE INC CR BARD INC CUBIC CORP CUBIST PHARMACEUTICALS CURAGEN CORPORATION CYPRESS SEMICONDUCTOR CORP CYTOGEN CORPORATION CYTYC CORP DADE BEHRING INC DAIMLERCHRYSLER AG DEL LABORATORIES INC DELL COMPUTER CORPORATION DENSO CORPORATION DEPUY INC DIEBOLD INC DIGENE CORPORATION
www.plunkettresearch.com
DIVERSA CORPORATION DOW CHEMICAL COMPANY (THE) DUALSTAR TECHNOLOGIES CORPORATION E I DU PONT DE NEMOURS & CO (DUPONT) EASTMAN KODAK CO EDWARDS LIFESCIENCES CORP EG&G INC ELAN CORP PLC ELECTRONIC ARTS INC ELECTRONIC DATA SYSTEMS CORP ELECTRONICS FOR IMAGING INC ELI LILLY & CO EMC CORP ENDO PHARMACEUTICALS HOLDINGS INC ENERGY CONVERSION DEVICES INC ENGLOBAL CORP ENI SPA ENTERASYS NETWORKS INC ENZO BIOCHEM INC ENZON INC EPIX MEDICAL INC ERESEARCH TECHNOLOGY INC EXELIXIS INC EXELIXIS PLANT SCIENCES INC EXXONMOBIL CORPORATION E-Z-EM INC FIAT SPA FILENET CORP FIRST HORIZON PHARMACEUTICALS FISHER SCIENTIFIC INTERNATIONAL INC FLUOR CORP FORD MOTOR CO FOREST LABORATORIES INC FOSTER WHEELER LTD FUELCELL ENERGY INC FUJI HEAVY INDUSTRIES LTD GELTEX PHARMACEUTICALS GENE LOGIC INC GENENTECH INC GENERAL DYNAMICS GENERAL ELECTRIC CO GENERAL MOTORS CORP GENOME THERAPEUTICS CORP GENZYME CORP GEORG FISCHER LTD GERBER SCIENTIFIC INC GETRONICS NV GILEAD SCIENCES INC GLAXOSMITHKLINE PLC GLENAYRE TECHNOLOGIES INC GLOBAL INDUSTRIES LTD GOODRICH CORPORATION GOODYEAR TIRE & RUBBER COMPANY (THE)
Plunkett Research, Ltd.
GOOGLE INC GRUPO DRAGADOS GTC BIOTHERAPEUTICS INC GUIDANT CORP GUILFORD PHARMACEUTICALS INC HADCO CORP HAEMONETICS CORPORATION HALLIBURTON COMPANY HAUSER INC HESKA CORP HEWLETT-PACKARD CO HI TECH PHARMACAL CO INC HLM DESIGN INC HONDA MOTOR CO LTD HONEYWELL INTERNATIONAL INC HUGHES ELECTRONICS CORP HUTCHINSON TECHNOLOGY INC HYBRIDON INC HYCOR BIOMEDICAL INC HYUNDAI MOTOR COMPANY I2 TECHNOLOGIES INC ICN PHARMACEUTICALS INC ICOS CORPORATION IDEC PHARMACEUTICALS CORP IDEXX LABORATORIES INC IDX SYSTEMS CORP ILEX ONCOLOGY INC IMC GLOBAL INC IMCLONE SYSTEMS INC IMMUNEX CORP IMMUNOMEDICS INC IMPAX LABORATORIES INC INCYTE GENOMICS INC INFOCUS CORP INSTRUMENTARIUM INTEL CORP INTERGRAPH CORP INTERNATIONAL BUSINESS MACHINES (IBM) INTERNATIONAL RECTIFIER CORP INTUIT INC INVACARE CORP INVITROGEN CORPORATION IOMED INC IOMEGA CORP ISIS PHARMACEUTICALS INC ISUZU MOTORS LTD ITT INDUSTRIES INC IVAX CORPORATION JABIL CIRCUIT INC JDS UNIPHASE CORP JOHNSON & JOHNSON JOHNSON CONTROLS INC JUNIPER NETWORKS INC
www.plunkettresearch.com
K V PHARMACEUTICAL CO KEITH COMPANIES INC (THE) KEMET CORP KENDLE INTERNATIONAL INC KINETIC CONCEPTS INC KING PHARMACEUTICALS INC KLA TENCOR CORP KOMAG INC KOS PHARMACEUTICALS INC L3 COMMUNICATIONS HOLDINGS INC LAM RESEARCH CORP LEXICON GENETICS INC LEXMARK INT'L GROUP INC LIFE SCIENCES RESEARCH LIFECELL CORPORATION LIFECORE BIOMEDICAL INC LIGAND PHARMACEUTICALS INC LINDE AG LOCKHEED MARTIN CORP LORAL SPACE & COMMUNICATIONS LTD LSI LOGIC CORP LUCENT TECHNOLOGIES INC LUMINEX CORPORATION LYNX THERAPEUTICS INC LYONDELL CHEMICAL COMPANY MALLINCKRODT INC MARATHON OIL MARTEK BIOSCIENCES CORP MATRIX PHARMACEUTICAL MAXIM INTEGRATED PRODUCTS INC MAXTOR CORP MAXYGEN INC MAZDA MOTOR CORPORATION MEDAREX INC MEDICIS PHARMACEUTICAL CORP MEDIMMUNE INC MEDPOINTE INC MEDTOX SCIENTIFIC INC MEDTRONIC AVE INC MEDTRONIC INC MEMC ELECTRONIC MATERIALS INC MENTOR GRAPHICS CORP MERCK & CO INC MERIDIAN BIOSCIENCE INC MGI PHARMA INC MICHAEL BAKER CORPORATION MICROCHIP TECHNOLOGY INC MICRON TECHNOLOGY INC MICROSOFT CORP MILLENNIUM PHARMACEUTICALS INC MILTOPE GROUP INC MITSUBISHI MOTORS CORP MONSANTO CO
Plunkett Research, Ltd.
MOTOROLA INC MSC.SOFTWARE CORP MYLAN LABORATORIES INC MYRIAD GENETICS INC NABI BIOPHARMACEUTICALS NAPRO BIOTHERAPEUTICS INC NATIONAL SEMICONDUCTOR CORP NBTY INC NCR CORPORATION NEOGEN CORPORATION NEORX CORPORATION NETWORK APPLIANCE INC NETWORK ASSOCIATES INC NETWORK EQUIPMENT TECHNOLOGIES INC NEUROCRINE BIOSCIENCES INC NEUROGEN CORP NISSAN MOTOR CO LTD NKK CORPORATION NOKIA CORPORATION NORTEL NETWORKS CORP NORTH AMERICAN SCIENTIFIC NOVARTIS AG NOVELL INC NOVELLUS SYSTEMS INC NOVEN PHARMACEUTICALS ONSITE ENERGY CORPORATION ORACLE CORP ORBITAL SCIENCES CORP ORCHID BIOSCIENCES INC ORPHAN MEDICAL INC OSI PHARMACEUTICALS INC OYO CORPORATION PALM INC PANVERA LLC PARADIGM GENETICS INC PARAMETRIC TECHNOLOGY CORP PAREXEL INTERNATIONAL PARSONS BRINCKERHOFF INC PENWEST PHARMACEUTICALS CO PEOPLESOFT INC PERFICIENT INC PERKINELMER INC PEROT SYSTEMS CORP PFIZER INC PHARMACEUTICAL FORMULATIONS INC PHARMACEUTICAL RESOURCES INC PHARMACOPEIA INC PHILIPP HOLZMANN GROUP PITNEY BOWES INC PLUG POWER INC PMC-SIERRA INC POLAROID CORP PRAXAIR INC
www.plunkettresearch.com
PROTEIN DESIGN LABS INC PROXIM CORPORATION PSA PEUGEOT CITROEN SA PURE WORLD INC QUALCOMM INC QUANTUM CORP QUIDEL CORP QUINTILES TRANSNATIONAL CORP RADISYS CORP RATIONAL SOFTWARE CORP RAYTHEON CO READ-RITE CORP REGENERON PHARMACEUTICALS INC RESPIRONICS INC ROCKWELL AUTOMATION ROYAL DUTCH PETROLEUM CO ROYAL PHILIPS ELECTRONICS SAMSUNG ELECTRONICS CO LTD SANGSTAT MEDICAL CORP SANYO ELECTRIC COMPANY LTD SAP AKTIENGESELLSCHAFT SAS INSTITUTE SCHERING-PLOUGH CORP SCICLONE PHARMACEUTICALS SCIENTIFIC ATLANTA INC SCIOS INC SCOTTS CO SEAGATE TECHNOLOGY INC SEPRACOR INC SEQUENOM INC SEROLOGICALS CORP SHARP CORPORATION SHELL OIL CO SHIRE-BIOCHEM INC SICOR INC SIEBEL SYSTEMS INC SIEMENS AG SIGMA ALDRICH CORP SILICON GRAPHICS INC SKIDMORE OWINGS & MERRILL LLP SOLA INTERNATIONAL INC SONY CORPORATION ST JUDE MEDICAL INC STANDARD MICROSYSTEMS CORPORATION STERIS CORP STORAGE TECHNOLOGY CORP STRYKER CORP STV GROUP INC SUN MICROSYSTEMS INC SUNGARD DATA SYSTEMS INC SUNRISE MEDICAL INC SUPERGEN INC SUZUKI MOTOR CORPORATION
Plunkett Research, Ltd.
SYBASE INC SYMANTEC CORP SYMBOL TECHNOLOGIES INC SYNBIOTICS CORP SYNCOR INTERNATIONAL CORPORATION SYNGENTA AG SYNOPSYS INC SYNOVIS LIFE TECHNOLOGIES INC TARGETED GENETICS CORP TARO PHARMACEUTICAL INDUSTRIES TECHNE CORP TECHNIP-COFLEXIP TECHNITROL INC TELEFLEX INC TELEFON AB LM ERICSSON TELLABS INC TERADYNE INC TERAYON COMMUNICATION SYSTEMS INC TERRA INDUSTRIES INC TEXAS INSTRUMENTS INC THERAGENICS CORP THERMO ELECTRON CORP TITAN CORP (THE) TOYOTA MOTOR CORPORATION TRANSKARYOTIC THERAPIES TRC COMPANIES INC TREVI-FINANZIARIA INDUSTRIALE SPA TRIANGLE PHARMACEUTICALS TRIPOS INC TULARIK INC UNISYS CORP UNITED THERAPEUTICS CORP URS CORPORATION US LABORATORIES UTSTARCOM INC VALLEN CORP VARIAN MEDICAL SYSTEMS INC VERISIGN INC VERTEX PHARMACEUTICALS INC VINCI VIRBAC INC VIROLOGIC INC VISTEON CORPORATION VOLKSWAGEN AG VYSIS INC WATSON PHARMACEUTICALS INC WEBMD CORPORATION WESTERN DIGITAL CORP WS ATKINS PLC WYETH XEROX CORP XILINX INC XOMA LTD
www.plunkettresearch.com
YAHOO! INC ZILA INC ZIMMER HOLDINGS INC
Plunkett Research, Ltd.
GEOGRAPHICAL INDEXES 1) Company headquarters locations by state 2) Foreign company headquarters locations by country 3) Offices and subsidiaries by regions of the U.S. 4) Firms with international operations The headquarters locations of each company are in the following indexes to help you locate members of THE ENGINEERING AND RESEARCH 500 within the part of the country, or the world, of interest. However, companies are constantly opening and closing various locations. You should consider contacting companies that particularly interest you, to see whether they have locations in your area.
INDEX OF HEADQUARTERS LOCATION BY STATE To help you locate members of THE ENGINEERING & RESEARCH 500 geographically, the city and state of the headquarters of each company are indexed. ALABAMA ADTRAN INC; Huntsville INTERGRAPH CORP; Huntsville MILTOPE GROUP INC; Hope Hull ARIZONA MEDICIS PHARMACEUTICAL CORP; Scottsdale MICROCHIP TECHNOLOGY INC; Chandler ZILA INC; Phoenix CALIFORNIA 3COM CORP; Santa Clara ABAXIS INC; Union City ABGENIX INC; Fremont ACUSON CORPORATION; Mountain View ADAC LABORATORIES; Milpitas ADAPTEC INC; Milpitas ADOBE SYSTEMS INC; San Jose ADVANCED FIBRE COMMUNICATIONS INC; Petaluma ADVANCED MICRO DEVICES INC; Sunnyvale AFFYMETRIX INC; Santa Clara AGILENT TECHNOLOGIES INC; Palo Alto ALARIS MEDICAL INC; San Diego ALLERGAN INC; Irvine
www.plunkettresearch.com
ALLIANCE PHARMACEUTICAL CORP; San Diego ALTERA CORP; San Jose ALZA CORP; Mountain View AMGEN INC; Thousand Oaks AMYLIN PHARMACEUTICALS INC; San Diego APPLE COMPUTER INC; Cupertino APPLIED MATERIALS INC; Santa Clara ASPECT COMMUNICATIONS CORP; San Jose ATMEL CORP; San Jose AUTODESK INC; San Rafael BEA SYSTEMS INC; San Jose BECHTEL GROUP INC; San Francisco BECKMAN COULTER INC; Fullerton BIO RAD LABORATORIES INC; Hercules BIOMARIN PHARMACEUTICAL; Novato BIOSITE INC; San Diego BIOSOURCE INTERNATIONAL INC; Camarillo BROADCOM CORP; Irvine CADENCE DESIGN SYSTEMS INC; San Jose CELL GENESYS INC; South San Francisco CHEVRONTEXACO CORPORATION; San Ramon CHIRON CORP; Emeryville CISCO SYSTEMS INC; San Jose COLLATERAL THERAPEUTICS; San Diego COMPUTER SCIENCES CORP; El Segundo CONNETICS CORPORATION; Palo Alto CUBIC CORP; San Diego CYPRESS SEMICONDUCTOR CORP; San Jose DIVERSA CORPORATION; San Diego EDWARDS LIFESCIENCES CORP; Irvine ELECTRONIC ARTS INC; Redwood City ELECTRONICS FOR IMAGING INC; Foster City EXELIXIS INC; South San Francisco FILENET CORP; Costa Mesa FLUOR CORP; Aliso Viejo GENENTECH INC; South San Francisco GILEAD SCIENCES INC; Foster City GOOGLE INC; Mountain View HAUSER INC; Long Beach HEWLETT-PACKARD CO; Palo Alto HUGHES ELECTRONICS CORP; El Segundo HYCOR BIOMEDICAL INC; Garden Grove ICN PHARMACEUTICALS INC; Costa Mesa IDEC PHARMACEUTICALS CORP; San Diego IMMUNEX CORP; Thousand Oaks IMPAX LABORATORIES INC; Hayward INCYTE GENOMICS INC; Palo Alto INTEL CORP; Santa Clara INTERNATIONAL RECTIFIER CORP; El Segundo INTUIT INC; Mountain View INVITROGEN CORPORATION; Carlsbad IOMEGA CORP; San Diego
Plunkett Research, Ltd.
ISIS PHARMACEUTICALS INC; Carlsbad JDS UNIPHASE CORP; San Jose JUNIPER NETWORKS INC; Sunnyvale KEITH COMPANIES INC (THE); Irvine KLA TENCOR CORP; San Jose KOMAG INC; San Jose LAM RESEARCH CORP; Fremont LIGAND PHARMACEUTICALS INC; San Diego LSI LOGIC CORP; Milpitas LYNX THERAPEUTICS INC; Hayward MATRIX PHARMACEUTICAL; Fremont MAXIM INTEGRATED PRODUCTS INC; Sunnyvale MAXTOR CORP; Milpitas MAXYGEN INC; Redwood City MEDTRONIC AVE INC; Santa Rosa MSC.SOFTWARE CORP; Santa Ana NATIONAL SEMICONDUCTOR CORP; Santa Clara NETWORK APPLIANCE INC; Sunnyvale NETWORK ASSOCIATES INC; Santa Clara NETWORK EQUIPMENT TECHNOLOGIES INC; Fremont NEUROCRINE BIOSCIENCES INC; San Diego NORTH AMERICAN SCIENTIFIC; Chatsworth NOVELLUS SYSTEMS INC; San Jose ONSITE ENERGY CORPORATION; Carlsbad ORACLE CORP; Redwood City PALM INC; Santa Clara PEOPLESOFT INC; Pleasanton PMC-SIERRA INC; Santa Clara PROTEIN DESIGN LABS INC; Fremont PROXIM CORPORATION; Sunnyvale QUALCOMM INC; San Diego QUANTUM CORP; Milpitas QUIDEL CORP; San Diego RATIONAL SOFTWARE CORP; Cupertino READ-RITE CORP; Freemont SANGSTAT MEDICAL CORP; Fremont SCICLONE PHARMACEUTICALS; San Mateo SCIOS INC; Sunnyvale SEAGATE TECHNOLOGY INC; Scotts Valley SEQUENOM INC; San Diego SICOR INC; Irvine SIEBEL SYSTEMS INC; San Mateo SILICON GRAPHICS INC; Mountain View SOLA INTERNATIONAL INC; San Diego SUN MICROSYSTEMS INC; Palo Alto SUNRISE MEDICAL INC; Carlsbad SUPERGEN INC; Dublin SYBASE INC; Dublin SYMANTEC CORP; Cupertino SYNBIOTICS CORP; San Diego
www.plunkettresearch.com
SYNCOR INTERNATIONAL CORPORATION; Woodland Hills SYNOPSYS INC; Mountain View TERAYON COMMUNICATION SYSTEMS INC; Santa Clara TITAN CORP (THE); San Diego TULARIK INC; South San Francisco URS CORPORATION; San Francisco US LABORATORIES; San Diego UTSTARCOM INC; Alameda VARIAN MEDICAL SYSTEMS INC; Palo Alto VERISIGN INC; Mountain View VIROLOGIC INC; South San Francisco WATSON PHARMACEUTICALS INC; Corona WESTERN DIGITAL CORP; Lake Forest XILINX INC; San Jose XOMA LTD; Berkeley YAHOO! INC; Sunnyvale COLORADO ATRIX LABORATORIES INC; Fort Collins CH2M HILL COMPANIES LTD; Englewood HESKA CORP; Fort Collins NAPRO BIOTHERAPEUTICS INC; Boulder STORAGE TECHNOLOGY CORP; Louisville CONNECTICUT CURAGEN CORPORATION; New Haven FUELCELL ENERGY INC; Danbury GENERAL ELECTRIC CO; Fairfield GERBER SCIENTIFIC INC; South Windsor NEUROGEN CORP; Branford PENWEST PHARMACEUTICALS CO; Danbury PITNEY BOWES INC; Stamford PRAXAIR INC; Danbury TRC COMPANIES INC; Windsor XEROX CORP; Stamford DELAWARE ASTROPOWER INC; Newark E I DU PONT DE NEMOURS & CO (DUPONT); Wilmington FLORIDA ANDRX CORP; Davie CITRIX SYSTEMS INC; Fort Lauderdale IVAX CORPORATION; Miami JABIL CIRCUIT INC; St. Petersburg KOS PHARMACEUTICALS INC; Miami NABI BIOPHARMACEUTICALS; Boca Raton NOVEN PHARMACEUTICALS; Miami
Plunkett Research, Ltd.
GEORGIA FIRST HORIZON PHARMACEUTICALS; Alpharetta GLENAYRE TECHNOLOGIES INC; Duluth SCIENTIFIC ATLANTA INC; Lawrenceville SEROLOGICALS CORP; Norcross THERAGENICS CORP; Buford IDAHO MICRON TECHNOLOGY INC; Boise ILLINOIS ABBOTT LABORATORIES; Abbott Park AKORN INC; Buffalo Grove BAXTER INTERNATIONAL INC; Deerfield BOEING CO; Chicago DADE BEHRING INC; Deerfield IMC GLOBAL INC; Lake Forest MOTOROLA INC; Schaumburg TELLABS INC; Naperville VYSIS INC; Downers Grove INDIANA BIOMET INC; Warsaw DEPUY INC; Warsaw ELI LILLY & CO; Indianapolis GUIDANT CORP; Indianapolis ZIMMER HOLDINGS INC; Warsaw IOWA TERRA INDUSTRIES INC; Sioux City KENTUCKY LEXMARK INT'L GROUP INC; Lexington LOUISIANA GLOBAL INDUSTRIES LTD; Carlyss MAINE IDEXX LABORATORIES INC; Westbrook MARYLAND ACTERNA CORPORATION; Germantown BIORELIANCE CORP; Rockville CELERA GENOMICS GROUP; Rockville CHESAPEAKE BIOLOGICAL LAB; Baltimore CIENA CORP; Linthicum DIGENE CORPORATION; Gaithersburg EG&G INC; Gaithersburg GENE LOGIC INC; Gaithersburg GUILFORD PHARMACEUTICALS INC; Baltimore LOCKHEED MARTIN CORP; Bethesda MARTEK BIOSCIENCES CORP; Columbia
www.plunkettresearch.com
MEDIMMUNE INC; Gaithersburg UNITED THERAPEUTICS CORP; Silver Spring MASSACHUSETTS ABLE LABORATORIES; Needham ALKERMES INC; Cambridge AMERICAN SUPERCONDUCTOR; Westborough ANALOG DEVICES INC; Norwood ANALOGIC CORP; Peabody ANIKA THERAPEUTICS INC; Woburn ASCENT PEDIATRICS INC; Wilmington ASCENTIAL SOFTWARE CORPORATION; Westboro BIOGEN INC; Cambridge BOSTON BIOMEDICA INC; West Bridgewater BOSTON SCIENTIFIC CORP; Natick CABOT CORPORATION; Boston COGNEX CORP; Natick CUBIST PHARMACEUTICALS; Lexington CYTYC CORP; Boxborough EMC CORP; Hopkinton EPIX MEDICAL INC; Cambridge GELTEX PHARMACEUTICALS; Waltham GENOME THERAPEUTICS CORP; Waltham GENZYME CORP; Cambridge GTC BIOTHERAPEUTICS INC; Framingham HAEMONETICS CORPORATION; Braintree HYBRIDON INC; Cambridge MILLENNIUM PHARMACEUTICALS INC; Cambridge PARAMETRIC TECHNOLOGY CORP; Needham PAREXEL INTERNATIONAL; Waltham PERKINELMER INC; Wellesley POLAROID CORP; Waltham RAYTHEON CO; Lexington SEPRACOR INC; Marlborough TERADYNE INC; Boston THERMO ELECTRON CORP; Waltham TRANSKARYOTIC THERAPIES; Cambridge VERTEX PHARMACEUTICALS INC; Cambridge MICHIGAN COMPUWARE CORP; Farmington Hills DOW CHEMICAL COMPANY (THE); Midland ENERGY CONVERSION DEVICES INC; Rochester Hills FORD MOTOR CO; Dearborn GENERAL MOTORS CORP; Detroit NEOGEN CORPORATION; Lansing STRYKER CORP; Kalamazoo VISTEON CORPORATION; Dearborn
Plunkett Research, Ltd.
www.plunkettresearch.com
MINNESOTA 3M COMPANY; St. Paul ADC TELECOMMUNICATIONS INC; Eden Prarie CHRONIMED INC; Minnetonka CIMA LABS INC; Eden Prairie HUTCHINSON TECHNOLOGY INC; Hutchinson LIFECORE BIOMEDICAL INC; Chaska MEDTOX SCIENTIFIC INC; St. Paul MEDTRONIC INC; Minneapolis MGI PHARMA INC; Bloomington ORPHAN MEDICAL INC; Minnetonka ST JUDE MEDICAL INC; St. Paul SYNOVIS LIFE TECHNOLOGIES INC; St. Paul TECHNE CORP; Minneapolis
LIFE SCIENCES RESEARCH; East Millstone LIFECELL CORPORATION; Branchburg LUCENT TECHNOLOGIES INC; Murray Hill MEDAREX INC; Princeton MEDPOINTE INC; Somerset MERCK & CO INC; Whitehouse Station ORCHID BIOSCIENCES INC; Princeton PHARMACEUTICAL FORMULATIONS INC; Edison PHARMACOPEIA INC; Cranbury PURE WORLD INC; Bedminster SCHERING-PLOUGH CORP; Kenilworth WEBMD CORPORATION; Elmwood Park WYETH; Madison
MISSOURI AMDOCS LTD; Chesterfield CERNER CORP; Kansas City K V PHARMACEUTICAL CO; St. Louis MALLINCKRODT INC; Hazelwood MEMC ELECTRONIC MATERIALS INC; St. Peters MONSANTO CO; St. Louis SIGMA ALDRICH CORP; St. Louis TRIPOS INC; St. Louis
NEW YORK ALBANY MOLECULAR RESEARCH; Albany AOL TIME WARNER INC; New York BARR LABORATORIES INC; Pomona BAUSCH & LOMB INC; Rochester BRISTOL MYERS SQUIBB CO; New York COMPUTER ASSOCIATES INTERNATIONAL INC; Islandia COMVERSE TECHNOLOGY INC; Woodbury CONMED CORP; Utica CORNING INC; Corning DEL LABORATORIES INC; Uniondale DUALSTAR TECHNOLOGIES CORPORATION; Long Island City EASTMAN KODAK CO; Rochester ENZO BIOCHEM INC; Farmingdale E-Z-EM INC; Westbury FOREST LABORATORIES INC; New York HI TECH PHARMACAL CO INC; Amityville IMCLONE SYSTEMS INC; New York INTERNATIONAL BUSINESS MACHINES (IBM); Armonk ITT INDUSTRIES INC; White Plains L3 COMMUNICATIONS HOLDINGS INC; New York LORAL SPACE & COMMUNICATIONS LTD; New York NBTY INC; Bohemia OSI PHARMACEUTICALS INC; Melville PARSONS BRINCKERHOFF INC; New York PFIZER INC; New York PHARMACEUTICAL RESOURCES INC; Spring Valley PLUG POWER INC; Latham REGENERON PHARMACEUTICALS INC; Tarrytown SKIDMORE OWINGS & MERRILL LLP; New York
NEW HAMPSHIRE APOGENT TECHNOLOGIES INC; Portsmouth BENTLEY PHARMACEUTICALS INC; North Hampton ENTERASYS NETWORKS INC; Rochester FISHER SCIENTIFIC INTERNATIONAL INC; Hampton HADCO CORP; Salem NEW JERSEY ALPHARMA INC; Fort Lee AVAYA INC; Basking Ridge BECTON DICKINSON & CO; Franklin Lakes BIO TECHNOLOGY GENERAL CORP; East Brunswick BRADLEY PHARMACEUTICALS; Fairfield CAMBREX CORP; East Rutherford CELGENE CORP; Warren COVANCE INC; Princeton CR BARD INC; Murray Hill CYTOGEN CORPORATION; Princeton ENZON INC; Bridgewater FOSTER WHEELER LTD; Clinton HONEYWELL INTERNATIONAL INC; Morristown IMMUNOMEDICS INC; Morris Plains JOHNSON & JOHNSON; New Brunswick
Plunkett Research, Ltd.
STANDARD MICROSYSTEMS CORPORATION; Hauppauge SYMBOL TECHNOLOGIES INC; Holtsville NORTH CAROLINA GOODRICH CORPORATION; Charlotte HLM DESIGN INC; Charlotte PARADIGM GENETICS INC; Research Triangle Park QUINTILES TRANSNATIONAL CORP; Durham SAS INSTITUTE; Cary TRIANGLE PHARMACEUTICALS; Durham OHIO DIEBOLD INC; North Canton GOODYEAR TIRE & RUBBER COMPANY (THE); Akron INVACARE CORP; Elyria KENDLE INTERNATIONAL INC; Cincinnati MERIDIAN BIOSCIENCE INC; Cincinnati NCR CORPORATION; Dayton SCOTTS CO; Marysville STERIS CORP; Mentor OREGON EXELIXIS PLANT SCIENCES INC; Portland INFOCUS CORP; Wilsonville MENTOR GRAPHICS CORP; Wilsonville RADISYS CORP; Hillsboro PENNSYLVANIA AIR PRODUCTS & CHEMICALS INC; Allentown AMKOR TECHNOLOGY INC; West Chester ARROW INTERNATIONAL INC; Reading CENTOCOR INC; Malvern CEPHALON INC; West Chester COLLAGENEX PHARMACEUTICAL; Newton COVALENT GROUP INC; Wayne ENDO PHARMACEUTICALS HOLDINGS INC; Chadds Ford ERESEARCH TECHNOLOGY INC; Philadelphia MICHAEL BAKER CORPORATION; Moon Township MYLAN LABORATORIES INC; Canonsburg RESPIRONICS INC; Murrysville STV GROUP INC; Douglassville SUNGARD DATA SYSTEMS INC; Wayne TECHNITROL INC; Trevose TELEFLEX INC; Plymouth Meeting UNISYS CORP; Blue Bell SOUTH CAROLINA KEMET CORP; Simpsonville
www.plunkettresearch.com
TENNESSEE KING PHARMACEUTICALS INC; Bristol TEXAS ALCATEL USA INC; Plano ALCON LABORATORIES INC; Ft. Worth BMC SOFTWARE INC; Houston CARRINGTON LABORATORIES INC; Irving CIRRUS LOGIC INC; Austin CONOCOPHILLIPS; Houston DELL COMPUTER CORPORATION; Round Rock ELECTRONIC DATA SYSTEMS CORP; Plano ENGLOBAL CORP; Houston EXXONMOBIL CORPORATION; Irving HALLIBURTON COMPANY; Houston I2 TECHNOLOGIES INC; Dallas ILEX ONCOLOGY INC; San Antonio KINETIC CONCEPTS INC; San Antonio LEXICON GENETICS INC; The Woodlands LUMINEX CORPORATION; Austin LYONDELL CHEMICAL COMPANY; Houston MARATHON OIL; Houston PERFICIENT INC; Austin PEROT SYSTEMS CORP; Plano SHELL OIL CO; Houston TEXAS INSTRUMENTS INC; Dallas VALLEN CORP; Houston VIRBAC INC; Fort Worth UTAH IOMED INC; Salt Lake City MYRIAD GENETICS INC; Salt Lake City NOVELL INC; Provo VERMONT IDX SYSTEMS CORP; Burlington VIRGINIA ALBEMARLE CORPORATION; Richmond AMERICAN MANAGEMENT SYSTEMS INC; Fairfax CACI INTERNATIONAL INC; Arlington GENERAL DYNAMICS; Falls Church ORBITAL SCIENCES CORP; Dulles WASHINGTON CELL THERAPEUTICS INC; Seattle CORIXA CORPORATION; Seattle ICOS CORPORATION; Bothell MICROSOFT CORP; Redmond NEORX CORPORATION; Seattle TARGETED GENETICS CORP; Seattle
Plunkett Research, Ltd.
WISCONSIN JOHNSON CONTROLS INC; Milwaukee PANVERA LLC; Madison ROCKWELL AUTOMATION; Milwaukee
www.plunkettresearch.com
INDEX OF HEADQUARTERS LOCATION BY COUNTRY To help you locate members of THE ENGINEERING & RESEARCH 500 that have nonU.S. headquarters, the city and country of the headquarters of such companies are included in the following index. BERMUDA ACCENTURE; Hamilton CANADA BALLARD POWER SYSTEMS; Burnaby BOMBARDIER INC; Montreal NORTEL NETWORKS CORP; Brampton SHIRE-BIOCHEM INC; Laval FINLAND INSTRUMENTARIUM; Helsinki NOKIA CORPORATION; Espoo FRANCE AIRBUS SAS; Blagnac Cedex AVENTIS SA; Schiltingheim COMPAGNIE MICHELIN; Clermont-Ferrand PSA PEUGEOT CITROEN SA; Paris TECHNIP-COFLEXIP; Paris La Defense Cedex VINCI; Rueil-Malmaison Cedex GERMANY ADAM OPEL AG; Rüsselsheim AUDI AG; Ingolstadt BASF AG; Ludwigshafen BAYER AG; Leverkusen BAYERISCHE MOTOREN WERKE AG; Munich DAIMLERCHRYSLER AG; Stuttgart LINDE AG; Wiesbaden PHILIPP HOLZMANN GROUP; Frankfurt SAP AKTIENGESELLSCHAFT; Walldorf SIEMENS AG; Munich VOLKSWAGEN AG; Wolfsburg IRELAND ELAN CORP PLC; Dublin ISRAEL TARO PHARMACEUTICAL INDUSTRIES; Haifa Bay ITALY ENI SPA; Rome FIAT SPA; Turin
Plunkett Research, Ltd.
TREVI-FINANZIARIA INDUSTRIALE SPA; Cesena JAPAN CANON INC; Tokyo CHIYODA CORPORATION; Yokohama DENSO CORPORATION; Aichi FUJI HEAVY INDUSTRIES LTD; Tokyo HONDA MOTOR CO LTD; Tokyo ISUZU MOTORS LTD; Tokyo MAZDA MOTOR CORPORATION; Hiroshima MITSUBISHI MOTORS CORP; Tokyo NISSAN MOTOR CO LTD; Tokyo NKK CORPORATION; Tokyo OYO CORPORATION; Tokyo SANYO ELECTRIC COMPANY LTD; Moriguchi City, Osaka SHARP CORPORATION; Osaka SONY CORPORATION; Tokyo SUZUKI MOTOR CORPORATION; Shizuoka TOYOTA MOTOR CORPORATION; Toyota SOUTH KOREA HYUNDAI MOTOR COMPANY; Seoul SAMSUNG ELECTRONICS CO LTD; Seoul SPAIN GRUPO DRAGADOS; Madrid SWEDEN AB VOLVO; Gothenburg TELEFON AB LM ERICSSON; Stockholm SWITZERLAND ABB LTD; Zurich GEORG FISCHER LTD; Schaffhausen NOVARTIS AG; Basel SYNGENTA AG; Basel THE NETHERLANDS ARCADIS NV; Arnhem GETRONICS NV; Amsterdam ROYAL DUTCH PETROLEUM CO; The Hague ROYAL PHILIPS ELECTRONICS; Amsterdam UNITED KINGDOM AMEY PLC; Abingdon ASTRAZENECA PLC; London BAE SYSTEMS; Farnborough BP PLC; London GLAXOSMITHKLINE PLC; Brentford WS ATKINS PLC; Epsom
www.plunkettresearch.com
INDEX BY REGIONS OF THE U.S. WHERE THE ENGINEERING & RESEARCH 500 FIRMS HAVE LOCATIONS WEST 3COM CORP 3M COMPANY AB VOLVO ABAXIS INC ABBOTT LABORATORIES ABGENIX INC ACCENTURE ACTERNA CORPORATION ACUSON CORPORATION ADAC LABORATORIES ADAPTEC INC ADC TELECOMMUNICATIONS INC ADOBE SYSTEMS INC ADTRAN INC ADVANCED FIBRE COMMUNICATIONS INC ADVANCED MICRO DEVICES INC AFFYMETRIX INC AGILENT TECHNOLOGIES INC AIR PRODUCTS & CHEMICALS INC AKORN INC ALARIS MEDICAL INC ALCATEL USA INC ALCON LABORATORIES INC ALLERGAN INC ALLIANCE PHARMACEUTICAL CORP ALPHARMA INC ALTERA CORP ALZA CORP AMDOCS LTD AMERICAN MANAGEMENT SYSTEMS INC AMGEN INC AMKOR TECHNOLOGY INC AMYLIN PHARMACEUTICALS INC ANALOG DEVICES INC AOL TIME WARNER INC APOGENT TECHNOLOGIES INC APPLE COMPUTER INC APPLIED MATERIALS INC ARCADIS NV ARROW INTERNATIONAL INC ASPECT COMMUNICATIONS CORP ASTRAZENECA PLC ASTROPOWER INC ATMEL CORP ATRIX LABORATORIES INC
Plunkett Research, Ltd.
AUDI AG AUTODESK INC AVAYA INC AVENTIS SA BAE SYSTEMS BASF AG BAUSCH & LOMB INC BAXTER INTERNATIONAL INC BAYER AG BAYERISCHE MOTOREN WERKE AG BEA SYSTEMS INC BECHTEL GROUP INC BECKMAN COULTER INC BECTON DICKINSON & CO BIO RAD LABORATORIES INC BIO TECHNOLOGY GENERAL CORP BIOMARIN PHARMACEUTICAL BIOMET INC BIOSITE INC BIOSOURCE INTERNATIONAL INC BMC SOFTWARE INC BOEING CO BOMBARDIER INC BOSTON BIOMEDICA INC BOSTON SCIENTIFIC CORP BP PLC BRISTOL MYERS SQUIBB CO BROADCOM CORP CACI INTERNATIONAL INC CADENCE DESIGN SYSTEMS INC CANON INC CELL GENESYS INC CELL THERAPEUTICS INC CEPHALON INC CERNER CORP CH2M HILL COMPANIES LTD CHEVRONTEXACO CORPORATION CHIRON CORP CHRONIMED INC CIENA CORP CIRRUS LOGIC INC CISCO SYSTEMS INC CITRIX SYSTEMS INC COGNEX CORP COLLATERAL THERAPEUTICS COMPAGNIE MICHELIN COMPUTER ASSOCIATES INTERNATIONAL INC COMPUTER SCIENCES CORP COMPUWARE CORP COMVERSE TECHNOLOGY INC CONMED CORP CONNETICS CORPORATION
www.plunkettresearch.com
CONOCOPHILLIPS CORIXA CORPORATION CORNING INC COVANCE INC CR BARD INC CUBIC CORP CYPRESS SEMICONDUCTOR CORP DADE BEHRING INC DAIMLERCHRYSLER AG DELL COMPUTER CORPORATION DENSO CORPORATION DEPUY INC DIEBOLD INC DIVERSA CORPORATION DOW CHEMICAL COMPANY (THE) E I DU PONT DE NEMOURS & CO (DUPONT) EASTMAN KODAK CO EDWARDS LIFESCIENCES CORP EG&G INC ELAN CORP PLC ELECTRONIC ARTS INC ELECTRONIC DATA SYSTEMS CORP ELECTRONICS FOR IMAGING INC ELI LILLY & CO EMC CORP ENERGY CONVERSION DEVICES INC ENTERASYS NETWORKS INC EXELIXIS INC EXELIXIS PLANT SCIENCES INC EXXONMOBIL CORPORATION FILENET CORP FISHER SCIENTIFIC INTERNATIONAL INC FLUOR CORP FORD MOTOR CO FOSTER WHEELER LTD FUELCELL ENERGY INC FUJI HEAVY INDUSTRIES LTD GENE LOGIC INC GENENTECH INC GENERAL DYNAMICS GENERAL ELECTRIC CO GENERAL MOTORS CORP GENZYME CORP GEORG FISCHER LTD GILEAD SCIENCES INC GLAXOSMITHKLINE PLC GLENAYRE TECHNOLOGIES INC GOODRICH CORPORATION GOODYEAR TIRE & RUBBER COMPANY (THE) GOOGLE INC GUIDANT CORP HADCO CORP HALLIBURTON COMPANY
Plunkett Research, Ltd.
HAUSER INC HESKA CORP HEWLETT-PACKARD CO HLM DESIGN INC HONDA MOTOR CO LTD HONEYWELL INTERNATIONAL INC HUGHES ELECTRONICS CORP HYCOR BIOMEDICAL INC HYUNDAI MOTOR COMPANY I2 TECHNOLOGIES INC ICN PHARMACEUTICALS INC ICOS CORPORATION IDEC PHARMACEUTICALS CORP IDEXX LABORATORIES INC IDX SYSTEMS CORP IMMUNEX CORP IMPAX LABORATORIES INC INCYTE GENOMICS INC INFOCUS CORP INTEL CORP INTERGRAPH CORP INTERNATIONAL BUSINESS MACHINES (IBM) INTERNATIONAL RECTIFIER CORP INTUIT INC INVACARE CORP INVITROGEN CORPORATION IOMED INC IOMEGA CORP ISIS PHARMACEUTICALS INC ISUZU MOTORS LTD ITT INDUSTRIES INC IVAX CORPORATION JABIL CIRCUIT INC JDS UNIPHASE CORP JOHNSON & JOHNSON JOHNSON CONTROLS INC JUNIPER NETWORKS INC KEITH COMPANIES INC (THE) KENDLE INTERNATIONAL INC KLA TENCOR CORP KOMAG INC L3 COMMUNICATIONS HOLDINGS INC LAM RESEARCH CORP LEXMARK INT'L GROUP INC LIGAND PHARMACEUTICALS INC LOCKHEED MARTIN CORP LORAL SPACE & COMMUNICATIONS LTD LSI LOGIC CORP LUCENT TECHNOLOGIES INC LYNX THERAPEUTICS INC MALLINCKRODT INC MARATHON OIL MARTEK BIOSCIENCES CORP
www.plunkettresearch.com
MATRIX PHARMACEUTICAL MAXIM INTEGRATED PRODUCTS INC MAXTOR CORP MAXYGEN INC MEDAREX INC MEDIMMUNE INC MEDTRONIC AVE INC MEDTRONIC INC MEMC ELECTRONIC MATERIALS INC MENTOR GRAPHICS CORP MERCK & CO INC MICHAEL BAKER CORPORATION MICROCHIP TECHNOLOGY INC MICRON TECHNOLOGY INC MICROSOFT CORP MILLENNIUM PHARMACEUTICALS INC MILTOPE GROUP INC MITSUBISHI MOTORS CORP MONSANTO CO MOTOROLA INC MSC.SOFTWARE CORP MYRIAD GENETICS INC NABI BIOPHARMACEUTICALS NAPRO BIOTHERAPEUTICS INC NATIONAL SEMICONDUCTOR CORP NBTY INC NEORX CORPORATION NETWORK APPLIANCE INC NETWORK ASSOCIATES INC NETWORK EQUIPMENT TECHNOLOGIES INC NEUROCRINE BIOSCIENCES INC NISSAN MOTOR CO LTD NOKIA CORPORATION NORTEL NETWORKS CORP NORTH AMERICAN SCIENTIFIC NOVELL INC NOVELLUS SYSTEMS INC ONSITE ENERGY CORPORATION ORACLE CORP ORBITAL SCIENCES CORP OSI PHARMACEUTICALS INC OYO CORPORATION PALM INC PARAMETRIC TECHNOLOGY CORP PAREXEL INTERNATIONAL PARSONS BRINCKERHOFF INC PEOPLESOFT INC PERKINELMER INC PEROT SYSTEMS CORP PFIZER INC PHARMACOPEIA INC PITNEY BOWES INC PMC-SIERRA INC
Plunkett Research, Ltd.
POLAROID CORP PRAXAIR INC PROTEIN DESIGN LABS INC PROXIM CORPORATION QUALCOMM INC QUANTUM CORP QUIDEL CORP QUINTILES TRANSNATIONAL CORP RADISYS CORP RATIONAL SOFTWARE CORP RAYTHEON CO READ-RITE CORP RESPIRONICS INC ROCKWELL AUTOMATION ROYAL DUTCH PETROLEUM CO ROYAL PHILIPS ELECTRONICS SAMSUNG ELECTRONICS CO LTD SANGSTAT MEDICAL CORP SANYO ELECTRIC COMPANY LTD SAP AKTIENGESELLSCHAFT SAS INSTITUTE SCHERING-PLOUGH CORP SCICLONE PHARMACEUTICALS SCIENTIFIC ATLANTA INC SCIOS INC SCOTTS CO SEAGATE TECHNOLOGY INC SEQUENOM INC SEROLOGICALS CORP SHELL OIL CO SICOR INC SIEBEL SYSTEMS INC SIEMENS AG SIGMA ALDRICH CORP SILICON GRAPHICS INC SKIDMORE OWINGS & MERRILL LLP SOLA INTERNATIONAL INC SONY CORPORATION ST JUDE MEDICAL INC STANDARD MICROSYSTEMS CORPORATION STERIS CORP STORAGE TECHNOLOGY CORP STRYKER CORP STV GROUP INC SUN MICROSYSTEMS INC SUNGARD DATA SYSTEMS INC SUNRISE MEDICAL INC SUPERGEN INC SUZUKI MOTOR CORPORATION SYBASE INC SYMANTEC CORP SYMBOL TECHNOLOGIES INC SYNBIOTICS CORP
www.plunkettresearch.com
SYNCOR INTERNATIONAL CORPORATION SYNGENTA AG SYNOPSYS INC TARGETED GENETICS CORP TECHNIP-COFLEXIP TECHNITROL INC TELEFLEX INC TELEFON AB LM ERICSSON TELLABS INC TERADYNE INC TERAYON COMMUNICATION SYSTEMS INC TEXAS INSTRUMENTS INC THERMO ELECTRON CORP TITAN CORP (THE) TOYOTA MOTOR CORPORATION TRC COMPANIES INC TRIPOS INC TULARIK INC UNISYS CORP URS CORPORATION US LABORATORIES UTSTARCOM INC VALLEN CORP VARIAN MEDICAL SYSTEMS INC VERISIGN INC VERTEX PHARMACEUTICALS INC VIROLOGIC INC WATSON PHARMACEUTICALS INC WESTERN DIGITAL CORP WS ATKINS PLC WYETH XEROX CORP XILINX INC XOMA LTD YAHOO! INC ZIMMER HOLDINGS INC
SOUTHWEST 3COM CORP 3M COMPANY ABBOTT LABORATORIES ACCENTURE ACUSON CORPORATION ADAC LABORATORIES ADC TELECOMMUNICATIONS INC ADTRAN INC ADVANCED FIBRE COMMUNICATIONS INC ADVANCED MICRO DEVICES INC AFFYMETRIX INC AGILENT TECHNOLOGIES INC AIR PRODUCTS & CHEMICALS INC AIRBUS SAS ALARIS MEDICAL INC
Plunkett Research, Ltd.
ALBEMARLE CORPORATION ALCATEL USA INC ALCON LABORATORIES INC ALLERGAN INC ALPHARMA INC ALTERA CORP AMDOCS LTD AMERICAN MANAGEMENT SYSTEMS INC AMYLIN PHARMACEUTICALS INC ANALOG DEVICES INC AOL TIME WARNER INC APOGENT TECHNOLOGIES INC APPLE COMPUTER INC APPLIED MATERIALS INC ARCADIS NV ASPECT COMMUNICATIONS CORP ASTRAZENECA PLC ATMEL CORP AUDI AG AVAYA INC AVENTIS SA BAUSCH & LOMB INC BAXTER INTERNATIONAL INC BAYERISCHE MOTOREN WERKE AG BEA SYSTEMS INC BECHTEL GROUP INC BECKMAN COULTER INC BECTON DICKINSON & CO BIO RAD LABORATORIES INC BIO TECHNOLOGY GENERAL CORP BIOMET INC BMC SOFTWARE INC BOEING CO BOMBARDIER INC BOSTON SCIENTIFIC CORP BP PLC BRISTOL MYERS SQUIBB CO BROADCOM CORP CABOT CORPORATION CACI INTERNATIONAL INC CADENCE DESIGN SYSTEMS INC CANON INC CARRINGTON LABORATORIES INC CERNER CORP CH2M HILL COMPANIES LTD CHEVRONTEXACO CORPORATION CHIRON CORP CHRONIMED INC CIENA CORP CIRRUS LOGIC INC CISCO SYSTEMS INC CITRIX SYSTEMS INC
www.plunkettresearch.com
COMPUTER ASSOCIATES INTERNATIONAL INC COMPUTER SCIENCES CORP COMPUWARE CORP COMVERSE TECHNOLOGY INC CONMED CORP CONNETICS CORPORATION CONOCOPHILLIPS CORNING INC CR BARD INC CYPRESS SEMICONDUCTOR CORP DADE BEHRING INC DAIMLERCHRYSLER AG DELL COMPUTER CORPORATION DENSO CORPORATION DEPUY INC DIEBOLD INC DOW CHEMICAL COMPANY (THE) E I DU PONT DE NEMOURS & CO (DUPONT) EASTMAN KODAK CO EG&G INC ELAN CORP PLC ELECTRONIC ARTS INC ELECTRONIC DATA SYSTEMS CORP ELI LILLY & CO EMC CORP ENGLOBAL CORP ENI SPA ENTERASYS NETWORKS INC EXXONMOBIL CORPORATION FILENET CORP FISHER SCIENTIFIC INTERNATIONAL INC FLUOR CORP FORD MOTOR CO FOSTER WHEELER LTD FUELCELL ENERGY INC GENENTECH INC GENERAL DYNAMICS GENERAL ELECTRIC CO GENERAL MOTORS CORP GENZYME CORP GERBER SCIENTIFIC INC GLAXOSMITHKLINE PLC GLENAYRE TECHNOLOGIES INC GLOBAL INDUSTRIES LTD GOODRICH CORPORATION GOODYEAR TIRE & RUBBER COMPANY (THE) GOOGLE INC GUIDANT CORP HADCO CORP HALLIBURTON COMPANY HEWLETT-PACKARD CO HLM DESIGN INC
Plunkett Research, Ltd.
HONDA MOTOR CO LTD HONEYWELL INTERNATIONAL INC HUGHES ELECTRONICS CORP I2 TECHNOLOGIES INC IDEXX LABORATORIES INC IDX SYSTEMS CORP ILEX ONCOLOGY INC IMC GLOBAL INC IMMUNEX CORP INTEL CORP INTERGRAPH CORP INTERNATIONAL BUSINESS MACHINES (IBM) INTUIT INC INVACARE CORP IOMEGA CORP ISUZU MOTORS LTD ITT INDUSTRIES INC IVAX CORPORATION JABIL CIRCUIT INC JDS UNIPHASE CORP JOHNSON & JOHNSON JOHNSON CONTROLS INC KEITH COMPANIES INC (THE) KINETIC CONCEPTS INC LAM RESEARCH CORP LEXICON GENETICS INC LEXMARK INT'L GROUP INC LINDE AG LOCKHEED MARTIN CORP LORAL SPACE & COMMUNICATIONS LTD LSI LOGIC CORP LUCENT TECHNOLOGIES INC LUMINEX CORPORATION LYONDELL CHEMICAL COMPANY MALLINCKRODT INC MARATHON OIL MAXIM INTEGRATED PRODUCTS INC MEDICIS PHARMACEUTICAL CORP MEDTRONIC INC MEMC ELECTRONIC MATERIALS INC MENTOR GRAPHICS CORP MERCK & CO INC MICHAEL BAKER CORPORATION MICROCHIP TECHNOLOGY INC MICRON TECHNOLOGY INC MICROSOFT CORP MITSUBISHI MOTORS CORP MONSANTO CO MOTOROLA INC MSC.SOFTWARE CORP NABI BIOPHARMACEUTICALS NATIONAL SEMICONDUCTOR CORP NBTY INC
www.plunkettresearch.com
NEORX CORPORATION NETWORK ASSOCIATES INC NETWORK EQUIPMENT TECHNOLOGIES INC NISSAN MOTOR CO LTD NOKIA CORPORATION NORTEL NETWORKS CORP NOVELL INC NOVELLUS SYSTEMS INC ORACLE CORP ORBITAL SCIENCES CORP ORCHID BIOSCIENCES INC OYO CORPORATION PARAMETRIC TECHNOLOGY CORP PARSONS BRINCKERHOFF INC PEOPLESOFT INC PERFICIENT INC PERKINELMER INC PEROT SYSTEMS CORP PFIZER INC PITNEY BOWES INC PMC-SIERRA INC POLAROID CORP PRAXAIR INC QUALCOMM INC QUANTUM CORP QUINTILES TRANSNATIONAL CORP RADISYS CORP RATIONAL SOFTWARE CORP RAYTHEON CO RESPIRONICS INC ROCKWELL AUTOMATION ROYAL DUTCH PETROLEUM CO ROYAL PHILIPS ELECTRONICS SAMSUNG ELECTRONICS CO LTD SAP AKTIENGESELLSCHAFT SAS INSTITUTE SCHERING-PLOUGH CORP SCOTTS CO SEAGATE TECHNOLOGY INC SHELL OIL CO SIEBEL SYSTEMS INC SIEMENS AG SIGMA ALDRICH CORP SILICON GRAPHICS INC SONY CORPORATION ST JUDE MEDICAL INC STANDARD MICROSYSTEMS CORPORATION STERIS CORP STORAGE TECHNOLOGY CORP STV GROUP INC SUN MICROSYSTEMS INC SUNGARD DATA SYSTEMS INC SYBASE INC
Plunkett Research, Ltd.
SYMBOL TECHNOLOGIES INC SYNCOR INTERNATIONAL CORPORATION SYNOPSYS INC TECHNIP-COFLEXIP TELEFLEX INC TELEFON AB LM ERICSSON TELLABS INC TERADYNE INC TERRA INDUSTRIES INC TEXAS INSTRUMENTS INC THERMO ELECTRON CORP TITAN CORP (THE) TOYOTA MOTOR CORPORATION TRC COMPANIES INC UNISYS CORP URS CORPORATION US LABORATORIES VALLEN CORP VIRBAC INC VISTEON CORPORATION WESTERN DIGITAL CORP WS ATKINS PLC WYETH XEROX CORP XILINX INC YAHOO! INC ZILA INC ZIMMER HOLDINGS INC
MIDWEST 3COM CORP 3M COMPANY ABBOTT LABORATORIES ACCENTURE ACTERNA CORPORATION ACUSON CORPORATION ADAC LABORATORIES ADAPTEC INC ADC TELECOMMUNICATIONS INC ADTRAN INC ADVANCED FIBRE COMMUNICATIONS INC ADVANCED MICRO DEVICES INC AFFYMETRIX INC AGILENT TECHNOLOGIES INC AIR PRODUCTS & CHEMICALS INC AIRBUS SAS AKORN INC ALARIS MEDICAL INC ALBANY MOLECULAR RESEARCH ALBEMARLE CORPORATION ALCATEL USA INC ALKERMES INC ALLERGAN INC
www.plunkettresearch.com
ALPHARMA INC ALTERA CORP AMDOCS LTD AMERICAN MANAGEMENT SYSTEMS INC AMERICAN SUPERCONDUCTOR AMGEN INC AMKOR TECHNOLOGY INC AMYLIN PHARMACEUTICALS INC ANALOG DEVICES INC ANALOGIC CORP AOL TIME WARNER INC APOGENT TECHNOLOGIES INC APPLE COMPUTER INC ARCADIS NV ASPECT COMMUNICATIONS CORP ASTRAZENECA PLC ATMEL CORP AUDI AG AVAYA INC AVENTIS SA BAE SYSTEMS BARR LABORATORIES INC BASF AG BAUSCH & LOMB INC BAXTER INTERNATIONAL INC BAYER AG BAYERISCHE MOTOREN WERKE AG BEA SYSTEMS INC BECHTEL GROUP INC BECKMAN COULTER INC BECTON DICKINSON & CO BIO RAD LABORATORIES INC BIOMET INC BMC SOFTWARE INC BOEING CO BOMBARDIER INC BOSTON SCIENTIFIC CORP BP PLC BRISTOL MYERS SQUIBB CO BROADCOM CORP CABOT CORPORATION CACI INTERNATIONAL INC CADENCE DESIGN SYSTEMS INC CAMBREX CORP CANON INC CERNER CORP CH2M HILL COMPANIES LTD CHEVRONTEXACO CORPORATION CHIRON CORP CHRONIMED INC CIENA CORP CIMA LABS INC CIRRUS LOGIC INC
Plunkett Research, Ltd.
CISCO SYSTEMS INC CITRIX SYSTEMS INC COGNEX CORP COMPAGNIE MICHELIN COMPUTER ASSOCIATES INTERNATIONAL INC COMPUTER SCIENCES CORP COMPUWARE CORP COMVERSE TECHNOLOGY INC CONOCOPHILLIPS CORNING INC COVANCE INC CR BARD INC CUBIC CORP CYPRESS SEMICONDUCTOR CORP DADE BEHRING INC DAIMLERCHRYSLER AG DELL COMPUTER CORPORATION DENSO CORPORATION DEPUY INC DIEBOLD INC DOW CHEMICAL COMPANY (THE) E I DU PONT DE NEMOURS & CO (DUPONT) EASTMAN KODAK CO EG&G INC ELAN CORP PLC ELECTRONIC ARTS INC ELECTRONIC DATA SYSTEMS CORP ELECTRONICS FOR IMAGING INC ELI LILLY & CO EMC CORP ENERGY CONVERSION DEVICES INC ENTERASYS NETWORKS INC EXXONMOBIL CORPORATION FILENET CORP FISHER SCIENTIFIC INTERNATIONAL INC FLUOR CORP FORD MOTOR CO FOREST LABORATORIES INC FOSTER WHEELER LTD FUELCELL ENERGY INC FUJI HEAVY INDUSTRIES LTD GENENTECH INC GENERAL DYNAMICS GENERAL ELECTRIC CO GENERAL MOTORS CORP GENZYME CORP GEORG FISCHER LTD GLAXOSMITHKLINE PLC GLENAYRE TECHNOLOGIES INC GOODRICH CORPORATION GOODYEAR TIRE & RUBBER COMPANY (THE) GOOGLE INC
www.plunkettresearch.com
GUIDANT CORP HADCO CORP HALLIBURTON COMPANY HESKA CORP HEWLETT-PACKARD CO HLM DESIGN INC HONDA MOTOR CO LTD HONEYWELL INTERNATIONAL INC HUGHES ELECTRONICS CORP HUTCHINSON TECHNOLOGY INC HYUNDAI MOTOR COMPANY I2 TECHNOLOGIES INC ICN PHARMACEUTICALS INC IDEXX LABORATORIES INC IDX SYSTEMS CORP IMC GLOBAL INC IMMUNEX CORP INCYTE GENOMICS INC INSTRUMENTARIUM INTEL CORP INTERGRAPH CORP INTERNATIONAL BUSINESS MACHINES (IBM) INTUIT INC INVACARE CORP ISUZU MOTORS LTD ITT INDUSTRIES INC IVAX CORPORATION JABIL CIRCUIT INC JDS UNIPHASE CORP JOHNSON & JOHNSON JOHNSON CONTROLS INC JUNIPER NETWORKS INC K V PHARMACEUTICAL CO KEITH COMPANIES INC (THE) KENDLE INTERNATIONAL INC KING PHARMACEUTICALS INC L3 COMMUNICATIONS HOLDINGS INC LAM RESEARCH CORP LEXMARK INT'L GROUP INC LIFECORE BIOMEDICAL INC LINDE AG LOCKHEED MARTIN CORP LORAL SPACE & COMMUNICATIONS LTD LSI LOGIC CORP LUCENT TECHNOLOGIES INC LYONDELL CHEMICAL COMPANY MALLINCKRODT INC MARATHON OIL MAXIM INTEGRATED PRODUCTS INC MAZDA MOTOR CORPORATION MEDPOINTE INC MEDTOX SCIENTIFIC INC MEDTRONIC INC
Plunkett Research, Ltd.
MEMC ELECTRONIC MATERIALS INC MENTOR GRAPHICS CORP MERCK & CO INC MERIDIAN BIOSCIENCE INC MGI PHARMA INC MICHAEL BAKER CORPORATION MICROCHIP TECHNOLOGY INC MICRON TECHNOLOGY INC MICROSOFT CORP MITSUBISHI MOTORS CORP MONSANTO CO MOTOROLA INC MSC.SOFTWARE CORP MYLAN LABORATORIES INC NABI BIOPHARMACEUTICALS NATIONAL SEMICONDUCTOR CORP NBTY INC NCR CORPORATION NEOGEN CORPORATION NETWORK ASSOCIATES INC NISSAN MOTOR CO LTD NOKIA CORPORATION NORTEL NETWORKS CORP NOVARTIS AG NOVELL INC NOVELLUS SYSTEMS INC ORACLE CORP ORPHAN MEDICAL INC PALM INC PANVERA LLC PARAMETRIC TECHNOLOGY CORP PAREXEL INTERNATIONAL PARSONS BRINCKERHOFF INC PEOPLESOFT INC PERFICIENT INC PERKINELMER INC PEROT SYSTEMS CORP PFIZER INC PITNEY BOWES INC PMC-SIERRA INC POLAROID CORP PRAXAIR INC PROTEIN DESIGN LABS INC QUALCOMM INC QUANTUM CORP QUINTILES TRANSNATIONAL CORP RADISYS CORP RATIONAL SOFTWARE CORP RAYTHEON CO RESPIRONICS INC ROCKWELL AUTOMATION ROYAL DUTCH PETROLEUM CO ROYAL PHILIPS ELECTRONICS
www.plunkettresearch.com
SAP AKTIENGESELLSCHAFT SAS INSTITUTE SCHERING-PLOUGH CORP SCOTTS CO SEAGATE TECHNOLOGY INC SEROLOGICALS CORP SHARP CORPORATION SHELL OIL CO SIEBEL SYSTEMS INC SIEMENS AG SIGMA ALDRICH CORP SILICON GRAPHICS INC SKIDMORE OWINGS & MERRILL LLP SONY CORPORATION ST JUDE MEDICAL INC STANDARD MICROSYSTEMS CORPORATION STERIS CORP STORAGE TECHNOLOGY CORP STRYKER CORP STV GROUP INC SUN MICROSYSTEMS INC SUNGARD DATA SYSTEMS INC SUNRISE MEDICAL INC SYBASE INC SYMANTEC CORP SYMBOL TECHNOLOGIES INC SYNCOR INTERNATIONAL CORPORATION SYNGENTA AG SYNOPSYS INC SYNOVIS LIFE TECHNOLOGIES INC TECHNE CORP TELEFLEX INC TELLABS INC TERADYNE INC TERRA INDUSTRIES INC TEXAS INSTRUMENTS INC THERMO ELECTRON CORP TITAN CORP (THE) TOYOTA MOTOR CORPORATION TRC COMPANIES INC TRIPOS INC UNISYS CORP UNITED THERAPEUTICS CORP URS CORPORATION US LABORATORIES VALLEN CORP VERISIGN INC VISTEON CORPORATION VYSIS INC WATSON PHARMACEUTICALS INC WESTERN DIGITAL CORP WS ATKINS PLC WYETH
Plunkett Research, Ltd.
XEROX CORP XILINX INC YAHOO! INC ZILA INC ZIMMER HOLDINGS INC
SOUTHEAST 3COM CORP 3M COMPANY AB VOLVO ABBOTT LABORATORIES ACCENTURE ACTERNA CORPORATION ACUSON CORPORATION ADAC LABORATORIES ADAPTEC INC ADC TELECOMMUNICATIONS INC ADTRAN INC ADVANCED FIBRE COMMUNICATIONS INC ADVANCED MICRO DEVICES INC AFFYMETRIX INC AGILENT TECHNOLOGIES INC AIR PRODUCTS & CHEMICALS INC ALARIS MEDICAL INC ALBEMARLE CORPORATION ALCATEL USA INC ALCON LABORATORIES INC ALLERGAN INC ALPHARMA INC ALTERA CORP AMDOCS LTD AMERICAN MANAGEMENT SYSTEMS INC AMKOR TECHNOLOGY INC AMYLIN PHARMACEUTICALS INC ANALOG DEVICES INC ANDRX CORP AOL TIME WARNER INC APOGENT TECHNOLOGIES INC APPLE COMPUTER INC APPLIED MATERIALS INC ARCADIS NV ASPECT COMMUNICATIONS CORP ASTRAZENECA PLC ASTROPOWER INC AUDI AG AUTODESK INC AVAYA INC AVENTIS SA BAE SYSTEMS BASF AG BAUSCH & LOMB INC BAXTER INTERNATIONAL INC BAYER AG
www.plunkettresearch.com
BAYERISCHE MOTOREN WERKE AG BEA SYSTEMS INC BECHTEL GROUP INC BECKMAN COULTER INC BECTON DICKINSON & CO BIO RAD LABORATORIES INC BIO TECHNOLOGY GENERAL CORP BIOMET INC BMC SOFTWARE INC BOEING CO BOMBARDIER INC BOSTON SCIENTIFIC CORP BP PLC BRISTOL MYERS SQUIBB CO BROADCOM CORP CABOT CORPORATION CACI INTERNATIONAL INC CADENCE DESIGN SYSTEMS INC CERNER CORP CH2M HILL COMPANIES LTD CHEVRONTEXACO CORPORATION CHIRON CORP CHRONIMED INC CIENA CORP CIRRUS LOGIC INC CISCO SYSTEMS INC CITRIX SYSTEMS INC COGNEX CORP COMPAGNIE MICHELIN COMPUTER ASSOCIATES INTERNATIONAL INC COMPUTER SCIENCES CORP COMPUWARE CORP COMVERSE TECHNOLOGY INC CONMED CORP CONOCOPHILLIPS CORNING INC CR BARD INC CUBIC CORP CYPRESS SEMICONDUCTOR CORP DADE BEHRING INC DAIMLERCHRYSLER AG DELL COMPUTER CORPORATION DENSO CORPORATION DEPUY INC DIEBOLD INC DOW CHEMICAL COMPANY (THE) E I DU PONT DE NEMOURS & CO (DUPONT) EASTMAN KODAK CO EDWARDS LIFESCIENCES CORP EG&G INC ELAN CORP PLC ELECTRONIC ARTS INC
Plunkett Research, Ltd.
ELECTRONIC DATA SYSTEMS CORP ELI LILLY & CO EMC CORP ENTERASYS NETWORKS INC EXXONMOBIL CORPORATION FILENET CORP FIRST HORIZON PHARMACEUTICALS FISHER SCIENTIFIC INTERNATIONAL INC FLUOR CORP FORD MOTOR CO FOSTER WHEELER LTD FUELCELL ENERGY INC GENENTECH INC GENERAL DYNAMICS GENERAL ELECTRIC CO GENERAL MOTORS CORP GENZYME CORP GEORG FISCHER LTD GLAXOSMITHKLINE PLC GLENAYRE TECHNOLOGIES INC GLOBAL INDUSTRIES LTD GOODRICH CORPORATION GOODYEAR TIRE & RUBBER COMPANY (THE) GOOGLE INC HADCO CORP HAEMONETICS CORPORATION HALLIBURTON COMPANY HEWLETT-PACKARD CO HLM DESIGN INC HONDA MOTOR CO LTD HONEYWELL INTERNATIONAL INC HUGHES ELECTRONICS CORP HYUNDAI MOTOR COMPANY I2 TECHNOLOGIES INC IDEXX LABORATORIES INC IDX SYSTEMS CORP IMC GLOBAL INC IMMUNEX CORP INTEL CORP INTERGRAPH CORP INTERNATIONAL BUSINESS MACHINES (IBM) INTUIT INC INVACARE CORP ISUZU MOTORS LTD ITT INDUSTRIES INC IVAX CORPORATION JABIL CIRCUIT INC JDS UNIPHASE CORP JOHNSON & JOHNSON JOHNSON CONTROLS INC KEMET CORP KING PHARMACEUTICALS INC KOS PHARMACEUTICALS INC
www.plunkettresearch.com
L3 COMMUNICATIONS HOLDINGS INC LAM RESEARCH CORP LEXMARK INT'L GROUP INC LINDE AG LOCKHEED MARTIN CORP LORAL SPACE & COMMUNICATIONS LTD LSI LOGIC CORP LUCENT TECHNOLOGIES INC LYONDELL CHEMICAL COMPANY MALLINCKRODT INC MARATHON OIL MARTEK BIOSCIENCES CORP MAXIM INTEGRATED PRODUCTS INC MAZDA MOTOR CORPORATION MEDTRONIC INC MENTOR GRAPHICS CORP MERCK & CO INC MERIDIAN BIOSCIENCE INC MICHAEL BAKER CORPORATION MICROCHIP TECHNOLOGY INC MICRON TECHNOLOGY INC MICROSOFT CORP MILTOPE GROUP INC MITSUBISHI MOTORS CORP MONSANTO CO MOTOROLA INC MSC.SOFTWARE CORP MYLAN LABORATORIES INC NABI BIOPHARMACEUTICALS NATIONAL SEMICONDUCTOR CORP NBTY INC NEOGEN CORPORATION NETWORK ASSOCIATES INC NISSAN MOTOR CO LTD NOKIA CORPORATION NORTEL NETWORKS CORP NOVARTIS AG NOVELL INC NOVELLUS SYSTEMS INC NOVEN PHARMACEUTICALS ORACLE CORP ORBITAL SCIENCES CORP PARADIGM GENETICS INC PARAMETRIC TECHNOLOGY CORP PAREXEL INTERNATIONAL PARSONS BRINCKERHOFF INC PEOPLESOFT INC PERKINELMER INC PEROT SYSTEMS CORP PFIZER INC PITNEY BOWES INC PMC-SIERRA INC POLAROID CORP
Plunkett Research, Ltd.
PRAXAIR INC PROXIM CORPORATION QUALCOMM INC QUANTUM CORP QUINTILES TRANSNATIONAL CORP RADISYS CORP RATIONAL SOFTWARE CORP RAYTHEON CO RESPIRONICS INC ROCKWELL AUTOMATION ROYAL DUTCH PETROLEUM CO ROYAL PHILIPS ELECTRONICS SAP AKTIENGESELLSCHAFT SAS INSTITUTE SCHERING-PLOUGH CORP SCIENTIFIC ATLANTA INC SCOTTS CO SEROLOGICALS CORP SHELL OIL CO SIEBEL SYSTEMS INC SIEMENS AG SIGMA ALDRICH CORP SILICON GRAPHICS INC SOLA INTERNATIONAL INC SONY CORPORATION ST JUDE MEDICAL INC STERIS CORP STORAGE TECHNOLOGY CORP STRYKER CORP STV GROUP INC SUN MICROSYSTEMS INC SUNGARD DATA SYSTEMS INC SUNRISE MEDICAL INC SYBASE INC SYMANTEC CORP SYMBOL TECHNOLOGIES INC SYNCOR INTERNATIONAL CORPORATION SYNGENTA AG SYNOPSYS INC TECHNIP-COFLEXIP TELEFLEX INC TELLABS INC TERRA INDUSTRIES INC TEXAS INSTRUMENTS INC THERAGENICS CORP THERMO ELECTRON CORP TITAN CORP (THE) TOYOTA MOTOR CORPORATION TRC COMPANIES INC UNISYS CORP URS CORPORATION US LABORATORIES VALLEN CORP
www.plunkettresearch.com
VERISIGN INC VISTEON CORPORATION WATSON PHARMACEUTICALS INC WESTERN DIGITAL CORP WS ATKINS PLC WYETH XEROX CORP XILINX INC YAHOO! INC ZIMMER HOLDINGS INC
NORTHEAST 3COM CORP 3M COMPANY AB VOLVO ABB LTD ABBOTT LABORATORIES ABLE LABORATORIES ACCENTURE ACTERNA CORPORATION ACUSON CORPORATION ADAC LABORATORIES ADAPTEC INC ADC TELECOMMUNICATIONS INC ADTRAN INC ADVANCED FIBRE COMMUNICATIONS INC ADVANCED MICRO DEVICES INC AFFYMETRIX INC AGILENT TECHNOLOGIES INC AIR PRODUCTS & CHEMICALS INC AIRBUS SAS AKORN INC ALARIS MEDICAL INC ALBANY MOLECULAR RESEARCH ALBEMARLE CORPORATION ALCATEL USA INC ALCON LABORATORIES INC ALKERMES INC ALLERGAN INC ALPHARMA INC ALTERA CORP AMDOCS LTD AMERICAN MANAGEMENT SYSTEMS INC AMERICAN SUPERCONDUCTOR AMGEN INC AMKOR TECHNOLOGY INC AMYLIN PHARMACEUTICALS INC ANALOG DEVICES INC ANALOGIC CORP ANIKA THERAPEUTICS INC AOL TIME WARNER INC APOGENT TECHNOLOGIES INC APPLE COMPUTER INC
Plunkett Research, Ltd.
APPLIED MATERIALS INC ARCADIS NV ARROW INTERNATIONAL INC ASCENT PEDIATRICS INC ASCENTIAL SOFTWARE CORPORATION ASPECT COMMUNICATIONS CORP ASTRAZENECA PLC ASTROPOWER INC ATMEL CORP AUDI AG AVAYA INC AVENTIS SA BAE SYSTEMS BARR LABORATORIES INC BASF AG BAUSCH & LOMB INC BAXTER INTERNATIONAL INC BAYER AG BAYERISCHE MOTOREN WERKE AG BEA SYSTEMS INC BECHTEL GROUP INC BECKMAN COULTER INC BECTON DICKINSON & CO BENTLEY PHARMACEUTICALS INC BIO RAD LABORATORIES INC BIO TECHNOLOGY GENERAL CORP BIOGEN INC BIOMET INC BIORELIANCE CORP BIOSOURCE INTERNATIONAL INC BMC SOFTWARE INC BOEING CO BOMBARDIER INC BOSTON BIOMEDICA INC BOSTON SCIENTIFIC CORP BP PLC BRADLEY PHARMACEUTICALS BRISTOL MYERS SQUIBB CO BROADCOM CORP CABOT CORPORATION CACI INTERNATIONAL INC CADENCE DESIGN SYSTEMS INC CAMBREX CORP CANON INC CELERA GENOMICS GROUP CELGENE CORP CENTOCOR INC CEPHALON INC CERNER CORP CH2M HILL COMPANIES LTD CHESAPEAKE BIOLOGICAL LAB CHEVRONTEXACO CORPORATION CHIRON CORP
www.plunkettresearch.com
CHRONIMED INC CIENA CORP CIRRUS LOGIC INC CISCO SYSTEMS INC CITRIX SYSTEMS INC COGNEX CORP COLLAGENEX PHARMACEUTICAL COMPAGNIE MICHELIN COMPUTER ASSOCIATES INTERNATIONAL INC COMPUTER SCIENCES CORP COMPUWARE CORP COMVERSE TECHNOLOGY INC CONMED CORP CONOCOPHILLIPS CORNING INC COVALENT GROUP INC COVANCE INC CR BARD INC CUBIC CORP CUBIST PHARMACEUTICALS CURAGEN CORPORATION CYTOGEN CORPORATION CYTYC CORP DADE BEHRING INC DAIMLERCHRYSLER AG DEL LABORATORIES INC DELL COMPUTER CORPORATION DENSO CORPORATION DEPUY INC DIEBOLD INC DIGENE CORPORATION DOW CHEMICAL COMPANY (THE) DUALSTAR TECHNOLOGIES CORPORATION E I DU PONT DE NEMOURS & CO (DUPONT) EASTMAN KODAK CO EG&G INC ELAN CORP PLC ELECTRONIC ARTS INC ELECTRONIC DATA SYSTEMS CORP ELECTRONICS FOR IMAGING INC ELI LILLY & CO EMC CORP ENDO PHARMACEUTICALS HOLDINGS INC ENI SPA ENTERASYS NETWORKS INC ENZO BIOCHEM INC ENZON INC EPIX MEDICAL INC ERESEARCH TECHNOLOGY INC EXXONMOBIL CORPORATION E-Z-EM INC FILENET CORP
Plunkett Research, Ltd.
FISHER SCIENTIFIC INTERNATIONAL INC FLUOR CORP FORD MOTOR CO FOREST LABORATORIES INC FOSTER WHEELER LTD FUELCELL ENERGY INC FUJI HEAVY INDUSTRIES LTD GELTEX PHARMACEUTICALS GENE LOGIC INC GENENTECH INC GENERAL DYNAMICS GENERAL ELECTRIC CO GENERAL MOTORS CORP GENOME THERAPEUTICS CORP GENZYME CORP GEORG FISCHER LTD GERBER SCIENTIFIC INC GETRONICS NV GILEAD SCIENCES INC GLAXOSMITHKLINE PLC GLENAYRE TECHNOLOGIES INC GOODRICH CORPORATION GOODYEAR TIRE & RUBBER COMPANY (THE) GOOGLE INC GTC BIOTHERAPEUTICS INC GUILFORD PHARMACEUTICALS INC HADCO CORP HAEMONETICS CORPORATION HALLIBURTON COMPANY HAUSER INC HESKA CORP HEWLETT-PACKARD CO HI TECH PHARMACAL CO INC HLM DESIGN INC HONDA MOTOR CO LTD HONEYWELL INTERNATIONAL INC HUGHES ELECTRONICS CORP HYBRIDON INC HYUNDAI MOTOR COMPANY I2 TECHNOLOGIES INC ICN PHARMACEUTICALS INC IDEXX LABORATORIES INC IDX SYSTEMS CORP ILEX ONCOLOGY INC IMC GLOBAL INC IMCLONE SYSTEMS INC IMMUNEX CORP IMMUNOMEDICS INC IMPAX LABORATORIES INC INCYTE GENOMICS INC INTEL CORP INTERGRAPH CORP INTERNATIONAL BUSINESS MACHINES (IBM)
www.plunkettresearch.com
INTERNATIONAL RECTIFIER CORP INTUIT INC INVACARE CORP ITT INDUSTRIES INC IVAX CORPORATION JABIL CIRCUIT INC JDS UNIPHASE CORP JOHNSON & JOHNSON JOHNSON CONTROLS INC JUNIPER NETWORKS INC KENDLE INTERNATIONAL INC KLA TENCOR CORP KOS PHARMACEUTICALS INC L3 COMMUNICATIONS HOLDINGS INC LAM RESEARCH CORP LEXICON GENETICS INC LEXMARK INT'L GROUP INC LIFE SCIENCES RESEARCH LIFECELL CORPORATION LINDE AG LOCKHEED MARTIN CORP LORAL SPACE & COMMUNICATIONS LTD LSI LOGIC CORP LUCENT TECHNOLOGIES INC LYONDELL CHEMICAL COMPANY MALLINCKRODT INC MARTEK BIOSCIENCES CORP MAXIM INTEGRATED PRODUCTS INC MAXTOR CORP MEDAREX INC MEDIMMUNE INC MEDPOINTE INC MEDTOX SCIENTIFIC INC MEDTRONIC INC MENTOR GRAPHICS CORP MERCK & CO INC MERIDIAN BIOSCIENCE INC MICHAEL BAKER CORPORATION MICROCHIP TECHNOLOGY INC MICRON TECHNOLOGY INC MICROSOFT CORP MILLENNIUM PHARMACEUTICALS INC MILTOPE GROUP INC MITSUBISHI MOTORS CORP MONSANTO CO MOTOROLA INC MSC.SOFTWARE CORP MYLAN LABORATORIES INC NABI BIOPHARMACEUTICALS NATIONAL SEMICONDUCTOR CORP NBTY INC NEOGEN CORPORATION NETWORK APPLIANCE INC
Plunkett Research, Ltd.
NETWORK ASSOCIATES INC NETWORK EQUIPMENT TECHNOLOGIES INC NEUROGEN CORP NISSAN MOTOR CO LTD NOKIA CORPORATION NORTEL NETWORKS CORP NORTH AMERICAN SCIENTIFIC NOVARTIS AG NOVELL INC NOVELLUS SYSTEMS INC ONSITE ENERGY CORPORATION ORACLE CORP ORBITAL SCIENCES CORP ORCHID BIOSCIENCES INC OSI PHARMACEUTICALS INC OYO CORPORATION PARAMETRIC TECHNOLOGY CORP PAREXEL INTERNATIONAL PARSONS BRINCKERHOFF INC PENWEST PHARMACEUTICALS CO PEOPLESOFT INC PERKINELMER INC PEROT SYSTEMS CORP PFIZER INC PHARMACEUTICAL FORMULATIONS INC PHARMACEUTICAL RESOURCES INC PHARMACOPEIA INC PITNEY BOWES INC PLUG POWER INC PMC-SIERRA INC POLAROID CORP PRAXAIR INC PROTEIN DESIGN LABS INC PROXIM CORPORATION PSA PEUGEOT CITROEN SA PURE WORLD INC QUALCOMM INC QUANTUM CORP QUINTILES TRANSNATIONAL CORP RADISYS CORP RATIONAL SOFTWARE CORP RAYTHEON CO REGENERON PHARMACEUTICALS INC RESPIRONICS INC ROCKWELL AUTOMATION ROYAL DUTCH PETROLEUM CO ROYAL PHILIPS ELECTRONICS SAMSUNG ELECTRONICS CO LTD SANGSTAT MEDICAL CORP SAP AKTIENGESELLSCHAFT SAS INSTITUTE SCHERING-PLOUGH CORP SCIENTIFIC ATLANTA INC
www.plunkettresearch.com
SCOTTS CO SEAGATE TECHNOLOGY INC SEPRACOR INC SEQUENOM INC SEROLOGICALS CORP SHELL OIL CO SHIRE-BIOCHEM INC SIEBEL SYSTEMS INC SIEMENS AG SIGMA ALDRICH CORP SILICON GRAPHICS INC SKIDMORE OWINGS & MERRILL LLP SOLA INTERNATIONAL INC SONY CORPORATION ST JUDE MEDICAL INC STANDARD MICROSYSTEMS CORPORATION STERIS CORP STORAGE TECHNOLOGY CORP STRYKER CORP STV GROUP INC SUN MICROSYSTEMS INC SUNGARD DATA SYSTEMS INC SUNRISE MEDICAL INC SYBASE INC SYMANTEC CORP SYMBOL TECHNOLOGIES INC SYNCOR INTERNATIONAL CORPORATION SYNGENTA AG SYNOPSYS INC TARO PHARMACEUTICAL INDUSTRIES TECHNITROL INC TELEFLEX INC TELEFON AB LM ERICSSON TELLABS INC TERADYNE INC TEXAS INSTRUMENTS INC THERMO ELECTRON CORP TITAN CORP (THE) TOYOTA MOTOR CORPORATION TRANSKARYOTIC THERAPIES TRC COMPANIES INC TREVI-FINANZIARIA INDUSTRIALE SPA TRIANGLE PHARMACEUTICALS TRIPOS INC TULARIK INC UNISYS CORP UNITED THERAPEUTICS CORP URS CORPORATION US LABORATORIES UTSTARCOM INC VALLEN CORP VERISIGN INC VERTEX PHARMACEUTICALS INC
Plunkett Research, Ltd.
VISTEON CORPORATION WATSON PHARMACEUTICALS INC WEBMD CORPORATION WESTERN DIGITAL CORP WS ATKINS PLC WYETH XEROX CORP XILINX INC YAHOO! INC ZIMMER HOLDINGS INC
www.plunkettresearch.com
INDEX OF FIRMS WITH INTERNATIONAL OPERATIONS 3COM CORP 3M COMPANY AB VOLVO ABAXIS INC ABB LTD ABBOTT LABORATORIES ACCENTURE ACTERNA CORPORATION ACUSON CORPORATION ADAC LABORATORIES ADAM OPEL AG ADAPTEC INC ADC TELECOMMUNICATIONS INC ADOBE SYSTEMS INC ADTRAN INC ADVANCED FIBRE COMMUNICATIONS INC ADVANCED MICRO DEVICES INC AFFYMETRIX INC AGILENT TECHNOLOGIES INC AIR PRODUCTS & CHEMICALS INC AIRBUS SAS ALARIS MEDICAL INC ALBEMARLE CORPORATION ALCATEL USA INC ALCON LABORATORIES INC ALKERMES INC ALLERGAN INC ALPHARMA INC ALTERA CORP ALZA CORP AMDOCS LTD AMERICAN MANAGEMENT SYSTEMS INC AMERICAN SUPERCONDUCTOR AMEY PLC AMGEN INC AMKOR TECHNOLOGY INC AMYLIN PHARMACEUTICALS INC ANALOG DEVICES INC ANALOGIC CORP AOL TIME WARNER INC APOGENT TECHNOLOGIES INC APPLE COMPUTER INC APPLIED MATERIALS INC ARCADIS NV ARROW INTERNATIONAL INC ASCENTIAL SOFTWARE CORPORATION ASPECT COMMUNICATIONS CORP ASTRAZENECA PLC ASTROPOWER INC
Plunkett Research, Ltd.
ATMEL CORP AUDI AG AUTODESK INC AVAYA INC AVENTIS SA BAE SYSTEMS BALLARD POWER SYSTEMS BASF AG BAUSCH & LOMB INC BAXTER INTERNATIONAL INC BAYER AG BAYERISCHE MOTOREN WERKE AG BEA SYSTEMS INC BECHTEL GROUP INC BECKMAN COULTER INC BECTON DICKINSON & CO BENTLEY PHARMACEUTICALS INC BIO RAD LABORATORIES INC BIO TECHNOLOGY GENERAL CORP BIOGEN INC BIOMARIN PHARMACEUTICAL BIOMET INC BIORELIANCE CORP BIOSOURCE INTERNATIONAL INC BMC SOFTWARE INC BOEING CO BOMBARDIER INC BOSTON SCIENTIFIC CORP BP PLC BRISTOL MYERS SQUIBB CO BROADCOM CORP CABOT CORPORATION CACI INTERNATIONAL INC CADENCE DESIGN SYSTEMS INC CAMBREX CORP CANON INC CARRINGTON LABORATORIES INC CENTOCOR INC CEPHALON INC CERNER CORP CH2M HILL COMPANIES LTD CHEVRONTEXACO CORPORATION CHIRON CORP CHIYODA CORPORATION CIENA CORP CIRRUS LOGIC INC CISCO SYSTEMS INC CITRIX SYSTEMS INC COGNEX CORP COMPAGNIE MICHELIN COMPUTER ASSOCIATES INTERNATIONAL INC COMPUTER SCIENCES CORP
www.plunkettresearch.com
COMPUWARE CORP COMVERSE TECHNOLOGY INC CONMED CORP CONNETICS CORPORATION CONOCOPHILLIPS CORNING INC COVALENT GROUP INC COVANCE INC CR BARD INC CUBIST PHARMACEUTICALS CYPRESS SEMICONDUCTOR CORP DADE BEHRING INC DAIMLERCHRYSLER AG DEL LABORATORIES INC DELL COMPUTER CORPORATION DENSO CORPORATION DEPUY INC DIEBOLD INC DIGENE CORPORATION DOW CHEMICAL COMPANY (THE) E I DU PONT DE NEMOURS & CO (DUPONT) EASTMAN KODAK CO EDWARDS LIFESCIENCES CORP EG&G INC ELAN CORP PLC ELECTRONIC ARTS INC ELECTRONIC DATA SYSTEMS CORP ELECTRONICS FOR IMAGING INC ELI LILLY & CO EMC CORP ENERGY CONVERSION DEVICES INC ENI SPA ENTERASYS NETWORKS INC ERESEARCH TECHNOLOGY INC EXELIXIS INC EXXONMOBIL CORPORATION E-Z-EM INC FIAT SPA FILENET CORP FISHER SCIENTIFIC INTERNATIONAL INC FLUOR CORP FORD MOTOR CO FOREST LABORATORIES INC FOSTER WHEELER LTD FUELCELL ENERGY INC FUJI HEAVY INDUSTRIES LTD GELTEX PHARMACEUTICALS GENERAL DYNAMICS GENERAL ELECTRIC CO GENERAL MOTORS CORP GENZYME CORP GEORG FISCHER LTD GERBER SCIENTIFIC INC
Plunkett Research, Ltd.
GETRONICS NV GILEAD SCIENCES INC GLAXOSMITHKLINE PLC GLENAYRE TECHNOLOGIES INC GLOBAL INDUSTRIES LTD GOODRICH CORPORATION GOODYEAR TIRE & RUBBER COMPANY (THE) GOOGLE INC GRUPO DRAGADOS GUIDANT CORP HADCO CORP HAEMONETICS CORPORATION HALLIBURTON COMPANY HAUSER INC HESKA CORP HEWLETT-PACKARD CO HLM DESIGN INC HONDA MOTOR CO LTD HONEYWELL INTERNATIONAL INC HUGHES ELECTRONICS CORP HUTCHINSON TECHNOLOGY INC HYCOR BIOMEDICAL INC HYUNDAI MOTOR COMPANY I2 TECHNOLOGIES INC ICN PHARMACEUTICALS INC IDEXX LABORATORIES INC ILEX ONCOLOGY INC IMC GLOBAL INC IMMUNOMEDICS INC INCYTE GENOMICS INC INFOCUS CORP INSTRUMENTARIUM INTEL CORP INTERGRAPH CORP INTERNATIONAL BUSINESS MACHINES (IBM) INTERNATIONAL RECTIFIER CORP INTUIT INC INVACARE CORP INVITROGEN CORPORATION IOMEGA CORP ISUZU MOTORS LTD ITT INDUSTRIES INC IVAX CORPORATION JABIL CIRCUIT INC JDS UNIPHASE CORP JOHNSON & JOHNSON JOHNSON CONTROLS INC JUNIPER NETWORKS INC KEITH COMPANIES INC (THE) KEMET CORP KENDLE INTERNATIONAL INC KINETIC CONCEPTS INC KLA TENCOR CORP
www.plunkettresearch.com
KOMAG INC L3 COMMUNICATIONS HOLDINGS INC LAM RESEARCH CORP LEXMARK INT'L GROUP INC LIFE SCIENCES RESEARCH LIFECORE BIOMEDICAL INC LINDE AG LOCKHEED MARTIN CORP LORAL SPACE & COMMUNICATIONS LTD LSI LOGIC CORP LUCENT TECHNOLOGIES INC LYNX THERAPEUTICS INC LYONDELL CHEMICAL COMPANY MALLINCKRODT INC MARATHON OIL MAXIM INTEGRATED PRODUCTS INC MAXTOR CORP MAXYGEN INC MAZDA MOTOR CORPORATION MEDAREX INC MEDIMMUNE INC MEDTRONIC INC MEMC ELECTRONIC MATERIALS INC MENTOR GRAPHICS CORP MERCK & CO INC MERIDIAN BIOSCIENCE INC MICHAEL BAKER CORPORATION MICROCHIP TECHNOLOGY INC MICRON TECHNOLOGY INC MICROSOFT CORP MILLENNIUM PHARMACEUTICALS INC MILTOPE GROUP INC MITSUBISHI MOTORS CORP MONSANTO CO MOTOROLA INC MSC.SOFTWARE CORP NABI BIOPHARMACEUTICALS NAPRO BIOTHERAPEUTICS INC NATIONAL SEMICONDUCTOR CORP NBTY INC NEOGEN CORPORATION NETWORK APPLIANCE INC NETWORK EQUIPMENT TECHNOLOGIES INC NISSAN MOTOR CO LTD NKK CORPORATION NOKIA CORPORATION NORTEL NETWORKS CORP NOVARTIS AG NOVELL INC NOVELLUS SYSTEMS INC ONSITE ENERGY CORPORATION ORACLE CORP ORCHID BIOSCIENCES INC
Plunkett Research, Ltd.
OSI PHARMACEUTICALS INC OYO CORPORATION PANVERA LLC PARAMETRIC TECHNOLOGY CORP PAREXEL INTERNATIONAL PARSONS BRINCKERHOFF INC PENWEST PHARMACEUTICALS CO PEOPLESOFT INC PERFICIENT INC PERKINELMER INC PEROT SYSTEMS CORP PFIZER INC PHARMACEUTICAL RESOURCES INC PHARMACOPEIA INC PHILIPP HOLZMANN GROUP PITNEY BOWES INC PLUG POWER INC PMC-SIERRA INC POLAROID CORP PRAXAIR INC PROTEIN DESIGN LABS INC PROXIM CORPORATION PSA PEUGEOT CITROEN SA QUALCOMM INC QUANTUM CORP QUIDEL CORP QUINTILES TRANSNATIONAL CORP RADISYS CORP RATIONAL SOFTWARE CORP RAYTHEON CO READ-RITE CORP RESPIRONICS INC ROCKWELL AUTOMATION ROYAL DUTCH PETROLEUM CO ROYAL PHILIPS ELECTRONICS SAMSUNG ELECTRONICS CO LTD SANGSTAT MEDICAL CORP SANYO ELECTRIC COMPANY LTD SAP AKTIENGESELLSCHAFT SAS INSTITUTE SCHERING-PLOUGH CORP SCICLONE PHARMACEUTICALS SCIENTIFIC ATLANTA INC SCOTTS CO SEPRACOR INC SEQUENOM INC SEROLOGICALS CORP SHARP CORPORATION SHELL OIL CO SHIRE-BIOCHEM INC SICOR INC SIEBEL SYSTEMS INC SIEMENS AG
www.plunkettresearch.com
SIGMA ALDRICH CORP SILICON GRAPHICS INC SKIDMORE OWINGS & MERRILL LLP SOLA INTERNATIONAL INC SONY CORPORATION ST JUDE MEDICAL INC STANDARD MICROSYSTEMS CORPORATION STERIS CORP STORAGE TECHNOLOGY CORP STRYKER CORP SUN MICROSYSTEMS INC SUNGARD DATA SYSTEMS INC SUNRISE MEDICAL INC SUZUKI MOTOR CORPORATION SYBASE INC SYMANTEC CORP SYMBOL TECHNOLOGIES INC SYNBIOTICS CORP SYNCOR INTERNATIONAL CORPORATION SYNGENTA AG SYNOPSYS INC TARO PHARMACEUTICAL INDUSTRIES TECHNE CORP TECHNIP-COFLEXIP TECHNITROL INC TELEFLEX INC TELEFON AB LM ERICSSON TELLABS INC TERADYNE INC TERAYON COMMUNICATION SYSTEMS INC TERRA INDUSTRIES INC TEXAS INSTRUMENTS INC THERMO ELECTRON CORP TITAN CORP (THE) TOYOTA MOTOR CORPORATION TRANSKARYOTIC THERAPIES TRC COMPANIES INC TREVI-FINANZIARIA INDUSTRIALE SPA TRIPOS INC TULARIK INC UNISYS CORP URS CORPORATION US LABORATORIES UTSTARCOM INC VALLEN CORP VERISIGN INC VERTEX PHARMACEUTICALS INC VINCI VIRBAC INC VISTEON CORPORATION VOLKSWAGEN AG VYSIS INC WATSON PHARMACEUTICALS INC
Plunkett Research, Ltd.
WESTERN DIGITAL CORP WS ATKINS PLC WYETH XEROX CORP XILINX INC YAHOO! INC ZIMMER HOLDINGS INC
www.plunkettresearch.com
Plunkett Research, Ltd.
www.plunkettresearch.com
Individual Data Profiles On Each Of THE ENGINEERING & RESEARCH 500
Plunkett Research, Ltd.
www.plunkettresearch.com
3COM CORP
www.3com.com
Industry Group Code: 334110 Ranks within this company's industry group: Sales:2 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:8
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Computer Networking Equipment-Diversified Modems
3Com is one of the leading industry providers of Ethernet, Fast Ethernet and Gigabit Ethernet connectivity. The company targets sectors of the enterprise and service provider markets and has recently restructured its operations. To improve the competitiveness of Business Connectivity Company (BCC) and Business Networks Company (BNC), 3Com merged BCC into BNC to drive further efficiencies in each business while leveraging growth opportunities. The company has structured its operations around these two businesses. BNC focuses on the enterprise market and now consists of three divisions: the local area network (LAN) infrastructure division, the personal systems division and the connectivity division. The connectivity division focuses on basic client connectivity products and solutions. The Network Jack product is now managed under the personal systems division; other offerings formerly managed under BCC are now managed under the LAN infrastructure division of BNC. CommWorks Corporation continues to focus on the telecommunications service provider market in which it provides Internet protocol-based access and infrastructure and services platforms. In recent news, 3Com entered into a patent right agreement with Infineon Technologies AG regarding Ethernet over DSL. Beyond salary, 3Com offers performance-based incentives, including a special bonus program, Kadoos. After four years of continuous service, employees are offered a paid sabbatical. Employees can schedule their own hours as long as they meet the needs of a position and respond to the advice of managers. 3Com's benefits package includes dental and vision coverage, semi-annual bonuses, flexible maternity, on-site fitness facilities and no enforced dress code.
BRANDS/DIVISIONS/AFFILIATES: Business Networks Company CommWorks Corporation Business Connectivity Company
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Bruce L. Claflin, CEO Bruce L. Claflin, Pres. Mark A. Slaven, CFO/VP-Finance Mark D. Michael, Corp. Sec. Mark D. Michael, General Counsel Mark A. Slaven, Sr. VP-Planning Jeanne Cox, VP-Corp. Branding and Comm. Irfan Ali, Pres., CommWorks Corp. Dennis Connors, Pres., Bus. Connectivity John McClelland, Pres., Bus. Networks Gwen McDonald, Sr. VP-Corp. Services Eric A. Benhamou, Chmn.
Phone: 408-326-5000 Fax: 408-326-5001 Toll-Free: 800-638-3266 Address: 5400 Bayfront Plaza, Santa Clara, CA 95052 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,477,900 (12 months) 2002 Profits: $-596,000 (12 months) Stock Ticker: COMS 2001 Sales: $2,820,900 2001 Profits: $-965,400 Employees: 4,615 2000 Sales: $4,333,942 2000 Profits: $674,303 Fiscal Year Ends: 5/31 1999 Sales: $5,202,253 1999 Profits: $403,874 1998 Sales: $5,156,016 1998 Profits: $30,214
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $781,250 Bonus: $210,375 Stock Purch. Plan: Y Second Exec. Salary: $508,653 Bonus: $122,458 ADVANTAGE: Maker of the first Ethernet interface/ Superior quality of network adapters that are competitive on an international level.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
3M COMPANY
www.mmm.com
Industry Group Code: 335000 Ranks within this company's industry group: Sales:2 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:2
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Y Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y
GROWTH PLANS/SPECIAL FEATURES:
Diversified Manufacturing Health Care Products Consumer and Office Markets Electro and Communications Products Transportation and Safety Products Security and Protection Service Products
3M Company, originally known as Minnesota Mining and Manufacturing Company, is an integrated enterprise involved in the research, manufacture and marketing of a variety of products. 3M operates in more than 60 countries, and its products are sold in nearly 200 countries. The firm controls 40 business units organized into seven segments: health care, industrial, consumer and office, display and graphics, electro and communications, transportation and safety and security and protection services. 3M additionally produces apparel, drink ware, bags and travel equipment, golf products and business products. 3M develops technologies in fuel cell components, light management, film solutions and light fiber. Among the company’s most popular products are Post-it products and Scotch Tape. Because of the company’s dedication to environmental safety, one out of every eight 3M scientists works with processes and chemicals aimed at minimizing impact on the environment. Via its technical collaboration with Nitto Denko, 3M has developed a two-in-one product that combines polarizing film with polarization conversion film for liquid crystal displays. Recently, 3M unveiled its newest concrete protection product, 3M Scotch-Clad TC deck coatings, which is the industry’s first two-coat concrete protection system. In other news, 3M acquired GuardiaNet Systems, Inc., a software company serving the public library market. Also, the 3M Telecom Enterprise Department joined Extreme, Inc.’s Go Purple Extreme Solution Partners Program, thus expanding the market for 3M’s complete LAN/campus network solution. Employees enjoy a gym, reduced price concert and sporting event tickets, merchandise discounts and flexible scheduling options.
BRANDS/DIVISIONS/AFFILIATES: Minnesota Mining and Manufacturing Company Nitto Denko GuardiaNet Systems, Inc. Extreme, Inc. 3M Telecom Enterprise Department Post-it Products Scotch Tape 3M Scotch-Clad TC Deck Coatings
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. W. James McNerney, Jr., CEO Patrick D. Campbell, Sr. VP/CFO David W. Powell, Sr. VP-Mktg. M. Kay Grenz, VP-Human Resources Jay V. Ihlenfeld, VP-Research & Dev. Ronald G. Nelson, Controller Ronald R. Belschner, Sr. VP-Eng. Ronald R. Belschner, Sr. VP-Mfg. & Logistics Gregg M. Larson, Sec. Robert F. Ziegler, Sr. VP-Legal Affairs & General Counsel Robert J. Burgstahler, Sr. VP-Bus. Dev. and Corp. Services J. Mark Borseth, Treas. Steven J. Landwehr, Exec. VP-Transportation Bus. Charles Reich, Exec. VP-Health Care Bus. Moe S. Nozari, Exec. VP-Consumer and Office Bus. Harold J. Wiens, Exec. VP-Industrial Bus. W. James McNerney, Jr., Chmn. Joseph A. Giordano, Exec. VP-Intl. Oper.
Phone: 651-733-1110 Fax: 651-736-2133 Toll-Free: 800-364-3577 Address: 3M Center, Bldg. 220-11W-02, St. Paul, MN 551441000 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $16,332,000 (12 months) 2002 Profits: $1,974,000 (12 months) Stock Ticker: MMM 2001 Sales: $16,079,000 2001 Profits: $1,430,000 Employees: 68,774 2000 Sales: $16,724,000 2000 Profits: $1,782,000 Fiscal Year Ends: 12/31 1999 Sales: $15,748,000 1999 Profits: $1,763,000 1998 Sales: $15,094,000 1998 Profits: $1,213,000
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Y Profit Sharing: Top Exec. Salary: $1,400,000 Stock Purch. Plan: Y Second Exec. Salary: $595,402 Significant research capabilities/ Lengthy history of product innovation. ADVANTAGE:
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Bonus: $3,310,830 Bonus: $512,514
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AB VOLVO
www.volvo.com
Industry Group Code: 336120 Ranks within this company's industry group: Sales:1 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Profits:1
Y
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Truck Manufacturer Marine Engines Construction Equipment
Volvo AB is one of the world's largest producers of trucks, buses and construction equipment. Having sold its automotive unit to Ford Motors, the company (which is also known as the Volvo Group) operates six divisions: Trucks, Volvo Bus Corporation, Volvo Construction Equipment, Volvo Penta, Volvo Aero and Volvo Financial Services. The Trucks division consists of Volvo Trucks, Renault Trucks and Mack Trucks. Volvo Bus Corporation is the second largest manufacturer of heavy buses and coaches in the world. Volvo Construction Equipment operates in the U.S., Canada, Mexico, Ireland, the U.K., Brazil, China and Korea, and offers a wide variety of heavy equipment including backhoes, compact wheel loaders and articulated haulers. Volvo Penta manufactures engines for use in shipping, leisure boating, power plants and heavy equipment. Volvo Aero is located exclusively in Sweden and constructs military engines, commercial engines, space propulsion components and land and marine gas turbines in addition to providing engine and aviation services. Volvo Financial Services covers customer financing, insurance, treasury, real estate and related services operations. In recent news, the Mack Truck division launched the new Granite, a truck with construction applications, while Renault Trucks introduced the Magnum and Midlum trucks. Volvo Bus Corporation was awarded the Bus Builder of the Year 2002. Volvo Construction Equipment announced the development of a backhoe loader and the acquisition of a range of skid steer loaders. Volvo Penta introduced a marine leisure diesel engine, KAD300, the D2-55 diesel engine for sailboats and a 16-liter engine for commercial marine use. Volvo Aero signed a new agreement for the manufacture of 23 Vulcain engines for the Ariane 5 rocket.
BRANDS/DIVISIONS/AFFILIATES: Volvo Aero Mack Trucks, Inc. Volvo Trucks North America, Inc. Volvo Construction Equipment Renault Trucks Volvo Financial Services Volvo Penta Volvo Bus Corporation
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Leif Johansson, CEO Volvo Group Leif Johansson, Pres. Jan Engstrom, Pres.-Volvo Bus Corporation Jorma Halonen, Pres./CEO-Volvo Truck Corporation Michel Gigou, Pres.-Volvo Trucks North America Lennart Jeansson, Exec. VP Lars Ramqvist, Chmn.
Phone: 46-31-59-66-00 Fax: 46-31-54-57-72 Toll-Free: Address: , Gothenburg, S-40508 Sweden
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $21,469,000 (12 months) 2002 Profits: $161,000 (12 months) Stock Ticker: VOLVY 2001 Sales: $18,057,000 2001 Profits: $-140,000 Employees: 71,160 2000 Sales: $13,800,000 2000 Profits: $500,000 Fiscal Year Ends: 12/31 1999 Sales: $ 1999 Profits: $ 1998 Sales: $ 1998 Profits: $
SALARIES/BENEFITS: Pension Plan: Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Stock Purch. Plan: Second Exec. Salary: $ ADVANTAGE: Owns some of the world's leading truck, engine and equipment brands.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest:
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ABAXIS INC
www.abaxis.com
Industry Group Code: 339113 Ranks within this company's industry group: Sales:37 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:33
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Equipment-Point-of-Care Blood Analyzer Systems Veterinary Products
Abaxis, Inc. develops, manufactures and markets a portable blood analysis system for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The system is marketed as the VetScan Chemistry System in the veterinary market and as the Piccolo Point-of-Care Analyzer in the human medical market. The system consists of a compact 6.9-kilogram analyzer and a series of single-use plastic discs, called reagent discs, containing all the chemicals required to perform a panel of up to 12 tests. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma using either venous or fingerstick samples. In addition to the blood analysis system, Abaxis sells the VetScan HMT Hematology Analyzer, which provides a complete blood count including a three-part white blood cell differential in less than two minutes, with results for eight selectable species, plus two user-configurable programs. Abaxis also produces a bi-monthly electronic newsletter entitled VetCom for the veterinary community. Abaxis markets its products in the U.S., Europe, Latin America and Asia and has offices located in California and Germany. In recent news, Abaxis signed distribution agreements with T. Chatani and Co., Ltd. and Milburn Distributions, Inc. to expand Abaxis’s distribution market to Japan and increase distribution in the United States. Abaxis offers its employees comprehensive medical benefits, as well as flexible time off and a flexible spending account plan.
BRANDS/DIVISIONS/AFFILIATES: Piccolo Point-of-Care Analyzer VetScan Chemistry System VetScan HMT Hematology Analyzer VetCom Newsletter
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Clinton H. Severson, CEO Robert B. Milder, COO Clinton H.Severson, Pres. Alberto R. Santa Ines, VP-Finance/CFO Robert Schoen, VP-Mktg. and Sales Kenneth Aron, VP-Research and Dev. Vladimir E. Ostioch, VP-Eng. Kenneth Aron, VP-Dev. Ron Blasig, U.S. Dir.-Mktg., Piccolo and Human Diagnostics Pam Conboy, U.S. Dir.-Mktg., Veterinary Products Achim Henkel, European Dir.-Sales and Mktg. Clinton H. Severson, Chmn.
Phone: 510-675-6500 Fax: 510-441-6150 Toll-Free: 800-822-2947 Address: 3240 Whipple Rd., Union City, CA 94587 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $30,600 (12 months) 2002 Profits: $1,300 (12 months) Stock Ticker: ABAX 2001 Sales: $29,501 2001 Profits: $ 188 Employees: 124 2000 Sales: $23,200 2000 Profits: $- 600 Fiscal Year Ends: 3/31 1999 Sales: $13,300 1999 Profits: $-4,200 1998 Sales: $12,200 1998 Profits: $-4,400
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $265,000 Stock Purch. Plan: Second Exec. Salary: $165,000 ADVANTAGE: Sophisticated portable systems that can perform up to 12 different blood tests.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Bonus: $82,500 Bonus: $66,000
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ABB LTD
www.abb.com
Industry Group Code: 541310 Ranks within this company's industry group: Sales:2 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Y Y Y Y
Profits:11
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Y Gases: Other: Y
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Diversified Engineering Services Transmission and Distribution Systems
ABB, Ltd. is a global technology company that serves the manufacturing, process and consumer industries and the utilities, oil and gas markets. The company is a leading global supplier of distribution systems, medium-voltage equipment and distribution transformers, which decrease voltage to levels needed by end-users. ABB’s core businesses are the power technologies and automation technologies divisions. Its oil, gas and petrochemicals division is scheduled for divestment. The power technologies division develops products, systems and services for power transmission, distribution and automation, including energy trading management software, natural gas and electricity retailing and customer billing systems. The automation technologies division develops solutions for control, motion, protection and plant integration for the process and utility industries. ABB anticipates a compound average annual revenue growth of approximately 4% from 2002 through 2005. In recent news, ABB signed a rail consortium agreement with Mowlem Railways and Network Rail to upgrade power supply systems on commuter routes in southeast England. The company also formed an alliance with Accenture, Intel Corporation and Microsoft Corporation to provide computing diagnostics, solution design, development and integration services for manufacturers. The alliance will utilize ABB’s Industrial IT, the comprehensive, standardsbased architecture that links products and services with the information needed to install, operate and maintain them. In mid-2002, the firm agreed to sell most of the assets of its structured-finance unit to GE, a move that will greatly reduce ABB's debt. The sale is part of the firm's strategy to refocus on its core business, after generally disappointing financial results and a failed bid to acquire Honeywell International. Also, the company will merge its power technologies and automation technologies units. Unfortunately, it is facing large potential losses from asbestos liability suits in the U.S.
BRANDS/DIVISIONS/AFFILIATES: Industrial IT
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Jürgen Dormann, CEO Peter Voser, CFO Gary Steel, VP-Human Resources Markus Bayegan, Chief Tech. Officer Haider Rashid, CIO John Scriven, General Counsel/VP-Legal Affairs and Compliance Bjorn Edlund, VP-Corp. Comm. Michel Gerber, VP-Investor Rel. Dinesh Paliwal, Div. Head-Automation Tech. Erik Fougner, Div. Head-Oli, Gas and Petrochemicals Peter Smits, Div. Head-Power Tech. Donald P. Aiken, U.S. Mgr. Jurgen Dormann, Chmn.
Phone: 41-1-317-7111 Fax: 41-1-317-4420 Toll-Free: Address: Affolternstrasse 44, Zurich, CH-8050 Switzerland
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $18,295,000 (12 months) 2002 Profits: $-787,000 (12 months) Stock Ticker: ABB 2001 Sales: $23,726,000 2001 Profits: $-691,000 Employees: 156,865 2000 Sales: $22,967,000 2000 Profits: $1,443,000 Fiscal Year Ends: 12/31 1999 Sales: $24,681,000 1999 Profits: $1,614,000 1998 Sales: $30,872,000 1998 Profits: $1,305,000
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Stock Purch. Plan: Second Exec. Salary: $ ADVANTAGE: Global company with large client base/ Currently dealing with financial difficulties.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ABBOTT LABORATORIES
www.abbott.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:9 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:8
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Antibiotics and Synthetic Hormones Nutritional Products Hospital Products Specialty Products
Abbott Laboratories is a global, broad-based health care company that specializes in the discovery, development, manufacture and sale of a diversified line of health care products and services. Abbott’s products are sold in 130 countries. The company operates through five major business segments: pharmaceutical products, diagnostic products, hospital products, specialty products and nutritional products (through its Ross products division). Principal pharmaceutical products include Depakote, Flomax, Prevacid and a broad line of cardiovascular products. The diagnostics segment markets the product AxSym and systems for blood banks, hospitals and commercial laboratories. Hospital products include drugs and drug delivery systems, perioperative and intensive care products, cardiovascular products and renal and oncology products. The specialty products division produces generic injectables as well as other pharmaceutical compounds, such as IsFlo, PropoFlo and SevoFlo, for perioperative health care for the veterinary market. Ross products include a broad line of adult and pediatric nutritionals, specialty pharmaceuticals and consumer products. Some popular Ross brands are Similac and Isomil infant formulas, Ensure, Pedialyte, Selsun Blue and the Fact Plus line of pregnancy tests. Abbott also conducts its own research and development. Among Abbott’s developments is Norvir, an AIDS drug that, when taken with another protease inhibitor or other anti-viral drugs, can reduce HIV in the blood to undetectable levels. Through a joint venture called TAP Pharmaceutical Products, Abbott makes the best-selling prostate cancer drug, Lupron. The company offers employees adoption assistance, legal assistance, flexible hours, telecommuting, an onsite childcare center, sports programs and wellness programs. It also offers 12-week summer internships to college students in such areas as engineering, research and marketing. Abbott has been recognized as one of the top 50 best companies for minorities in Fortune Magazine and has been ranked among the top 10 best companies for working mothers by Working Mother magazine.
BRANDS/DIVISIONS/AFFILIATES: Ross AxSym Depakote Ensure Flomax Isomil Similac IsFlo
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Miles D. White, CEO Thomas C. Freyman, Sr. VP-Finance/CFO Thomas M. Wascoe, Sr. VP-Human Resources Jeffrey M. Leiden, Exec. VP/Chief Scientific Officer Karen L. Miller, VP-IT Gary L. Flynn, Controller John C. Landgraf, VP-Corp. Eng. Jose M. de Lasa, Corp. Sec. Jose M. de Lasa, General Counsel John C. Landgraf, VP-Oper., Diagnostics Steven J. Weger, Jr., VP-Corp. Planning and Dev. Catherine V. Babington, VP-Public Affairs Catherine V. Babington, VP-Investor Rel. Terrence C. Kearney, Treas. Richard A. Gonzalez, Pres./COO-Medical Products Joy A. Amundson, Sr. VP-Ross Products Christopher B. Begley, Sr. VP-Hospital Products Jeffrey M. Leiden, Pres./COO-Pharmaceutical Products Miles D. White, Chmn. William G. Dempsey, Sr. VP-Int'l Oper.
Phone: 847-937-6100 Fax: 847-937-1511 Toll-Free: Address: 100 Abbott Park Rd., Abbott Park, IL 60064-6400 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $17,685,000 (12 months) 2002 Profits: $2,794,000 (12 months) Stock Ticker: ABT 2001 Sales: $16,285,000 2001 Profits: $1,550,000 Employees: 71,819 2000 Sales: $13,745,900 2000 Profits: $2,786,000 Fiscal Year Ends: 12/31 1999 Sales: $13,177,600 1999 Profits: $2,445,800 1998 Sales: $12,512,700 1998 Profits: $2,334,400
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Top Exec. Salary: $1,497,388 Stock Purch. Plan: Second Exec. Salary: $807,408 ADVANTAGE: Heavily involved in research/ Worldwide recognition.
OTHER THOUGHTS: Apparent Women Officers or Directors: 3 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $1,250,000 Bonus: $680,000
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ABGENIX INC
www.abgenix.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:73 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:97
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Diversified Antibody Research
Abgenix, a leading biopharmaceutical company, develops and intends to commercialize several products for a variety of diseases. The company specializes in developing treatments for inflammatory and autoimmune disorders and cancer, as well as cardiovascular diseases, transplant-related and infectious diseases. Abgenix has developed a proprietary technology known as XenoMouse to help rapidly generate highly specific, fully human antibody product candidates. Under the XenoMouse model, the antibody gene of a genetically engineered mouse is suppressed and replaced with human antibody gene expression. The rest of the mouse’s immune system is left intact. The firm generates revenues by licensing XenoMouse technology to pharmaceutical and biotechnology companies interested in developing antibody-based products. The company also owns SLAM technology, which enables the rapid identification of antibodies with desired functions and characteristics. In its XenoMax technology, Abgenix uses SLAM technology to select and isolate antibodies with particular functions and characteristics from antibody-producing cells generated by XenoMouse animals. Client customers Pfizer, Inc. and Amgen, Inc. have recently initiated clinical trials with fully human antibodies generated from XenoMouse animals. In addition, under a joint development and commercialization agreement Abgenix is co-developing ABX-EGF, its leading proprietary antibody product candidate, with Amgen and Immunex Corporation. The company provides a comprehensive program of employee compensation and benefits, including medical, dental, vision, EAP, a flexible spending program and stock options.
BRANDS/DIVISIONS/AFFILIATES: XenoMouse ABX-EGF XenoMax SLAM
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Raymond M. Withy, CEO Raymond M. Withy, Pres. Kurt W. Leutzinger, CFO John C. Meyer, Dir.-Human Resources C. Geoffery Davis, Chief Scientific Officer H. David Miller, VP-IT Gisela M. Schwab, Chief Medical Officer Patrick M. Murphy, VP-Mfg. Susan L. Thorner, Corp. Sec. Susan L. Thorner, VP/General Counsel Gregory M. Bell, VP-Oper. Gayle M. Mills, VP-Bus. Dev. Gregory M. Bell, VP-Clinical Dev., Inflammation Steve M. Chamow, VP-Process Sciences Bruce A. Keyt, VP-Preclinical Dev. Gregory M. Landes, VP-Product Discovery R. Scott Greer, Chmn.
Phone: 510-608-6500 Fax: 510-608-6511 Toll-Free: Address: 6701 Kaiser Dr., Fremont, CA 94555 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $39,438 (12 months) 2002 Profits: $-208,898 (12 months) Stock Ticker: ABGX 2001 Sales: $63,606 2001 Profits: $-60,856 Employees: 387 2000 Sales: $59,449 2000 Profits: $-8,793 Fiscal Year Ends: 12/31 1999 Sales: $15,330 1999 Profits: $-19,499 1998 Sales: $4,803 1998 Profits: $-16,827
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $366,667 Stock Purch. Plan: Y Second Exec. Salary: $273,000 ADVANTAGE: Collaboration with major firms/ Proprietary XenoMouse technology.
OTHER THOUGHTS: Apparent Women Officers or Directors: 3 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $158,000 Bonus: $157,500
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International:
Plunkett Research, Ltd.
www.plunkettresearch.com
ABLE LABORATORIES
www.ablelabs.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:62 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:36
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Generic
Able Laboratories, Inc., which recently merged with DynaGen, Inc., develops, manufactures and sells prescription generic medications. These generic drugs are the chemical and therapeutic equivalents of brandname drugs. Its manufacturing facility produces the medications in tablet, capsule and suppository dosage form. Some of these generic drugs deal with the treatment of health issues involving tension headaches, attention disorder, anxiety disorder, obesity and rheumatoid arthritis. The company has received 16 abbreviated new drug application (ANDA) approvals and one new drug application approval from the FDA. There are several drug applications pending. Recently, Able Labs announced that it entered into an ANDA transfer and marketing agreement with IVAX Pharmaceuticals, Inc., a subsidiary of IVAX Corporation, for Able Labs' Tramadol Hydrochloride Tablets. Able Labs will manufacture and supply Tramadol exclusively to IVAX under their label, and IVAX will exclusively sell Able Labs' manufactured product. In other news, Able Labs received FDA approval for its ANDAs for hydrocodone bitartrate and acetaminophen tablets and its acetaminophen and codeine phosphate tablets.
BRANDS/DIVISIONS/AFFILIATES: Superior Pharmaceutical Co. Able Labs DynaGen, Inc. Tramadol
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Dhananjay G. Wadekar, CEO Dhananjay G. Wadekar, Pres. Dhananjay G. Wadekar, CFO Loken Patel, VP-Mktg. and Sales George H. Sager, Jr., Controller Dhananjay G. Wadekar, Corp. Sec. Kamlesh Haribhakti, Dir.-Product Dev. Dhananjay G. Wadekar, Treas. Shailesh Daftari, Exec. VP Shashikant Shah, VP-Quality/Regulatory Dwight Nix, VP-Nat'l Accounts Iva Klemick, Dir.-Regulatory Affairs Dhananjay G. Wadekar, Chmn.
Phone: 781-449-4926 Fax: 781-890-0118 Toll-Free: Address: 200 Highland Ave., Ste. 301, Needham, MA 02494 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $52,930 (12 months) 2002 Profits: $23,446 (12 months) Stock Ticker: ABLA 2001 Sales: $19,600 2001 Profits: $-4,500 Employees: 288 2000 Sales: $31,500 2000 Profits: $-8,500 Fiscal Year Ends: 12/31 1999 Sales: $29,100 1999 Profits: $-8,200 1998 Sales: $25,000 1998 Profits: $-12,600
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Stock Purch. Plan: ADVANTAGE: Merger with DynaGen.
OTHER THOUGHTS: Apparent Women Officers or Directors: 3 Hot Spot for Advancement for Women/Minorities: Y
Top Exec. Salary: $145,000 Second Exec. Salary: $
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International:
Plunkett Research, Ltd.
www.plunkettresearch.com
ACCENTURE
www.accenture.com
Industry Group Code: 541611 Ranks within this company's industry group: Sales:1 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:1
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y Y Y Y
GROWTH PLANS/SPECIAL FEATURES:
Consulting Services Outsourcing Performance Management Technology Research Solutions Engineering Solutions Operations
Accenture (formerly Andersen Consulting) is a leading provider of management and technology consulting services and solutions. The company has more than 110 offices in 46 countries, providing customers with a wide range of consulting, technology and outsourcing services. Accenture serves 84 of the Fortune Global 100 and more than half of the Global 500. Clients of the company include AT&T, Microsoft, Sony, Sprint, Bank of America, London Stock Exchange, Visa, DaimlerChrysler, the City of Boston, the U.S. Postal Service and the U.S. Department of Commerce. The firm delivers services and solutions through five global market units: communications and high tech, financial services, products, resources and government. Together these comprise 18 industry groups. Accenture offers its customers eight primary service lines, including strategy and business architecture, customer relationship management, supply chain management, human performance, finance and performance management, technology research and innovation, solutions engineering and solutions operations. Moreover, the company has over 150 alliances with leading technology-related solutions providers around the world. Through its strategic alliances, Accenture is able to offer an unparalleled array of technology solutions to meet its clients’ diverse business needs. In recent news, the firm signed a seven-year deal with Telecom Italia Group, under which it will provide outsourced payroll processing and administration services. Accenture also announced an agreement with global transportation and logistics company Neptune Orient Lines for the outsourcing of the group’s transaction-based finance functions. In other news, the company was awarded a five-year outsourcing contract to provide Borden Chemical, Inc. with human resource administrative services, claims processing, payroll processing and information technology management. Accenture provides employee training for a full range of learning and places an emphasis on hiring recent college graduates.
BRANDS/DIVISIONS/AFFILIATES: Andersen Consulting Accenture Technology Ventures
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Joe W. Forehand, CEO Stephan A. James, COO-Capabilities Harry L. You, CFO Joellin Comerford, Group Dir.-Sales Dev. Arnaud Andre, Managing Partner-People Mgmt. Douglas G. Scrivner, Corp. Sec. Douglas G. Scrivner, General Counsel William Copacino, Group Chief Exec.-Bus. Consulting Capability Group James E. Murphy, Managing Dir.-Comm. Michael G. McGrath, Treas. Pamela J. Craig, Managing Partner-Bus. Oper. William D. Green, COO-Client Services Jackson L. Wilsom, Chief Exec.-Bus.-Process Outsourcing Diego Visconti, Group Chief Exec.-Comm. and High-Tech Oper. Joe W. Forehand, Chmn.
Phone: 441-296-8262 Fax: 441-296-4245 Toll-Free: Address: 41 Cedar House, Hamilton, HM12 Bermuda
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $13,105,000 (12 months) 2002 Profits: $244,900 (12 months) Stock Ticker: ACN 2001 Sales: $13,348,000 2001 Profits: $377,000 Employees: 75,000 2000 Sales: $9,752,100 2000 Profits: $2,463,900 Fiscal Year Ends: 8/31 1999 Sales: $9,549,900 1999 Profits: $2,022,700 1998 Sales: $8,214,800 1998 Profits: $1,685,300
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Top Exec. Salary: $2,112,000 Stock Purch. Plan: Second Exec. Salary: $1,848,000 ADVANTAGE: One of the world's largest consulting firms/ First-class client base worldwide.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Bonus: $40,624 Bonus: $35,546
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ACTERNA CORPORATION
www.acterna.com
Industry Group Code: 334515 Ranks within this company's industry group: Sales:6 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:4
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Network Testing Equipment Manufacturer Computer Products and Systems
Acterna Corporation, formerly Dynatech, is a leading developer and manufacturer of communications equipment in three categories: communications testing equipment, industrial computing and communications and visual communications. The company’s TTC division, formerly known as Telecommunications Techniques Co., provides telecommunications testing equipment that enables service providers (such as long-distance and competitive access providers), large service users (such as large corporate and government network operators) and equipment manufacturers to test and analyze systems from a central location. Acterna's industrial computer source division produces and markets durable computer equipment for companies that require such that withstands excessive stresses, such as those found in production facilities and field technician environments. The company’s visual communications division is focused on two market niches: the production of passenger cabin video information systems for the aviation market (through its Airshow, Inc. subsidiary) and digital color enhancement technologies (through subsidiary da Vinci Systems, Inc.) Acterna recently sold its status and performance monitoring product line to Tollgrade Communications in order to further concentrate resources on its communications testing capabilities. The firm continues to search for growth in the cable market through the development of its test tools, as well as the integration of workforce management solutions through its TechSync portfolio. In other news, Marconi selected the company as its advanced network tester at its optical network research and development labs in Genoa, Italy. Additionally, Acterna was selected to provide performance-enhancing testing solutions tools for Powercor Australia, one of the country's largest electricity distributors. The firm offers its employees dental and vision insurance, credit union membership, flextime, tuition reimbursement and a referral program. Additionally, the company provides its workers with discounts on auto and homeowners' insurance, cell phones and financial planning assistance.
BRANDS/DIVISIONS/AFFILIATES: Dynatech DataViews Airshow, Inc. da Vinci Systems ComCoTec Parallax Graphics TechSync Telecommunications Techniques Co.
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. John R. Peeler, CEO John R. Peeler, Pres. John Ratliff, CFO John D’Anna, Sr. VP-Americas Sales Carol Cristiano, VP-Human Resources S. David Bent, CIO Richard H. Goshorn, Corp. Sec. Richard H. Goshorn, General Counsel Douglas J. Halbert, Jr., Sr. VP-Oper. Wolfgang Schuster, Pres.-Transport, Fiber Optics and Wireless Helmut Berg, Pres.-Data Network Services Roger Friedli, Sr. VP-Europe, Middle East and Africa Sales Jim Platner, VP-Asia Pacific Sales Ned C. Lautenbach, Chmn.
Phone: 301-353-1550 Fax: 301-353-1536 Toll-Free: 800-638-2049 Address: 20400 Observation Dr., Germantown, MD 20876-4023 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,132,700 (12 months) 2002 Profits: $-374,900 (12 months) Stock Ticker: ACTR 2001 Sales: $1,167,800 2001 Profits: $-171,800 Employees: 4,973 2000 Sales: $453,200 2000 Profits: $6,000 Fiscal Year Ends: 3/31 1999 Sales: $522,900 1999 Profits: $6,400 1998 Sales: $472,948 1998 Profits: $41,776
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $440,600 Bonus: $150,000 Stock Purch. Plan: Second Exec. Salary: $306,269 Bonus: $150,000 ADVANTAGE: Unique network provides entertainment for airline passengers/ Strategic acquisitions.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ACUSON CORPORATION
www.acuson.com
Industry Group Code: 339113 Ranks within this company's industry group: Sales: Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Equipment-Diagnostic Ultrasound Systems
Acuson is a leading manufacturer of upgradeable diagnostic medical ultrasound systems that generate and display ultrasound images. The firm is a part of the ultrasound division of Siemens Medical Solutions, a subsidiary of Siemens USA. Siemens USA is owned by the giant German firm Siemens AG. Acuson develops general imaging products for various medical fields, including radiology, obstetrics, gynecology and urology. Acuson also offers digital lab solutions, which enable users to access, review and manage medical images taken in a digital format. The firm also produces transducers for various applications, including breast, pediatric, neonatal head, cardiac and intraoperative uses. Acuson’s main focus is on echocardiographic products that specialize in the heart. Its revolutionary products include the Sequoia Echo, Sequoia GI, CV70, Aspen Echo, Aspen GI and Cypress. In addition, the company has developed the AcuNav diagnostic ultrasound catheter that aids in the diagnosis and the treatment management of heart disease sufferers by enabling doctors to see through the blood into cardiac chambers. The AcuNav catheter is compatible with Acuson’s echocardiographic products. The firm provides educational services and training seminars regarding its products. The firm’s corporate culture seeks to foster innovation, technology, diversity and teamwork, as evidenced by the fact that two-thirds of Siemens medical products are less than three years old. Benefits offered to employees include business-casual dress, vision and hearing coverage, dental and prescription coverage, an employee assistance program, mental health/substance abuse coverage and flexible work schedules. Additionally, employees are entitled to receive tuition assistance, scholarship programs for children, adoption assistance and career training and development programs.
BRANDS/DIVISIONS/AFFILIATES: Siemens Ecton, Inc. Sequoia Aspen 128XP CV70 Cypress AcuNav
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. John Pavlidis, CEO Lars Becker, VP/COO John Pavlidis, Pres. Karl Blaim, Sr. VP/CFO Rick E. Smith, Sr. VP-Worldwide Sales and Mktg. Charles H. Dearborn, VP-Human Resources and Legal Affairs Jin Kim, Sr. VP/Chief Tech. Officer L. Thomas Morse, Corp. Controller Edward P. Cornell, Sr. VP-Eng. Bradford C. Anker, VP-Mfg. Corinne Z. Augustine, VP-Strategic Programs Robert J. Gallagher, Sr. VP Lourens B. Steger, VP-Worldwide Services Bus. Organization John Allison, VP-Product Creation Bill Carrano, VP-Worldwide Mktg.
Phone: 650-969-9112 Fax: 650-943-7006 Toll-Free: 800-422-8766 Address: 1230 Shorebird Way, Mountain View, CA 94043-1344 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for months. 2002 Sales: $ ( months) 2002 Profits: $ ( months) Stock Ticker: Subsidiary 2001 Sales: $ 2001 Profits: $ Employees: 1,932 2000 Sales: $ 2000 Profits: $ Fiscal Year Ends: 12/31 1999 Sales: $ 1999 Profits: $ 1998 Sales: $ 1998 Profits: $
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Bonus: $ Stock Purch. Plan: Second Exec. Salary: $ Bonus: $ ADVANTAGE: Highly regarded medical diagnostic ultrasound systems and image management products.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADAC LABORATORIES
www.adaclabs.com
Industry Group Code: 339113 Ranks within this company's industry group: Sales: Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Equipment-Medical Imaging Systems Health Care Information Systems Radiation Therapy Systems PET Systems CT Systems
ADAC Laboratories, a Philips Medical Systems company, is a world leader in the development of nuclear medicine imaging, positron emission tomograpy (PET) and radiation therapy planning systems and a leading supplier of radiology and cardiology information and image management systems. The parent company is Netherlands-based Koninklijke (Royal) Philips Electronics N.V. ADAC produces a wide variety of nuclear medicine products, including leading-edge single-, dual- and triplehead gamma cameras. The company's SKYLight nuclear medicine camera allows dual-detector total body spots, standing body imaging and full-brain single photon emission computed tomography imaging. ADAC offers a full line of PET products including MCD/AC, CPET Plus and the GSO-based PET system, ADAC-Allegro. The firm develops turnkey systems to assist hospitals in planning patient radiation treatments. The Pinnacle radiation oncology system's computers deliver three-dimensional volumetric image processing and dose computation capabilities, allowing physicians to precisely estimate the amount of high-energy radiation needed to target a specific area for the treatment of cancer. ADAC provides health care providers with computer software applications that process and archive patient and clinical information, including ENVOI (which focuses on radiology) and the CorCAAT (which focuses on cardiology). ADAC provides its employees with insurance, an employee assistance program, up to $3500 per year in tuition reimbursement, flexible spending accounts and membership in a credit union. In addition, the company sponsors family picnics, rallies, parties, car pool services, a series of awards, a basketball court, shower and locker facilities, sports teams and discounts at local health clubs.
BRANDS/DIVISIONS/AFFILIATES: Koninklijke (Royal) Philips Electronics N.V. Philips Medical Systems SKYLight CPET ENVOI CorCAAT Pinnacle SmartSim
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Gerhard F. Burbach, CEO Gerhard F. Burbach, Pres. Arno Kolen, CFO Larry McAlister, VP-Human Resources
Phone: 408-321-9100 Fax: 408-321-9536 Toll-Free: 800-538-8531 Address: 540 Alder Dr., Milpitas, CA 95035 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for months. 2002 Sales: $ ( months) 2002 Profits: $ ( months) Stock Ticker: Subsidiary 2001 Sales: $ 2001 Profits: $ Employees: 900 2000 Sales: $324,000 2000 Profits: $-1,000 Fiscal Year Ends: 9/30 1999 Sales: $342,131 1999 Profits: $-33,620 1998 Sales: $300,528 1998 Profits: $7,386
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Stock Purch. Plan: Y Second Exec. Salary: $ ADVANTAGE: Significant global market share in nuclear medicine.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADAM OPEL AG
www.opel.com
Industry Group Code: 336111 Ranks within this company's industry group: Sales:15 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Profits:
Y
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Automobile Manufacturing
Adam Opel AG, a subsidiary of General Motors, is a manufacturer of cars and trucks including the Astra, Corsa, Speedster, Vectra and Frontera. In addition, Opel builds commercial vehicles, the Arena and Vivaro, as well as automotive components. The company is GM's largest non-U.S. subsidiary. Opel operates 10 plants in 7 countries in Europe, and 26 manufacturing and assembly plants on 5 continents, including a newly opened plant in Rüsselsheim, Germany. In recent news, the firm's alternative fuel vehicle, the Opel Zafira 1.6 CNG, which runs alternatively on gas and diesel engines, was honored as the best car of the year for 2002 in the Alternative Propulsion category by the German automotive industry magazine Autoflotte. The company plans to launch The Signum, Opel/Vauxhall’s Business Class vehicle in early 2003. Also planned are the Vectra station wagon and the Vectra GTS. Opel’s other initiatives include: ECOTEC 4and 6-cylinder engines, the G90 concept car and a new fuel cell propulsion system.
BRANDS/DIVISIONS/AFFILIATES: General Motors Agila Corsa Astra Zafira Vectra Omega Frontera
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Jan Jozef Brems, Managing Dir. Walter G. Borst, Financial Dir. Martin Smith, Dir.-Design Ditmar W. Porth, Dir. Production Alain Uyttenhoven, Dir.-Brand Kris Vilhelmsson, Brand Communication Dir. Hans H. Demant, Exec. Dir.-Opel ITDC Carl-Peter Forster, Chmn.
Phone: 49-6142-660 Fax: 49-6142-664-859 Toll-Free: Address: Postfach 1710, Rüsselsheim, 65423 Germany
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $14,459,000 (12 months) 2002 Profits: $ (12 months) Stock Ticker: Subsidiary 2001 Sales: $14,173,000 2001 Profits: $ Employees: 36,000 2000 Sales: $ 2000 Profits: $ Fiscal Year Ends: 1999 Sales: $ 1999 Profits: $ 1998 Sales: $ 1998 Profits: $
SALARIES/BENEFITS: Pension Plan: Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Stock Purch. Plan: Second Exec. Salary: $ ADVANTAGE: This firm is GM's major operation in Europe.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADAPTEC INC
www.adaptec.com
Industry Group Code: 334110 Ranks within this company's industry group: Sales:5 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:7
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Computer Networking Equipment-Adapters & Controllers Input/Output Software Products Single Chip SCSI Host Adapters Storage Systems Technology Storage Networking
Adaptec develops storage solutions for e-business and Internet applications that move, manage and protect data and critical content. Its storage solutions are used in highperformance networks, servers, network attached storage devices, workstations and desktop personal computers, from the world's leading manufacturers of computer, storage and networking products. The company’s solutions are sold through original equipment manufacturers (OEMs) and distribution channels to a wide variety of end users, ranging from large-scale enterprises to retail consumers. Adaptec currently operates in three business segments: the storage solutions group (SSG), the desktop solutions group (DSG) and the storage networking group (SNG). SSG's interface products enable the movement, storage and protection of data across a range of server platforms, direct attached storage, servers, storage area networks, based servers, network attached storage, devices and storage subsystems. DSG provides high-performance I/O connectivity solutions for personal computing platforms, including notebook and desktop PCs and consumer electronic devices. SNG provides storage connectivity solutions for servers, storage devices, fabric switches and network attached storage devices. Recently, the company acquired the outstanding technology of Tricord Systems, Inc., a company that develops technology for managing network attached storage systems.
BRANDS/DIVISIONS/AFFILIATES: Tricord Systems, Inc.
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Robert N. Stephens, CEO Robert N. Stephens, Pres. David A. Young, CFO Thomas M. Flageollet, VP-Worldwide Sales Shirley Olerich, VP-Human Resources Mark Delsman, VP-Chief Tech. Officer Joan Konsdorf, CIO John Lazlo, VP-Bus. Dev. John Lazlo, VP-Investor Rel. Ahmet Houssein, VP/Mgr.-Host I/O Products Group Steve Cochran, VP/Mgr.-RAID Products Group Carl J. Conti, Chmn.
Phone: 408-945-8600 Fax: 408-262-2533 Toll-Free: Address: 691 S. Milpitas Blvd., Milpitas, CA 95035 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $418,700 (12 months) 2002 Profits: $-196,200 (12 months) Stock Ticker: ADPT 2001 Sales: $582,000 2001 Profits: $39,700 Employees: 1,713 2000 Sales: $811,200 2000 Profits: $170,800 Fiscal Year Ends: 3/31 1999 Sales: $692,400 1999 Profits: $-13,300 1998 Sales: $1,007,300 1998 Profits: $172,900
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $616,751 Stock Purch. Plan: Y Second Exec. Salary: $379,539 Strong market penetration/Strong brand image. ADVANTAGE:
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $1,200,000 Bonus: $350,000
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADC TELECOMMUNICATIONS INC
www.adc.com
Industry Group Code: 334210 Ranks within this company's industry group: Sales:12 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y Y Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:11
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y
GROWTH PLANS/SPECIAL FEATURES:
Telecommunications Equipment-Voice, Data & Video Signal Transmission Transmission and Networking Systems Integrated Equipment Solutions Software Consulting Systems Integration Internet Protocol Based Offerings
ADC Telecommunications provides a broad range of network equipment, software and integration services for broadband, multi-service networks that deliver Internet/data, video and voice communications over telephone, cable television, Internet, broadcast, wireless and enterprise networks. The company’s broadband, multi-service network solutions enable local access, highspeed transmission and software management of communication services from service providers to consumers and businesses over fiber-optic, copper, coaxial and wireless media. ADC serves its customers through two main business units: broadband infrastructure and access and integrated solutions. The broadband infrastructure and access unit focuses on Internet Protocol (IP)-based offerings for the cable industry, digital subscriber line (DSL) offerings for the telecommunications industry and broadband connectivity products for wireline, cable and wireless communications network applications. The integrated solutions division focuses on operations support system (OSS) software and system integration services for broadband, multiservice communications over wireline and wireless networks. Systems integration services are used to design, equip and build communications networks that deliver Internet, data, video and voice services to consumers and businesses. OSS software includes communications billing, customer management, network performance and service-level assurance software used by service providers to operate communications networks. ADC customers include local and long-distance telephone companies, cable television operators, wireless service providers, new competitive service providers, broadcasters, governments, businesses, system integrators and communications equipment manufacturers and distributors. Recently, the company announced an extension of its supply agreement with SBC Services, Inc., in which the company is a preferred supplier to SBC of connectivity products. ADC offers employees child care and elder care referrals, as well as tax-advantaged reimbursement programs for day care and health care expenses.
BRANDS/DIVISIONS/AFFILIATES:
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Richard R. Roscitt, CEO Richard R. Roscitt, Pres. Robert E. Switz, Exec. VP/CFO William F. O'Brien, VP/Chief Mktg. Officer Laura N. Owen, VP-Human Resources Charles T. Roehrick, VP/Controller Jeffrey D. Pflaum, Corp. Sec. Jeffrey D. Pflaum, Chief Legal Officer Mary E. Quay, VP-Worldwide Oper. Barclay W. Firzpatrick, VP-Bus. Dev. Gokul Hemmady, VP/Treas. Jo Anne M. Anderson, VP/Pres.-Systems Integration Lawrence S. Barker, VP/Pres.-Software Systems Michael K. Pratt, VP/Pres.-Wireline Patrick D. O'Brien, VP/Pres.-Connectivity Richard R. Roscitt, Chmn.
Phone: 952-938-8080 Fax: 952-917-1717 Toll-Free: 800-366-3889 Address: 13625 Technology Dr., Eden Prarie, MN 55343 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,047,700 (12 months) 2002 Profits: $-1,145,000 (12 months) Stock Ticker: ADCT 2001 Sales: $2,402,800 2001 Profits: $-1,287,700 Employees: 7,600 2000 Sales: $3,287,900 2000 Profits: $868,100 Fiscal Year Ends: 10/31 1999 Sales: $1,926,900 1999 Profits: $87,600 1998 Sales: $1,379,700 1998 Profits: $146,700
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Y Profit Sharing: Top Exec. Salary: $924,000 Stock Purch. Plan: Second Exec. Salary: $386,000 ADVANTAGE: Capable of providing turn-key consulting, software and systems integration.
OTHER THOUGHTS: Apparent Women Officers or Directors: 3 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $1,994,258 Bonus: $1,500,000
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADOBE SYSTEMS INC
www.adobe.com
Industry Group Code: 511200 Ranks within this company's industry group: Sales:18 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:7
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Computer Software-Desktop & Publishing
Adobe Systems, Inc. develops graphic design, publishing and imaging software using web, print, video, wireless and broadband applications. The company’s most widely used products include Adobe Acrobat, which enables users to transmit and read PDF (portable document format) files; Adobe Pagemaker, which allows users to create business documents and web pages with layout tools, templates and stock arts; and Adobe Photoshop, which enables users to edit graphic images. The company’s products are used by a variety of customers, including web and graphic designers, professional publishers, business users and individual consumers. In addition, Adobe develops software solutions for the nascent e-book industry. Through Adobe Ventures, a joint venture formed with Granite Ventures, LLC, Adobe invests in firms that develop authoring, publishing or distributing information products that will prove beneficial to the firm. In recent news, Adobe signed an agreement with ACCESS Co., Ltd., a Japan-based mobile content delivery and access technologies provider, to integrate Adobe Reader software into a future version of ACCESS’s NetFront web browser. This will allow consumers to utilize Adobe Reader on consumer electronics and mobile platforms. Adobe takes part in several community relations programs. The company offers support such as cash grants, software donations, software training and volunteers to underserved populations living in areas where Adobe employees live and work. Recipients are often schools and nonprofit organizations. Adobe offers its employees a full range of medical benefits, as well as group legal services, long-term care, educational assistance, adoption benefits, a matching gift program and a cafeteria and on-site fitness center at the corporate headquarters.
BRANDS/DIVISIONS/AFFILIATES: Adobe Acrobat Adobe Pagemaker Adobe Photoshop Adobe Ventures
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Bruce Chizen, CEO Bruce R. Chizen, Pres. Murray Demo, Sr. VP/CFO Melissa Dyrdahl, Sr. VP-Corp. Mktg. Theresa Townsley, Sr. VP-Human Resources Karen Cottle, Sr. VP/Corp. Sec. Karen Cottle, General Counsel Jim Stephens, Sr. VP-Worldwide Sales and Field Oper. Kyle Mashima, Sr. VP-Strategic Dev. Kevin Burr, VP-Corp. Comm. Shantanu Narayen, Exec. VP-Worldwide Products James Heeger, Sr. VP-Digitial Imaging and Video Products John E. Warnock, Chmn. Pierre Van Beneden, VP-Europe, Middle East and Africa
Phone: 408-536-6000 Fax: 408-537-6000 Toll-Free: 800-833-6687 Address: 345 Park Ave., San Jose, CA 95110-2704 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,164,800 (12 months) 2002 Profits: $191,400 (12 months) Stock Ticker: ADBE 2001 Sales: $1,229,700 2001 Profits: $205,600 Employees: 3,341 2000 Sales: $1,266,000 2000 Profits: $288,000 Fiscal Year Ends: 11/30 1999 Sales: $1,015,434 1999 Profits: $237,751 1998 Sales: $894,791 1998 Profits: $105,144
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Top Exec. Salary: $874,999 Bonus: $233,113 Stock Purch. Plan: Y Second Exec. Salary: $467,500 Bonus: $108,675 ADVANTAGE: Owns a well-known line of graphics software/Growing popularity of Acrobat product.
OTHER THOUGHTS: Apparent Women Officers or Directors: 3 Hot Spot for Advancement for Women/Minorities: Y
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADTRAN INC
www.adtran.com
Industry Group Code: 334210 Ranks within this company's industry group: Sales:15 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:8
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Telecommunications Equipment-High Speed Digital Transmission Service and Installation
ADTRAN, Inc. designs, develops and manufactures digital transmission products, particularly digital subscriber line (DSL) products, providing high-speed communications over existing telephone networks for telephone companies and corporate end users. Products are marketed globally through direct sales forces, resellers and distributors. The company's product lines, which are comprised of over 500 principal products, are built around core technologies developed to address the local loop and central office digital communications marketplace. These products include a comprehensive line of transmission, repeater, extension and termination products. The company is divided into two operating segments: carrier networks (CN) and enterprise networks (EN). CN customers include all of the major domestic incumbent local exchange carriers, large independent carriers and competitive service providers. Its global markets include China, Europe, Canada, Latin America and Australia. The company’s EN customers include private and public enterprises worldwide in numerous vertical industries. The main product lines for the CN division include the Total Access System and HDSL/HDSL2/HDSL4 transport technologies. The Total Access System is a distributed access solution that includes broadband and narrowband access platforms, outside plant access terminals, voice concentrators and system management and professional services. The EN division provides product line solutions for wide area connectivity across today's diverse communications networks and technologies. Key product lines include the ATLAS series of integrated access devices, the NetVanta Series of VPN networking devices, the TSU series of T1 services units, the IQ series of frame relay performance monitoring devices, the ISU series of ISDN service units, the TRACER series of wireless products and the DSU series of DDS service units. Recently, the company introduced the newest access router, the NetVanta 3305. ADTRAN offers employees a full range of benefits including tuition reimbursement, a technical development program and other training.
BRANDS/DIVISIONS/AFFILIATES: ATLAS Series NetVanta Series Total Access System HDSL/HDSL2/HDSL4 TRACER Series DSU Series TSU Series IQ Series
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Mark C. Smith, CEO Howard A. Thrailkill, COO Howard A. Thrailkill, Pres. James E. Matthews, Sr. VP-Finance/CFO Pete Ritch, Dir.-Human Resources Kevin W. Schneider, VP-Tech. Tom Elkins, VP-IT Lonnie S. McMillian, Sr. VP-Eng. Lonnie S. McMillian, Corp. Sec. James L. North, General Counsel Peter E. Voetsch, Sr. VP-Oper. John R. Cooper, VP-Finance Thomas R. Stanton, VP/General Mgr.-Carrier Networks Danny J. Windham, Sr. VP/General Mgr.-Enterprise Networks M. Melvin Bruce, VP-Carrier Networks Eng. Robert A. Fredrickson, VP-Carrier Networks Sales Mark C. Smith, Chmn.
Phone: 256-963-8000 Fax: 256-963-8699 Toll-Free: 800-923-8726 Address: 901 Explorer Blvd., Huntsville, AL 35814 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $345,700 (12 months) 2002 Profits: $24,800 (12 months) Stock Ticker: ADTN 2001 Sales: $387,100 2001 Profits: $17,300 Employees: 1,549 2000 Sales: $462,900 2000 Profits: $120,800 Fiscal Year Ends: 12/31 1999 Sales: $367,200 1999 Profits: $50,900 1998 Sales: $286,600 1998 Profits: $40,300
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Y Profit Sharing: Top Exec. Salary: $308,288 Stock Purch. Plan: Y Second Exec. Salary: $303,519 ADVANTAGE: Over 500 principal products and 24-hour, 7-days-a-week telephone support.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Bonus: $97,500 Bonus: $95,875
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADVANCED FIBRE COMMUNICATIONS INC Industry Group Code: 334210 Ranks within this company's industry group: Sales:16 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
www.afc.com
Profits:7 Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Telecommunications Equipment-Voice, Video & Data Signal Transmission Loop Carrier Systems
Advanced Fibre Communications, Inc. designs and manufactures end-to-end distributed multi-service access solutions for the portion of the telecommunications network between the carrier's central office and its subscribers. The company's OmniMAX product family is a multiservice broadband solution for providing voice and data services to the telecommunications industry. The OmniMAX portfolio consists of integrated multiservice access platforms, integrated access devices, optical network access concentrators, network services, network element management systems, environmentally hardened outside plant cabinets, indoor cabinets and related service and transmission technologies. The OmniMAX product family provides narrowband, wideband and broadband services to customers and consists of AccessMAX, PremMAX, TransMAX, ATLAS and Panorama. AccessMAX is the product family of IMAPs and environmentally hardened cabinets and technology for last-mile voice, data and broadband DSL solutions. Its products include the UMC1000, DMAX, AccessMAX System 8, EMAX and EMAXplus. The PremMAX IAD aggregates voice and data traffic at the customer premise onto the access loop. TransMAX is a family of optical network access platforms and includes a multiservice access concentrator allowing voice and data integration over packet-aware optical networks, enhancing data handling efficiencies over traditional non-packet-aware optical networks, saving bandwidth and money. ATLAS is a professional service organization made up of teams of professionals, regionally located, who provide consulting and complete end-to-end installation and operations, maintenance and provisioning services for voice, data and video networks. The Panorama element management system is a software application product providing a centralized graphic user interface for point and click management of the OmniMAX network. Recently, Advanced Fibre Communications introduced TransMAX 1500, the first-ever environmentally hardened optical add/drop multiplexer.
BRANDS/DIVISIONS/AFFILIATES: OmniMAX AccessMAX PremMAX TransMAX ATLAS Panorama EMAXplus UMC1000
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. John A. Schofield, CEO John A. Schofield, Pres. Keith Pratt, CFO/Sr. VP-Finance and Admin. Charles C. Geiger, VP-Mktg. E. James Sackman, VP/Chief Tech. Officer Leon Blackburn, VP/Corp. Controller Jorge Valdes, VP-Eng. Amy M. Paul, Corp. Sec. Amy M. Paul, VP/General Counsel Jeffrey Rosen, VP-Oper. Victoria L. Perrault, VP-Admin. Services Jack Ermey, VP-Global Sales Doak K. Smailer, VP-Quality and IT Charles C. Geiger, VP-Project Mgmt. John A. Schofield, Chmn.
Phone: 707-794-7700 Fax: 707-794-7777 Toll-Free: Address: 1465 N. McDowell Blvd., Petaluma, CA 94954 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $344,100 (12 months) 2002 Profits: $31,800 (12 months) Stock Ticker: AFCI 2001 Sales: $327,600 2001 Profits: $167,800 Employees: 843 2000 Sales: $416,800 2000 Profits: $77,600 Fiscal Year Ends: 12/31 1999 Sales: $296,600 1999 Profits: $249,100 1998 Sales: $312,700 1998 Profits: $27,200
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $403,846 Stock Purch. Plan: Y Second Exec. Salary: $254,086 ADVANTAGE: Expertise in complex telecommunication systems and services.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $341,402 Bonus: $188,281
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ADVANCED MICRO DEVICES INC
www.amd.com
Industry Group Code: 334413 Ranks within this company's industry group: Sales:3 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:21
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Microprocessors Semiconductors
Advanced Micro Devices, Inc. (AMD) designs, develops, manufactures and markets complex monolithic integrated circuits for use by manufacturers of a broad range of electronic equipment and systems, particularly for personal computers, workstations, servers, telecommunications equipment, data and network communications equipment and consumer electronics. AMD has manufacturing operations in the United States, Europe and Asia, and is a major competitor to Intel, the industry leader. The company makes mid-priced microprocessors such as the K6 chip, as well as network and voice/data communication chipsets, erasable programmable read-only memories, flash memories and programmable flash devices. AMD's Alchemy Semiconductor, Inc. designs, develops and markets lowpower, high-performance microprocessors for personal connectivity devices such as personal digital assistants, web tablets and portable and wired Internet access devices and gateways. The company recently introduced the AMD Athlon MP Processor 2600, used to run missioncritical applications. The advanced Hammer 64 bit chip was scheduled to be introduced by the end of 2002, but was later moved back to April 2003. Staff members have the option to telecommute, are given maternity benefits and are offered a discount on public transportation. There is no dress code at Advanced Micro Devices, and the company offers gym memberships, a sabbatical program and elder care referral.
BRANDS/DIVISIONS/AFFILIATES: Am486 AMD-K6 NexGen, Inc. Duron Athlon Hammer Alchemy Semiconductor, Inc. Barton
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Hector Ruiz, CEO Hector Ruiz, Pres. Bob Rivet, Sr. VP/CFO Rob Herb, Exec. VP/Chief Sales and Mktg. Officer William T. Siegle, Sr. VP-Tech./Chief Scientist Thomas M. McCoy, Sr. VP/General Counsel Michael Haase, Dir.-Investor Rel. Bertrand Cambou, VP-Memory Group Billy Edwards, VP-Personal Connectivity Solutions Dirk Meyer, Sr. VP-Computation Products W. J. Sanders, III, Chmn.
Phone: 408-732-2400 Fax: 408-894-0547 Toll-Free: 800-538-8450 Address: One AMD Pl., Sunnyvale, CA 94086 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $2,697,000 (12 months) 2002 Profits: $-1,303,000 (12 months) Stock Ticker: AMD 2001 Sales: $3,891,800 2001 Profits: $-60,600 Employees: 12,146 2000 Sales: $4,664,200 2000 Profits: $983,000 Fiscal Year Ends: 12/31 1999 Sales: $2,857,600 1999 Profits: $-88,900 1998 Sales: $2,542,100 1998 Profits: $-104,000
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Stock Purch. Plan: Y ADVANTAGE: Award winning high-speed chips.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Top Exec. Salary: $1,000,000 Second Exec. Salary: $775,962
Bonus: $1,217,412 Bonus: $19,337
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AFFYMETRIX INC
www.affymetrix.com
Industry Group Code: 334413 Ranks within this company's industry group: Sales:20 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:8
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Chips-Genetics Genetic Testing Instruments
Affymetrix develops technology for examining and managing complex genetic information for use in biomedical research, genomics and clinical diagnostics. The cornerstone of the company is its GeneChip technology, used for sequence analysis, genotyping and gene expression monitoring. Its integrated GeneChip platform includes disposable DNA probe arrays (chips) consisting of gene sequences set out in an ordered, highdensity pattern, certain reagents for use with the probe arrays, a scanner and other instruments to process the probe arrays and software to analyze and manage genomic information from the probe arrays. The firm maintains three primary focuses as part of its business strategy: gene expression monitoring, DNA analysis and clinical applications. Markets for its products include all aspects of molecular biology research in the life sciences, including basic human disease research, genetic analysis, pharmaceutical drug discovery and development, pharmacogenomics, toxicogenomics and agricultural research. Affymetrix currently sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics and consumer products companies as well as academic research centers, government research laboratories, private foundation laboratories and clinical reference laboratories in North America, Europe and Japan. In recent news, the company entered into a supply agreement with Perlegen Sciences, Inc. for Perlegen's core SNP discovery and genotying research. A license to new single nucleotide polymorphism content and broader surveying methods and access to whole genome technologies will be made available through the CustomSeq product line. In other news, Affymetrix announced an agreement with ParAllele BioScience, Inc. With this supply agreement, the company provides certain instrumentation and arrays to be used by ParAllele in combination with its proprietary typing technology for research and third-party genotyping services. The company offers its workers an employee discount program, legal and financial services, health fitness discounts, a tuition assistance plan and a lunch program.
BRANDS/DIVISIONS/AFFILIATES: GeneChip CustomSeq Spotted Array Systems GeneChip CustomExpress GenFlex Tag Array
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Stephen P. A. Fodor, CEO Susan E. Siegel, Pres. Gregory T. Schiffman, Sr. VP/CFO Barbara A. Caulfield, Exec. VP/General Counsel Trevor J. Nicholls, Global Oper. Trevor J. Nicholls, Chief Commercial Officer Stephen P. A. Fodor, Chmn.
Phone: 408-731-5000 Fax: 408-731-5441 Toll-Free: 888-362-2447 Address: 3380 Central Expy., Santa Clara, CA 95051 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $289,947 (12 months) 2002 Profits: $-1,630 (12 months) Stock Ticker: AFFX 2001 Sales: $224,900 2001 Profits: $-33,121 Employees: 877 2000 Sales: $200,830 2000 Profits: $-53,990 Fiscal Year Ends: 12/31 1999 Sales: $109,074 1999 Profits: $-25,504 1998 Sales: $52,413 1998 Profits: $-26,800
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $470,194 Stock Purch. Plan: Second Exec. Salary: $420,196 ADVANTAGE: Owns leading gene analysis technology/Growth through acquisitions.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $500,000 Bonus: $300,000
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AGILENT TECHNOLOGIES INC
www.agilent.com
Industry Group Code: 334515 Ranks within this company's industry group: Sales:1 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:6
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Test Equipment Fiber Optic Communication Devices Image Sensors Patient Monitoring Equipment Ultrasound Imaging Equipment Bioinstrumentation
Agilent Technologies, Inc. is an international diversified technology company that manufactures instruments, test equipment and other solutions to markets within the communications, electronics, life sciences and chemical analysis industries. The company separated from Hewlett-Packard as part of a corporate realignment. Agilent operates through three main businesses: test and measurement, semiconductor products and life sciences and chemical analysis. Its test and measurement business provides standard and customized solutions that are used in the design, development, manufacture, installation, deployment and operation of electronic equipment and systems and communications networks and services. These solutions include test and measurement instruments and systems, automated test equipment, communications network monitoring, management, optimization tools, software design tools and associated services. The company’s semiconductor products business is a leading supplier of semiconductor components, modules and assemblies for highperformance communications systems. It designs, develops and manufactures products for the networking and personal systems markets. Agilent’s life sciences and chemical analysis business provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. The seven key product categories include: microarrays, microfluidics, gas chromatography, liquid chromatography, mass spectrometry, informatics and related consumables and services. Agilent recently introduced the HFBR-1506AM transmitter and HFBR-2506AM receiver to be used in industrial networks. The company offers employees retirement savings, profit sharing, educational reimbursement, flexible work hours, flexible time off, sports teams and health and fitness facilities. Agilent also provides flexible maternity benefits and telecommuting. Dress code is business casual.
BRANDS/DIVISIONS/AFFILIATES: Agilent 1100 Series Hewlett-Packard Co. HFBR-1506AM HFBR-2506AM
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Edward W. Barnholt, CEO William P. Sullivan, Exec. VP/COO Edward W. Barnholt, Pres. Adrian T. Dillon, CFO Larry C. Holmberg, Sr. VP-Sales, Mktg. and Customer Support Jean M. Halloran, VP-Human Resources Thomas A. Saponas, Chief Tech. Officer Marty Chuck, CIO Dorothy D. Hayes, Controller G. Craig Nordlund, Corp. Sec. G. Craig Nordlund, General Counsel William R. Hahn, Sr. VP-Strategic Programs William R. Hahn, Sr. VP-Corp. Rel. William P. Sullivan, Sr. VP-Semiconductor Products Jack P. Trautman, Sr. VP/General Mgr.-Automated Test Group Chris van Ingen, Sr. VP/General Mgr.-Life Sciences Thomas White, Sr. VP/General Mgr.-Comm. Solutions Edward W. Barnholt, Chmn.
Phone: 650-752-5000 Fax: 650-752-5633 Toll-Free: Address: 395 Page Mill Rd., Palo Alto, CA 94306 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $6,010,000 (12 months) 2002 Profits: $-1,032,000 (12 months) Stock Ticker: A 2001 Sales: $8,396,000 2001 Profits: $168,000 Employees: 36,000 2000 Sales: $10,773,000 2000 Profits: $757,000 Fiscal Year Ends: 10/31 1999 Sales: $8,331,000 1999 Profits: $512,000 1998 Sales: $7,952,000 1998 Profits: $257,000
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Top Exec. Salary: $925,000 Stock Purch. Plan: Second Exec. Salary: $552,493 ADVANTAGE: Operates worldwide/One of the world's leaders in testing products.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $474,684 Bonus: $650,000
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AIR PRODUCTS & CHEMICALS INC
www.airproducts.com
Industry Group Code: 325000 Ranks within this company's industry group: Sales:6 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:3
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Y Oil/Chem. Svcs.: Gases: Y Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Industrial Gases & Chemicals Manufacturer Air Pollution Control Equipment
Air Products and Chemicals is a leader in the United States industrial gases market. It produces argon, helium, hydrogen, nitrogen, oxygen and other gases. The company serves corporations in the steel and petroleum industries, the chemical processing business and electronics manufacturing. The company also produces chemicals, air pollution control equipment and hydrogen purification systems. Air Products continues to grow its wide-scale distribution of industrial gases through the establishment of on-site plants. The company recently acquired Sanwa Chemical Industry Co., Ltd., a leading Japanese producer of specialty polyamide resins and epoxy curing agents with operations in Tokyo, Japan and in Singapore. The acquisition marks Air Products' first performance products operations in Asia and will enhance existing performance materials division businesses currently operating in the region. Air Products entered into a 10-year agreement with Boeing for the supply of highpressure helium and a proprietary pumping system, to be used by Boeing's Delta IV rocket program in California. The rocket system is part of an ongoing U.S. Air Force initiative to reduce space launch costs through use of evolved expendable launch vehicles. The firm also signed an exclusive multi-year agreement to supply Shanghai LanBao Photoelectric Materials Co., Ltd of China with its ultra-high purity White Ammonia product, as well as other electronic specialty gases. In other news, Air Products agreed to build, own and operate a 34-million standardcubic-feet-per-day hydrogen facility for Catlettsburg Refining, a subsidiary of Marathon Ashland Petroleum. To encourage, recognize and reward outstanding environmental, health and safety achievements, Air Products recently created the EH&S Leadership Awards Program. The company strives to demonstrate integrity and ethical conduct in its business and professional relationships. The company is also focused on employee and product safety and respect for the environment. In fact, Air Products now enjoys one of the safest workplaces of any company in its industry.
BRANDS/DIVISIONS/AFFILIATES: Sanwa Chemical Industry Co. BOC Group
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. John P. Jones, III, CEO John P. Jones, III, Pres. John R. Owings, CFO Leonard V. Broese van Groenou, VP-Human Resources Miles P. Drake, Chief Tech. Officer Joseph H. McMakin, VP-Global IT Paul E. Huck, Controller Nirmal Chatterjee, VP-Corp. Eng. W. Douglas Brown, Corp. Sec. W. Douglas Brown, General Counsel Hermann Ortega, VP-Oper. Michael Parsell, VP-Bus. Dev. Alexander W. Masetti, VP-Investor Rel. Marshall L. Sullivan, Treas. Mark L. Bye, Pres.-Air Products Asia Jeffry L. Byrne, VP-Chemical and Process Industries William J. Cantwell, VP-Process Mgmt. Cecil C. Chappelow, VP-Gases and Equipment Tech. John P. Jones, III, Chmn.
Phone: 610-481-4911 Fax: 610-481-5900 Toll-Free: Address: 7201 Hamilton Blvd., Allentown, PA 18195 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $5,401,000 (12 months) 2002 Profits: $525,000 (12 months) Stock Ticker: APD 2001 Sales: $5,717,200 2001 Profits: $560,200 Employees: 17,200 2000 Sales: $5,467,100 2000 Profits: $124,200 Fiscal Year Ends: 9/30 1999 Sales: $5,039,800 1999 Profits: $450,500 1998 Sales: $4,934,500 1998 Profits: $546,800
SALARIES/BENEFITS: Pension Plan: Y Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $900,000 Stock Purch. Plan: Second Exec. Salary: $620,000 ADVANTAGE: Worldwide operations/Large market share.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AIRBUS SAS
www.airbus.com
Industry Group Code: 336410 Ranks within this company's industry group: Sales:4 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Profits: Y
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Aircraft Manufacturer
Airbus SAS, a joint venture formed by the European Aeronautic Defense and Space Company and U.K.-based BAE Systems, is the world’s second-largest commercial aircraft manufacturer behind Boeing. The company currently has more than 2,700 aircraft in operation. Airbus’s single-aisle and wide-body jets have capacities ranging from 110 to 400 passengers. The firm’s A380 model, due in 2006, will carry 555 passengers. The company also produces A300, A310, A318, A319, A320, A330, A340 and 600ST aircraft as well as corporate jetliners and freighters. Airbus has operations in nearly 200 locations around the globe that are overseen by its divisions: Airbus North America, Airbus China, Airbus Japan and Airbus Transport International. Engineering operations are organized around five main design offices, which manufacture cockpit systems and avionics; fuselage, fin, cabin interior and pressurization and air conditioning systems; wings, fuel systems and landing gear; flap and slat systems and cargo holds and handling systems; and horizontal and other tail plane systems. In recent news, Airbus signed an agreement with U.S. Airways, following its emergence from bankruptcy protection, to replace a prior order of aircraft and more than double the size of U.S. Airways’ fleet of Airbus widebody aircraft. China Aviation Supplies and JetBlue Airways signed agreements with Airbus for aircraft to be delivered beginning in 2004. Also, Airbus recently delivered aircraft to Thomas Cook Airlines and PrivatAir, a German business aviation specialist. There are at least 50 different nationalities and over 20 languages spoken among Airbus's 45,000 employees. English is the company's working language.
BRANDS/DIVISIONS/AFFILIATES: European Aeronautic Defence and Space Co. BAE Systems Airbus North America Airbus Transport International Airbus China Airbus Japan A380
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Noel Forgeard, CEO Gustav Humbert, COO Noel Forgeard, Pres. Andreas Sperl, CFO Erik Pillet, Exec. VP-Human Resources Alain Garcia, Exec. VP/Pres.-Eng. Karl-Heinz Hartmann, Exec. VP-Mfg. Philippe Delmas, Exec. VP-Gov't Rel., Comm. and External Affairs Bill Black, Exec. VP-Quality and Integration Ray Wilson, Exec. VP-Procurement Francisco Fernandez Sainz, Exec. VP/Pres.-Airbus Military SAS John Leahy, Chief Commercial Officer Manfred Bischoff, Chmn.
Phone: 33-5-61-93-33-87 Fax: 33-5-61-93-49-55 Toll-Free: Address: One Rond Point Maurice Bellonte, Blagnac Cedex, 31707 France
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $20,333,000 (12 months) 2002 Profits: $ (12 months) Stock Ticker: Foreign 2001 Sales: $18,159,000 2001 Profits: $ Employees: 46,000 2000 Sales: $ 2000 Profits: $ Fiscal Year Ends: 12/31 1999 Sales: $ 1999 Profits: $ 1998 Sales: $ 1998 Profits: $
SALARIES/BENEFITS: Pension Plan: Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Stock Purch. Plan: ADVANTAGE: Growing market share worldwide.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Top Exec. Salary: $ Second Exec. Salary: $
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West:
Southwest: Y
Midwest: Y
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AKORN INC
www.akorn.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:64 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:58
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Ophthalmic and Injectable Surgical Products
Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes. Through its ophthalmics division, the company markets an extensive line of diagnostic and therapeutic ophthalmic pharmaceutical products as well as surgical instruments and related supplies. Diagnostic products, primarily used in the office setting, include mydriatics, cycloplegics, anesthetics, topical stains, gonioscopic solutions and angiography dyes. Therapeutic products, sold primarily to wholesalers and other national account customers, include antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines and anti-edema medications. Akorn also markets surgical products such as surgical instruments, balanced salt solution, post-operative kits, surgical tapes, eye shields, anti-ultraviolet goggles, facial drape supports and other supplies. Non-pharmaceutical products include various artificial tear solutions, preservative-free lubricating ointments, lid cleansers, vitamin supplements and contact lens accessories. Additionally, Akorn markets a line of specialty injectable pharmaceutical products, including anesthesia products used in the treatment of rheumatoid arthritis and pain management. Contract services and injectable pharmaceutical products are marketed under the name Taylor Pharmaceuticals, a former subsidiary that has been absorbed into the company. The Taylor name is used because of its recognizability. In recent news, the company received approval from the U.S. Food and Drug Administration for Lidocaine Jelly 2%, which is used as a topical anesthetic by urologists and hospitals. The company provides its employees with tuition reimbursement and a comprehensive health benefits plan.
BRANDS/DIVISIONS/AFFILIATES: Taylor Pharmaceuticals, Inc. Lidocaine Jelly
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Arthur S. Przybyl, CEO Arthur S. Przybyl, COO Arthur S. Przybyl, Pres. Ben J. Pothast, VP/CFO Abu Alam, VP-Research and Dev. Ben J. Pothast, Corp. Sec. Ben J. Pothast, Treas. John N. Kooper, Chmn.
Phone: 847-279-6100 Fax: 847-279-6123 Toll-Free: 800-535-7155 Address: 2500 Millbrook Dr., Buffalo Grove, IL 60089-4694 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $51,419 (12 months) 2002 Profits: $-12,952 (12 months) Stock Ticker: AKRN 2001 Sales: $42,200 2001 Profits: $-19,600 Employees: 326 2000 Sales: $66,927 2000 Profits: $2,187 Fiscal Year Ends: 12/31 1999 Sales: $64,632 1999 Profits: $6,670 1998 Sales: $56,667 1998 Profits: $4,647
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Y Profit Sharing: Top Exec. Salary: $148,263 Stock Purch. Plan: Y Second Exec. Salary: $145,186 ADVANTAGE: Merger with Pasadena Research Laboratories, Inc.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $137,116 Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest: Y
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International:
Plunkett Research, Ltd.
www.plunkettresearch.com
ALARIS MEDICAL INC
www.alarismed.com
Industry Group Code: 339113 Ranks within this company's industry group: Sales:25 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:28
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Equipment-Infusion Systems Intravenous Infusion Pumps Pacemaker Recorders
Alaris Medical, Inc. is a leading provider of infusion systems and related technologies to the United States hospital and international infusion systems markets. The company’s intravenous infusion systems are used to deliver one or more fluids, primarily pharmaceuticals or nutritionals, to patients. The systems consist of medication safety systems, single- and multi-channel large volume infusion pumps, syringe pumps and dedicated and non-dedicated disposable administration sets. In addition, Alaris Medical is a leading provider of patient monitoring products that measure and monitor temperature, pulse, pulse oximetry and blood pressure. The company’s Medley Medication Safety System permits integration of administration, monitoring and clinical best practice guidelines from a single platform. The infusion pumps include large-volume infusion pumps such as the Gemini series, Signature Edition Family, MedSystem III and Asena GW and syringe infusion pumps such as P1000, P3000, PCAM, P6000, P7000 and Asena GS, GH and CC, which are sold primarily in Western Europe. Alaris Medical also manufactures and markets hospital thermometry instruments, related disposable probe covers and stand-alone, non-invasive, multi-parameter instruments, which measure and monitor a combination of temperature, pulse and blood pressure and other vital signs. The Alaris Center for Medication Safety and Clinical Improvement informs health care professionals of the risks associated with critical drug delivery errors. Alaris Medical’s wholly-owned subsidiary, Alaris Medical Systems, Inc., develops solutions for medication safety. Recently, the subsidiary was granted a patent license relating to needle-free valve products from Filtertek, Inc.
BRANDS/DIVISIONS/AFFILIATES: Alaris Medical Systems, Inc. Signature Edition Family Medley Medication Safety System MedSystem III P1000 Asena Gemini PCAM
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. David L. Schlotterbeck, CEO David L. Schlotterbeck, Pres. William C. Bopp, Sr. VP/CFO Kevin Whitely, VP-Mktg. James Runchey, VP-Human Resources Stuart Rickerson, Corp. Sec. Stuart Rickerson, VP/General Counsel Sally M. Grigoriev, VP-Oper. Anthony B. Semedo, VP-Corp. Dev. Bill Murphy, VP-Quality and Regulatory Affairs Jake St. Philip, VP/Mgr.-North America Robert F. Mathews, VP-Finance Frederic Denerolle, VP/Mgr.-Int'l Bus. Unit
Phone: 858-458-7000 Fax: 858-458-7760 Toll-Free: 800-854-7128 Address: 10221 Wateridge Cir., San Diego, CA 92121-2772 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $460,300 (12 months) 2002 Profits: $8,200 (12 months) Stock Ticker: AMI 2001 Sales: $412,800 2001 Profits: $-9,800 Employees: 2,899 2000 Sales: $378,948 2000 Profits: $-11,558 Fiscal Year Ends: 12/31 1999 Sales: $389,927 1999 Profits: $-28,400 1998 Sales: $373,795 1998 Profits: $-24,400
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $493,275 Stock Purch. Plan: Y Second Exec. Salary: $283,165 ADVANTAGE: A global leader in infusion systems and proprietary disposable products.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Bonus: $712,001 Bonus: $181,371
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALBANY MOLECULAR RESEARCH
www.albmolecular.com
Industry Group Code: 541710 Ranks within this company's industry group: Sales:6 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:3
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Research and Development Services Drug Discovery and Development
Albany Molecular Research, Inc. (Albany) is a leading, fully integrated provider of drug discovery and development, chemistry research and manufacturing services to companies in the pharmaceutical, genomic and biotechnology industries. Albany also provides contract chemistry services to customers across the entire product development cycle, from lead discovery to commercial manufacturing. These services include drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. The company has also expanded its service offerings to include commercial manufacturing through its strategic relationship with Organichem Corporation. Albany’s services permit its customers to reduce overall drug development time and cost and to simultaneously pursue a greater number of drug discovery and development opportunities. Albany’s proprietary research and development activities led to the development, patenting and manufacturing of a substantially pure form of the active ingredient in the nonsedating antihistamine marketed by Aventis as Allegra. The company’s key research facilities include Albany Research Center, Bothell Research Center, Bruno Biotechnology Development Center and Syracuse Research Center. Recently, Albany added drug metabolism assay and metabolite production capabilities to its drug discovery and development technologies, which will provide information concerning the metabolic properties and enzyme interactions of compounds. In other news, the company signed a three-year drug discovery research agreement with Merck & Co., Inc. Under this agreement, Albany will perform chemistry research and lead optimization using computer-assisted chemical design and synthesis technologies. Albany also announced a drug discovery collaboration with Genzyme Corp., in which it will provide libraries of natural product extracts for biological screening.
BRANDS/DIVISIONS/AFFILIATES: Allegra Organichem Corp. Flourous Technologies, Inc. EnzyMed Bothell Research Center Syracuse Research Center Bruno Biotechnology Development Center Albany Research Center
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Thomas E. D'Ambra, CEO Donald E. Kuhla, COO Donald E. Kuhla, Pres. David P. Waldek, CFO Harold Meckler, VP-Science and Tech. David P. Waldek, Corp. Sec. James J. Grates, VP-Oper. Lawrence D. Jones, Sr. VP-Bus. Dev. David P. Waldek, Treas. Barry A. Berkowitz, Corp. VP Michael P. Trova, Sr. VP-Medicinal Chemistry Thomas E. D'Ambra, Chmn.
Phone: 518-464-0279 Fax: 518-464-0289 Toll-Free: Address: 21 Corporate Circle, Albany, NY 12203 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $122,800 (12 months) 2002 Profits: $40,600 (12 months) Stock Ticker: AMRI 2001 Sales: $56,800 2001 Profits: $34,400 Employees: 860 2000 Sales: $66,603 2000 Profits: $23,593 Fiscal Year Ends: 12/31 1999 Sales: $43,471 1999 Profits: $13,800 1998 Sales: $33,294 1998 Profits: $10,497
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $279,231 Stock Purch. Plan: Second Exec. Salary: $250,000 ADVANTAGE: Highly diversified research and development.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $108,750 Bonus: $36,000
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest: Y
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International:
Plunkett Research, Ltd.
www.plunkettresearch.com
ALBEMARLE CORPORATION
www.albemarle.com
Industry Group Code: 325000 Ranks within this company's industry group: Sales:14 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:8
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Y Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Polymer and Fine Chemicals Manufacturer
Albemarle Corporation is a producer of polymer and fine chemicals, including additives to or intermediates for plastics, elastomers, cleaning products, agricultural compounds, pharmaceuticals, photographic chemicals, drilling compounds and biocides. The majority of the firm’s sales are made directly to cleaning product manufacturers and chemical, pharmaceutical, drilling and water treatment companies. The company’s Polymer Chemicals division manufactures flame retardants that enable polymer materials to meet fire-safety requirements. Additionally, the division is a leading producer of aluminum alkyls, which are used as co-catalysts in the production of polyolefins. The firm’s Fine Chemicals division produces agrichemicals and alkyl and inorganic bromides. The division’s bromine-based chemicals are often utilized during chemical synthesis, oil and gas well drilling, water purification and glass production. Albemarle has entered into a joint venture with Arab Potash Company, Ltd. in order to expand its bromine production capabilities. The Fine Chemicals division is also a leading manufacturer of ibuprofen. Moreover, the division’s pilot plant in Dayton, Ohio produces pharmaceutical intermediaries for a wide array of drugs under clinical trial. In recent news, Albemarle has acquired Ethyl Corporation’s fuel and lubricant antioxidants working capital, patents and intellectual property for $27 million.
BRANDS/DIVISIONS/AFFILIATES: Polymer Chemicals Division Fine Chemicals Division Arab Potash Company, Ltd.
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Mark C. Rohr, CEO Mark C. Rohr, Pres. Paul F. Rocheleau, CFO John M. Steitz, VP-Bus. Oper. E. Whitehead Elmore, Exec. VP William M. Gottwald, Chmn.
Phone: 804-788-6000 Fax: 804-788-6020 Toll-Free: 800-535-3030 Address: 330 S. Fourth St., PO Box 1335, Richmond, VA 23219 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $980,200 (12 months) 2002 Profits: $74,700 (12 months) Stock Ticker: ALB 2001 Sales: $916,900 2001 Profits: $68,200 Employees: 3,000 2000 Sales: $917,500 2000 Profits: $101,800 Fiscal Year Ends: 12/31 1999 Sales: $845,900 1999 Profits: $88,800 1998 Sales: $820,900 1998 Profits: $84,700
SALARIES/BENEFITS: Pension Plan: Y Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Stock Purch. Plan: ADVANTAGE: High profit margins.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Top Exec. Salary: $528,850 Second Exec. Salary: $500,000
Bonus: $170,000 Bonus: $175,000
LOCATIONS: ("Y" = Yes) West:
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALCATEL USA INC
www.usa.alcatel.com
Industry Group Code: 334210 Ranks within this company's industry group: Sales: Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Transmission Equipment-Data, Video and Voice Network System Products
Alcatel USA, Inc. designs, develops, manufactures and markets digital switching, transmission, access and private network system products for the worldwide telecommunications marketplace. Alcatel USA was formed when the Plano, Texas-based company DSC Communications was purchased by Paris-based Alcatel, Inc. Products offered by the company allow telecommunications service providers to build and upgrade their networks to support a wide range of voice, data and video services. The company supplies products to a domestic and international customer base, including local exchange telephone companies, long-distance carriers, cellular telephone companies, international telephone companies, various Fortune 1000 companies and utility companies. Alcatel's domestic customers include the RHCs and most major domestic independent telephone and long-distance companies, including WorldCom, U.S. Sprint Communications Company and GTE Communications Systems. In recent news, the company sold the majority of its assets to Sanmina.
BRANDS/DIVISIONS/AFFILIATES: Litespan-2000 Starspan Metrospan Airspan NKT Elektronic A/S Alcatel DSC/Celcore, Inc. Sanmina
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Serge Tchuruk, CEO Andre Navarri, COO Andre Navarri, Pres. Jean-Pascal Beaufret, CFO Thomas Edig, Sr. VP-Corp. Human Resources Niel Ransom, Chief Tech. Officer Pascal Durand-Barthez, General Counsel Olivier Baujard, VP-Corp. Strategy Olivier Houssin, Pres.-e-Bus. Group Caroline Mille, Sr. VP-Corp. Comm. Claire Pedini, VP-Investor Rel. Etienne Fouques, Exec. VP/Pres.-Mobile Comm. Group Christian Reinaudo, Exec. VP Jacques Dunoque, Pres.-Europe and South America Mike Quigley, Sr. Exec. VP/Pres.-North America Serge Tchuruk, Chmn. Ron Spithill, Exec. VP/Pres.-Asia Pacific
Phone: 972-477-2555 Fax: 972-519-3999 Toll-Free: Address: 1000 Coit Rd., Plano, TX 75075 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for months. 2002 Sales: $ ( months) 2002 Profits: $ ( months) Stock Ticker: Private 2001 Sales: $ 2001 Profits: $ Employees: 2000 Sales: $ 2000 Profits: $ Fiscal Year Ends: 12/31 1999 Sales: $ 1999 Profits: $ 1998 Sales: $ 1998 Profits: $
SALARIES/BENEFITS: Pension Plan: Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Stock Purch. Plan: Y Second Exec. Salary: $ ADVANTAGE: A leader in proprietary architecture for digital switching, with offices worldwide.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALCON LABORATORIES INC
www.alconlabs.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:14 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:13
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Manufacturer Ophthalmic Equipment Manufacturer
Founded in 1945, Alcon Laboratories is the largest eye care company in the world. It specializes in the development, manufacture and marketing of ophthalmic products and instrumentation. The firm was a subsidiary of Swiss food giant Nestlé, S.A. until it was spun off in March 2002. Nestlé currently owns about 75% of the company. Alcon maintains manufacturing plants, laboratories and offices in 50 countries. Its products are sold in over 75 countries. The company makes more than 10,000 unique products including prescription and over the counter drugs, contact lens solutions, surgical instruments, intraocular lenses and office systems for ophthalmologists. Brand names such as the Acrysof foldable lens, Patanol solution for eye allergies, AcrySof intraocular lenses, Betoptic for glaucoma and the Opti-Free system for contact lens care are known throughout the world. Alcon has a history of heavy investment in research and development. Housed at the company's headquarters in Fort Worth is the 400,000 square-foot William C. Conner Research Center, the largest eye research center in the world. From 2002 through 2005, Alcon plans to spend more than $1 billion on eye-related research, more than any entity outside of the National Eye Institute. Alcon's subsidiaries include Alcon Summit Autonomous, Alcon Surgical, Inc. and Falcon Pharmaceuticals, Ltd. Alcon offers employee education programs, wellness programs, a dependent care plan and an employee credit union. Some locations offer onsite fitness centers, cafeterias and company stores. Alcon also offers discounts on laser eye surgery.
BRANDS/DIVISIONS/AFFILIATES: Opti-Free Patanol Vexol AcrySof Alcon Summit Autonomous Nestlé, S.A. LADARVision Falcon Pharmaceuticals
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Tim Sear, CEO Allen Baker, Exec. VP/COO Tim Sear, Pres. Charles Miller, Sr. VP-Finance/CFO Jack Walters, VP-Human Resources Gerald D. Cagle, Sr. VP-Research and Dev. Andre Bens, Sr. VP-Global Mfg. Cary Rayment, Sr. VP-U.S. Oper. Mary Dulle, Dir.-Corp. Comm. Andre Bens, Tech. Support Fred Pettinato, Sr. VP-Int'l Oper.
Phone: 817-551-6878 Fax: 817-568-7201 Toll-Free: Address: 6201 South Fwy., Ft. Worth, TX 76134 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $3,009,100 (12 months) 2002 Profits: $466,900 (12 months) Stock Ticker: ACL 2001 Sales: $2,747,700 2001 Profits: $315,600 Employees: 11,000 2000 Sales: $2,553,600 2000 Profits: $331,700 Fiscal Year Ends: 12/31 1999 Sales: $2,401,000 1999 Profits: $346,900 1998 Sales: $2,174,000 1998 Profits: $335,000
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Stock Purch. Plan: ADVANTAGE: A global leader in eye care.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Top Exec. Salary: $ Second Exec. Salary: $
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest:
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALKERMES INC
www.alkermes.com
Industry Group Code: 339113 Ranks within this company's industry group: Sales:32 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:38
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Sustained-Release Injection Systems
Alkermes specializes in the development of sophisticated drug delivery technologies. Two of the company's main areas of focus, ProLease and Medisorb technologies, release injectable drugs in controlled amounts over a specified short period of time. Significant concentration is also placed on Alkermes’ Advanced Inhalation Research (AIR) technology, a major innovation among pulmonary delivery systems, which maximizes drug delivery to the lungs. Aside from patenting new products, the company’s expansion is concentrated toward forming partnerships to license its products. Alkermes first product, Nutropin Depot, developed in collaboration with Genetech, Inc., is based on ProLease technology. Risperdal Consta, an anti-psychotic drug developed in collaboration with Janssen Pharmaceutica, is based on Medisorb technology and is expected to be the firm’s second product to reach the U.S. market. Recently, the company announced its partner, Johnson & Johnson Pharmaceutical Research and Development, received approval to market Risperdal Consta in Germany. Alkermes also entered an alliance with Eli Lilly and Company to develop an inhaled form of insulin for the treatment of diabetes based on the Alkermes AIR pulmonary drug delivery system. The company has proprietary projects in development stages including Albuterol for the treatment of asthma and Vivitrex for the treatment of alcohol abuse. Employee benefits at Alkermes include tuition reimbursement, a comprehensive health plan and transportation subsidies. Notably, every employee starts with an allowance of three weeks of vacation time per year.
BRANDS/DIVISIONS/AFFILIATES: ProLease Medisorb Nutropin Depot Albuterol Vivitrex Albulast Risperdal Consta AIR
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Richard F. Pops, CEO David Broecker, COO David Broecker, Pres. James M. Frates, VP/CFO J. Duncan Higgons, Sr. VP-Mktg. Raymond T. Bartus, Sr. VP-Life Sciences Research and Dev. Elliot W. Ehrich, VP-Medical Affairs Gordon Pugh, VP-Oper. J. Duncan Higgons, Sr. VP-Bus. Dev. James M. Frates, Treas. Michael J. Landine, VP-Corp. Dev. Paul F. Hebert, VP-Process Dev. Stephen E. Zale, VP-Formulations
Phone: 617-494-0171 Fax: 617-494-9263 Toll-Free: Address: 88 Sidney St., Cambridge, MA 02139-4234 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $54,100 (12 months) 2002 Profits: $-61,400 (12 months) Stock Ticker: ALKS 2001 Sales: $56,000 2001 Profits: $-16,900 Employees: 415 2000 Sales: $22,900 2000 Profits: $-68,000 Fiscal Year Ends: 3/31 1999 Sales: $33,900 1999 Profits: $-41,100 1998 Sales: $25,500 1998 Profits: $-12,600
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $406,462 Stock Purch. Plan: Y Second Exec. Salary: $294,685 ADVANTAGE: Focus on new drug delivery technologies.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $175,000 Bonus: $100,000
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest: Y
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALLERGAN INC
www.allergan.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:18 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:26
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Supplies-Eye Care Niche Pharmaceuticals
Allergan is a technology-driven global health care company that develops and commercializes specialty pharmaceutical products for the ophthalmic, neurological, dermatological and other specialty markets. The company focuses on products for the treatment of a wide range of disease areas, including glaucoma and retinal disease, cataracts, dry eye, psoriasis, acne, photodamage, movement disorders, metabolic disease and various cancers. The company recently completed the spin-off of its optical medical device business. The spin-off was effected by contributing the company’s optical medical device business to a newly formed subsidiary, Advanced Medical Optics, Inc. The company produces Alphagan and Lumigan ophthalmic solutions, which are used for the treatment of open-angle glaucoma and ocular hypertension. Botox is used therapeutically in the treatment of certain neuromuscular disorders which are characterized by involuntary muscle contractions or spasms. The FDA recently granted approval for the use of Botox in smoothing wrinkles. This innovative application of the muscle relaxant has become one of the fastest growing cosmetic treatments performed by surgeons in the United States. Allergan’s skin care product line is comprised of tazarotene products in cream and gel formulations marketed under the names Tazorac, Zorac and Avage; Azelex, an acne product; and M.D. Forte, a line of alpha hydroxy acid products for ultraviolet sunscreen protection. Other products introduced by Allergan include Array multifocal lens for cataract patients and Refresh Tears for dry eyes. In recent news, the company announced that the FDA approved its antiinfective ZYMAR product. ZYMAR was developed to treat ocular infection due to susceptible bacteria.
BRANDS/DIVISIONS/AFFILIATES: Alphagan Lumigan Azelex Tazorac Botox Refresh Tears ZYMAR Advanced Medical Optics, Inc.
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. David E.I. Pyott, CEO David E.I. Pyott, Pres. Eric Brandt, VP/CFO Lester J. Kaplan, VP/Pres.-Research and Dev. Douglas S. Ingram, VP/Corp. Sec. Douglas S. Ingram, General Counsel Jacqueline J. Schiavo, VP-Oper. Jeffrey L. Edwards, VP-Corp. Dev. Jeffrey L. Edwards, VP-Investor Rel. Jeffrey L. Edwards, Treas. David A. Fellows, VP/Pres.-Europe, Africa and Asia Pacific Region Nelson R. A. Marques, VP/Pres.-Latin American Region F. Michael Ball, VP/Pres.-North American Region David E.I. Pyott, Chmn.
Phone: 714-246-4500 Fax: 714-246-4971 Toll-Free: 800-347-4500 Address: 2525 Dupont Dr., Irvine, CA 92612-9534 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,425,300 (12 months) 2002 Profits: $75,200 (12 months) Stock Ticker: AGN 2001 Sales: $1,745,500 2001 Profits: $224,900 Employees: 4,900 2000 Sales: $1,625,500 2000 Profits: $215,100 Fiscal Year Ends: 12/31 1999 Sales: $1,452,400 1999 Profits: $188,200 1998 Sales: $1,296,100 1998 Profits: $-90,200
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Stock Purch. Plan: Y ADVANTAGE: Technology-based growth strategy.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Top Exec. Salary: $870,384 Second Exec. Salary: $367,538
Bonus: $875,000 Bonus: $223,000
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALLIANCE PHARMACEUTICAL CORP Industry Group Code: 325412 Ranks within this company's industry group: Sales:103 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
www.allp.com Profits:73
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Cardiovascular and Respiratory Diagnostic Products
Alliance Pharmaceutical Corp. uses perfluorochemical and surfactant technologies to develop therapeutic and diagnostic products. The firm’s products are primarily intended for use during acute care situations, including cardiology and surgical applications. The company’s leading product candidate, Oxygent, is an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients at risk of acute tissue oxygen deficit. Oxygent is primarily intended to provide oxygen to tissues during elective surgeries in which a blood transfusion is anticipated. The blood substitute is universally compatible with all blood types and has a shelf-life of approximately two years. A single unit of Oxygent is expected to deliver as much oxygen as one to two units of red blood cells. The company and Baxter Healthcare Corporation have formed a joint venture to further develop and market Oxygent in the United States, Canada and Europe. Additionally, Alliance manufactures Imagent, an intravenous contrast agent designed to enhance ultrasound images of the heart. Recently, the company agreed to sell its Imagent assets to Photogen Technologies. The company’s Molecular Biosystems subsidiary manufactures Optison, an intravenous ultrasound contrast agent that is marketed by Amersham in the United States and Europe.
BRANDS/DIVISIONS/AFFILIATES: Oxygent Molecular Biosystems Optison
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Duane J. Roth, CEO Tim Hart, CFO B. Jack DeFranco, VP-Mktg. Dev. Carole McWilson, Dir.-Human Resources David H. Klein, Sr. VP-Pharmaceutical Dev. N. Simon Faithfull, VP-Medical Affairs Joni Harvey, VP-Oper. Gwen Rosenberg, VP-Corp. Comm. Tim Hart, Treas. H. Joerg Limmer, VP-Clinical Dev. Christiane O. Rockwell, VP-Quality Assurance Duane J. Roth, Chmn.
Phone: 858-410-5200 Fax: 858-410-5201 Toll-Free: Address: 6175 Lusk Blvd., San Diego, CA 92121 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $10,300 (12 months) 2002 Profits: $-34,200 (12 months) Stock Ticker: ALLP.OB 2001 Sales: $1,900 2001 Profits: $-60,700 Employees: 92 2000 Sales: $16,000 2000 Profits: $-46,467 Fiscal Year Ends: 6/30 1999 Sales: $8,251 1999 Profits: $-62,473 1998 Sales: $21,209 1998 Profits: $-33,003
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $472,850 Bonus: $200,000 Stock Purch. Plan: Second Exec. Salary: $351,260 Bonus: $110,000 Has several collaborative relationships with multinational pharmaceutical companies. ADVANTAGE:
OTHER THOUGHTS: Apparent Women Officers or Directors: 4 Hot Spot for Advancement for Women/Minorities: Y
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International:
Plunkett Research, Ltd.
www.plunkettresearch.com
ALPHARMA INC
www.alpharma.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:20 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:86
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Animal Health Human Pharmaceuticals
Alpharma, Inc. is a multinational pharmaceutical company that develops, manufactures and markets specialty generic and proprietary human pharmaceutical and animal health products. The company is one of the largest manufacturers of generic liquid and topical pharmaceuticals in the United States and has an established and growing market position in finished pharmaceuticals in Europe and the Far East. Alpharma offers a comprehensive range of over 800 tablet, capsule, liquid and topical generic human phrmaceutical products and over 100 animal health products. It is one of the world's leading producers of important specialty antibiotics. The company is also known as a leading provider of animal feed additives for poultry and livestock and vaccines for farmed fish. Alpharma is continuing to strengthen its international market presence and is accelerating research and development for new products. The company's human pharmaceuticals business is comprised of the U.S. and international businesses. The U.S. human pharmaceuticals business is comprised of the generic and branded pharmaceuticals businesses. The human pharmaceuticals international business is comprised of the international generics and active pharmaceutical ingredients businesses. In recent news, the international generics segment divested its vitamin business to Nopal AS, a subsidiary of Industrier, the company's controlling stockholder. In connection with this sale, the unit entered into a supply agreement with Nopal to supply certain vitamin products and two distribution agreements, through which Nopal will continue to sell the company's medical plaster and tape products to the grocery sector, and the company will sell Nopal's acquired vitamin products to the pharmacy and health care sector.
BRANDS/DIVISIONS/AFFILIATES:
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Ingrid Wiik, CEO Ingrid Wiik, Pres. Matthew T. Farrell, Exec. VP/CFO Robert F. Wrobel, Exec. VP/Corp. Sec. Robert F. Wrobel, Chief Legal Officer Michael J. Nestor, Exec. VP/Pres.-U.S. Human Pharmaceuticals Carol A. Wrenn, Exec. VP/Pres.-Animal Health Div. Einar W. Sissener, Chmn.
Phone: 201-947-7774 Fax: 201-947-4879 Toll-Free: 800-645-4216 Address: One Executive Dr., Fort Lee, NJ 07024 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,238,000 (12 months) 2002 Profits: $-98,800 (12 months) Stock Ticker: ALO 2001 Sales: $975,000 2001 Profits: $-37,900 Employees: 4,700 2000 Sales: $919,523 2000 Profits: $61,143 Fiscal Year Ends: 12/31 1999 Sales: $732,443 1999 Profits: $36,972 1998 Sales: $604,584 1998 Profits: $24,211
SALARIES/BENEFITS: Pension Plan: Y Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $705,000 Stock Purch. Plan: Second Exec. Salary: $475,000 ADVANTAGE: The largest manufacturer of generic liquid and topical pharmaceuticals in the U.S.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $290,000 Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALTERA CORP
www.altera.com
Industry Group Code: 334413 Ranks within this company's industry group: Sales:15 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:5
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Circuits-CMOS Programmable Logic Devices Development System Software
Altera Corporation designs, manufactures and markets high-performance, high-density programmable logic devices (PLDs); intellectual property cores, also known as megafunctions; and associated development tools. Founded in 1983, Altera was the first supplier of complementary metal oxide semiconductor (CMOS) PLDs and is currently a global leader in this market. Altera offers a broad range of general-purpose PLDs that present unique features as well as differing densities and performance specifications for implementing particular applications. Programmable logic's primary advantage is that it allows for quicker design cycles, meeting customers' needs for quick time-to-market. Programmable logic allows customers to experiment and iterate their designs in a relatively short amount of time and with minimum cost. In most instances, this is quicker and easier than achieving a design in a deterministic fashion. The firm offers a broad line of CMOS programmable logic devices that address high-speed, high-density and low-power applications. Its products serve a wide range of markets, including telecommunications, data communication, electronic data processing, computer peripheral and industrial applications. Altera’s proprietary development tools consists of the Quartus II and MAX+PLUS II software. These tools enable customers to design and program PLDs. Recently, Altera entered into a distribution agreement with Pioneer Standard Electronics, Inc. Pioneer will provide technical support and distribution to customers in North America. Altera offers its employees 85-100% paid dental and vision coverage, bonuses, maternity benefits, limited telecommuting allowances and gym membership benefits. There is no dress code.
BRANDS/DIVISIONS/AFFILIATES: APEX MAX+PLUS II MAX 7000 FLEX 8000 MAX 9000 Quartus II FLASHlogic Multi-Chip Module
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. John Daane, CEO Denis M. Berlan, Exec. VP/COO John Daane, Pres. Nathan Sarkisian, Sr. VP/CFO Erik Cleage, Sr. VP-Mktg. John R. Finzhenry, VP-Human Resources Martin Langhammer, VP-Science John E. Turner, VP-Design Eng. Katherine Schuelke, Corp. Sec. Katherine Schuelke, General Counsel Thomas B. Murchie, VP-Oper. Lance Lissner, Sr. VP-Bus. Dev. Scott Wylie, VP-Investor Rel. George A. Papa, Sr. VP-Worldwide Sales Jordan Plofsky, Sr. VP-Vertical Markets John P. Daane, Chmn.
Phone: 408-544-7000 Fax: 408-544-8303 Toll-Free: Address: 101 Innovation Dr., San Jose, CA 95134-2020 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $711,700 (12 months) 2002 Profits: $91,300 (12 months) Stock Ticker: ALTR 2001 Sales: $839,400 2001 Profits: $-39,800 Employees: 1,882 2000 Sales: $1,376,800 2000 Profits: $496,900 Fiscal Year Ends: 12/31 1999 Sales: $836,600 1999 Profits: $224,000 1998 Sales: $654,300 1998 Profits: $154,400
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $614,815 Bonus: $450,000 Stock Purch. Plan: Y Second Exec. Salary: $472,935 Bonus: $1,116,150 Continual expansion of Altera's product lines, including the acquisition of the Intel programmable logic ADVANTAGE: business.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ALZA CORP
www.alza.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales: Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Drug Delivery Technologies Drug Therapies and Systems
ALZA Corporation, a wholly owned subsidiary of Johnson & Johnson, develops and markets innovative pharmaceutical products by using advanced drug delivery technologies to add medical and economic value to drug therapies. ALZA markets over 30 commercialized products and holds over 3,000 issued or pending patents worldwide. The company focuses on several therapeutic areas, including oncology, AIDS, pain management, endocrinology and urology. ALZA selects and develops new human pharmaceutical products, combining the company's proprietary drug delivery systems with various drug compounds. Some of the company’s more commonly known drugs are Ditropan XL for the treatment of urge urinary incontinence, DUROS for the palliative treatment of advanced prostate cancer, OROS for the treatment of attention deficit/hyperactivity disorder, ETRANS (fentanyl) for chronic pain, E-TRANS (LHRH) for infertility, E-TRANS Macroflux for Type II diabetes, Caelyx for the treatment of advanced ovarian cancer and NicoDerm CQ, which is a smoking-cessation aid. ALZA recently announced an expanded collaboration agreement with Pfizer, Inc. for Pfizer’s use of ALZA’s push-pull oral drug delivery technology. ALZA offers employees an extensive benefits package including 85% paid dental coverage, stock options, bonuses, adoption assistance, maternity leave, telecommuting and transit. In addition, the company also matches gifts to charities and has a holiday shutdown period and a sabbatical program.
BRANDS/DIVISIONS/AFFILIATES: Johnson & Johnson Pfizer, Inc. NicoDerm CQ Ditropan XL Caelyx DUROS OROS E-TRANS
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Howard B. Rosen, Pres. B. Michael Silber, VP-Research and Tech. Dev. Ellen Rose, Dir.-Corp. Comm. Kathy Kim, Corp. Comm. Specialist
Phone: 650-564-5000 Fax: 650-564-7070 Toll-Free: 800-233-5222 Address: 1900 Charleston Rd., Mountain View, CA 94039 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for months. 2002 Sales: $ ( months) 2002 Profits: $ ( months) Stock Ticker: Subsidiary 2001 Sales: $ 2001 Profits: $ Employees: 2,442 2000 Sales: $988,500 2000 Profits: $223,300 Fiscal Year Ends: 12/31 1999 Sales: $795,900 1999 Profits: $91,000 1998 Sales: $646,900 1998 Profits: $108,300
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Stock Purch. Plan: Y ADVANTAGE: Advanced drug delivery technologies.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Top Exec. Salary: $ Second Exec. Salary: $
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AMDOCS LTD
www.amdocs.com
Industry Group Code: 511200 Ranks within this company's industry group: Sales:11 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:6
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y
GROWTH PLANS/SPECIAL FEATURES:
Computer Software-Customer Services & Business Operations Outsourcing Operations Customer Relationship Management
Amdocs, Ltd. is a holding company that provides information system solutions and software products and services to major communications companies in North America, Europe and other countries around the world. Its subsidiaries include Amdocs, Ltd. and Amdocs Management, Ltd. in the U.K.; Amdocs Development, Ltd. in Cyprus; Amdocs, Ltd. in Israel; Amdocs Software Systems, Ltd. in Ireland; Amdocs Canada, Inc.; and Amdocs, Inc., Amdocs Champaign, Inc. and Amdocs Stamford, Inc. in the United States. Amdocs provides products and services to leading communications and Internet protocol (IP) companies worldwide; these offerings include customer relationship management (CRM), billing and order management systems for communications providers and business support systems (BSS) for directory publishing companies. The firm's delivery options include stand-alone applications modules, pre-integrated products, product-based customized solutions and a range of outsourcing operations. Amdocs' BSS products are software products designed to support the business operations of communications companies, including order management, call rating, invoice calculation, bill formatting, fraud management and collections. Its systems support a range of communications services, including wireline, wireless, broadband and electronic and mobile commerce. The firm's customers include Verizon, BellSouth, Deutsche Telekom, Sprint PCS and SBC Internet Services. In 2001, the company formed Certen, Inc. with Bell Canada to provide customer care and billing solutions to Bell Canada and its affiliated companies. Certen is 10%-owned by Amdocs. Recently Amdocs was chosen by Cable and Wireless, a global telecommunications group, to provide end-to-end billing and customer care for its mobile operations in the West Indies and Macau.
BRANDS/DIVISIONS/AFFILIATES: Amdocs Management, Ltd. Amdocs Development, Ltd. Amdocs, Inc. Amdocs Software Systems, Ltd. Amdocs Champaign, Inc. Amdocs Stamford, Inc. Bell Canada Certen, Inc.
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Bruce K. Anderson, CEO Ron Moskovitz, CFO Paul Joseph, Dir.-Human Resources Thomas G. O'Brien, Corp. Sec. Thomas G. O'Brien, Dir.-Investor Rel. Thomas G. O'Brien, Treas. Dov Baharav, CEO/Pres., Amdocs Management Shlomo Baleli, Sr. VP, Amdocs Management Yigal Bar-Yossef, Sr. VP-UK Mario Segal, Sr. VP/COO, Amdocs Management
Phone: 314-212-7000 Fax: 314-212-7500 Toll-Free: 888-727-8508 Address: 1390 Timberlake Manor Pkwy., Chesterfield, MO 63017 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,613,600 (12 months) 2002 Profits: $249,000 (12 months) Stock Ticker: DOX 2001 Sales: $1,533,900 2001 Profits: $66,400 Employees: 9,000 2000 Sales: $1,118,300 2000 Profits: $6,000 Fiscal Year Ends: 9/30 1999 Sales: $626,900 1999 Profits: $98,500 1998 Sales: $403,800 1998 Profits: $30,400
SALARIES/BENEFITS: Pension Plan: Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Stock Purch. Plan: Y Second Exec. Salary: $ ADVANTAGE: A leading provider of customer service solutions for the Internet.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $ Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AMERICAN MANAGEMENT SYSTEMS INC Industry Group Code: 541512 Ranks within this company's industry group: Sales:7 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
www.amsinc.com
Profits:6 Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y
GROWTH PLANS/SPECIAL FEATURES:
Consulting-Computer System Integration & Design E-Commerce Programming Business & Technology Consulting E-Business & E-Government Soultions Homeland Security & Training Learning Solutions
American Management Systems (AMS) is an international information-technology consulting firm. The firm’s primary services include business and technology consulting, systems integration, e-business and e-government solutions, customer relationship management, information security, homeland security and training and learning solutions. The company’s focus industries include new media and communications firms, financial services institutions, state and local governments and education, federal government agencies and other corporate clients. AMS is a business partner for many of the largest and most respected organizations in its specialty markets, including eight out of 10 of the world’s largest communication firms; many of the top U.S. banks; most federal agencies; 43 state and local governments; some of the largest energy companies in the U.S., Canada and Europe; and hundreds of companies in the Fortune 500. Approximately 85% of the company’s revenues come from clients it has worked with in previous years. AMS has formed a cross-target market practice to focus on delivering high-value, customer-facing web solutions, including eBill, eCare and eMarketing - tailored to clients in the financial services, telecommunications, government and utilities sectors. These solutions help firms achieve greater cost savings, deliver improved customer service and leverage cross-sell and up-sell opportunities. The firm’s new eCustomer practice builds upon the company's existing e-commerce client base. Recently, AMS selected Marketswitch Corporation as a partner to deliver advanced decision management solutions. AMSprovides leading edge e-business services and solutions to transform both private and public businesses into organizations that fully utilize emerging technologies to succeed in the digital economy. AMS was spotlighted in Working Mother magazine's 100 Best Companies for Working Mothers. The firm hires a balanced mix of recent university graduates and experienced professionals.
BRANDS/DIVISIONS/AFFILIATES: AMS Management Systems Deutschland Nordic Business Management Systems AMS Management Systems Netherlands AMS Management Systems Australia AMS Management Systems Mexico
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Alfred T. Mockett, CEO William M. Purdy, COO William M. Purdy, Pres. John S. Brittain, Jr., CFO/Exec. VP Tim Matlack, Chief Human Resources Officer Paul Turner, Chief Tech. Officer/Exec. VP Frank A. Nicolai, Corp. Sec./Exec. VP Frank A. Nicolai, Chief Admin. Officer Greg Hero, Exec. VP-New Media and Comm. Ronald L. Schillereff, Exec. VP/Investor Relations John S. Brittain, Jr., Treasurer Ronald L. Schillereff, Exec. VP Larry R. Seidel, Exec. VP Donna Morea, Exec. VP Vernon Irvin, Exec. VP
Phone: 703-267-8000 Fax: 703-267-5073 Toll-Free: Address: 4050 Legato Rd., Fairfax, VA 22033 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $986,700 (12 months) 2002 Profits: $28,200 (12 months) Stock Ticker: AMSY 2001 Sales: $1,183,300 2001 Profits: $15,900 Employees: 6,300 2000 Sales: $1,279,300 2000 Profits: $43,800 Fiscal Year Ends: 12/31 1999 Sales: $1,240,300 1999 Profits: $56,900 1998 Sales: $1,057,800 1998 Profits: $51,800
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $400,000 Stock Purch. Plan: Y Second Exec. Salary: $66,667 ADVANTAGE: Expansion in Europe to answer a growing overseas need.
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
Bonus: $150,000 Bonus: $1,046,666
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AMERICAN SUPERCONDUCTOR
www.amsuper.com
Industry Group Code: 335929 Ranks within this company's industry group: Sales:1 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:1
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Superconductivity Products Power Electronic Switches Superconductivity Technology Electric Transmission Cables
American Superconductor Corp. is engaged in developing products using the company’s two core technologies, superconducting materials and power electronic switches. The firm produces high-temperature superconductor (HTS) wires, which are capable of carrying more than 140 times the electrical current of conventional copper wire of the same dimension. These wires can carry electric power with zero resistance, meaning no loss of electricity as it travels through the cable. American Superconductor also develops and markets advanced power electronic switches that control, modulate and move large amounts of power efficiently and inexpensively. The company sells products based on these two technologies to electrical equipment manufacturers, industrial power users and businesses that produce and deliver power. American Superconductor also manufactures and sells superconducting magnetic energy storage (SMES) systems, which are used by customers to improve power quality and reliability and increase power transfer capacity in constrained transmission grids. In order to accelerate commercial deployment of its products, American Superconductor has formed strategic alliances with major electric power infrastructure companies including Electricite de France, one of the world’s largest electric utilities, and General Electric. The company recently secured contracts from the Tennessee Valley Authority, Dupont, Northeast Utilities and Rayburn Electric. The firm also announced its selection by the U.S. Department of Energy as prime contractor for a high-temperature superconductor power transmission cable project in the Long Island Power Authority transmission grid. The nearly half-mile power cable system will be the world’s first live grid installation of a superconductor cable at transmission voltages. In other news, the company was selected by the U.S. Navy’s Office of Naval Research as prime contractor to lead a team in designing and building a prototype 36.5-megawatt high-temperature superconductor propulsion motor for electric warships. Benefits offered to employees include vision insurance, tuition reimbursement and wholesale club memberships.
BRANDS/DIVISIONS/AFFILIATES: Integrated Electronics, LLC GE Industrial Systems PowerModule
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Gregory J. Yurek, CEO Gregory J. Yurek, Pres. Kevin Bisson, CFO Chet Lyons, VP-Corp. Strategic Mktg. Michele L. Shindelman, VP-Human Resources Alexis P. Malozemoff, Sr. VP/Chief Tech. Officer Ross S. Gibson, Corp. Sec. Ross S. Gibson, VP/Chief Admin. Officer Thomas M. Rosa, VP-Acc. and Finance David Paratore, VP-SuperMachines Eric Snitgen, VP-AMSC Wires Charles W. Stankiewicz, VP-Power Electronic Systems Gregory J. Yurek, Chmn.
Phone: 508-836-4200 Fax: 508-836-4248 Toll-Free: Address: 2 Technology Dr., Westborough, MA 01581 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $11,700 (12 months) 2002 Profits: $-57,000 (12 months) Stock Ticker: AMSC 2001 Sales: $16,800 2001 Profits: $-21,700 Employees: 340 2000 Sales: $15,100 2000 Profits: $-17,600 Fiscal Year Ends: 3/31 1999 Sales: $11,300 1999 Profits: $-15,300 1998 Sales: $15,100 1998 Profits: $-12,400
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $365,750 Stock Purch. Plan: Second Exec. Salary: $228,228 ADVANTAGE: Excellent technology/Strong government contracts.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $122,500 Bonus: $43,770
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest: Y
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AMEY PLC
www.amey.co.uk
Industry Group Code: 541310 Ranks within this company's industry group: Sales: Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Y Y Y Y
Profits:
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y Y
GROWTH PLANS/SPECIAL FEATURES:
Engineering Services Construction Risk Management and Implementation Environmental Services Engineering Design and Analysis Systems Engineering & Integration
Amey PLC, based in the United Kingdom, provides business support services such as facilities management, procurement, consulting and plant equipment and hire. The firm provides a broad range of support services to public and private organizations in addition to its ownership of large-scale transportation infrastructure concessions. The company also operates a construction division, Amey Construction, which provides building contracting, tunneling and civil engineering. The company also provides risk management and implementation services. This division provides other companies with information on business continuity planning and disaster recovery; financial accounting and business support services; project and program management; health, safety and environmental services; engineering design and analysis; and systems engineering and systems integration. Additionally, the firm owns Comax, a company that specializes in business outsourcing. Amey recently announced the sale of Amey Vectra, Ltd. to Volvere PLC. The decision to divest Vectra, which provides specialist technical and business consulting as well as environmental services to the nuclear, oil and gas, defense and transportation sectors, will allow Amey to refocus management resources on its core business activities. The company also recently applied for cancellation of its listing of shares on the London Stock Exchange.
BRANDS/DIVISIONS/AFFILIATES: Amey Rail Amey Construction Comax
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Brian L. Staples, Group Chief Exec. José Leo, Group Finance Dir. Alan Springett, Human Resources Carol Hui, Corp. Sec. Carol Hui, Dir.-Legal Affiars Charles M Mogg, Group Dir.-Corp. Dev. Robert Osborne, Group Dir./Managing Dir., Amey Construction Richard W. Entwhistle, Group Dir./Managing Dir., Amey Rail Richard W Entwistle, Group Dir.-Strategic Partnerships Ian Robinson, Chmn.
Phone: 44-1235-848-811 Fax: 44-1235-848-822 Toll-Free: Address: Sutton Courtenay, Abingdon, Oxfordshire OX14 4PP UK
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for months. 2002 Sales: $ ( months) 2002 Profits: $ ( months) Stock Ticker: Foreign 2001 Sales: $1,141,200 2001 Profits: $-21,900 Employees: 6,886 2000 Sales: $1,009,300 2000 Profits: $30,000 Fiscal Year Ends: 12/31 1999 Sales: $826,200 1999 Profits: $6,900 1998 Sales: $781,900 1998 Profits: $20,500
SALARIES/BENEFITS: Pension Plan: Savings Plan:
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $ Bonus: $ Stock Purch. Plan: Second Exec. Salary: $ Bonus: $ Wide range of integrated services enables the firm to manage complete project needs. ADVANTAGE:
OTHER THOUGHTS: Apparent Women Officers or Directors: 1 Hot Spot for Advancement for Women/Minorities:
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AMGEN INC
www.amgen.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:13 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:102
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Diversified Advanced Cellular and Molecular Biology
Amgen, Inc. is a global biotechnology company that develops, manufactures and markets human therapeutics based on advanced cellular and molecular biology. Its products are used for the treatment of nephrology, oncology, inflammation, neurology, and metabolic disorders. The company has research facilities in the United States and has clinical development staff in the United States, Europe, Canada, Australia and Japan. Amgen manufactures and markets a line of human therapeutic products: Neupogen, Epogen, Aranesp, Enbrel, Kineret and Neulasta. Neupogen and Neulasta selectively stimulate the growth of infection-fighting white blood cells (known as neutrophils). Kineret and Enbrel reduce the signs and symptoms of moderately to severely active rheumatoid arthritis. Epogen and Aranesp stimulate the production of red blood cells. The firm recently acquired Immunex Corporation, a leading biotechnology company dedicated to developing immune system science to protect human health. The acquisition enhanced Amgen’s strategic position within the biotechnology industry by strengthening and diversifying its product base and product pipeline in key therapeutic areas and discovery research capabilities in proteins and antibodies. Employee benefits include dental and vision insurance, tuition reimbursement, relocation benefits, child care assistance, a fitness program and team-building entertainment such as art shows, picnics and a children’s holiday party. Amgen’s MBA Leadership Program provides career opportunities in finance and marketing for MBA students.
BRANDS/DIVISIONS/AFFILIATES: Neupogen Epogen Aranesp Enbrel Kineret Neulasta Immunex Corp.
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Kevin W. Sharer, CEO Kevin W. Sharer, Pres. Richard D. Nanula, CFO George Morrow, Sr. VP-Sales and Mktg. Brian McNamee, VP-Human Resources Roger Perlmutter, Exec. VP-Research and Dev. Hassan Dayem, Sr. VP/CIO Marc M.P. de Garidel, VP/Controller George Morstyn, Sr. VP-Dev./Chief Medical Officer Edward E. Bjurstrom, VP-Mfg. Steven M. Orde, Sr. VP/Corp. Sec. Steven M. Orde, General Counsel Dennis M. Fenton, Exec. VP-Oper. Richard D. Nanula, Exec. VP-Strategy Richard D. Nanula, Exec. VP-Corp. Comm. John J. Elginer, Treas. Beth C. Seidenberg, Sr. VP-Dev. Sarah M. Jensen, VP-Eng. and Oper. Services Kevin W. Sharer, Chmn.
Phone: 805-447-1000 Fax: 805-447-1010 Toll-Free: 800-772-6436 Address: One Amgen Center Dr., Thousand Oaks, CA 913201799 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $5,523,000 (12 months) 2002 Profits: $-1,392,000 (12 months) Stock Ticker: AMGN 2001 Sales: $3,763,000 2001 Profits: $1,119,700 Employees: 10,100 2000 Sales: $3,629,400 2000 Profits: $1,138,500 Fiscal Year Ends: 12/31 1999 Sales: $3,340,100 1999 Profits: $1,096,400 1998 Sales: $2,718,200 1998 Profits: $863,200
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Top Exec. Salary: $933,333 Bonus: $860,533 Stock Purch. Plan: Y Second Exec. Salary: $637,917 Bonus: $1,500,000 ADVANTAGE: A global biotechnology company with a specific market niche/One of the best-known and fastest growing biotech firms.
OTHER THOUGHTS: Apparent Women Officers or Directors: 2 Hot Spot for Advancement for Women/Minorities: Y
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest: Y
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AMKOR TECHNOLOGY INC
www.amkor.com
Industry Group Code: 334413 Ranks within this company's industry group: Sales:7 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:19
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y
GROWTH PLANS/SPECIAL FEATURES:
Semiconductors-Packaging & Testing
Amkor is one of the world's largest independent providers of semiconductor packaging and test services and technology. The firm offers one of the industry's broadest integrated sets of packaging and test services, which are the final procedures necessary to prepare semiconductor devices for further use. The company’s customer base consists of more than 300 companies, including most of the world's largest semiconductor companies. Atmel Corporation, Intel Corporation, LSI Logic Corporation, Motorola, Inc., Philips Electronics, Sony Semiconductor Corporation, Texas Instruments, Inc. and Toshiba Corporation all utilize the company’s services. With over 1,000 different package types, Amkor offers one of the semiconductor industry's broadest lines of packaging and test services. The company provides customers with a wide array of packaging alternatives, including mature leadframe packages and newer advanced leadframe and laminate packages. Amkor also offers an extensive line of services to test digital logic, analog and mixed signal semiconductor devices. The company has designed and developed state-of-the-art thin package formats and laminate packages including PowerQuad, Super BGA, fleXBGA and ChipArray BGA packages. Recently, Amkor reached an agreement to sell its wafer fabrication services, provided by Anam Semiconductor, Inc., to Anam itself. The company also recently introduced a low-cost memory and I/O card to be used in portable applications.
BRANDS/DIVISIONS/AFFILIATES: PowerQuad SuperBGA fleXBGA ChipArray BGA Metric Quad Flat Pack ePad MicroLeadFrame Think Shrink
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. James J. Kim, CEO John N. Bourch, COO John N. Bourch, Pres. Kenneth T. Joyce, Exec. VP/CFO Bruce Freyman, Exec. VP-Worldwide Product and Mfg. Oper. Eric R. Larson, Exec. VP-Corp. Dev. James J. Kim, Chmn.
Phone: 610-431-9600 Fax: 610-431-5881 Toll-Free: Address: 1345 Enterprise Dr., West Chester, PA 19380 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,639,707 (12 months) 2002 Profits: $-826,759 (12 months) Stock Ticker: AMKR 2001 Sales: $1,517,900 2001 Profits: $-450,900 Employees: 20,276 2000 Sales: $2,387,300 2000 Profits: $154,200 Fiscal Year Ends: 12/31 1999 Sales: $1,909,972 1999 Profits: $76,719 1998 Sales: $1,567,983 1998 Profits: $75,460
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $790,000 Bonus: $79,000 Stock Purch. Plan: Second Exec. Salary: $580,000 Bonus: $58,000 ADVANTAGE: One of the largest independent providers of semiconductor packaging and test services in the world.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
LOCATIONS: ("Y" = Yes) West: Y
Southwest:
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
AMYLIN PHARMACEUTICALS INC
www.amylin.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:99 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:89
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Diabetes Drugs for Metabolic Disorders
Amylin Pharmaceuticals, Inc. develops novel medicines for treating diabetes and related metabolic disorders. The company was founded after the discovery of amylin, a hormone that is missing in persons with type 1 diabetes and deficient in those with type 2 diabetes. Amylin Pharmaceuticals, Inc. is currently developing and testing four products. SYMLIN, a drug intended to treat diabetics who use insulin, is in phase III clinical studies. This drug is a synthetic version of the human hormone (amylin) that demonstrates activity in blood glucose regulation. Marketing authorization applications for SYMLIN have been accepted for filing by the EMEA and Swiss Regulatory Authorities. AC2993 is currently in phase III evaluation for the treatment of type 2 diabetes. It is an amino acid peptide that exhibits several anti-diabetic, or glucose lowering, actions. AC2993 LAR, an injectable long-acting formulation of AC2993, is currently in phase II evaluation also. AC3056, an in-licensed drug from Aventis Pharma, is being evaluated as a treatment to prevent restenosis after vascular repair procedures and for diseases resulting from atherosclerosis. AC3056 is currently in phase I studies. Recently, Amylin signed a global agreement with Eli Lilly to collaborate on the development and commercialization of its AC2993, receiving $325 million from Lilly, which greatly improved Amylin's financial condition..
BRANDS/DIVISIONS/AFFILIATES: Amylin Europe, Ltd. Pramlintide SYMLIN AC2993 LAR AC2993 AC3056
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Joseph C. Cook, Jr., CEO Mark G. Foletta, CFO/VP-Finance Cathy Jackson, Human Resources Admin. Andrew A. Young, VP/Sr. Research Fellow Nancy K. Dahl, VP/Corp. Sec. Nancy K. Dahl, General Counsel Martin R. Brown, Sr. VP-Oper. Michael Step, Sr. VP-Corp. Dev. Alain D. Baron, Sr. VP-Clinical Research Daniel M. Bradbury, Exec. VP Julia R. Brown, Exec. VP Joann L. Data, Sr. VP-Regulatory Affairs and Quality Assurance Joseph C. Cook, Jr., Chmn.
Phone: 858-552-2200 Fax: 858-552-2212 Toll-Free: Address: 9373 Towne Centre Dr., San Diego, CA 92121 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $13,400 (12 months) 2002 Profits: $-109,800 (12 months) Stock Ticker: AMLN 2001 Sales: $ 2001 Profits: $-72,000 Employees: 350 2000 Sales: $ 100 2000 Profits: $-44,000 Fiscal Year Ends: 12/31 1999 Sales: $ 100 1999 Profits: $-30,600 1998 Sales: $16,200 1998 Profits: $-51,098
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $475,000 Stock Purch. Plan: Second Exec. Salary: $300,000 ADVANTAGE: Has developed a synthetic hormone with excellent potential to treat diabetes.
OTHER THOUGHTS: Apparent Women Officers or Directors: 4 Hot Spot for Advancement for Women/Minorities: Y
Bonus: $250,000 Bonus: $
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ANALOG DEVICES INC
www.analog.com
Industry Group Code: 334413 Ranks within this company's industry group: Sales:6 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:3
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Integrated Circuits-Analog & Digital
Analog Devices, Inc. designs, manufactures and markets a broad line of high-performance analog, mixed-signal and digital signal processing (DSP) integrated circuits (ICs) that address a wide range of real-world signal-processing applications. The company’s principal products are used in a wide array of electronic equipment ranging from industrial process control, factory automation systems equipment, smart munitions, base stations, central office equipment, wireless telephones, computers, cars, CAT scanners, digital cameras and DVD players. Its products are sold primarily to original equipment manufacturers (OEMs) that incorporate them into a wide variety of equipment and systems for use in communications, computer, industrial, scientific instrumentation, military/aerospace, automotive and high-performance consumer electronics products. Analog operates manufacturing facilities in Massachusetts, California, North Carolina, Ireland, the United Kingdom, the Philippines and Taiwan. The company recently introduced the AD7655, which is an analog-to-digital converter used in complex applications.
BRANDS/DIVISIONS/AFFILIATES: SHARC 32-Bit Floating-Point DSP ADSP-21171 AD899 Complete Read Channel AD8001 AD7655 AD20msp815 Personal Soundcomm Chipset ADM663/666 Voltage Regulators AD835 Multiplier
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Jerald G. Fishman, CEO Jerald G. Fishman, Pres. Joseph E. McDonough, VP-Finance/CFO Vincent Roche, VP-Worldwide Sales Ross Brown, VP-Human Resources Samuel H. Fuller, VP-Research and Dev. Robert R. Marshall, VP-Worldwide Mfg. Russell K. Johnsen, VP-Corp. Bus. Dev. William A. Martin, Treas. Brian McAloon, Group VP-DSP and System Products Group William N. Giudice, VP/General Mgr.-Micromachined Products Robert McAdam, VP/General Mgr.-Analog Semiconductor Components
Phone: 781-329-4700 Fax: 781-461-3638 Toll-Free: 800-262-5643 Address: One Technology Way, Norwood, MA 02062-9106 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $1,707,500 (12 months) 2002 Profits: $105,300 (12 months) Stock Ticker: ADI 2001 Sales: $2,276,900 2001 Profits: $356,400 Employees: 9,000 2000 Sales: $2,577,500 2000 Profits: $607,100 Fiscal Year Ends: 10/31 1999 Sales: $1,450,400 1999 Profits: $196,800 1998 Sales: $1,230,600 1998 Profits: $82,400
SALARIES/BENEFITS: Pension Plan: Y Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $860,146 Stock Purch. Plan: Y Second Exec. Salary: $398,977 Expanding core technology through extensive research and development. ADVANTAGE:
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $317,630 Bonus: $105,585
LOCATIONS: ("Y" = Yes) West: Y
Southwest: Y
Midwest: Y
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ANALOGIC CORP
www.analogic.com
Industry Group Code: 339113 Ranks within this company's industry group: Sales:29 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Y
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:30
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Equipment-Medical Image Processing Signal Processing Equipment Portable, Multi-Functional Patient Monitors Explosive Detection Security Systems
Analogic Corporation designs, manufactures and sells advanced health and security systems and subsystems to be utilized in medical, industrial and scientific applications. Analogic’s divisions specialize in computed tomography, digital radiography systems, life care systems, medical imaging components, test and measurement, ultrasound systems and customer service. Its subsidiaries include BK Medical A/S, Camtronics Medical Systems, International Security Systems, SKY Computers, Sound Technology and Peabody Marriott Hotel. The company is a leader in precision analog-to-digital and digital-to-analog signals, such as those representing temperature, pressure, voltage, weight, velocity, ultrasound and X-ray intensity into and from the numeric form required by data processing equipment. Analogic's medical imaging data acquisition systems and related computing equipment are incorporated into computer assisted tomography scanners that generate images of the internal anatomy to diagnose medical conditions. The company also manufactures a lightweight, portable, multi-functional, custom patient monitor instrument, used in a variety of hospital settings, that acquires, calculates and displays combinations of the five most common vital sign parameters: ECG, respiration, temperature, NIBP and SpO2. Analogic also manufactures the EXACT system, an advanced computed tomography imaging system capable of providing data for full 3-D images of every object in a package, parcel or bag. The company also entered into an agreement with Sanders Design International to develop, manufacture and deploy an aircraft infrared countermeasures system for commercial airlines. Additionally, Analogic announced the formulation of a strategic marketing agreement with Lockheed Martin Corporation to market threat detection products. Employee benefits include medical and dental insurance and tuition reimbursement. The Boston Globe recently named Analogic Boston's Company of the Year.
BRANDS/DIVISIONS/AFFILIATES: Sound Technology EXACT System B-K Medical A/S Camtronics Medical Systems International Security Systems SKY Computers Sanders Design International Lockheed Martin Corporation
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Bernard M. Gordon, CEO John W. Wood, Jr., Pres. John J. Millerick, Sr. VP/CFO John W. Kirby, VP-Human Resources Thor T. Wallace, VP-Info. Tech. Thor T. Wallace, CIO Julian Soshnick, VP/General Counsel Michael Magnifico, VP-Corp. Oper. Paul M. Roberts, Dir.-Corp. Comm. John J. Millerick, Treas. Lothar Koob, Exec. VP Bernard M. Gordon, Chmn.
Phone: 978-977-3000 Fax: 978-977-6809 Toll-Free: Address: 8 Centennial Dr., Peabody, MA 01960 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $313,600 (12 months) 2002 Profits: $3,300 (12 months) Stock Ticker: ALOG 2001 Sales: $360,600 2001 Profits: $15,200 Employees: 1,860 2000 Sales: $297,619 2000 Profits: $14,108 Fiscal Year Ends: 7/31 1999 Sales: $279,694 1999 Profits: $19,513 1998 Sales: $294,472 1998 Profits: $23,888
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Y Top Exec. Salary: $366,300 Bonus: $50,000 Stock Purch. Plan: Second Exec. Salary: $215,100 Bonus: $25,000 ADVANTAGE: Expertise in several important technologies enables the firm to obtain very desirable contracts under which it supplies electronics systems to other firms.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest: Y
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International: Y
Plunkett Research, Ltd.
www.plunkettresearch.com
ANDRX CORP
www.andrx.com
Industry Group Code: 325412 Ranks within this company's industry group: Sales:29 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:83
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Controlled Release Drug Delivery Technologies
Andrx Corporation formulates and commercializes controlled-release oral pharmaceuticals using proprietary drug delivery technologies. To date, the company has developed 10 different drug delivery technologies that have been patented or for which patent applications have been filed. Andrx believes that its technologies are flexible and can be modified to apply to a variety of pharmaceutical products. Through Andrx Pharmaceuticals and Andrx Laboratories, the company is applying proprietary drug delivery technologies and formulation skills, either directly or through collaborative arrangements, to the development of generic versions of select brand-name pharmaceuticals. Andrx also markets and distributes generic drugs manufactured by third parties. Andrx currently manufactures and sells bioequivalent versions of Cardizem CD, Dilacor XR, Ventolin, Glucophage, K-Dur and Naprelan. The company also manufactures and sells a bioequivalent version of Oruvail, which was developed through Andrx's ANCIRC Pharmaceuticals joint venture with Watson and is used for the treatment of patients with rheumatoid arthritis and osteoarthritis. In its brand program, Andrx sells and markets internally developed products including Altocor, Metformin XT and Valproate. Anda, a unit of the company, purchases products directly from manufactures and wholesalers and markets them through its telemarketing staff and sales representatives. In recent news, the company signed a multi-year agreement with L. Perrigo Company, whereby Andrx will manufacture and supply Perrigo bioequivalent versions of Claritin-D 12 Hour, Claritin Reditabs and Claritin-D 24 Hour, which Perrigo will market as over-the-counter products.
BRANDS/DIVISIONS/AFFILIATES: Andrx Laboratories Andrx Pharmaceuticals Anda, Inc. Cartia XT Diltia XT Metformin IR Ketroprofen ANCIRC Pharmaceuticals
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Richard J. Lane, CEO Elliot F. Hahn, Pres. Angelo C. Malahias, Sr. VP/CFO Scott Lodin, Exec. VP/Corp. Sec. Scott Lodin, General Counsel Daniel H. Movens, Exec. VP-Oper., Anda, Inc. Lawrence J. Rosenthal, Exec. VP-Sales and Mktg., Andrx Pharmaceuticals Elliot F. Hahn, Chmn.
Phone: 954-584-0300 Fax: 954-217-4327 Toll-Free: Address: 4955 Orange Dr., Davie, FL 33314 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $771,000 (12 months) 2002 Profits: $-91,800 (12 months) Stock Ticker: ADRX 2001 Sales: $749,000 2001 Profits: $37,500 Employees: 2,100 2000 Sales: $520,000 2000 Profits: $58,500 Fiscal Year Ends: 12/31 1999 Sales: $476,000 1999 Profits: $94,100 1998 Sales: $247,100 1998 Profits: $8,400
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $348,400 Bonus: $175,000 Stock Purch. Plan: Y Second Exec. Salary: $323,600 Bonus: $150,000 ADVANTAGE: Applies proprietary drug delivery technologies and formulation skills to the development of generic versions of brand name drugs.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest:
Southeast: Y
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast:
International:
Plunkett Research, Ltd.
www.plunkettresearch.com
ANIKA THERAPEUTICS INC
www.anikatherapeutics.com
Industry Group Code: 325414 Ranks within this company's industry group: Sales:2 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Y
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:2
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
GROWTH PLANS/SPECIAL FEATURES:
Drugs-Bone, Cartilage and Soft Tissue Tissue Repair Technology
Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices intended to promote the protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Due to its unique biophysical and biochemical properties, HA plays an important role in a number of physiological functions, such as the protection and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues and the transport of molecules to and within cells. The company's currently marketed products consist of ORTHOVISC, an HA product used in the treatment of some forms of osteoarthritis in humans, and HYVISC, an HA product used in the treatment of equine osteoarthritis. ORTHOVISC is approved for sale and marketed in Canada, Europe, Turkey, Israel and Iceland. The company also manufactures AMVISC and AMVISC Plus, used as viscoelastic supplements in ophthalmic surgery, for Bausch & Lomb Surgical, a subsidiary of Bausch & Lomb. STAARVISC II, an injectable ophthalmic viscoelastic, is produced for STAAR Surgical Company, and ShellGel, also an injectable ophthalmic viscoelastic, is produced for Cytosol Ophthalmics, Inc. Anika is currently developing INCERT, an HA-based product designed for use in the prevention of post-surgical adhesions. Anika holds exclusive rights to manufacture OSSIGEL for Orquest, Inc. Recently, Anika announced a three-year supply agreement with a unit of Allergan, Inc. Allergan will market Anika's CoEase, a product used during opthalamic surgery, including cataract and intraocular lens implantation. In other news, the company signed an exclusive distribution agreement for ORTHOVISC in Canada with Rivex Pharma, Inc. and in the U.K. with Surgicraft, Ltd., a manufacturer and distributor of medical devices.
BRANDS/DIVISIONS/AFFILIATES: ORTHOVISC HYVISC INCERT AMVISC STAARVISC II ShellGel CoEase
CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. Charles H. Sherwood, CEO Charles H. Sherwood, Pres. William J. Knight, VP-Finance/CFO Bob Tellis, Sr. VP-Sales and Mktg. Scott P. Bruder, VP-Research and Dev. Frank Luppino, Exec. Dir.-Oper. Ed Gaj, Jr., Exec. Dir.-New Bus. Dev. William J. Knight, Treas. Ed Gaj, Jr., Exec. Dir.-Mktg.
Phone: 781-932-6616 Fax: 781-935-4120 Toll-Free: Address: 236 W. Cummings Park, Woburn, MA 01801 US
FINANCIALS:
Sales and profits are in thousands of dollars—add 000 to get the full amount. Yr. 2002 note: Fiscal 2002 results were not available for all companies at press time. For this company, yr. 2002 is for 12 months. 2002 Sales: $13,200 (12 months) 2002 Profits: $-3,000 (12 months) Stock Ticker: ANIK 2001 Sales: $11,300 2001 Profits: $-6,800 Employees: 60 2000 Sales: $16,335 2000 Profits: $ 174 Fiscal Year Ends: 12/31 1999 Sales: $13,500 1999 Profits: $-2,500 1998 Sales: $13,273 1998 Profits: $3,752
SALARIES/BENEFITS: Pension Plan: Savings Plan: Y
COMPETITIVE
ESOP Stock Plan: Profit Sharing: Top Exec. Salary: $205,750 Stock Purch. Plan: Second Exec. Salary: $203,696 ADVANTAGE: Focus on unique technologies based on hyaluronic acid.
OTHER THOUGHTS: Apparent Women Officers or Directors: Hot Spot for Advancement for Women/Minorities:
Bonus: $54,500 Bonus: $54,500
LOCATIONS: ("Y" = Yes) West:
Southwest:
Midwest:
Southeast:
Note: Financial information, benefits and other data can change quickly and may vary from those stated here.
Northeast: Y
International:
Plunkett Research, Ltd.
www.plunkettresearch.com
AOL TIME WARNER INC
www.aoltimewarner.com
Industry Group Code: 513210 Ranks within this company's industry group: Sales:1 Technology: Computers: Software: Communications: Electronics: Alternative Energy:
Medical/Drugs Manufacturer: Contract Research: Medical Services: Labs: Bio. Services:
Engineering: Design: Construction: Eng. Services: Consulting:
Profits:1
Transportation: Aerospace: Automotive:
TYPES OF BUSINESS:
Chemicals/Petrochem.: Oil/Gas Products: Chemicals: Oil/Chem. Svcs.: Gases: Other:
Specialty Specialty Services: Consulting: Specialty Management:: Products: Other:
Y
GROWTH PLANS/SPECIAL FEATURES:
Internet Access Service Television Production Music Production Film Production E-Commerce Entertainment Investments
AOL Time Warner, Inc., the result of the merger of America Online and Time Warner, is the world’s leading media and entertainment company. Its principal business objective is to create and distribute branded information and entertainment throughout the world. AOL Time Warner’s business classifications are entertainment, including interests in recorded music and music publishing, filmed entertainment, television production and television broadcasting; cable networks, including interests in cable television programming and sports franchises; publishing, including interests in magazine publishing, book publishing and direct marketing; and cable systems. With 12.7 million cable subscribers, AOL Time Warner is the second-largest cable television provider in the nation, and through its cable systems, it is a major provider of cable modem-based Internet access